Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.7397902284827093,1.9127275700112265,0.0,0.031009185623574378,0.03,24/49,14.04%,LDB3;JPH2;RASL12;MYOM2;NOTCH1;FILIP1;CKMT2;OBSCN;HEY2;SGPL1;RBM20;PTH1R;PRKG1;CPT1A;SLC25A4;MITF;COL21A1;ITGA7;RYR2;MYOCD;SORBS2;CKB;PDLIM5;TTN
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.797490620533481,1.9012618599019946,0.0,0.025840988019645315,0.05,7/30,6.18%,SLC35F1;LDB3;ANO5;FILIP1;CKMT2;DTNA;HIF3A
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.8809484680336584,1.8581646520179609,0.0,0.020672790415716253,0.06,2/13,4.35%,HSPA1A;GNAI1
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.8306424971694178,1.7635750838981625,0.0,0.17830281733555267,0.42,1/19,0.03%,HSPA1A
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.8500929052194856,1.7622989471537112,0.0,0.1550459281178719,0.44,4/17,9.08%,WTIP;CNOT7;CNOT6;AGO2
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.9364303339355421,1.761564168466913,0.0,0.1378186027714417,0.45,1/12,0.03%,HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.8742024648978977,1.7603062778219705,0.0,0.11960685883378688,0.46,1/15,0.03%,HSPA1A
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.8297915582132279,-1.7599893515941156,0.0,0.22466223400484853,0.17,20/41,14.04%,HERC6;DDX60;GBP2;IFITM3;WARS1;IFIT3;EPSTI1;SAMD9L;IFI44;PROCR;CMTR1;SP110;CD47;IFI44L;NCOA7;NUB1;C1S;PARP9;PLSCR1;OGFR
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.784974296647111,1.7481736623818294,0.0,0.1317890389001911,0.51,5/20,9.08%,WTIP;CNOT7;CNOT6;PUM2;AGO2
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.8866391041397308,1.7390482353044292,0.023809523809523808,0.12309707020267403,0.61,1/10,0.61%,GATAD2A
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.8866391041397308,1.7390482353044292,0.023809523809523808,0.12309707020267403,0.61,1/10,0.61%,GATAD2A
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.8866391041397308,1.7390482353044292,0.023809523809523808,0.12309707020267403,0.61,1/10,0.61%,GATAD2A
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.7044320535585208,-1.7390301203871796,0.0,0.2197782723960475,0.33,29/96,10.59%,THSD4;COL24A1;LAMA1;COL15A1;COL23A1;COL6A3;JAM2;ADAMTSL3;COL3A1;ADAMTS12;COL1A1;LAMC1;COL1A2;COL6A1;TGFBR1;CD47;THBS1;VCAN;DCN;COL11A1;LAMA4;LAMB1;FN1;JAM3;ADAM12;COL13A1;COL6A2;SMOC1;COL4A6
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.7264310855934916,-1.7234429732941408,0.0,0.2409421060341854,0.49,33/68,20.13%,RPL30;RPS4X;RPL19;RPL23A;RPL5;RPL34;SRP14;RPS18;RPLP1;SRP54;RPL15;RPS25;RPL27;RPS20;RPL35A;RPS12;RPL36;RPL37A;RPL6;RPS3;RPS21;RPL10A;RPL11;RPL37;RPL13A;RPS24;RPS29;SEC62;RPS14;RPS7;RPL7A;RPL28;RPL35
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.7354948428560895,-1.7207100429404887,0.0,0.19047450274324115,0.52,38/67,21.91%,RPL30;RPS4X;RPL19;RPL23A;RPL5;RPL34;SRP14;RPS18;RPLP1;SRP54;RPL15;RPS25;RPL27;RPS20;RPL35A;RPS12;RPL36;SSR1;RPL37A;RPL6;RPS3;RPS21;RPL10A;RPL11;RPL37;RPL13A;RPS24;RPS29;SEC62;RPS14;RPS7;RPL7A;RPL28;RPL35;UBA52;TRAM1;RPL23;RPLP2
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.70100133630683,-1.7185633515148282,0.0,0.16410111005571543,0.52,28/95,10.59%,THSD4;COL24A1;LAMA1;COL15A1;COL23A1;COL6A3;JAM2;ADAMTSL3;COL3A1;ADAMTS12;COL1A1;LAMC1;COL1A2;COL6A1;CD47;THBS1;VCAN;DCN;COL11A1;LAMA4;LAMB1;FN1;JAM3;ADAM12;COL13A1;COL6A2;SMOC1;COL4A6
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.7781553482891387,-1.7161755531577962,0.0,0.14326287385816427,0.52,18/49,11.89%,COL24A1;COL15A1;TGFB2;COL23A1;COL6A3;COL3A1;COL1A1;COL1A2;COL6A1;TGFBR1;P4HA3;COL12A1;COL11A1;COL13A1;COL6A2;COL4A6;CYP1B1;COL4A5
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.6766425798207213,-1.7118330766137528,0.0,0.1409371778539733,0.56,39/126,13.47%,THSD4;COL24A1;LAMA1;COL15A1;TGFB2;COL23A1;COL6A3;JAM2;CTSL;ADAMTSL3;COL3A1;ADAMTS12;COL1A1;LAMC1;GSN;COL1A2;COL6A1;TGFBR1;CD47;THBS1;P4HA3;VCAN;COL12A1;DCN;COL11A1;LAMA4;LAMB1;FN1;JAM3;ADAM12;COL13A1;COL6A2;SMOC1;COL4A6;CYP1B1;COL4A5;TIMP2;FLRT2;MMP24
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7353426120973097,-1.7061409861414945,0.0,0.13552993464422927,0.6,32/63,20.13%,RPL30;RPS4X;RPL19;RPL23A;RPL5;RPL34;SRP14;RPS18;RPLP1;SRP54;RPL15;RPS25;RPL27;RPS20;RPL35A;RPS12;RPL36;RPL37A;RPL6;RPS3;RPS21;RPL10A;RPL11;RPL37;RPL13A;RPS24;RPS29;RPS14;RPS7;RPL7A;RPL28;RPL35
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.8951756726252528,1.7025871691256655,0.0,0.1963915089493044,0.84,3/11,3.83%,HSPA1A;TMBIM6;BCL2L1
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.6727024357007811,1.6998665779088615,0.0,0.18685022106512766,0.85,15/58,8.63%,SLC35F1;NOL4;ADGRB3;CACNA1B;NOTCH1;LSAMP;CSRNP3;BCL2;CTNND2;OPCML;NXPH1;SOX5;NRXN1;CTNNA2;NOTCH3
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.7344942287549211,-1.6910604543588221,0.0,0.16822534430314745,0.68,32/64,20.13%,RPL30;RPS4X;RPL19;RPL23A;RPL5;RPL34;RPS18;RPLP1;RPL15;RPS25;RPL27;RPS20;RPL35A;RPS12;RPL36;EIF2B3;RPL37A;RPL6;RPS3;RPS21;RPL10A;TMA7;RPL11;RPL37;RPL13A;RPS24;RPS29;RPS14;RPS7;RPL7A;RPL28;RPL35
prerank,PanglaoDB_Augmented_2021__Basophils,0.7492101430927791,1.6876415894164127,0.0,0.21041947387425472,0.93,5/31,8.82%,CSF1R;INF2;H2AC6;SLC26A3;CD44
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.8637557743467854,1.666896192723841,0.021739130434782608,0.2728808334874545,0.98,3/9,2.09%,JPH2;CACNA1C;ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.7594348715870469,-1.6650401890191624,0.0,0.25396600365765487,0.81,10/46,9.13%,FGF1;TGFB2;VEGFA;NRP1;ENPP2;RIN2;ADAM9;THBS1;SASH1;BCAS3
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.7258482064706112,1.6630113395685295,0.0,0.27779062121118714,0.98,7/36,2.95%,SLC35F1;NOL4;CACNA1B;NOTCH1;CSRNP3;CTNND2;OPCML
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.6905881615712536,1.6604239396101863,0.0,0.27239441488943766,0.98,6/23,15.43%,CDH2;CNTN4;IGSF11;NPTN;NECTIN3;KIRREL3
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.7741313380097361,-1.6534982729449772,0.0,0.2894857244489353,0.88,10/29,12.09%,FGF1;TGFB2;NR4A1;VEGFA;NR4A3;LAMC1;BMP5;LAMB1;PRKDC;TGFBR3
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.9650255531501347,1.6534769771434872,0.0,0.29516150760217097,0.98,1/7,0.03%,HSPA1A
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),-0.8895380483377069,-1.6527671803121737,0.0,0.26780389488259115,0.88,3/17,2.90%,NRP1;LEPR;ACTG1
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.8845443342110294,1.6515879681293604,0.0,0.2877870034187868,0.98,3/12,4.73%,HSPA1A;HSPA8;PTGES3
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.6588699199700816,1.649710990879625,0.0,0.2852845077368843,0.99,12/42,11.39%,NOL4;CACNA1B;KCNC2;LSAMP;CSRNP3;OPCML;NXPH1;NRXN1;CTNNA2;TNR;GRIN1;MEIS2
prerank,PanglaoDB_Augmented_2021__Basal Cells,0.7175536539052967,1.6377266928728504,0.02631578947368421,0.32042825144360193,1.0,8/31,8.74%,HSPB1;BCL2;ACADVL;CD151;EPAS1;TINAGL1;BNIP3;ITGA3
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),0.739153917973107,1.6331626153173306,0.03225806451612903,0.3260662851933427,1.0,5/19,10.75%,WTIP;PDZD8;BCL9L;CD44;CAMSAP1
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.8561824384619366,1.632733813537158,0.0,0.31458594110872556,1.0,3/14,4.73%,HSPA1A;HSPA8;PTGES3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.8408073671761118,-1.6217886767278489,0.0,0.4568382551001602,0.98,4/14,5.33%,XPA;PARP1;DDB2;XPC
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.752902683734516,1.6194499057982015,0.0,0.3686647624136066,1.0,7/18,7.75%,CACNA1B;GRID1;EIF4EBP2;NRG3;GRID2;ABR;NLGN4Y
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.7012645771484286,1.6159815266133737,0.027777777777777776,0.3762447855660358,1.0,5/33,3.19%,SLC35F1;NOL4;CACNA1B;CSRNP3;ERBB4
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.8330678893352366,1.6139885509848415,0.021739130434782608,0.3685322445263262,1.0,4/16,3.69%,CSF1R;NOX4;NCK2;GPRC5B
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),-0.9132334170478132,-1.604684229044452,0.0,0.5595624586083494,1.0,3/10,5.73%,VEGFA;ARNT2;TGFBR1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.8534780637024837,-1.6040106681888169,0.0,0.5281190486316873,1.0,4/14,5.33%,XPA;PARP1;DDB2;XPC
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.8224921033069458,-1.5997763155335851,0.0,0.4918436631922003,1.0,6/18,8.42%,GBP2;IFITM3;IFIT3;STAT1;XAF1;HLA-B
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.8224921033069458,-1.5997763155335851,0.0,0.4918436631922003,1.0,6/18,8.42%,GBP2;IFITM3;IFIT3;STAT1;XAF1;HLA-B
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.6799011408222647,-1.5979944012968388,0.015151515151515152,0.47754291286054756,1.0,19/74,9.10%,HERC6;DDX60;MT2A;IFITM3;WARS1;IFIT3;STAT1;CMKLR1;EPSTI1;XAF1;RNF213;SAMD9L;IFI44;CMTR1;SP110;ST3GAL5;IFI44L;HLA-B;PELI1
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.8267683267587735,-1.5962572931847019,0.017241379310344827,0.46937441566688026,1.0,3/18,1.14%,RPL30;GBP2;COLEC12
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.7835847388515027,-1.5953547334294251,0.0,0.45420842961849806,1.0,11/37,6.77%,TWIST1;TGFB2;SPRY1;PHLDB2;COL1A1;EPHA3;LDLRAD4;BMP5;TGFBR1;GCNT2;OLFM1
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.6842804105042131,1.5909783869058476,0.0,0.481982280247903,1.0,9/24,10.96%,GUCY1A1;RCAN2;GUCY1B1;PPP2R1A;CAMKK2;INPP5A;RYR2;P2RX4;MCU
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.8939992203131675,1.5907912735420102,0.02702702702702703,0.4666144122404525,1.0,2/6,3.77%,SORCS1;SORT1
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.8895588445981434,-1.5890633932500473,0.0,0.4763025416583124,1.0,2/11,1.68%,VEGFA;NRP1
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.8712646991458752,1.587606313075038,0.0,0.4662070666164976,1.0,4/8,9.19%,SMARCA4;ZBTB7A;HEYL;HDAC1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),-0.941668147153591,-1.5839038270257546,0.0,0.49505610852847054,1.0,2/6,4.65%,IGFBP5;NR4A3
prerank,MSigDB_Hallmark_2020__Coagulation,-0.7447763546495966,-1.5827234461056248,0.015873015873015872,0.48287516080059123,1.0,13/35,13.51%,PRSS23;CLU;ANXA1;GSN;CPQ;ADAM9;THBS1;F3;PROS1;FN1;C1S;ARF4;CFH
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.7083593242439375,1.5822112310808512,0.024390243902439025,0.4830542027139031,1.0,8/33,13.11%,CSF1R;HEY2;MED24;MED23;CEBPB;CDKN1A;LEF1;NFKB1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.674181598566778,-1.5819379622834309,0.0,0.4700813048471015,1.0,34/76,20.13%,RPL30;RPS4X;RPL19;RPL23A;RPL5;RPL34;RPS18;RPLP1;RPL15;RPS25;RPL27;RPS20;RPL35A;SMG6;RPS12;RPL36;UPF3A;RPL37A;RPL6;RPS3;RPS21;RPL10A;PPP2R2A;RPL11;RPL37;RPL13A;RPS24;RPS29;EIF4G1;RPS14;RPS7;RPL7A;RPL28;RPL35
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.6705814157841594,1.5808572156144907,0.0,0.47380701904407735,1.0,7/44,4.94%,MYH11;MYOM2;GJC1;SORBS3;CKMT2;GNAO1;DTNA
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.7433652018715006,-1.5789142240659422,0.015873015873015872,0.47433035144675845,1.0,11/35,8.95%,FGF1;NR4A1;VEGFA;NRP1;NR4A3;LAMC1;BMP5;TGFBR1;F3;NOTCH2;LAMB1
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.8422863790706149,-1.5721617942202961,0.0,0.49891546280675386,1.0,1/13,0.43%,TWIST1
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.6568854730084658,-1.5680768653447599,0.0,0.5133586313250886,1.0,41/104,20.13%,RPL30;RPS4X;RPL19;WARS1;RPL23A;RPL5;RPL34;RRBP1;EPRS1;RPS18;RPLP1;RPL15;RPS25;RPL27;RPS20;RPL35A;FASTKD2;RPS12;RPL36;RPL37A;NARS1;RPL6;RPS3;RPS21;RPL10A;EEF2;LARS1;TMA7;RPL11;RPL37;RPL13A;RPS24;RPS29;EIF4G1;GTPBP2;GTPBP1;RPS14;RPS7;RPL7A;RPL28;RPL35
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.9144881911543283,1.5667184203108213,0.022222222222222223,0.5571963041736021,1.0,3/8,3.83%,HSPA1A;TMBIM6;BCL2L1
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.8269680057195766,-1.5667094881259194,0.017543859649122806,0.5065365897127951,1.0,4/17,5.00%,CIRBP;DDB2;UVSSA;MSH6
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.8771165674425515,-1.5666603392376832,0.0196078431372549,0.48906981075718153,1.0,3/10,4.65%,IGFBP5;NRP1;NR4A3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.8054238508112992,-1.5658379965716425,0.0,0.4796050299842635,1.0,5/18,9.08%,XPA;PARP1;DDB2;XPC;RPA1
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.8296398827924614,-1.560669810996523,0.016666666666666666,0.49910936698973357,1.0,4/16,5.33%,XPA;PARP1;DDB2;XPC
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.8783837200989837,-1.5598810511649641,0.0,0.4883961608801055,1.0,3/10,3.29%,IFITM3;STAT1;XAF1
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.8666908108492306,1.558954012683308,0.0,0.5951257846948618,1.0,1/8,0.16%,JPH2
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.9428479941458657,-1.5576383656195094,0.018867924528301886,0.4901721469196695,1.0,1/5,0.42%,RPL30
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.8437166164642823,-1.5539235723399365,0.0,0.5053463805812385,1.0,4/14,6.40%,VEGFA;NRP1;GLI2;SLIT2
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.9606701224305795,-1.5537234863497098,0.0,0.4914660796056375,1.0,1/5,0.38%,CLU
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.9704022727022439,1.550021516845325,0.0,0.6496728399762594,1.0,1/5,0.03%,HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.830075275210997,-1.5493919570926333,0.03278688524590164,0.5106453193201992,1.0,5/15,10.70%,ACTG1;ANXA1;PLPP3;THBS1;ST3GAL4
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.636597435828695,-1.5430645750275864,0.0,0.5401397541409166,1.0,34/108,13.09%,LAMA1;SAT1;COL6A3;VEGFA;NT5E;FBLN1;IGFBP2;THBS2;COL3A1;SFRP4;NTM;COL1A1;LAMC1;FBLN2;SGCD;COL1A2;THBS1;GEM;SLIT2;VCAN;SPOCK1;COL12A1;NOTCH2;DCN;COL11A1;FN1;MGP;ADAM12;COL6A2;TPM2;CALU;TGFBR3;PMP22;CCN1
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),-0.9817277678112859,-1.5390838525194903,0.0,0.5577998258472784,1.0,2/5,1.62%,NR4A2;VEGFA
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.8522532784064893,1.5387856786247358,0.06382978723404255,0.7188224553121907,1.0,1/8,0.13%,TRPC6
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.664999444017517,-1.5382166073188739,0.014705882352941176,0.549007376743175,1.0,33/78,20.13%,RPL30;RPS4X;RPL19;WARS1;RPL23A;RPL5;RPL34;RRBP1;RPS18;RPLP1;RPL15;RPS25;RPL27;RPS20;RPL35A;RPS12;RPL36;RPL37A;RPL6;RPS3;RPS21;RPL10A;RPL11;RPL37;RPL13A;RPS24;RPS29;EIF4G1;RPS14;RPS7;RPL7A;RPL28;RPL35
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.9293115538029669,1.5370410229276137,0.0196078431372549,0.7137855135204251,1.0,1/5,0.03%,HSPA1A
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.885130442882785,1.5350349260959346,0.0,0.7143287174727899,1.0,4/8,8.69%,DGKB;DGKH;DGKG;DGKE
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.7150091013101206,-1.5345319454545754,0.014925373134328358,0.5638533677360817,1.0,7/33,6.61%,NR4A1;VEGFA;NRP1;STAT1;TGFBR1;THBS1;F3
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.8417678966295661,1.5344864032260999,0.0,0.6982506973308371,1.0,1/10,1.62%,ABL2
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.5624064949886632,1.5291007422743836,0.0,0.725402914971992,1.0,13/55,9.45%,SLC35F1;ADGRB3;CACNA1B;LSAMP;GJC1;CSRNP3;OPCML;FMN2;CNTN1;GRID2;NRXN1;CTNNA2;GABRB3
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.8026878841884831,-1.527930444168895,0.0,0.6101378380555853,1.0,4/16,4.17%,CLU;ABCA8;LIMA1;AKR1C1
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.598475532542519,1.5266812953491764,0.027777777777777776,0.7279406325134086,1.0,6/69,6.51%,HSPA1A;HSPB1;CNOT7;HSPA8;RC3H2;PUM2
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.8490001203882078,1.5266003601676787,0.02631578947368421,0.7111944117406774,1.0,3/11,3.83%,HSPA1A;BCL2;BCL2L1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.9112712843925582,1.5253242010669252,0.05405405405405406,0.7075508624426693,1.0,1/5,0.59%,EPN2
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),-0.9077188522175135,-1.5204715387132415,0.0,0.6553811339810177,1.0,2/8,3.55%,PGR;CALCOCO1
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),-0.8906559334954063,-1.5196222342260552,0.0,0.6458187373870418,1.0,5/8,9.69%,XPA;DDB2;XPC;POLA1;INO80
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.6042007391516983,-1.5191992091411008,0.0,0.6349150091441371,1.0,48/132,18.66%,RPL30;RPS4X;NR4A2;RPL19;WARS1;RPL23A;EXT1;RPL5;RPL34;RRBP1;RPS18;RPLP1;RPL15;POLA1;RPS25;RPL27;RPS20;RPL35A;RPS12;BRCA1;RPL36;RPA1;RAD17;RPL37A;RPL6;ST3GAL4;ORC3;RPS3;THRB;ORC5;RPS21;RPL10A;APOE;WRN;EEF2;RPL11;RPL37;RPL13A;PTMA;TOPBP1;RPS24;RPS29;EIF4G1;GTPBP2;GTPBP1;RPS14;RPS7;MRE11
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.5961227885700494,1.5191891933164567,0.027777777777777776,0.749508843211666,1.0,3/44,4.73%,HSPA1A;HSPA8;PTGES3
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),-0.6895961239855856,-1.5190897266513437,0.016129032258064516,0.6221081764810589,1.0,10/44,9.13%,FGF1;VEGFA;NRP1;RIN2;THBS1;SLIT2;DCN;SASH1;BMPER;BCAS3
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.8729752013370727,1.5189225122726178,0.025,0.7367030766327973,1.0,1/5,0.13%,TRPC6
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.6842430745568883,1.5175425214275478,0.02702702702702703,0.733884059757927,1.0,6/38,3.82%,SLC35F1;ADGRB3;CACNA1B;DPP10;OPCML;NXPH1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.7016438703425913,-1.5172435833012128,0.03389830508474576,0.6238730089851087,1.0,12/47,11.29%,CLU;VEGFA;XPA;PARP1;WARS1;DDB2;RACK1;SLF1;RPA1;LGALS3;PSMC2;RPS3
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),-0.7327612176133202,-1.5168664252098543,0.03773584905660377,0.6130930530197068,1.0,8/24,8.53%,NR4A1;VEGFA;NRP1;RNF213;THBS1;SLIT2;OTULIN;BMPER
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.8972292019481667,1.5164953160662533,0.0425531914893617,0.7271429324484543,1.0,2/6,2.57%,VAPB;ATL2
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.8012751652501959,-1.5162201242089313,0.0,0.6052042426905974,1.0,9/29,8.61%,TGFB2;COLEC12;COL3A1;COL1A1;ERAP1;COL1A2;N4BP1;HLA-B;BIRC2
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.8939195693118283,-1.51515981069705,0.018867924528301886,0.6018236774273626,1.0,3/11,5.04%,PRAG1;COL3A1;ARHGEF3
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.9548415246597867,1.5133940139176039,0.0,0.7378426791992343,1.0,2/5,3.19%,CSF1R;ERBB4
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.9331930276286557,-1.5126499369639923,0.041666666666666664,0.6077601825992033,1.0,2/5,3.19%,VEGFA;ANXA1
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.7126436957573483,-1.5120202149418163,0.05660377358490566,0.6015891534605535,1.0,8/33,10.41%,NRP1;FBLN1;COL3A1;PLPP3;ADAM9;CD47;FN1;ITGBL1
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),-0.8428653293438693,-1.5116712569069208,0.05555555555555555,0.5926499567602819,1.0,6/12,13.97%,CMKLR1;CD47;THBS1;HLA-B;MAPK14;IL16
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.9139368151550608,1.5112609026616277,0.022727272727272728,0.7375448663940435,1.0,3/6,7.19%,DLC1;BCL2L1;FZD3
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.6267294468799955,1.509117337485964,0.07317073170731707,0.740845305510158,1.0,10/45,5.45%,SLC35F1;CSPG4;ADGRB3;EPN2;CTNND2;OPCML;GPRC5B;NXPH1;GFAP;CORO2B
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),-0.8747401876211037,-1.5075214721209882,0.019230769230769232,0.615194862270865,1.0,4/9,6.40%,NR4A1;VEGFA;NRP1;SLIT2
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),-0.8609153900574066,-1.505688420751468,0.01639344262295082,0.6215293365866823,1.0,3/10,3.05%,GLCE;SULF2;EXT1
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.6379028997261805,-1.5054482205319812,0.027777777777777776,0.6121823878377176,1.0,37/78,24.13%,RPL30;RPL19;RPL23A;RPL5;RPL34;RPLP1;RPL15;RPS25;RPL27;RPL35A;RPL36;RPL37A;RPL6;PRKDC;RPL10A;DDX52;RPL11;RPL37;RPL13A;WDR12;RPS24;EXOSC10;RPS14;RPS7;RPL7A;RPL28;RPL35;UBA52;RPL23;RPLP2;MPHOSPH10;WDR43;RPL8;LAS1L;RPL24;RPS28;RPL31
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.8720078895946584,-1.5053534932090702,0.017857142857142856,0.602471549885673,1.0,3/11,1.68%,NR4A1;VEGFA;NRP1
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.885978068943575,1.505059150049074,0.02127659574468085,0.7599317756817294,1.0,5/8,10.64%,GUCY1A1;ADCY9;GUCY1B1;ADCY3;ADCY5
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.8331002196001369,-1.5045932606689258,0.02040816326530612,0.5948151138297706,1.0,2/7,13.68%,TERF2IP;TNKS2
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.7814156597718459,-1.5036370831675205,0.0,0.5955064913351907,1.0,9/23,10.60%,VEGFA;ARNT2;KIAA1217;SULF2;COL1A1;BMP5;TGFBR1;BRCA1;PTCH1
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.8508221974045005,-1.503383218655316,0.0,0.5880620893037745,1.0,2/11,4.65%,PARP1;NR4A3
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.8477709778720013,1.5030979225054968,0.018867924528301886,0.7616504547280556,1.0,3/7,13.81%,USP7;MAP2K2;MAP2K1
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.6387009572770148,-1.502870479521592,0.02857142857142857,0.5816798276082056,1.0,37/81,24.13%,RPL30;RPL19;RPL23A;RPL5;RPL34;RPLP1;RPL15;RPS25;RPL27;RPL35A;RPL36;RPL37A;RPL6;RPL10A;DDX52;RPL11;RPL37;RPL13A;WDR12;RPS24;EXOSC10;RPS14;RPS7;RPL7A;RPL28;RPL35;UBA52;EIF2A;RPL23;RPLP2;MPHOSPH10;WDR43;RPL8;LAS1L;RPL24;RPS28;RPL31
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),-0.8685859507773415,-1.5028337520874933,0.06896551724137931,0.5723042226181958,1.0,1/8,0.43%,TWIST1
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.9011863230006971,1.5019251078582792,0.0,0.7583336099611299,1.0,4/8,5.18%,DNAH11;NOTCH1;RFX3;BBS7
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.8698925140610834,-1.5014253542501768,0.01639344262295082,0.5737867154597884,1.0,2/9,3.19%,ACTG1;ANXA1
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.575176961307139,1.5006958940230355,0.06060606060606061,0.7547518764983199,1.0,11/59,13.62%,HSPA1A;HSPA8;PTGES3;CORO2B;SMG1;AMFR;DNAJB6;CEBPB;MCL1;NUP54;EP300
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.6907320979891992,-1.4996367155799364,0.05357142857142857,0.5778579338413184,1.0,4/28,6.40%,CLU;TWIST1;COL3A1;SLIT2
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.7766261948958312,-1.49811678250435,0.015873015873015872,0.583633412251726,1.0,7/16,9.90%,CDKL1;PGR;NKD1;DKK3;ST6GAL1;BRCA1;IL1R1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.8626275702971253,-1.4950298743586836,0.05263157894736842,0.590219360481776,1.0,1/7,2.12%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.8626275702971253,-1.4950298743586836,0.05263157894736842,0.590219360481776,1.0,1/7,2.12%,TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.8286609268260132,-1.4949391343344152,0.0,0.5824306455868721,1.0,2/13,4.65%,PARP1;NR4A3
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.8144488689985347,1.4947996269182284,0.025,0.7859488652493605,1.0,3/11,2.01%,NOTCH1;BCL2;PDK4
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.8063602791457585,1.494739810084416,0.02631578947368421,0.7720347547978397,1.0,4/10,15.26%,CNOT7;CNOT6;DCP1A;DIS3
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.7011014128695602,1.4944178063083924,0.06666666666666667,0.7608325186927,1.0,3/23,8.49%,DENND3;OGA;STT3B
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.5691436185510845,1.4934580222185494,0.027777777777777776,0.7543755099068388,1.0,21/61,17.65%,WTIP;FMNL3;PDZD8;PACSIN2;MICAL2;ARHGAP10;SYNE3;RHOA;RHOB;BRWD1;KLHL20;PPP2R3C;CAMSAP1;RANBP10;BIN1;CECR2;RANBP9;SEMA6A;LRCH3;BRWD3;ZMYM4
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.9555366818198017,-1.4921160632974835,0.022222222222222223,0.5935449813989988,1.0,2/5,1.91%,JAM2;SLC8B1
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.8799860581711103,1.4920209668571798,0.02,0.7547350638841236,1.0,2/6,2.23%,NOTCH1;HEY2
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.6775499848795088,1.4919734856567513,0.07692307692307693,0.741942944157274,1.0,6/26,4.06%,NOL4;CACNA1B;CSRNP3;CTNND2;NXPH1;LONRF2
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.8385295873543441,1.491938855860397,0.0,0.7295772284213194,1.0,6/10,11.36%,NCK2;ZFYVE28;CBLB;CBL;FBXW7;ADAM17
prerank,GO_Biological_Process_2021__lung development (GO:0030324),-0.8354253841722747,-1.4904078522120259,0.0,0.597258957319758,1.0,3/10,5.09%,FGF1;VEGFA;GLI2
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),-0.88332309607249,-1.4895019787689703,0.037037037037037035,0.5948665239519684,1.0,2/6,3.99%,ANXA1;EYS
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.6454466639778947,-1.488726932175345,0.02857142857142857,0.5928166358401055,1.0,36/73,24.13%,RPL30;RPL19;RPL23A;RPL5;RPL34;RPLP1;RPL15;RPS25;RPL27;RPL35A;RPL36;RPL37A;RPL6;RPL10A;DDX52;RPL11;RPL37;RPL13A;WDR12;RPS24;EXOSC10;RPS14;RPS7;RPL7A;RPL28;RPL35;UBA52;RPL23;RPLP2;MPHOSPH10;WDR43;RPL8;LAS1L;RPL24;RPS28;RPL31
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),0.873350341807677,1.488621992075005,0.021739130434782608,0.7292160103092169,1.0,3/6,10.64%,GNAI1;ADCY3;ADCY5
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),0.873350341807677,1.488621992075005,0.021739130434782608,0.7292160103092169,1.0,3/6,10.64%,GNAI1;ADCY3;ADCY5
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.8142743659248575,1.4880524608000236,0.030303030303030304,0.7209225483068034,1.0,4/11,6.19%,TNFRSF10B;BCL2;SORT1;CASP8AP2
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.7057579699233312,1.4880092878987838,0.05405405405405406,0.709981145839755,1.0,3/14,9.50%,ABL2;ARHGAP6;EGFR
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.7897652110095661,-1.4854005937836956,0.015625,0.6090028794974427,1.0,10/18,15.70%,CYP3A5;AKR1C2;LSS;AKR1C1;HSD11B1;CYP4V2;CYP1B1;CYP27A1;NPC1;LIPA
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.9353432351956703,-1.4835958603452555,0.02564102564102564,0.6145763197047464,1.0,1/5,2.98%,STAT1
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.5732156473679091,-1.482775546827022,0.0,0.6119471896865322,1.0,40/181,13.09%,PRSS23;RPL30;IGFBP5;AFG3L2;RPS4X;RPL19;WARS1;RPL23A;RPL5;RPL34;IGFBP2;RRBP1;GPC3;LAMC1;RPS18;RPLP1;RPL15;RPS25;VCAN;RPL27;APH1B;RPS20;UBL5;RPL35A;RPS12;RPL36;FBXW2;LAMB1;FBXO22;FN1;RPL37A;RPL6;PRKDC;RPS3;CALU;RPS21;RPL10A;APOE;CHRM3;CCN1
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.8204714979553603,1.4818166799380537,0.023809523809523808,0.748195991584192,1.0,1/9,1.32%,CNOT7
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),0.841821749117635,1.4811003345576501,0.02,0.7440638429171811,1.0,2/8,3.87%,INTS7;INTS2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.8036337792632248,1.4807953547680242,0.12903225806451613,0.7355810798666798,1.0,2/9,4.65%,HSPB1;UBQLN1
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.7421414172917699,-1.4805972192703103,0.06557377049180328,0.6204584827820859,1.0,7/33,8.10%,ABCA4;ABCA8;ABCA9;ALDH1A1;SLCO1A2;PEX1;ABCA6
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.802642472763234,-1.4804670343904318,0.05660377358490566,0.6131942325155219,1.0,3/14,6.26%,MEGF10;ANXA1;THBS1
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.8079067526492663,1.4796811875660394,0.025,0.7335800481341666,1.0,4/9,15.26%,CNOT7;CNOT6;DCP1A;DIS3
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.9374431656086613,-1.47958915434685,0.01694915254237288,0.6122077590668543,1.0,1/6,2.57%,SUPT6H
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),-0.9181271827999573,-1.4795251700384928,0.057692307692307696,0.6053607799216487,1.0,1/5,1.65%,SPRY1
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.680023564443796,1.4794654992396548,0.09375,0.7244464815246652,1.0,6/19,9.50%,WTIP;EIF4ENIF1;PUM2;MAP2K2;AGO2;EGFR
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.787454936737444,1.479439431565064,0.1,0.7143925716516801,1.0,2/11,3.19%,NOTCH1;ERBB4
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.6527034749381762,-1.479150525811761,0.046153846153846156,0.6006654555836841,1.0,8/42,9.08%,XPA;PARP1;DDB2;UVSSA;XPC;POLA1;HMGN1;RPA1
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.8554886759044754,1.4791500149563732,0.021739130434782608,0.706660032942864,1.0,3/7,10.64%,ADCY9;ADCY3;ADCY5
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.7741711070157861,1.479085284399452,0.02564102564102564,0.6972759933967627,1.0,1/15,0.03%,HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.9326305161470408,1.4769139705429837,0.0,0.7042908186833742,1.0,1/5,0.03%,HSPA1A
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.9000246439441846,-1.4761854803007468,0.06521739130434782,0.6152570636687129,1.0,2/6,8.39%,CD55;SASH1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.7276218905520955,-1.4758628840069348,0.045454545454545456,0.6098319470544922,1.0,7/26,6.00%,TGFB2;VEGFA;MEGF10;AFDN;FBLN2;ADAM9;CD47
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.7894967743289407,1.4740141127359054,0.10869565217391304,0.7160048896686588,1.0,2/10,5.52%,HSPA1A;CD58
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.549619078684716,1.4734730046433784,0.0,0.7110061716978676,1.0,6/60,2.95%,ADGRB3;CACNA1B;LSAMP;CSRNP3;DGKH;OPCML
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.7774566448155351,1.4725843557360352,0.023809523809523808,0.7096751341395224,1.0,3/13,2.01%,NOTCH1;BCL2;PDK4
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.8856003648262629,-1.4718112656896682,0.07272727272727272,0.6333664359511025,1.0,1/6,0.98%,MT2A
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.9493935526319217,-1.4710202223935074,0.0,0.6325612927061607,1.0,1/6,0.43%,TWIST1
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.8857054414896648,1.4693785374361052,0.024390243902439025,0.7227422311572488,1.0,4/7,9.72%,RNF185;UBQLN1;TMEM259;ATXN3
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),-0.937440265677953,-1.46915590122514,0.0,0.6393338315521,1.0,2/5,3.19%,MEGF10;ANXA1
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),-0.8910260493901648,-1.4688798829581906,0.015625,0.6346851756566642,1.0,2/6,5.73%,TWIST1;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.769124631664952,1.4667206765387957,0.046511627906976744,0.7360043459544108,1.0,6/16,11.36%,CSF1R;NOX4;GPRC5B;DOCK3;FBXW7;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.8001074032989965,1.464128466506197,0.125,0.7474914661075124,1.0,2/8,6.51%,WTIP;PUM2
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.6817662779328825,-1.4640996091794412,0.04411764705882353,0.6671718718627302,1.0,4/28,8.61%,COLEC12;CTSL;PIK3R4;BIRC2
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),0.9251696015066176,1.4634122188666436,0.02127659574468085,0.743057610504901,1.0,2/6,2.05%,NOTCH1;TNFRSF1B
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.7696595579568163,-1.4630182516508905,0.0,0.6700570777316022,1.0,4/17,9.08%,XPA;PARP1;DDB2;RPA1
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),-0.8639270868302017,-1.4614637172471767,0.05172413793103448,0.6757626880541097,1.0,1/9,1.03%,AFG3L2
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.8295089666949198,1.4603437161417325,0.024390243902439025,0.7568538268865007,1.0,3/11,6.06%,PTPRK;DLC1;ARHGEF7
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.6727155631827146,-1.4594418691290731,0.08196721311475409,0.6844131369097388,1.0,8/36,13.60%,CLU;VEGFA;WARS1;RACK1;SLF1;LGALS3;RPS3;SPIDR
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),0.7921033065472534,1.4591097690406876,0.045454545454545456,0.7593468869772848,1.0,1/10,0.16%,JPH2
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.8316928203898819,1.4585535049049927,0.0,0.7550549897017327,1.0,3/9,12.59%,RAB27A;KIF5B;DNM2
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),-0.8469381150165236,-1.4583837015082601,0.029850746268656716,0.6851655474746902,1.0,4/13,9.13%,RIPOR2;RACK1;GSN;BCAS3
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),-0.8907990201374918,-1.457973572054267,0.043478260869565216,0.6813931492894307,1.0,3/7,10.14%,CD55;CD47;LGALS3
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.7653408948286831,1.4578555944771812,0.16666666666666666,0.7506191758087448,1.0,3/9,8.39%,SOX6;SOX5;ZBTB16
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.7557837877287599,-1.4569474254553259,0.09259259259259259,0.6820558559769125,1.0,8/13,15.35%,GBP2;IFITM3;STAT1;EPRS1;CD47;NUB1;SP100;RPL13A
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.9359628394918225,-1.455599333957213,0.0,0.6842797823943844,1.0,2/6,0.88%,CD55;TGFB2
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.8000941124284682,-1.4554433709849015,0.0,0.6781432650858656,1.0,6/11,17.55%,POLA1;RPA1;ORC3;ORC5;TOPBP1;PURA
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.8207877627335717,-1.4549877414975096,0.03773584905660377,0.6749120842141078,1.0,2/8,9.90%,ZFPM1;IL1R1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.9525840141791225,1.4535322102125003,0.0,0.7710950825062163,1.0,1/6,0.21%,CSF1R
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.8069299243257817,-1.4529307313959734,0.031746031746031744,0.687010599638015,1.0,2/10,7.23%,VAMP4;MYO18A
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.8884188829194241,1.4515574422321262,0.0851063829787234,0.7783545972801073,1.0,4/5,7.48%,BCL2;BCL2L1;BNIP3;SLC25A4
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.8792625060826659,1.451388897248734,0.023809523809523808,0.7705960841168714,1.0,1/6,0.50%,ADGRB3
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.8983354252598308,-1.4512498085561545,0.017857142857142856,0.692716946534896,1.0,3/7,3.19%,TGFB2;VEGFA;ANXA1
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.749612530639892,-1.4498157841710722,0.07352941176470588,0.6968117470842484,1.0,5/21,4.43%,ABCA4;CYP3A5;ALDH1A1;AKR1C1;GPC3
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.7740880242273107,1.4479728634954012,0.02564102564102564,0.788385052672088,1.0,3/9,9.10%,NOTCH1;HEY2;HEYL
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.9340738322451101,-1.4478877949593665,0.0,0.7047704600336553,1.0,1/8,1.22%,RIMS1
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.6374052556752037,-1.44651156406341,0.028985507246376812,0.708272112508329,1.0,16/64,10.44%,ABCA8;COL15A1;COL6A3;PAMR1;THBS2;COL3A1;CPED1;ADAMTS12;COL1A1;FBLN2;SGCD;COL1A2;DCN;LAMA4;GALNT15;COL6A2
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.7225743284943519,1.4463193484502257,0.022727272727272728,0.7921859743011268,1.0,5/18,11.36%,BCL2;ZBTB7A;HDAC9;MSH2;ADAM17
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.6550662739102949,1.4462272936966123,0.05,0.783498756755646,1.0,3/25,3.19%,CSF1R;ABL2;ERBB4
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.9083075476872189,-1.4443720360201204,0.017241379310344827,0.7184742731046146,1.0,2/7,1.68%,VEGFA;NRP1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),-0.717865538962349,-1.444176714432353,0.015384615384615385,0.7125795751193852,1.0,1/27,0.06%,PRAG1
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.9037213547592652,1.4439359303583956,0.06976744186046512,0.7918133076261429,1.0,1/6,4.54%,SOX13
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.9038487200529027,1.4433569410930327,0.06521739130434782,0.7877007261118839,1.0,3/5,8.87%,PTH1R;IRS2;IRS1
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.762696709708733,1.4429400926148421,0.02564102564102564,0.7818982826589453,1.0,5/18,8.50%,HSPB1;TRAK1;AP3M1;AP3D1;KIF5B
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),-0.8639286881450485,-1.441633936927148,0.05084745762711865,0.726145515312421,1.0,1/8,1.03%,AFG3L2
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.8377450376889386,1.4409159026702607,0.04081632653061224,0.7897445785408198,1.0,4/8,11.02%,ZBTB7A;NOTCH3;EGFR;FBXW7
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.7936345200235208,-1.4399475721127704,0.05454545454545454,0.7336273870450969,1.0,2/12,3.19%,ACTG1;ANXA1
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.8476610427412866,1.4395091780497724,0.0625,0.7914414604416843,1.0,3/7,12.67%,HDAC9;HDAC1;HDAC2
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.5790542381592948,-1.437614306055578,0.014925373134328358,0.7470135565461423,1.0,32/156,11.89%,COL24A1;SHROOM3;COL15A1;TGFB2;COL23A1;COL6A3;ELMO1;TUBGCP5;COL3A1;COL1A1;GSN;COL1A2;COL6A1;TGFBR1;P4HA3;HSP90AB1;APH1B;COL12A1;SHROOM4;COL11A1;MARCKS;CEP126;MTM1;COL13A1;COL6A2;NCKAP5;COL4A6;FGF13;HDGFL3;TPM2;CYP1B1;COL4A5
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.8685214239918755,-1.4364724692522697,0.03773584905660377,0.7495498816224109,1.0,1/9,0.43%,TWIST1
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),0.6870404507612285,1.4360840215034694,0.11428571428571428,0.8125914024344301,1.0,2/15,4.09%,TRPC6;TCAF1
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),-0.9522694731921773,-1.4358478654471682,0.017543859649122806,0.7484785276740159,1.0,2/5,1.68%,VEGFA;NRP1
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.9439938876793188,-1.435429078238873,0.0,0.7386879915843504,1.0,1/5,1.25%,JAM2
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.9439938876793188,-1.435429078238873,0.0,0.7386879915843504,1.0,1/5,1.25%,JAM2
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,-0.5967413341705693,-1.4339152039948115,0.027777777777777776,0.7431613582555641,1.0,16/70,9.02%,ABCA8;COL15A1;IGFBP5;COL6A3;PAMR1;THBS2;COL3A1;SFRP4;COL1A1;SGCD;COL1A2;SLIT2;COL12A1;DCN;LAMA4;SEMA3D
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.8576171788718692,1.433676814466236,0.02127659574468085,0.8221163817384066,1.0,1/7,0.21%,CSF1R
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.770488977796397,-1.43338230414062,0.015873015873015872,0.7416581700716268,1.0,4/16,9.08%,XPA;PARP1;DDB2;RPA1
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.8373993697363696,-1.4333102797098292,0.04081632653061224,0.722654951028563,1.0,6/10,13.51%,CLU;CD55;C7;PROS1;C1S;CFH
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.8373993697363696,-1.4333102797098292,0.04081632653061224,0.722654951028563,1.0,6/10,13.51%,CLU;CD55;C7;PROS1;C1S;CFH
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.8373993697363696,-1.4333102797098292,0.04081632653061224,0.722654951028563,1.0,6/10,13.51%,CLU;CD55;C7;PROS1;C1S;CFH
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.8745084829452714,-1.4330529611776182,0.07142857142857142,0.7185793949644682,1.0,3/11,2.01%,AK5;NME3;TXNRD1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.7935247825229491,1.4327651761545002,0.06666666666666667,0.8206886848198377,1.0,1/9,1.28%,MFHAS1
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.8991976204334702,1.4325748065399775,0.07407407407407407,0.8143826527403372,1.0,3/6,5.18%,DNAH11;NOTCH1;BBS7
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.5845197569011565,1.4322976149537783,0.03125,0.8084094692065841,1.0,8/42,3.93%,ADGRB3;KCNC2;LSAMP;GABRB1;CSRNP3;OPCML;NXPH1;GFAP
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.8735146709657275,1.4319070896438757,0.021739130434782608,0.8038849936408474,1.0,3/6,10.64%,ADCY9;ADCY3;ADCY5
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.5470691111190891,1.431296100859377,0.0,0.7994492332822819,1.0,9/48,7.75%,CACNA1B;GRID1;CDH2;SLC12A2;EIF4EBP2;NRG3;GRID2;ABR;NLGN4Y
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.5831797127036412,1.4311342527601902,0.030303030303030304,0.793293243865228,1.0,4/43,2.09%,TRPC6;CACNA1B;CACNA1C;ATP2B4
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),-0.9004940895970324,-1.4304263247342939,0.029850746268656716,0.7331836849625997,1.0,2/6,5.73%,TWIST1;TGFBR1
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.9355637104555399,1.4296599301265815,0.017543859649122806,0.7951073236813943,1.0,2/5,6.35%,ERBB4;BNIP3
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.9326131654809566,-1.427867072509451,0.0,0.7478722750707666,1.0,1/5,0.63%,COL15A1
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.8964740905795997,-1.427234406292676,0.0,0.7476600211981547,1.0,1/6,2.98%,STAT1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.8963487281754553,-1.4270966709727486,0.03508771929824561,0.7421979977609939,1.0,1/6,0.56%,CD55
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.8342346602816504,-1.4267262704838302,0.045454545454545456,0.7385363946108661,1.0,3/12,9.13%,RIPOR2;RACK1;BCAS3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.8198304395717795,-1.4267117378012637,0.06779661016949153,0.726429240600852,1.0,4/10,9.08%,XPA;PARP1;DDB2;RPA1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.8198304395717795,-1.4267117378012637,0.06779661016949153,0.726429240600852,1.0,4/10,9.08%,XPA;PARP1;DDB2;RPA1
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.7161432307759898,1.423851576163401,0.0975609756097561,0.8280929189381195,1.0,1/21,0.03%,HSPA1A
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.5902563879613402,-1.4233505613373043,0.0,0.7495888394385879,1.0,18/100,9.11%,COL15A1;FGF1;IGFBP5;COL6A3;NR4A2;PAMR1;AKAP12;DKK3;THBS2;COL3A1;COL1A1;COL1A2;COL6A1;PLPP3;COL12A1;DCN;LAMA4;FN1
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.7128707731599628,-1.4223916589256385,0.07142857142857142,0.7516574463093495,1.0,5/19,9.90%,GBP2;ANXA1;ADAMTS12;CD47;IL1R1
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.829465812178267,1.4219736992417005,0.0625,0.8340300774793449,1.0,4/7,9.10%,NOTCH1;CDH2;HEY2;HEYL
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),-0.9116354373083491,-1.419659635824188,0.017857142857142856,0.7665084707316727,1.0,1/5,0.88%,TGFB2
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.590552559994541,-1.4184265736199533,0.028169014084507043,0.7729838285929415,1.0,26/78,10.44%,COL15A1;IGFBP5;COL6A3;VEGFA;PAMR1;STAT1;DKK3;THBS2;COL3A1;GLI3;ADAMTS12;COL1A1;SGCD;COL1A2;COL6A1;PLPP3;COL12A1;PDZRN3;DCN;CREB3L2;COL11A1;LAMA4;FN1;MGP;BOC;COL6A2
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.6181168415215713,1.418411199677558,0.027777777777777776,0.8569547840084994,1.0,6/31,3.21%,CSF1R;GJC1;CDH2;GJA4;CTNND2;CDH10
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.6350277562987255,1.4178469004202916,0.06896551724137931,0.8537096782786526,1.0,7/25,13.81%,HSPA1A;RBM20;MAP2K2;EGFR;GRSF1;NFKB1;MAP2K1
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),0.8358634580346167,1.4177347758913796,0.022222222222222223,0.8469206018475314,1.0,2/6,2.04%,MYOM2;OBSCN
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.6735121215276588,-1.417405678030142,0.05660377358490566,0.7748962710026871,1.0,4/38,1.65%,PDGFD;FGF1;VEGFA;SPRY1
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.7058621178258943,1.4172197530936903,0.1,0.8429800128154114,1.0,6/19,12.83%,GNB1;GNAO1;MAP3K7;FZD3;AGO2;LEF1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.8455278097598098,1.4171441314759305,0.075,0.8362236843834773,1.0,3/7,11.07%,BCL2;BCL2L1;MCL1
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.7425870788047501,-1.4167773233301695,0.109375,0.7741842268951048,1.0,5/18,6.02%,ABCA4;ALDH1A1;AKR1C1;GPC3;ALDH3A2
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.7638840117296549,-1.4164675573946037,0.038461538461538464,0.7713630528504859,1.0,2/12,0.91%,SHROOM3;MLPH
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.5565664592481657,1.415995186962938,0.02631578947368421,0.838078615022854,1.0,8/45,5.00%,CSF1R;PDK4;CHL1;NDRG2;OPCML;GFAP;EPOR;TNS1
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),-0.8714386201086398,-1.415614693194768,0.05263157894736842,0.7725675886414223,1.0,2/6,1.68%,VEGFA;NRP1
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.7005590913157962,-1.4150771945654164,0.0847457627118644,0.7700255196044045,1.0,5/16,9.11%,COL6A1;COL12A1;COL11A1;LAMB1;FN1
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),-0.829305545783019,-1.4147373235744085,0.08333333333333333,0.7671519696733415,1.0,2/12,1.68%,VEGFA;NRP1
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.8704519936442855,-1.4143625188700983,0.03508771929824561,0.7648357322414164,1.0,4/9,8.53%,FGF1;VEGFA;PKM;BMPER
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.7640801056674916,-1.4141413037048611,0.0625,0.7609503766309583,1.0,2/19,0.88%,CLU;TGFB2
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.8290162083451262,-1.413792161635741,0.1111111111111111,0.758497326593503,1.0,1/7,0.98%,MT2A
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),-0.8549096407625404,-1.412727465414034,0.019230769230769232,0.7609643124301055,1.0,2/8,0.50%,SLC47A1;ABCA8
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.6671970096374727,-1.4116033063717293,0.047619047619047616,0.7647499593576659,1.0,6/40,6.53%,ELMO1;MYO10;ACTG1;VAV3;NR4A3;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.8187919831926178,1.4115419475577886,0.058823529411764705,0.8627688460222819,1.0,3/8,3.98%,NOTCH1;ERBB4;MGAT5
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.8217848098391753,1.4114423896558161,0.06521739130434782,0.8558353891839725,1.0,4/8,14.45%,NOTCH1;ATP2B4;P2RX4;GLRX3
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.7586489674709689,1.4113425775052497,0.11627906976744186,0.8492921592960995,1.0,4/10,18.33%,VAPA;RYR2;UBAC2;ANK2
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.68555803386297,-1.41125655269497,0.05,0.7616148827637587,1.0,11/26,18.66%,XPA;PARP1;DDB2;ANXA1;XPC;RPA1;WRN;ASCC3;GTF2H1;PURA;MRE11
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,0.7916026635312473,1.4109646511629053,0.08,0.8448220945319215,1.0,1/6,0.21%,CSF1R
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.8352133451827001,1.4104802390802398,0.057692307692307696,0.8411352031967283,1.0,3/7,12.59%,RAB27A;KIF5B;DNM2
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.5827148560982405,-1.4097043416928925,0.0,0.7682225655742898,1.0,33/123,11.69%,CD55;COL15A1;COL6A3;NR4A2;NR4A1;VEGFA;PAMR1;NT5E;P4HTM;DKK3;THBS2;COL3A1;COL1A1;LAMC1;GSN;FBLN2;SGCD;COL1A2;COL6A1;FMO2;COL12A1;DCN;LAMA4;LAMB1;FN1;MGP;IL1R1;COL13A1;ITGBL1;COL6A2;PTCH1;NGF;CYP1B1
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.6291148230205346,-1.4094414340267445,0.04285714285714286,0.765107471458748,1.0,21/62,15.11%,COL15A1;COL6A3;PAMR1;DKK3;THBS2;COL3A1;COL1A1;FBLN2;BMP5;SGCD;COL1A2;COL6A1;DCN;LAMA4;COL6A2;C1S;SVEP1;CFH;AEBP1;ABI3BP;PRRX1
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.7142025709022113,-1.4083331479629069,0.019230769230769232,0.7685485118870766,1.0,3/26,4.07%,CLU;VEGFA;SFRP4
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.8205739361941309,-1.4075925561418152,0.14583333333333334,0.7680201600318842,1.0,4/10,13.68%,PARP1;SMG6;DHX36;TNKS2
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.7808802617631689,-1.406537241386301,0.05172413793103448,0.7711194769476238,1.0,4/8,14.44%,ABCA8;SOAT1;APOE;NPC1
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.8925758651194833,-1.4060311053369356,0.034482758620689655,0.7690204549857995,1.0,3/8,5.21%,SPTLC3;CYP3A5;TSHR
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.9046463395095121,1.4059031854774198,0.0,0.8680820043209664,1.0,1/5,2.09%,ATP2B4
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.7413306200470133,-1.4034719114865102,0.030303030303030304,0.7807602075310929,1.0,6/18,17.98%,SLC47A1;SLC38A1;SLC6A20;SLC25A13;SLC6A13;SLC7A11
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.7835246635478568,1.4025008536787207,0.0425531914893617,0.8845001042152882,1.0,2/8,11.47%,KLF15;MYOCD
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.6572718842539381,-1.4024473215964797,0.06060606060606061,0.7833740613349527,1.0,10/37,12.72%,ABCA4;ABCA8;ABCA9;AKR1C1;ABCA10;SLCO1A2;ABCA6;SLCO1C1;PEX3;APOE
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.8050908386005511,1.4021299127838278,0.0625,0.8794549589352623,1.0,3/10,12.59%,RAB27A;KIF5B;DNM2
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.7473803417470177,-1.4019398880501146,0.046875,0.7817660996944817,1.0,5/16,16.91%,STAT1;THBS1;APOE;PDCD10;RGCC
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.8420750806669354,1.4016979004747059,0.04081632653061224,0.8679182992565462,1.0,4/8,9.74%,SMARCA4;IRS2;IRS1;BRWD1
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.8420750806669354,1.4016979004747059,0.04081632653061224,0.8679182992565462,1.0,4/8,9.74%,SMARCA4;IRS2;IRS1;BRWD1
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.7349189548918419,1.401060772111399,0.09615384615384616,0.8659041969249605,1.0,3/13,10.07%,NOTCH1;ERBB4;SH2B3
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.6743643144556299,-1.4008945429831443,0.09375,0.7842058356185694,1.0,6/37,7.17%,PRAG1;RIPOR2;NRP1;COL3A1;ARHGEF3;RALBP1
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.8007131101188623,-1.4001520350569219,0.0392156862745098,0.7857605884978449,1.0,4/12,10.67%,CDC37;BIRC2;PELI1;ASAH1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.6574440221236076,1.3999518819994186,0.08108108108108109,0.8658398147098578,1.0,3/28,3.19%,CSF1R;ABL2;ERBB4
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.7977198389063114,-1.3996075976004532,0.0,0.7851456682308576,1.0,5/14,11.41%,TGFB2;ANXA1;SRP54;LGALS3;PPIA
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.6491720857723181,-1.3982556373156108,0.06557377049180328,0.7913958453254584,1.0,8/36,9.16%,ABCA4;SLC47A1;ABCA8;ABCA9;ABCA10;SLCO1A2;ABCA6;CALCRL
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),-0.8681142675423972,-1.3982283509449236,0.06896551724137931,0.7864463443224645,1.0,3/7,10.14%,VEGFA;NRP1;LGALS3
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.8803551248940361,-1.3980647791167193,0.06451612903225806,0.7822638116684879,1.0,2/6,1.68%,PLXNC1;NRP1
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),0.8235251762042374,1.3977855109717618,0.06521739130434782,0.8762782401413804,1.0,2/7,3.85%,DNAH11;DNAH9
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.8918296222328271,1.3971672701245064,0.0392156862745098,0.8730152206510015,1.0,4/6,8.69%,DGKB;DGKH;DGKG;DGKE
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),-0.8104734399486757,-1.3968476786493422,0.05454545454545454,0.7865081032354945,1.0,8/13,17.47%,SLC47A1;SLC38A1;SLC6A20;SLC25A13;SLC7A2;SLC1A2;SLC1A3;SLC1A1
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.8072225831958073,1.3967792603360014,0.044444444444444446,0.861958456630294,1.0,3/6,11.79%,SMARCD3;SMARCA4;ARID1A
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.8072225831958073,1.3967792603360014,0.044444444444444446,0.861958456630294,1.0,3/6,11.79%,SMARCD3;SMARCA4;ARID1A
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),-0.7931491999039301,-1.3965059953926724,0.07017543859649122,0.7842066872247784,1.0,7/10,17.47%,SLC47A1;SLC6A20;SLC7A2;SLC6A13;SLC1A2;SLC1A3;SLC1A1
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.7500876490642332,1.3960135366651896,0.11627906976744186,0.8608053776590686,1.0,1/9,0.16%,JPH2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.8891027966186136,1.3956956679715538,0.08620689655172414,0.8567281412667023,1.0,2/5,2.05%,NOTCH1;TNFRSF1B
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),0.7363619730101679,1.3946164141297608,0.07692307692307693,0.8568950531094599,1.0,2/12,2.04%,MYOM2;OBSCN
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.7387362232954175,1.3943916527709694,0.09375,0.8518129323566719,1.0,3/12,11.52%,EPN2;ARNT;TMEM204
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.8182266406712035,-1.3940355097354793,0.07547169811320754,0.7990912570707572,1.0,2/8,7.23%,DDX60;MYO18A
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.9337150083653428,-1.3939959895685659,0.015625,0.7943125841982557,1.0,1/5,1.68%,NRP1
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.8486834527409878,-1.3938023875149534,0.0967741935483871,0.7905835576373149,1.0,4/10,8.61%,CD55;ERAP1;N4BP1;BIRC2
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.7191258833193408,-1.3928880874730405,0.09836065573770492,0.7936591198000104,1.0,2/13,4.07%,VEGFA;SFRP4
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.7794749685697677,1.3926242851502777,0.11363636363636363,0.8566773261369934,1.0,3/9,7.75%,CNTN4;NRXN1;NLGN4Y
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.8490441913890034,1.392476329821082,0.02631578947368421,0.8453639962219376,1.0,3/9,3.83%,HSPA1A;BCL2;BCL2L1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.8490441913890034,1.392476329821082,0.02631578947368421,0.8453639962219376,1.0,3/9,3.83%,HSPA1A;BCL2;BCL2L1
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.768136219764984,-1.3924670818238483,0.0784313725490196,0.792178572947531,1.0,3/10,5.09%,FGF1;VEGFA;GLI2
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),-0.7820282069540141,-1.3923269043000763,0.09302325581395349,0.7879255827763888,1.0,1/8,0.50%,ABCA8
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.7510317534846848,1.3916573927212548,0.15555555555555556,0.8445442908067611,1.0,1/11,0.16%,JPH2
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.83191866210836,1.3915161733363277,0.08695652173913043,0.8392096634817953,1.0,4/6,11.82%,GJC1;CACNA1C;CACNB2;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.7378793456948756,-1.3911448742092039,0.09523809523809523,0.7909605973364474,1.0,5/15,6.14%,MEGF10;AFDN;PLPP3;CD47;GCNT2
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.7984260215111968,1.3904636370537993,0.14285714285714285,0.8401691670039464,1.0,3/6,18.33%,RYR2;UBASH3B;ANK2
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.8756924655609174,-1.3901819388530245,0.04838709677419355,0.7928797060864634,1.0,1/6,2.12%,TERF2IP
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.7881132137367901,-1.3895615129871544,0.1111111111111111,0.792571672296532,1.0,3/13,4.62%,VEGFA;NKD1;IFT122
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.8453558113931583,1.3881547290892093,0.15217391304347827,0.850187096485194,1.0,2/5,10.47%,ABCA1;PPARA
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.8359523683902943,1.3878537489828342,0.08888888888888889,0.8459601163688457,1.0,2/6,3.35%,PDK4;SLC12A2
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.7447175349852483,1.3877537808644163,0.1,0.8406201691383626,1.0,3/13,4.65%,HSPA1A;EPAS1;UBQLN1
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),-0.837153160159202,-1.386886703215203,0.046875,0.8072448545164991,1.0,1/8,2.79%,LEPR
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.5720923845688014,-1.3866596099253001,0.043478260869565216,0.8040883781236917,1.0,6/91,3.46%,PRAG1;CLU;CD55;IGFBP5;MDFIC;IGFBP2
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.9380887615785185,-1.3865916688321995,0.016129032258064516,0.7950973214327909,1.0,2/6,2.92%,ALDH1A1;ADH5
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),-0.9380887615785185,-1.3865916688321995,0.016129032258064516,0.7950973214327909,1.0,2/6,2.92%,ALDH1A1;ADH5
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.861539923350676,1.3857322197185384,0.06666666666666667,0.8497681525108153,1.0,3/6,12.74%,CAB39;NEDD4L;BIN1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.8105877909643215,-1.3833468227776644,0.1346153846153846,0.815766084575362,1.0,1/10,0.43%,TWIST1
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),-0.7472992618939368,-1.383205002603794,0.06896551724137931,0.8119442528702084,1.0,3/17,2.28%,TGFB2;NRP1;SEMA3C
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.76479877603587,1.3829069717344094,0.07142857142857142,0.8618240563866605,1.0,4/15,13.11%,TNFRSF10B;CASP8AP2;BNIP3;NFKB1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.8145496850083199,1.382657797613179,0.18,0.857777241207671,1.0,1/5,3.34%,ACADVL
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.7310259354718331,1.3817585810997604,0.06818181818181818,0.857136661926111,1.0,1/10,4.12%,ARF1
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.9296800509775425,-1.3816537565796752,0.05660377358490566,0.8190203689706377,1.0,3/5,5.17%,IGFBP5;IGFBP2;BMP5
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.6100038479069896,-1.381615349902755,0.06451612903225806,0.8147697349007991,1.0,9/51,14.21%,XPA;PARP1;DDB2;XPC;RPA1;PSMC2;ORC3;ORC5;PSMD8
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.8379320182309827,1.3812755625791877,0.11363636363636363,0.854947318699279,1.0,3/6,4.43%,KCNC2;GUCY1A1;GUCY1B1
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.661767856241376,-1.379969968208459,0.046153846153846156,0.8212395560694953,1.0,8/37,11.60%,VEGFA;NRP1;PHLDB2;ACTG1;EPHA3;THBS1;BCAS3;LIMCH1
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.515789905449512,1.3797983229294808,0.03125,0.8593974301390614,1.0,14/71,15.01%,PPM1L;PTPRK;PPP2R1A;PPM1A;CTDSP2;PPP2CB;PPP6C;CTDSP1;PPP1CC;MTMR4;BTRC;PTPN9;PPP4R2;UBASH3B
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.8386086129001582,1.379672054339794,0.0784313725490196,0.8542890958278418,1.0,1/7,1.28%,MFHAS1
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.8155443501191869,1.3789296024294895,0.14,0.8536197518972768,1.0,3/6,16.03%,RHOA;RHOB;RBPJ
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.7071630733417893,1.3789004773981308,0.09302325581395349,0.8482045907568377,1.0,4/14,14.40%,MTHFD2L;DLST;MTHFR;MDH1
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.6287779312836526,1.378349912705475,0.07894736842105263,0.846352253973231,1.0,4/25,4.03%,HSPA1A;HSPB1;TMBIM6;HSPA8
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.7751769527842007,-1.3783114668038046,0.07692307692307693,0.8280841113956824,1.0,2/14,1.68%,VEGFA;NRP1
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),-0.8537077944087373,-1.37817500059882,0.078125,0.8243569028615175,1.0,2/6,8.69%,CENATAC;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.811383717660889,1.3777576324400114,0.1282051282051282,0.8437762614414713,1.0,3/9,8.82%,BCL2;MARCHF7;CD44
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.7669661707259692,-1.3776665276900768,0.08695652173913043,0.8234470271566051,1.0,4/13,10.78%,FGF1;VEGFA;GLI2;SPEF2
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.8640612309416396,-1.377645088011209,0.078125,0.818960342085962,1.0,1/6,0.50%,ABCA8
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),0.8732034793483048,1.3759332398539548,0.0425531914893617,0.8480573140146606,1.0,3/5,10.07%,C1QTNF1;PRKG1;SH2B3
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),0.8420439157600113,1.3753647736996477,0.1320754716981132,0.8401155279264302,1.0,4/5,15.61%,SLC25A4;SLC25A24;ABCC5;SLC25A17
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),0.8420439157600113,1.3753647736996477,0.1320754716981132,0.8401155279264302,1.0,4/5,15.61%,SLC25A4;SLC25A24;ABCC5;SLC25A17
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),0.7822127721177575,1.3744811327117,0.06,0.8392357801457117,1.0,2/9,2.23%,NOTCH1;HEY2
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.8642783743967754,1.3737206286574455,0.04,0.8388280977281554,1.0,3/5,9.72%,RNF185;TMEM259;ATXN3
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.8675893659486977,-1.3736678276202832,0.05660377358490566,0.845528994027041,1.0,1/6,6.10%,NMD3
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.770685388749722,-1.373600321672236,0.09615384615384616,0.8410782153793369,1.0,4/8,15.51%,SPTLC3;PLPP3;ASAH1;SPTLC1
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.7850678081929267,-1.3734438318585103,0.12,0.8379250133499677,1.0,1/8,1.22%,RIMS1
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.8592535408603716,-1.3733635586378874,0.06557377049180328,0.8338352576528741,1.0,2/10,6.26%,TGFB2;THBS1
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),-0.7090759165495023,-1.3721557891975698,0.06896551724137931,0.8396120374514693,1.0,5/24,12.72%,PRAG1;SPOCK1;SPRY3;EPHA4;APOE
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.6975278864457738,1.3720766976578325,0.06666666666666667,0.8440517150113008,1.0,3/14,4.03%,HSPA1A;TMBIM6;HSPA8
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.565964507848043,1.371932409640983,0.07692307692307693,0.8401083979317645,1.0,5/44,3.69%,CSPG4;CSF1R;NOX4;ERBB4;GPRC5B
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),-0.820502655725027,-1.3718634274357453,0.14285714285714285,0.8376394483815842,1.0,4/8,14.82%,RIPOR2;BOC;MAPK14;BTG1
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.7968387359427086,1.3716499493442509,0.06,0.8364081797258698,1.0,2/11,3.87%,INTS7;INTS2
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.7276231181238252,1.3714196521217348,0.12903225806451613,0.8327539269635265,1.0,3/9,7.86%,FMN2;MCM9;TOB2
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.6537260833004833,1.3712625543864736,0.10810810810810811,0.8284429344372216,1.0,7/21,15.74%,NOTCH1;GFAP;HSPA8;RAP1A;RAPGEF2;TJP1;RAPGEF1
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.8906640835441845,1.3712460643531317,0.058823529411764705,0.8234238759143421,1.0,3/5,7.01%,RC3H2;SMAD7;NFKBIZ
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.7894187057763821,-1.371138115966255,0.06349206349206349,0.8385018870762246,1.0,6/10,14.89%,RPL23A;RPL5;DHX30;FASTKD2;RPL6;RPL11
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.8052610183324822,-1.3698530754737916,0.09230769230769231,0.8428925743016219,1.0,2/15,6.26%,TGFB2;THBS1
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.8190103482350424,1.3695512652598583,0.08571428571428572,0.8308192782316208,1.0,2/5,16.20%,NRXN1;NLGN2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.6921331566287292,1.3694833634194152,0.13513513513513514,0.8262851684342346,1.0,1/11,0.16%,JPH2
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.7929147867604119,1.3686422201066457,0.15217391304347827,0.8257285352494375,1.0,1/10,0.21%,CSF1R
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),0.8307582524608353,1.3685949778313542,0.10416666666666667,0.8211554204949327,1.0,1/5,3.45%,EMP2
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.7425739570940626,1.368372523896137,0.08695652173913043,0.8174365876881134,1.0,3/11,10.11%,DNAJC15;RALA;HK1
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.8638467311531769,-1.367151415526524,0.1016949152542373,0.8598398217301041,1.0,2/7,8.69%,TWIST1;BRCA1
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),0.6909500187263046,1.366645340730659,0.1590909090909091,0.822263296890205,1.0,1/9,0.35%,ST3GAL2
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.7072281608968439,-1.3655392610481594,0.10714285714285714,0.8672557710259242,1.0,5/14,9.11%,COL6A1;COL12A1;COL11A1;LAMB1;FN1
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.7691425694630433,-1.3654176186654592,0.09259259259259259,0.8631622787979992,1.0,8/12,21.56%,TGFB2;SPRY1;SLIT2;SPRY3;SPRY4;CD2AP;ARHGAP12;MAPKAP1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.818950567604915,1.3654118133415714,0.14893617021276595,0.8252699538603433,1.0,2/7,6.62%,KLF15;MYO1E
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),-0.7634855958544772,-1.364371424950762,0.05357142857142857,0.8660375098272939,1.0,1/16,0.72%,CIRBP
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.8110485206798084,1.3642039662943972,0.16666666666666666,0.8276369776958682,1.0,4/8,16.28%,CACNA1C;RYR2;BIN1;CTNNA3
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),0.703245546499317,1.3639691145419184,0.1956521739130435,0.8243876131476615,1.0,1/10,3.66%,TMBIM6
prerank,PanglaoDB_Augmented_2021__Interneurons,0.5023805868883007,1.363883887918393,0.02857142857142857,0.8202198463206726,1.0,15/96,8.29%,SLC35F1;NOL4;ADGRB3;CACNA1B;KCNC2;CSRNP3;CTNND2;OPCML;NXPH1;AGAP1;CHN1;ABR;NRXN1;ADGRL2;CTNNA2
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.7068837760657848,1.363567115277449,0.11363636363636363,0.8175850991135137,1.0,3/13,4.03%,HSPA1A;TMBIM6;HSPA8
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),-0.8626096151795841,-1.3630676935841481,0.08333333333333333,0.8720699028430766,1.0,3/7,5.49%,PHLDB2;RACK1;TENM4
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.7472934482102274,-1.3628810520692447,0.11320754716981132,0.8688848977332976,1.0,2/13,4.97%,IFITM3;GSN
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5824852968711645,1.3625488771383545,0.0,0.8192922167325719,1.0,4/29,3.83%,HSPA1A;TNFRSF10B;BCL2;BCL2L1
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.791423062037034,1.3616213999727076,0.08695652173913043,0.8209799352877769,1.0,3/9,10.88%,ZNFX1;HDAC1;MBD2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),-0.6818015763470575,-1.3610365389608183,0.09523809523809523,0.8803340799863901,1.0,5/27,6.61%,NR4A1;VEGFA;NRP1;TGFBR1;F3
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.7891950858640915,-1.3598287908914004,0.11764705882352941,0.8850345767161042,1.0,4/6,20.10%,PARP1;PARP9;TNKS2;PARP14
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.8357676415654343,-1.3593934847560865,0.04918032786885246,0.8836446003552424,1.0,3/8,13.78%,CTSL;PGK1;C1RL
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.8813105805812345,-1.3591935428418005,0.09433962264150944,0.8806659389162188,1.0,2/5,4.65%,RACK1;NR4A3
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.641668665808099,-1.3591353028383686,0.0625,0.872171418262036,1.0,5/39,6.53%,ELMO1;MYO10;ACTG1;VAV3;HSP90AB1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.641668665808099,-1.3591353028383686,0.0625,0.872171418262036,1.0,5/39,6.53%,ELMO1;MYO10;ACTG1;VAV3;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.8158975494601536,1.3590077303939954,0.125,0.832926581071641,1.0,2/5,9.18%,DENND3;MADD
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.6330383696942491,-1.358754473773536,0.11475409836065574,0.8706771558962608,1.0,4/27,5.20%,FGF1;KLHL13;RACK1;PIK3R4
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.8093098935671131,-1.3582505705310215,0.13559322033898305,0.8699341868621215,1.0,1/10,1.62%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.8353880653734025,-1.3581003596749097,0.15,0.8667078270978352,1.0,3/7,9.13%,NRP1;BAIAP2L2;BCAS3
prerank,PanglaoDB_Augmented_2021__B Cells,-0.6902299138997081,-1.35797793598195,0.15517241379310345,0.8629790074536233,1.0,6/22,8.02%,CD55;IFIT3;SEMA6D;BACH2;WDFY4;RALGPS2
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.7906943727800533,-1.357870912345766,0.047619047619047616,0.8595288870934529,1.0,1/11,0.88%,TGFB2
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.5806737968172466,1.357588091805053,0.10810810810810811,0.8371318725645099,1.0,3/37,3.74%,VAPB;ATL2;VAPA
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.7488574894862646,1.3570134539682386,0.07692307692307693,0.8360353621193852,1.0,4/13,14.08%,DACH1;GNL3L;CDKN1A;XRN1
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.6889348634779444,-1.356516207557648,0.03571428571428571,0.8657363277393948,1.0,3/23,5.55%,RIMS1;ANXA1;SEPTIN4
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.7951893879037553,-1.356110884189098,0.09259259259259259,0.8639823849922179,1.0,1/7,1.22%,RIMS1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.8953737535021876,1.3559355324502143,0.08333333333333333,0.8343355468884377,1.0,3/5,8.82%,BCL2;MARCHF7;CD44
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.8953737535021876,1.3559355324502143,0.08333333333333333,0.8343355468884377,1.0,3/5,8.82%,BCL2;MARCHF7;CD44
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.583058240537787,1.3557709803274052,0.05263157894736842,0.8307735664865312,1.0,9/38,8.29%,ADGRB3;CACNA1B;KCNC2;SATB2;OPCML;NXPH1;GFAP;NRXN1;CTNNA2
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.8901930499423549,1.3552172255812602,0.0625,0.8292839040534045,1.0,3/5,9.50%,NCOA3;LCOR;EGFR
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.8291685601703989,-1.3552109874977842,0.12280701754385964,0.8654856454854863,1.0,4/8,13.46%,RACK1;CD47;PIP4P2;PLSCR1
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.8967046370230429,1.355056032285249,0.025,0.8257319193494923,1.0,2/5,3.30%,PML;HIPK2
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.7107790530997493,1.3541855482425056,0.24489795918367346,0.8261294029372447,1.0,3/10,12.45%,PTP4A3;CORO2B;CEP290
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.8520669465743085,1.353807439566921,0.1388888888888889,0.8240218717318295,1.0,1/6,8.71%,RNF139
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.8538932652657425,-1.3536757718809609,0.08163265306122448,0.8720479412374778,1.0,2/5,5.79%,SPTLC3;PLPP3
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.8933118240792224,1.3533227850385996,0.05555555555555555,0.8221579803298491,1.0,1/5,1.07%,NOTCH1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.7736497919245274,1.353321069345484,0.15555555555555556,0.8177847995834138,1.0,2/7,14.04%,CDH2;TTN
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.8622722035129478,-1.3532240525502273,0.09615384615384616,0.87090237151722,1.0,2/5,6.53%,CLU;HSP90AB1
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.8243624329784801,1.3523784614218362,0.058823529411764705,0.8190909578205882,1.0,1/6,1.78%,CDH2
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.8014506480873365,1.3519351568198756,0.13636363636363635,0.8170104380611228,1.0,1/9,0.37%,MYH11
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),-0.6623809049580961,-1.351562637864,0.09375,0.877939060351305,1.0,5/24,13.46%,RACK1;EPHA3;PIP4P2;LGALS3;PLSCR1
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.8826817577903581,1.350681626634183,0.05555555555555555,0.8195516703026359,1.0,1/5,1.32%,CNOT7
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",-0.8832718773318576,-1.350285461443791,0.037037037037037035,0.8825715887138671,1.0,1/7,2.04%,PHLDB2
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),-0.9038129606365081,-1.3499227264525115,0.058823529411764705,0.8815318134285485,1.0,4/5,9.11%,ANXA1;COL3A1;THBS1;FN1
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.6837217357909346,1.3492718484074677,0.10810810810810811,0.825081213310592,1.0,4/15,8.87%,PDK4;IRS2;USP7;IRS1
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.5674129578160619,-1.3489813137700946,0.05084745762711865,0.8843905457301929,1.0,16/78,9.83%,ISM1;TWIST1;FGF1;TGFB2;VEGFA;WARS1;STAT1;THBS2;THBS1;F3;DCN;SASH1;BMPER;PGK1;BRCA1;ADAM12
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.8076049689771126,-1.3483500940521074,0.06349206349206349,0.8850567787118817,1.0,2/9,1.91%,AFG3L2;SLC8B1
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),-0.6774548443147985,-1.3480583174064924,0.1,0.8825066403734038,1.0,13/33,21.33%,NR4A2;VEGFA;NRP1;SPOCK1;GPM6A;FGF13;SDCCAG8;DCDC2;CCK;MARK1;AUTS2;ADGRL3;ASTN2
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.8784559510207823,1.3478560048989008,0.0625,0.8289467617991093,1.0,1/5,1.86%,BCL2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),0.8221086189846726,1.3469520915219901,0.14583333333333334,0.8308010849285142,1.0,1/5,1.07%,NOTCH1
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),0.8825993541236622,1.3469248196071262,0.1111111111111111,0.8268056023188258,1.0,2/5,10.97%,VAPA;YTHDC2
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5632373751034373,-1.3468430226552106,0.06944444444444445,0.8881050562845058,1.0,39/109,20.13%,RPL30;RPS4X;RPL19;RPL23A;RPL5;RPL34;RPS18;RPLP1;RPL15;RPS25;RPL27;RPS20;RPL35A;SMG6;RPS12;RPL36;UPF3A;DDX5;SAMD4A;RPL37A;RPL6;RPS3;RPS21;RPL10A;PPP2R2A;RPL11;RPL37;RPL13A;NBAS;RPS24;RPS29;EIF4G1;EXOSC10;RPS14;RPS7;TUT7;RPL7A;RPL28;RPL35
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),-0.6411122936723461,-1.3459253586690336,0.08196721311475409,0.8910617584503728,1.0,11/39,12.93%,CIRBP;XPA;PARP1;DDB2;UVSSA;MSH6;N4BP1;INO80;MAP3K4;DHX36;WRN
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.8465357900009838,1.3459119718040156,0.10638297872340426,0.8290210850384171,1.0,2/7,5.69%,HPRT1;AK3
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.7973070977518596,-1.344564035360441,0.19298245614035087,0.8971113925499566,1.0,3/10,13.12%,TGFB2;MID1;PDCD10
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),0.8564480190773673,1.3445072053268348,0.14285714285714285,0.8328406148950865,1.0,2/5,4.48%,EMP2;PACSIN2
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),0.8492154929033746,1.3442966699231063,0.14285714285714285,0.8297828375197217,1.0,4/5,15.11%,SNAP29;AP3D1;SNAP23;STX2
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),-0.9054174090640934,-1.3442965825282447,0.07547169811320754,0.89486780445129,1.0,2/5,5.49%,CLU;TENM4
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),-0.7560688382872697,-1.3441562940474518,0.05454545454545454,0.8917038529977046,1.0,4/15,11.58%,HINT1;NDRG1;DDX5;FHIT
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.8653985434758706,1.3440814329150954,0.06,0.8267557915752654,1.0,2/6,3.87%,INTS7;INTS2
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.6568108128556092,1.3436502553634846,0.1388888888888889,0.8248960195631178,1.0,6/18,14.84%,BCL2;BCL2L1;BNIP3;SLC25A4;SLC25A24;ABCB10
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),-0.8648953158815686,-1.3432240295849085,0.14814814814814814,0.8938318779942752,1.0,1/5,0.88%,TGFB2
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.8467867581983948,-1.342692277101851,0.08928571428571429,0.8931433792967456,1.0,2/6,1.96%,SLC25A36;PARP1
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.7546408961438125,1.3426900295397233,0.18421052631578946,0.8273744402946736,1.0,5/8,24.46%,GRID2;GRIN1;GRIN2B;GSK3B;MEF2C
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.5530388932169167,1.3425617330951796,0.02857142857142857,0.8240460813235013,1.0,1/47,0.03%,HSPA1A
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.8283962776214857,-1.3423433185566365,0.06153846153846154,0.892151720123523,1.0,1/8,1.32%,FOXQ1
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),0.8373786220707419,1.3418112477116733,0.08333333333333333,0.824162033666954,1.0,3/5,9.10%,NOTCH1;HEY2;HEYL
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.7021726217809612,-1.341577222311481,0.09090909090909091,0.8934129771775263,1.0,3/16,7.62%,SULF2;SFRP4;SLC10A7
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.8341931487031342,-1.3411775949229974,0.07142857142857142,0.891903374694234,1.0,1/8,2.12%,TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.8217719747298023,-1.3410442919492902,0.05555555555555555,0.8887501924015562,1.0,1/8,0.43%,TWIST1
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.7893111723267816,1.3409264751579797,0.13333333333333333,0.8255435643217277,1.0,4/6,10.07%,PDGFA;C1QTNF1;PRKG1;SH2B3
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.878010268144953,1.3407778103564676,0.0,0.8221720012650467,1.0,3/6,9.19%,NOTCH1;SOX6;HDAC1
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.6308083574985369,-1.339752538079131,0.03389830508474576,0.8932223120096151,1.0,7/32,8.42%,GBP2;MT2A;STAT1;EPRS1;CD47;MID1;HLA-B
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.5478234896431703,1.3396003054052177,0.07142857142857142,0.8245533128676339,1.0,16/55,13.01%,HSPA1A;NOTCH1;HIPK2;LEMD3;PPM1A;BCL9L;ZBTB7A;SMAD7;PMEPA1;ACVR2A;PPARA;MTMR4;BMPR1A;ADAM17;UBE2D1;RBPMS2
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.763496229730303,-1.3391944758953729,0.08333333333333333,0.8893113177893515,1.0,2/11,6.53%,CLU;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.763496229730303,-1.3391944758953729,0.08333333333333333,0.8893113177893515,1.0,2/11,6.53%,CLU;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.5314938398328057,1.3391058189377916,0.09375,0.8231166116247988,1.0,7/51,10.94%,HSPA1A;TMBIM6;RBM20;RRP1B;GRSF1;HNRNPF;RBM23
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),-0.5732246566876864,-1.339096313972359,0.07462686567164178,0.8859249307754123,1.0,5/55,2.41%,PLXNC1;RIPOR2;VEGFA;FBLN1;ADAM22
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.8070577383797388,1.3389671299146146,0.2413793103448276,0.8197059565077873,1.0,1/5,4.94%,DTNA
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),-0.8683518413186917,-1.3387664944094215,0.12962962962962962,0.8838904144766415,1.0,4/5,13.23%,NRP1;SLIT2;ALCAM;ROBO2
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.5200512860491465,1.3383499067531937,0.11904761904761904,0.8193447818592612,1.0,6/41,8.57%,HSPA1A;TNFRSF1B;APC;BNIP3L;BNIP3;RAD18
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.6332217422821438,-1.3380943217192274,0.1,0.8845066819695614,1.0,8/34,9.46%,MT2A;FTL;FTH1;ACO1;SLC11A2;ABCB7;SLC22A17;HEPH
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.836310769904812,-1.3375804692697904,0.08163265306122448,0.8847370453761426,1.0,4/8,13.68%,PARP1;TERF2IP;SMG6;TNKS2
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.575739027493525,1.3369990634142237,0.041666666666666664,0.8237614771367314,1.0,6/35,3.93%,ADGRB3;KCNC2;CTNND2;OPCML;NXPH1;GFAP
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.8674243473178793,1.3363870197762424,0.11363636363636363,0.8237764067077832,1.0,3/5,12.74%,CAB39;NEDD4L;BIN1
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.7696543538958036,-1.3362393730710846,0.07142857142857142,0.8898072813827715,1.0,4/11,13.27%,STAT1;CDC37;HSP90AB1;PARP9
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.7709934338102453,-1.3359720095822063,0.06896551724137931,0.8881264092914193,1.0,1/10,0.90%,PIGG
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),0.7968682981267622,1.3355490668072978,0.11764705882352941,0.8245225441513622,1.0,3/6,10.07%,C1QTNF1;PRKG1;SH2B3
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),-0.8709602811840212,-1.3349098697637922,0.08928571428571429,0.8918447843763635,1.0,2/6,3.38%,VEGFA;NKD1
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.5627860359551028,-1.3345485607412844,0.0379746835443038,0.89054363803032,1.0,26/80,15.06%,ABCA8;COL15A1;MT2A;COL6A3;EPSTI1;THBS2;COL3A1;COL1A1;GSN;COL1A2;COL6A1;PLPP3;FMO2;DCN;ADAM12;HSD11B1;IL1R1;EBF2;COL6A2;CYP1B1;C1S;SVEP1;CFH;CYP27A1;FAM114A1;ASPN
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.5255977398635365,1.3342992873354027,0.058823529411764705,0.8265233952123925,1.0,12/70,7.70%,NOL4;CMTM8;CSRNP3;CNTN4;RCAN2;KALRN;ERBB4;LONRF2;CNTN1;LIFR;NRXN1;ADGRL2
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),0.83053138973106,1.3326031104316618,0.17777777777777778,0.8312103978132266,1.0,3/5,14.45%,NOTCH1;P2RX4;GLRX3
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.7347731866500911,1.3325822675156365,0.20408163265306123,0.8274404554532383,1.0,1/9,1.07%,NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.6621394151152833,-1.332102800783238,0.125,0.9044434667417005,1.0,7/28,8.58%,ISM1;TGFB2;STAT1;THBS2;THBS1;DCN;PGK1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.6831948188651524,1.3320508117920424,0.175,0.8265766408580251,1.0,1/13,0.72%,HSPB1
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.8551446157075832,1.3313677310110548,0.0,0.8266258176828106,1.0,1/6,2.66%,APC
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.6468053449134212,-1.3313187510361608,0.12121212121212122,0.9052020996970259,1.0,7/28,9.46%,FTL;FTH1;ACO1;SLC11A2;ABCB7;SLC22A17;HEPH
prerank,PanglaoDB_Augmented_2021__Erythroblasts,0.6498204703523909,1.3309608392193628,0.05714285714285714,0.8252521036365627,1.0,6/17,10.52%,EPOR;RAB27A;SNAP23;CD44;SH2B3;GRSF1
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.7304622545632974,1.3305404056390475,0.07142857142857142,0.8241741238338749,1.0,3/10,15.30%,KCNC2;GRIN1;GRIN2B
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.5200212594174236,1.3303030845102468,0.041666666666666664,0.8215085009518152,1.0,13/61,13.84%,PPM1L;PTPRK;PPP2R1A;PPM1A;CTDSP2;PPP2CB;PPP6C;CTDSP1;PPP1CC;MTMR4;BTRC;PTPN9;PPP4R2
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),-0.8063347597979571,-1.33014555808963,0.14893617021276595,0.9094839432859779,1.0,1/7,0.88%,TGFB2
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.6407734292695844,1.3298622526573185,0.13513513513513514,0.8201298188678382,1.0,3/19,7.23%,ATP2B4;SLC12A2;HCN2
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.8130421623803801,-1.3296457704695372,0.14545454545454545,0.9097246983288927,1.0,2/7,4.52%,CD55;BACH2
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),-0.8742848066909253,-1.329441918039732,0.08771929824561403,0.9074807665953093,1.0,1/5,0.38%,CLU
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.7750660522012683,-1.3293972766797744,0.07692307692307693,0.9002231054635531,1.0,4/12,11.41%,TGFB2;SRP54;LGALS3;PPIA
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.7750660522012683,-1.3293972766797744,0.07692307692307693,0.9002231054635531,1.0,4/12,11.41%,TGFB2;SRP54;LGALS3;PPIA
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.6844849962931716,1.329271174847293,0.16666666666666666,0.818996359037047,1.0,2/15,4.09%,TRPC6;TCAF1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.8706775525362453,1.3292574222295594,0.1111111111111111,0.8154164327203595,1.0,2/5,10.78%,MTMR1;MTMR4
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.834166135970083,1.328961722732044,0.044444444444444446,0.8135758210256545,1.0,3/6,14.89%,MTMR1;MTMR4;ABCA3
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.6886885782034489,1.3287914237615825,0.11904761904761904,0.8111084168441914,1.0,5/15,11.82%,GJC1;CACNA1C;RYR2;NEDD4L;KCNQ1
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.8052646013614115,-1.3286926065343696,0.1016949152542373,0.9012617549870654,1.0,3/9,5.17%,SPRY1;LDLRAD4;BMP5
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.8455277590126057,1.3286483899796024,0.18181818181818182,0.8080682766922008,1.0,3/5,8.39%,SOX6;SOX5;ZBTB16
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.6605455752465451,1.3283400744088687,0.09523809523809523,0.8060566870903284,1.0,4/21,4.65%,SNAP29;APC;HSPA8;UBQLN1
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),-0.6038944118917973,-1.328284174341433,0.11475409836065574,0.900170169963119,1.0,8/52,7.12%,PRAG1;TWIST1;PLXNC1;FGF1;FBLN1;ENPP2;TMSB10;SGK1
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.8900237020379835,-1.327948086359641,0.12727272727272726,0.8988482813911819,1.0,1/5,1.62%,VEGFA
prerank,PanglaoDB_Augmented_2021__Neurons,0.45826905652869776,1.3273654625344804,0.03125,0.808006893814278,1.0,15/104,8.29%,NOL4;ADGRB3;CACNA1B;DGKB;CSRNP3;OPCML;NXPH1;GNAI1;MEG3;ATP6V1H;TESC;GNL3L;CHN1;NRXN1;CTNNA2
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.8317447269619299,1.326866861998775,0.19230769230769232,0.8069610197645747,1.0,3/6,9.30%,ZFYVE28;CBLB;CBL
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.838712713662459,-1.326798986535987,0.0625,0.9025005154995055,1.0,5/6,15.62%,SPRY1;SULF2;THBS1;SPRY3;SPRY4
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),-0.8773650360223698,-1.3264015259179505,0.13333333333333333,0.8979399738503745,1.0,2/5,6.32%,P4HTM;P4HA3
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-0.8773650360223698,-1.3264015259179505,0.13333333333333333,0.8979399738503745,1.0,2/5,6.32%,P4HTM;P4HA3
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),0.7980098608573223,1.3263861969040958,0.16666666666666666,0.8058343585743655,1.0,2/6,16.15%,CERT1;SLC27A1
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.676505674849764,-1.3262163301693768,0.15625,0.8957852476865228,1.0,7/17,24.00%,NRP1;WDFY4;IL16;MAP3K8;CD4;MCTP2;TCF4
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.8326910937914032,-1.3259877822963142,0.12280701754385964,0.8934914725605001,1.0,1/5,0.85%,GBP2
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.8256123622791117,-1.3259105666027602,0.13559322033898305,0.8904376539520075,1.0,2/6,11.69%,ALDH3A2;CYP1B1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.767403140217334,1.3257824592225507,0.21739130434782608,0.8050754224233048,1.0,1/7,1.28%,MFHAS1
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.6194198375512018,1.3256229865528808,0.11428571428571428,0.8024072314376072,1.0,1/18,1.28%,MFHAS1
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.7414807684945433,1.3255905755520856,0.19148936170212766,0.795725740488702,1.0,4/12,5.33%,NOTCH1;MICAL2;BBS7;TBX3
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.7414807684945433,1.3255905755520856,0.19148936170212766,0.795725740488702,1.0,4/12,5.33%,NOTCH1;MICAL2;BBS7;TBX3
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),-0.9034258708953258,-1.3254714581984632,0.1111111111111111,0.8903151920043764,1.0,1/5,2.09%,MEGF10
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.7716831604662406,-1.3249330079475692,0.10344827586206896,0.8912361247238225,1.0,1/9,0.90%,PIGG
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),-0.8482621124813303,-1.324641233064139,0.11764705882352941,0.8900347045204063,1.0,2/7,6.26%,MEGF10;THBS1
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.7876700587810999,-1.324416951290018,0.1076923076923077,0.888268123501864,1.0,4/12,12.09%,TGFB2;THBS1;SLIT2;TGFBR3
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),-0.8011428718096991,-1.3242943449077578,0.08695652173913043,0.8857522248961538,1.0,3/8,12.32%,MTM1;SLIRP;NUBPL
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.812704764185645,-1.32415868404574,0.14545454545454545,0.8832939127512569,1.0,1/8,2.21%,FBLN1
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.6795368152546643,-1.32398049848676,0.1774193548387097,0.8810818182947143,1.0,8/21,10.14%,PPP1R14A;ANXA1;FTL;NR4A3;WDFY4;VCAN;HLA-B;LGALS3
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.6279266711780984,-1.3236754701506657,0.06896551724137931,0.8797542274015614,1.0,4/28,6.26%,CLU;TWIST1;CD47;THBS1
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.7296366200322736,1.32298914358755,0.13636363636363635,0.804567409115493,1.0,5/8,26.02%,RHOA;CDC42;RAB10;EZR;OPHN1
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.789991517779089,-1.3223610765576788,0.12280701754385964,0.8853495328692743,1.0,5/9,17.47%,SLC47A1;SLC6A20;SLC6A13;SLC1A3;SLC1A1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),-0.776096272028523,-1.3220593457680088,0.09259259259259259,0.8840906136759182,1.0,6/11,16.91%,SFRP4;GSN;THBS1;PDCD4;ANO6;RGCC
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.7524593708438579,-1.3214129727148332,0.09523809523809523,0.884966387084814,1.0,3/11,15.74%,LMF1;APOE;LPL
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.6364047754922137,1.3213012768551262,0.1282051282051282,0.8098740838495958,1.0,9/16,27.17%,SPOPL;RNF139;HDAC2;BTRC;CAMK2N1;DNAJC1;TRAF3;OGT;IST1
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.8108460838768716,-1.320740009220299,0.14545454545454545,0.8860954833671146,1.0,1/5,0.79%,DDX60
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.8059889796420924,1.320516007201178,0.2826086956521739,0.8038169093441471,1.0,2/6,8.50%,HSPB1;KIF5B
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.8059889796420924,1.320516007201178,0.2826086956521739,0.8038169093441471,1.0,2/6,8.50%,HSPB1;KIF5B
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.8059889796420924,1.320516007201178,0.2826086956521739,0.8038169093441471,1.0,2/6,8.50%,HSPB1;KIF5B
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.6433982186558822,1.3201980179017925,0.19148936170212766,0.8021473364431567,1.0,3/17,7.12%,HSPA1A;CD58;MAPKBP1
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.7833398785823525,-1.319981552331957,0.12727272727272726,0.8875860229812765,1.0,1/9,3.13%,TET1
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.6184790420066719,1.3198157029020026,0.12195121951219512,0.8005773981322812,1.0,10/23,21.37%,EMP2;UGCG;NRXN1;NLGN4Y;STX2;NLGN2;PICALM;PTPRD;UBXN2A;CHMP4B
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.772520665197866,1.319619850344663,0.14705882352941177,0.7985078859954864,1.0,3/8,8.39%,SOX6;SOX5;ZBTB16
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.7076853683858038,-1.3192580520487878,0.1016949152542373,0.8889915930646328,1.0,8/18,15.85%,AGPAT4;ENPP2;PLPP3;AGPAT5;GNPAT;PLA2G4C;LPL;GPX4
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,0.8020183437990247,1.3181749466172268,0.14893617021276595,0.8036866298653145,1.0,1/5,0.21%,CSF1R
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.7585674975860306,1.3181335664471143,0.07692307692307693,0.8004775567528162,1.0,2/12,3.35%,JPH2;SLC12A2
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.6637526479498006,-1.317944171531564,0.14516129032258066,0.8945361262435617,1.0,7/25,9.46%,FTL;FTH1;ACO1;SLC11A2;ABCB7;SLC22A17;HEPH
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),-0.6183200251053708,-1.3178450561293213,0.05970149253731343,0.8918077313688637,1.0,9/42,17.81%,CDKL1;DYNC2LI1;GSN;TBC1D2B;NPRL3;TBC1D22A;SDCCAG8;DCDC2;TBC1D8
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.8265297002144845,-1.3173153042620513,0.1111111111111111,0.8922341804735061,1.0,2/6,4.17%,STAT1;AKR1C1
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),-0.8273109300310266,-1.317309048185236,0.1509433962264151,0.8889173247840135,1.0,1/5,2.90%,ACTG1
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.6568203837009329,1.316823796156187,0.16666666666666666,0.8035808960166275,1.0,5/15,23.28%,HSPA8;NDFIP2;DNAJC1;SNX3;PTPN1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.8465194247781597,1.3165335555396243,0.08333333333333333,0.8014067715425938,1.0,2/5,6.35%,BNIP3L;BNIP3
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.7856486230021702,-1.3165045613807833,0.15625,0.8909069524321094,1.0,1/8,0.43%,TWIST1
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),-0.8879477707477521,-1.3162308386044193,0.08333333333333333,0.8892054087758082,1.0,1/5,2.74%,KCNMA1
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),-0.6541729705086522,-1.3160788368827172,0.125,0.886582677927062,1.0,7/27,11.05%,XPA;PARP1;DDB2;XPC;N4BP1;INO80;DHX36
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.5291413923027756,1.3140635871986523,0.02702702702702703,0.8098795808003171,1.0,11/52,14.12%,SATB2;SMARCD3;SMARCA4;ZBTB7A;HDAC1;ARID1B;MBD2;SMARCA1;ARID1A;HDAC2;CECR2
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.7488531909071752,-1.313967699850685,0.15,0.8968599390930934,1.0,2/12,8.07%,DDB2;KDM2B
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.7556230886573738,-1.313929112192116,0.09615384615384616,0.8936580263461668,1.0,3/13,8.42%,CD55;FBXO38;HLA-B
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.649614864374753,-1.313635702821704,0.06666666666666667,0.8932499384591195,1.0,5/26,8.42%,GBP2;MT2A;STAT1;MID1;HLA-B
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.7361119903083906,-1.3135493834315481,0.16666666666666666,0.890473608978575,1.0,4/11,14.20%,GLCE;EXT1;CSGALNACT1;XYLT1
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),-0.8895441429756366,-1.3121968854833281,0.037037037037037035,0.8962510342908853,1.0,2/5,9.64%,SUPT6H;DDX5
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.7836279866133736,1.3118311328237797,0.15384615384615385,0.8192009992356916,1.0,2/10,3.87%,INTS7;INTS2
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.7667483356655853,-1.3112987486483427,0.14814814814814814,0.8993868007228821,1.0,3/11,4.65%,PDGFD;NRP1;NR4A3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.64831361199794,1.310538423569321,0.1388888888888889,0.8223868492485035,1.0,4/11,13.62%,PML;HIPK2;MSH2;EP300
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.8694112196235977,-1.3104996136825746,0.11538461538461539,0.9022550152000859,1.0,2/5,4.33%,CD55;GLI3
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.8718265861638927,1.3104870200267036,0.125,0.8193453753364979,1.0,3/6,12.19%,KLF15;SLC26A3;RAP1A
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.5806017317117805,-1.3098811511659987,0.057971014492753624,0.9028003033868749,1.0,18/81,10.44%,IGFBP5;COL6A3;PAMR1;DKK3;THBS2;COL3A1;SFRP4;ADAMTS12;COL1A1;MRC2;COL1A2;COL6A1;PLPP3;COL12A1;DCN;COL11A1;FN1;COL6A2
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.5670527815644049,-1.309678315982219,0.08064516129032258,0.9010822265006472,1.0,22/77,15.58%,SAT1;NR4A2;SLC2A3;NR4A1;VEGFA;NR4A3;PLPP3;GEM;F3;SGK1;BTG2;BIRC2;MARCKS;TSC22D1;NAMPT;BHLHE40;CCN1;MAP3K8;SQSTM1;BTG1;GADD45B;PHLDA1
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.6775338961130942,-1.3096519054673772,0.14754098360655737,0.8979561755075074,1.0,1/15,0.43%,TWIST1
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.7373400354463691,-1.3090709025072218,0.0625,0.898821514168115,1.0,2/14,0.43%,CLU;TWIST1
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.7697676313976974,-1.3086912721411619,0.15517241379310345,0.8986833301152306,1.0,1/6,1.14%,COLEC12
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),-0.8368883511634948,-1.308609275781737,0.17857142857142858,0.8963868906426862,1.0,2/5,4.65%,LEPR;NR4A3
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.6490595899057449,-1.308321968922774,0.12121212121212122,0.8950286567848982,1.0,9/30,11.29%,GBP2;ADAMTS12;ADAM9;ZFP36L2;YBX3;BRCA1;NUB1;ASAH1;RPS3
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),-0.6606596758624848,-1.3078779404017742,0.1724137931034483,0.8944286486361792,1.0,6/20,5.73%,TGFB2;VEGFA;SULF2;STAT1;GLI2;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.7402596528814855,-1.3075217890193565,0.15151515151515152,0.8931205628094318,1.0,4/13,11.05%,CIRBP;SNW1;NCL;DHX36
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.7184937156023181,-1.307395239029508,0.1791044776119403,0.890807558211492,1.0,1/12,0.38%,CLU
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.6009932467453875,-1.3071394390928033,0.046875,0.8893188852218914,1.0,3/34,6.66%,FGF1;NR4A1;ZFP36L2
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.7346271131094728,1.306608972077107,0.12195121951219512,0.8350654263942116,1.0,4/11,9.08%,CNOT7;TOB1;EIF4ENIF1;AGO2
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),-0.828114316420147,-1.3064241559214667,0.14,0.8912306850534487,1.0,2/6,6.61%,VEGFA;F3
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.8298735255013474,1.3062637215772481,0.12727272727272726,0.8329411804999006,1.0,1/5,1.80%,DGKH
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.7157049721224669,-1.3059810243576833,0.11290322580645161,0.8908212167285758,1.0,3/14,5.73%,TGFB2;BMP5;TGFBR1
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.677038863253911,-1.3059582036544612,0.12903225806451613,0.8879475593885057,1.0,2/18,4.59%,PHLDB2;EPHA3
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.7986319300142539,-1.3057946483059761,0.20754716981132076,0.8858243837677124,1.0,1/7,0.56%,CD55
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.6562710872907725,-1.3057909519734343,0.1111111111111111,0.8828878124547208,1.0,7/26,13.12%,PDGFD;FGF1;VEGFA;SASH1;MAP3K4;RPS3;PDCD10
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.823730850834917,-1.3055435272314582,0.13559322033898305,0.8815550703885904,1.0,2/5,10.14%,ANXA1;LGALS3
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.8025534404389555,1.305303866055348,0.09803921568627451,0.8350826800340716,1.0,3/7,10.56%,NOTCH1;HEY2;RYR2
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.7646516187570092,1.3049453825460136,0.11764705882352941,0.8337482874747923,1.0,5/12,18.03%,MYO1E;SYNE2;MYO1D;MYO1B;MYO5A
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5689438231667784,1.304744960749646,0.09375,0.8316541979593144,1.0,11/38,11.36%,HSPA1A;LEMD3;PPM1A;BCL9L;ZBTB7A;SMAD7;LTBP1;PMEPA1;PPARA;MTMR4;ADAM17
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.7817022868225998,1.304180065475374,0.12195121951219512,0.831191530269404,1.0,2/9,6.02%,IRS2;SMAD7
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),0.8482012182986538,1.3037856547020856,0.21428571428571427,0.8266311717974292,1.0,2/5,12.77%,MTHFD2L;MTHFR
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),0.8482012182986538,1.3037856547020856,0.21428571428571427,0.8266311717974292,1.0,2/5,12.77%,MTHFD2L;MTHFR
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.745852095513536,1.3034469655987482,0.21818181818181817,0.8251556267091685,1.0,3/6,9.72%,RNF185;TMEM259;ATXN3
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),0.8003405597980506,1.3033446188397475,0.11538461538461539,0.8224987709822184,1.0,2/5,5.33%,NOTCH1;TBX3
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),-0.8069753286966959,-1.301786647810991,0.1791044776119403,0.9047004440060565,1.0,2/7,13.52%,SLC4A4;ATP1B1
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.621322812662356,1.3017244719204322,0.09090909090909091,0.8282977232657193,1.0,4/22,4.52%,CSF1R;CNOT7;ERBB4;PPP2R1A
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.6911528837965099,-1.3009298004414225,0.18032786885245902,0.9068107242112832,1.0,1/13,0.43%,TWIST1
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),-0.7395198868217965,-1.3007587063876778,0.13432835820895522,0.9046272970522409,1.0,2/12,10.14%,EPHA3;LGALS3
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),-0.7818466016444857,-1.3000961128145019,0.09803921568627451,0.9053562432954808,1.0,3/7,19.75%,ANXA1;PRKN;STXBP6
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),0.6073123609048546,1.3000952947986086,0.13333333333333333,0.833618437946726,1.0,4/29,8.49%,DENND3;HSPA8;OGA;STT3B
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.7270982414178524,-1.299772510149399,0.1111111111111111,0.9047498315838765,1.0,2/17,3.19%,IGFBP5;ANXA1
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.7520526924641441,1.2990066432283485,0.20588235294117646,0.8360296534660002,1.0,5/9,24.46%,GRID2;GRIN1;GRIN2B;GSK3B;MEF2C
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.7840158575816267,1.298774517269625,0.1702127659574468,0.8338416997793731,1.0,2/6,5.74%,PDZD8;PACS2
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.7459816448495218,1.2983538232731267,0.10526315789473684,0.8328014116338825,1.0,4/9,20.98%,NLGN4Y;NLGN2;LRRTM3;PTPRD
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.8303781066421629,1.2982331981053774,0.15555555555555556,0.8299814482881268,1.0,4/7,10.47%,ZFYVE28;CBLB;CBL;PPARA
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.7380107374250462,-1.297834732857683,0.19642857142857142,0.9148209943266824,1.0,2/8,6.40%,VEGFA;SLIT2
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),-0.7273159739607731,-1.2976660151652162,0.14035087719298245,0.9126399547535172,1.0,3/9,12.86%,PER2;ADM;CHRM3
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.5109952371421385,1.2974302617560094,0.08333333333333333,0.8310926304205927,1.0,8/43,10.35%,CSF1R;ERBB4;EMP2;IRS2;CAMKK2;AXL;EGFR;RBL1
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.774545543599055,-1.2966573191194408,0.19642857142857142,0.9156785389974503,1.0,3/10,6.40%,GSN;TMSB10;SLIT2
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.47379083085997,1.2964930627090356,0.13513513513513514,0.8331211674811321,1.0,11/76,6.67%,SLC35F1;NOL4;DACH1;ADGRB3;CACNA1B;CSRNP3;OPCML;KCNH7;GNL3L;GRID2;CHN1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.6754493720879915,-1.2958621541985391,0.15384615384615385,0.9171599511661941,1.0,9/18,19.70%,IGFBP5;STAT1;NR4A3;THBS1;PRKDC;TCF7L2;APOD;XRCC6;OGN
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.6374666293114117,1.2957896999733318,0.13333333333333333,0.8330212331269752,1.0,1/23,0.03%,HSPA1A
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),-0.7458804408181539,-1.295712925030118,0.17857142857142858,0.9150245720018447,1.0,2/10,8.07%,DDB2;KDM2B
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.8583307445823576,-1.2956652712441084,0.14285714285714285,0.9123622093314023,1.0,1/5,2.31%,CTSL
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.8276956547194647,1.2955478456882936,0.14,0.831543852999579,1.0,1/5,7.60%,NRXN1
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.6898630867893586,1.2955164412979308,0.09302325581395349,0.8285517088572032,1.0,4/16,10.28%,DACH1;PDGFA;HMBOX1;CDKN1A
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.7147104019088272,1.2954286721132902,0.12,0.8258855773984582,1.0,3/13,6.96%,WTIP;DLG5;MOB3B
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),-0.8143765844885378,-1.2952848181243821,0.16279069767441862,0.9117468330611787,1.0,1/6,0.88%,TGFB2
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.7739079945410758,1.2952112590733766,0.13636363636363635,0.8236933250804158,1.0,4/9,14.23%,ATP2B4;NEDD4L;UTRN;COMMD1
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),-0.7134969969560156,-1.295167397745793,0.10714285714285714,0.9092703670909613,1.0,5/15,10.67%,ST6GALNAC3;ST3GAL5;HEXB;GALC;ASAH1
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),-0.6305109628521676,-1.29487734320047,0.12727272727272726,0.9082593120883252,1.0,4/27,5.73%,FGF1;TGFB2;COL3A1;TGFBR1
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),-0.7543074950681676,-1.29454214505559,0.16071428571428573,0.9074117996133201,1.0,3/6,15.51%,SPTLC3;ASAH1;SPTLC1
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.7519236880065502,-1.2944392203389192,0.12727272727272726,0.905192192277339,1.0,1/10,0.64%,FGF1
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.7083247362707197,-1.2938575925019167,0.1774193548387097,0.90592026544336,1.0,4/16,13.65%,IFITM3;N4BP1;PLSCR1;SRPK1
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),-0.7073382021878514,-1.2937388161828858,0.1935483870967742,0.9040617342355175,1.0,2/18,6.66%,ZFPM1;ZFP36L2
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.6718822777297749,-1.293196281529283,0.16071428571428573,0.9042616157095084,1.0,7/18,16.15%,RPL23A;RPL5;RPL35A;RPL6;RPL10A;RPL11;WDR12
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.5624486555930969,-1.2927859498846137,0.10294117647058823,0.904429320961456,1.0,19/59,10.44%,COL15A1;IGFBP5;COL6A3;PAMR1;DKK3;THBS2;COL3A1;ADAMTS12;COL1A1;FBLN2;COL1A2;COL6A1;GEM;COL12A1;DCN;LAMA4;FN1;MGP;COL6A2
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),-0.8375174491903897,-1.2927584220438693,0.16363636363636364,0.9016378588967044,1.0,1/5,2.07%,NT5E
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.6893509776774867,1.2925771844181342,0.19148936170212766,0.8341546380881713,1.0,5/10,20.39%,UBE2N;SMAD7;FBXW7;DCUN1D4;DCUN1D1
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.8046708290239997,-1.2924862106801194,0.1346153846153846,0.9006762408381416,1.0,1/7,2.98%,STAT1
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.7314477348490671,-1.2917087209889406,0.13114754098360656,0.903027660220388,1.0,4/13,13.27%,STAT1;CDC37;HSP90AB1;PARP9
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.7249753452662582,1.2916794385386405,0.17391304347826086,0.8355190148199211,1.0,1/9,0.56%,ANO5
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.6074507396150219,1.2915978273662776,0.08571428571428572,0.8330535326217252,1.0,5/26,11.36%,NCK2;CBL;EGFR;RPS6KA5;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.7331301315540459,-1.2911290772809745,0.15254237288135594,0.9038686699888001,1.0,1/11,0.88%,TGFB2
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),0.8161630810593188,1.2911002744049886,0.1875,0.8323969960349863,1.0,3/5,6.35%,PISD;BNIP3L;BNIP3
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.8371273948460253,-1.2909856065815404,0.11864406779661017,0.9020874884293287,1.0,2/5,4.97%,IFITM3;GSN
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),-0.7094178694871862,-1.2908876083648042,0.20833333333333334,0.9000140184566366,1.0,4/11,6.40%,NR4A1;VEGFA;NRP1;SLIT2
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.8231276581797003,-1.2908159335906149,0.14516129032258066,0.8976509748237878,1.0,3/6,9.06%,RACK1;NR4A3;NONO
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.6103101411541488,1.290794752918091,0.16666666666666666,0.8310759197339742,1.0,2/17,1.32%,VAPB;CNOT7
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.7241896295372439,-1.290787135076103,0.21875,0.8950311866795415,1.0,1/11,0.43%,TWIST1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.7055997581241612,1.290689693610867,0.10810810810810811,0.828652873169042,1.0,1/10,0.72%,HSPB1
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.7967168765693082,-1.289929781040695,0.23333333333333334,0.8968756822660449,1.0,4/7,10.60%,TGFB2;BMP5;TGFBR1;PTCH1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),-0.7442121673020963,-1.2894265109554237,0.09836065573770492,0.8969110846493913,1.0,7/15,21.83%,THBS1;SLIT2;DCN;APOE;SP100;EVL;STC1
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.6195711336398373,1.2890985998375213,0.13636363636363635,0.8335195264222451,1.0,2/25,2.79%,INF2;PISD
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.5565524059604335,1.2885406793774625,0.05405405405405406,0.8336431480273621,1.0,7/39,9.91%,HSPB1;NCK2;EIF4EBP2;EIF4B;EIF3B;AGO2;CEBPB
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.5004751912196941,-1.2885068820489223,0.07042253521126761,0.8992463625158835,1.0,50/175,20.45%,RPL30;RPS4X;LMF1;NR4A2;RPL19;WARS1;RPL23A;RPL5;RPL34;RRBP1;RPS18;RPLP1;RPL15;RPS25;RPL27;RPS20;RPL35A;SMG6;FASTKD2;RPS12;RPL36;RPL37A;RPL6;NUP58;RPS3;THRB;THOC1;RPS21;RPL10A;SEC13;CELF2;RPL11;RPL37;RPL13A;PTMA;ADARB1;DHX8;RPS24;RPS29;EIF4G1;RPS14;RPS7;SRSF7;NUP107;RPL7A;DDX17;RPL28;SRSF5;RPL35;RANBP2
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.6100046909873481,-1.2883662534416223,0.1267605633802817,0.8973683851097692,1.0,11/37,17.84%,CD55;ANXA1;ADAMTS12;ERAP1;N4BP1;BIRC2;IL1R1;UFL1;APPL2;TMSB4X;EFNB2
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.7141836058237966,-1.288329799680215,0.20967741935483872,0.8947892703103111,1.0,4/13,8.02%,NT5E;BACH2;WDFY4;RALGPS2
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.7983193766679741,-1.2879941756431552,0.16666666666666666,0.8942385706878101,1.0,2/7,8.58%,ENO1;PGK1
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.7422823974009319,-1.287921662994293,0.13043478260869565,0.8922156814531182,1.0,5/10,23.50%,DDX18;PRMT3;MPHOSPH10;WDR43;LAS1L
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.6567928674716319,-1.2877607417387649,0.17857142857142858,0.8906757215857489,1.0,7/15,15.61%,CD55;PARP1;IL1R1;LGALS3;BHLHE40;S100A11;ANXA2
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.7385997349109844,1.287510781093396,0.18181818181818182,0.8323537469677698,1.0,3/7,11.82%,ATP2B4;RYR2;KCNQ1
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.7385997349109844,1.287510781093396,0.18181818181818182,0.8323537469677698,1.0,3/7,11.82%,ATP2B4;RYR2;KCNQ1
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),-0.7717081534340613,-1.287381034900841,0.21428571428571427,0.8900250038092589,1.0,2/10,6.59%,BACH2;RSRC1
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.5502026228518713,-1.286874071540916,0.14705882352941177,0.8906649748265636,1.0,18/78,14.57%,PRSS23;THSD4;ABLIM1;MLPH;FHL2;PGR;KAZN;OLFM1;SLC24A3;RETREG1;ADD3;AKAP1;ELOVL2;DYNLT3;BHLHE40;FOXC1;SVIL;SLC7A2
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),-0.6911892540979325,-1.2868396763389038,0.1509433962264151,0.8882978532067113,1.0,2/14,6.75%,NR4A2;SPOCK1
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.6740744324200505,-1.2868213247089018,0.14814814814814814,0.8858285367962914,1.0,7/28,15.40%,SAT1;SLC8B1;ANXA5;IL1R1;LGALS3;BHLHE40;S100A11
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.7666447980596172,-1.2865564639315337,0.21666666666666667,0.8846202273033128,1.0,4/9,19.83%,PEX1;PEX3;TMEM135;LONP2
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),-0.8607541340295761,-1.2865171755897145,0.14814814814814814,0.8822053019637266,1.0,2/5,4.60%,ST6GALNAC3;ST3GAL5
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),0.8276123864803043,1.2861725154669124,0.16279069767441862,0.8271277085145285,1.0,1/5,2.66%,APC
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),0.8276123864803043,1.2861725154669124,0.16279069767441862,0.8271277085145285,1.0,1/5,2.66%,APC
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),0.8276123864803043,1.2861725154669124,0.16279069767441862,0.8271277085145285,1.0,1/5,2.66%,APC
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.8276123864803043,1.2861725154669124,0.16279069767441862,0.8271277085145285,1.0,1/5,2.66%,APC
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.7363972016064091,-1.2858932049495915,0.15151515151515152,0.8832046680411205,1.0,5/12,19.09%,TWIST1;NGF;FOXC1;HES1;PRKN
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),-0.7765450929633088,-1.285844832639352,0.2,0.8810666742277105,1.0,3/9,8.07%,VEGFA;IFT122;KDM2B
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.770977877213487,-1.285839586154651,0.171875,0.8785401908617498,1.0,3/10,10.20%,AKAP7;AKAP12;PRKAR1A
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.8046759064027256,-1.2857267694327705,0.18867924528301888,0.8764568999372979,1.0,1/6,2.98%,STAT1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.6656163066339065,-1.285687874797699,0.17391304347826086,0.8741579331997502,1.0,4/18,6.26%,IGFBP5;STAT1;NR4A3;THBS1
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),0.7537066660612228,1.2854309118459817,0.15217391304347827,0.8276653121125563,1.0,1/6,1.07%,NOTCH1
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.5464064698016486,-1.2852079130384506,0.08064516129032258,0.8747686353624075,1.0,19/79,10.38%,CLU;IGFBP5;VEGFA;PAMR1;MEGF10;SEMA6D;DKK3;THBS2;COL3A1;NTM;COL1A1;COL1A2;COL6A1;PLPP3;PDZRN3;COL11A1;HEPH;PCDH17;BOC
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),-0.7059077206266703,-1.2852021936314093,0.1746031746031746,0.8722613869214081,1.0,3/16,6.00%,MEGF10;AFDN;CD47
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.8030572623166332,-1.2848783379710633,0.1509433962264151,0.8716318767152171,1.0,1/6,0.90%,PIGG
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.7231985573733871,1.2846379401251222,0.13157894736842105,0.8281634291970759,1.0,3/10,5.74%,PML;BCL2;PACS2
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.730757057655953,-1.284264751949018,0.16393442622950818,0.8722445787337721,1.0,4/11,18.90%,ENPP2;CYP1B1;MT3;ACBD5
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.8424023348492842,-1.2837635372708123,0.14,0.8730783094353839,1.0,1/5,0.38%,CLU
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.7949471758448476,-1.2834125507947896,0.1320754716981132,0.8723679047834961,1.0,2/6,13.27%,PRKDC;PARP9
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.6818303329502421,-1.2826997136498277,0.14814814814814814,0.8743686697356402,1.0,1/14,0.64%,FGF1
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),0.8372188958796936,1.2823134669958878,0.14285714285714285,0.8367133707050672,1.0,2/5,14.81%,AXL;CDC42
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,0.8384317529310716,1.2822074396559222,0.13043478260869565,0.8341932696101308,1.0,2/5,2.05%,CSF1R;TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.792520766183551,1.2820469951134283,0.21739130434782608,0.8319736183914026,1.0,1/6,2.66%,APC
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.4965462689250719,1.2820159534007427,0.07142857142857142,0.8293457847834016,1.0,6/75,9.50%,CSF1R;ERBB4;CAMKK2;SMG1;MAP2K2;EGFR
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.8226670793599579,-1.2819359827183798,0.08928571428571429,0.8769424399802783,1.0,1/8,0.38%,CLU
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),-0.7072211856857384,-1.2818298234506216,0.19298245614035087,0.8751171209951709,1.0,1/10,1.22%,RIMS1
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),-0.7900727369343482,-1.281743329528627,0.13793103448275862,0.8732468014195108,1.0,3/7,15.40%,TSPYL2;RAD17;S100A11
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),-0.8317658223741242,-1.2816376404526555,0.1111111111111111,0.8716077926486311,1.0,1/5,1.03%,AFG3L2
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),-0.7685696905872434,-1.281404324358471,0.1724137931034483,0.8706108690933756,1.0,4/11,11.58%,AK5;NMNAT2;NMNAT3;FHIT
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.6906139530077249,1.2809880370864544,0.14634146341463414,0.827752543696408,1.0,6/16,18.83%,WDR33;PCF11;GRSF1;CPSF2;PAPOLG;TENT4B
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.6906139530077249,1.2809880370864544,0.14634146341463414,0.827752543696408,1.0,6/16,18.83%,WDR33;PCF11;GRSF1;CPSF2;PAPOLG;TENT4B
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.6267530026602359,-1.280368851182789,0.21428571428571427,0.8738724341500269,1.0,4/19,12.72%,CLU;HSP90AB1;AZIN1;APOE
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),-0.7528725867793734,-1.280285708509218,0.12727272727272726,0.8719444736653893,1.0,4/11,14.20%,GLCE;EXT1;CSGALNACT1;XYLT1
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),-0.5765732330372103,-1.2802316776896767,0.1016949152542373,0.8696998674890146,1.0,4/43,6.26%,KCNMB1;KCNMA1;ADAM9;THBS1
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),0.858975234678518,1.279798260479423,0.10869565217391304,0.8304036420367101,1.0,2/6,6.06%,HSPA1A;ARHGEF7
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.6908467810315086,1.2797527856767321,0.16666666666666666,0.8279208942752087,1.0,4/13,11.36%,ZBTB7A;HDAC9;MSH2;ADAM17
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.8148733678939777,1.2795768353151553,0.1956521739130435,0.8206753248532422,1.0,2/5,4.43%,KCNC2;GUCY1B1
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.8148733678939777,1.2795768353151553,0.1956521739130435,0.8206753248532422,1.0,2/5,4.43%,KCNC2;GUCY1B1
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.8148733678939777,1.2795768353151553,0.1956521739130435,0.8206753248532422,1.0,2/5,4.43%,KCNC2;GUCY1B1
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.7813016490062563,1.279535963824316,0.15,0.8152746154012601,1.0,2/5,4.96%,ST3GAL2;ABO
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.7813016490062563,1.279535963824316,0.15,0.8152746154012601,1.0,2/5,4.96%,ST3GAL2;ABO
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.6682423541288702,-1.2794147084369047,0.08196721311475409,0.8720660363436357,1.0,6/20,14.13%,PKM;NR4A3;ENO1;PGK1;DLD;LDHA
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),-0.8460232947641654,-1.2793886133297454,0.125,0.8697250300472723,1.0,2/6,10.60%,TGFB2;PTCH1
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.8057209400857734,-1.2793713077206486,0.12962962962962962,0.8673699353558261,1.0,1/5,1.14%,COLEC12
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.7964496486027259,-1.2793567618481938,0.140625,0.8651088018771858,1.0,3/7,18.24%,HSD11B1;LPL;MT3
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),-0.6697456145665841,-1.279326641167051,0.15,0.8628332175548531,1.0,2/15,6.79%,CSE1L;STRADB
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.7427173844579734,-1.2784183514690515,0.16,0.8656419427291453,1.0,1/10,0.38%,CLU
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.7712140282835861,1.2783170223050946,0.20454545454545456,0.8189972810239534,1.0,2/6,12.64%,ADCY9;RAPGEF2
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),-0.769810375123271,-1.2779084425269012,0.14285714285714285,0.8664014086845707,1.0,4/9,14.20%,SULF2;ADAMTS12;CSGALNACT1;XYLT1
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.5159346181571886,1.2773560860998188,0.1111111111111111,0.8214034060244626,1.0,10/64,6.22%,PPM1L;ST3GAL2;VAPB;MOCS1;SLC44A2;SGPL1;VAPA;PCSK5;HACD2;CERS6
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.7515318179184833,1.2770524458441654,0.23255813953488372,0.8200997627375698,1.0,2/8,8.87%,IRS2;IRS1
prerank,PanglaoDB_Augmented_2021__Myocytes,0.5572642435496311,1.2768055464112025,0.11428571428571428,0.8186019655791955,1.0,10/41,10.38%,LDB3;JPH2;RASL12;CKMT2;MEF2D;PRKG1;NOTCH3;ITGA3;PXN;ITGA7
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",-0.7104620018168943,-1.2766334365516907,0.1896551724137931,0.8710799068287302,1.0,4/14,6.26%,ELMO1;MEGF10;GSN;THBS1
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.7611659426258108,-1.2761010230418168,0.23333333333333334,0.8717938010696378,1.0,3/8,4.51%,KIAA1217;SULF2;COL1A1
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.7098952999878134,1.275878271098831,0.21052631578947367,0.8202451467551781,1.0,4/13,9.08%,CNOT7;TOB1;EIF4ENIF1;AGO2
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.6811406065381479,-1.2754067491465826,0.16071428571428573,0.8732470269997059,1.0,8/18,15.70%,FAXDC2;SOAT1;CYP4V2;CYP1B1;PRKAG2;APOE;CYP27A1;LIPA
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),-0.854531096238446,-1.275085603493237,0.19298245614035087,0.8724952554259229,1.0,1/5,0.43%,TWIST1
prerank,GO_Biological_Process_2021__secretion (GO:0046903),-0.851337739139077,-1.2749330108542503,0.1111111111111111,0.8711667520477081,1.0,2/5,11.37%,RIMS1;SLC22A6
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.5540456023535634,-1.2746323677100535,0.07692307692307693,0.8701876826548984,1.0,8/51,7.06%,THSD4;SHROOM3;VEGFA;KIAA1217;FBLN1;COL1A1;F3;COL12A1
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.7406119930820143,1.2741286745284193,0.20588235294117646,0.8260390637864283,1.0,5/10,24.46%,GRID2;GRIN1;GRIN2B;GSK3B;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.7585080168576457,1.2736131334270187,0.17142857142857143,0.8259749853476791,1.0,1/5,1.62%,ABL2
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.7536387515516056,-1.273428451829254,0.171875,0.8742553858335007,1.0,3/11,8.57%,CIRBP;SNW1;NCL
prerank,PanglaoDB_Augmented_2021__Motor Neurons,-0.6876959709781544,-1.273101697470711,0.15873015873015872,0.8739279721657308,1.0,4/18,8.16%,FGF1;GLI2;NR2F1;MID1
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.7225027094896563,1.2730966792220992,0.2,0.8254111721629933,1.0,2/12,3.66%,SRSF12;TMBIM6
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.5116202956695427,1.272975334725889,0.17647058823529413,0.8230562409241113,1.0,10/36,10.81%,APC;HIPK2;PPM1A;MAP3K7;SMAD7;PMEPA1;RAB31;RHOA;HDAC1;BMPR1A
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.6761685774725166,-1.2727892663025333,0.2153846153846154,0.8733150175138484,1.0,6/15,14.89%,SVIP;UCHL5;N4BP1;HSP90AB1;FHIT;RPL11
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.6603451004037206,1.272418158763512,0.1951219512195122,0.8234992810311842,1.0,4/10,16.62%,PUM2;AGO2;PRKRA;ZC3H7B
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.6611499013487261,1.272365945655164,0.2,0.8210664346740466,1.0,7/16,13.62%,BCL9;SMARCA4;BCL9L;PYGO1;HDAC1;LEF1;EP300
prerank,GO_Biological_Process_2021__artery development (GO:0060840),-0.6900098518852344,-1.2722654374240983,0.1746031746031746,0.8740858651015306,1.0,3/13,5.73%,VEGFA;NRP1;TGFBR1
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.744723593999061,1.2719952489980098,0.17777777777777778,0.820064577764846,1.0,3/7,11.79%,SMARCD3;SMARCA4;ARID1A
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.7890703033149788,1.271850151994874,0.22727272727272727,0.8182487330258738,1.0,2/5,16.20%,NRXN1;NLGN2
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.6147621144706209,1.2712502512995147,0.1794871794871795,0.8185051179944111,1.0,2/15,8.85%,INTS7;TIPRL
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.6435546964232719,1.2712106947109003,0.17391304347826086,0.8160535106216572,1.0,5/15,10.56%,NOTCH1;MICAL2;BBS7;TBX3;RYR2
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.48665904299869794,1.2710598451908592,0.125,0.8140398791999965,1.0,6/54,9.50%,CSF1R;ERBB4;LIFR;ACVR2A;AXL;EGFR
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.5503060569652873,-1.2705710699920616,0.11594202898550725,0.8802821229479987,1.0,16/62,10.78%,TGFB2;PRDX1;KIAA1217;SULF2;CMKLR1;EXT1;COL1A1;GLI2;BMP5;COL1A2;TGFBR1;VCAN;SLC10A7;CREB3L2;COL13A1;SPEF2
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.7447265682522265,1.2705582327471383,0.1956521739130435,0.81388581451718,1.0,3/10,9.30%,ZFYVE28;CBLB;CBL
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.5962528106072243,-1.2694095029007975,0.11940298507462686,0.8838804579450354,1.0,13/40,13.11%,CLU;CIRBP;RPS4X;RPL5;RACK1;PLD1;THBS1;UPF3A;SAMD4A;NSMAF;PRKDC;EPHA4;EEF2
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.5163631901390665,-1.2689535454505498,0.11267605633802817,0.8840487333264174,1.0,29/97,19.73%,XPA;PARP1;NT5E;TERF2IP;RAD51B;DDB2;MSH6;XPC;POLA1;BTG2;BRCA1;RPA1;INO80;RAD17;PRKDC;ORC3;ORC5;WRN;SP100;ZRANB3;MGMT;TCF7L2;TOPBP1;GTF2H1;PURA;MRE11;PARG;XRCC6;FANCC
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.473432248071364,1.2688363638526736,0.12903225806451613,0.8189009103425602,1.0,16/59,14.26%,ABL2;PDK4;TNFRSF1B;NCOA3;GNAI1;ADCY3;TESC;LCOR;AXL;IRS1;RHOA;EGFR;ADCY5;PLAA;NFKB1;TFPI
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.74174075654844,-1.2686483016354484,0.20754716981132076,0.8831852053318973,1.0,5/10,17.74%,MIS18BP1;ITGB3BP;NASP;RNF8;RBBP7
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),0.6952700522254303,1.2684518632972104,0.16666666666666666,0.8184106560838696,1.0,2/11,4.91%,PHC1;UBE2N
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.5145976432960897,-1.2683407890110154,0.15873015873015872,0.8830202588712307,1.0,9/68,9.80%,CLU;TGFB2;RIMS1;VEGFA;ANXA5;THBS1;PROS1;FN1;PHACTR2
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.7125297532473043,-1.2682087969323148,0.2153846153846154,0.8814461106151658,1.0,3/12,19.10%,TRIM13;WRN;XRCC6
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.710145810838459,1.2669587930262285,0.18421052631578946,0.8221607269057836,1.0,6/12,16.20%,GRID2;DLG5;NRXN1;SEMA4D;CLSTN2;NLGN2
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),-0.7932811158961734,-1.2668534718066746,0.24074074074074073,0.8873979249834126,1.0,2/5,15.61%,ANXA1;ANXA2
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.5980455279625179,1.2663705523949247,0.08571428571428572,0.8223354416604651,1.0,4/28,9.21%,RGS6;RGS12;MGRN1;RGS5
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.8058221082693577,-1.2661670535537504,0.1896551724137931,0.8883709384823348,1.0,2/5,13.30%,RACK1;UFL1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.762900838273125,1.265973792507438,0.2727272727272727,0.8212967846638878,1.0,1/10,0.72%,HSPB1
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.757533517354295,1.2659685605747821,0.22,0.8187697176341526,1.0,2/5,20.60%,PPARA;NFIB
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.773212476953735,1.2657221460005292,0.22,0.81730447629742,1.0,1/8,0.21%,CSF1R
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.8206694256943341,1.2651095279257534,0.26666666666666666,0.8173338559314605,1.0,1/6,2.17%,TMEM30A
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.7154068302742376,1.2647198388035774,0.18181818181818182,0.8165752214207919,1.0,2/11,2.63%,CSPG4;CHST3
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),-0.7382097710464446,-1.2642011653952403,0.1836734693877551,0.8964867655154978,1.0,2/12,1.62%,PDGFD;VEGFA
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.6635334195874876,-1.263701948500855,0.21666666666666667,0.8974057457916992,1.0,1/15,1.22%,RIMS1
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.7599507867241062,-1.2635495830348842,0.2727272727272727,0.8961436914635843,1.0,1/7,4.33%,GLI3
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,-0.5420167987338352,-1.26268998203609,0.12307692307692308,0.8987246563544143,1.0,16/73,8.95%,SLC47A1;IGFBP5;PAMR1;FBLN1;SEMA6D;IGFBP2;DKK3;COL3A1;COL1A2;COL6A1;PLPP3;SLIT2;PDZRN3;DCN;LAMA4;LAMB1
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.7100656003954487,1.262576128163104,0.22448979591836735,0.8236756023234544,1.0,2/10,10.11%,PML;HK1
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),0.756353661990651,1.2621907468457882,0.19047619047619047,0.8225264792677406,1.0,1/8,3.45%,EMP2
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.5328206776945283,1.2621700120798764,0.16666666666666666,0.8202288716906392,1.0,10/41,10.91%,CSF1R;ABL2;PDGFA;DLC1;CORO2B;ARHGAP44;RHOA;RHOB;ARHGAP35;RICTOR
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.7505817317917409,-1.2617425536289626,0.22448979591836735,0.9013678424820256,1.0,4/9,10.64%,SPRY1;SULF2;THBS1;SPRY3
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),-0.7189092179599362,-1.2617414107198694,0.1111111111111111,0.8990507014987813,1.0,4/11,8.95%,TGFB2;GLI2;COL1A2;LAMB1
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.6672634424068156,-1.261505107010728,0.16363636363636364,0.897922603267316,1.0,3/21,5.45%,VEGFA;NRP1;RIN2
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.7688011391946267,1.2613168914029549,0.19047619047619047,0.8212141457761258,1.0,3/6,10.25%,KCNC2;GUCY1B1;PDE3A
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.7610216891095265,1.2612950830436593,0.21739130434782608,0.8189032383594987,1.0,3/8,13.39%,CLEC16A;BNIP3;ETF1
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.6240293597194213,-1.2612806956725802,0.1774193548387097,0.8965254744503501,1.0,4/25,6.26%,ZFPM1;NR4A3;FAXDC2;THBS1
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),-0.7800132289804704,-1.2609920649179776,0.11320754716981132,0.8935785636621655,1.0,3/5,15.51%,SPTLC3;ASAH1;SPTLC1
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),-0.7800132289804704,-1.2609920649179776,0.11320754716981132,0.8935785636621655,1.0,3/5,15.51%,SPTLC3;ASAH1;SPTLC1
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.7216700712246518,-1.2606997398829867,0.234375,0.8928972654953238,1.0,2/12,2.74%,KCNMB1;KCNMA1
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.5746595280592685,1.2606364081462405,0.175,0.8192985830324432,1.0,6/31,13.68%,HSPB1;ABL2;MTMR4;USP10;EP300;SCARB2
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.6944687460911754,-1.2602875152386912,0.2,0.8934558629163651,1.0,1/16,2.98%,STAT1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),-0.8294655431548298,-1.2600497382257005,0.16393442622950818,0.8924083184081484,1.0,2/6,5.73%,TGFB2;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.7857102845927232,-1.2599686318023278,0.12727272727272726,0.8905295036218911,1.0,3/6,12.00%,JAM2;LGALS3;ANO6
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.6625854088746378,-1.259716899389359,0.21818181818181817,0.8894209482560314,1.0,6/19,8.53%,FGF1;VEGFA;EPN1;PKM;THBS1;BMPER
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.6585469309651155,-1.2596771657831116,0.17857142857142858,0.8873387091358548,1.0,4/26,9.08%,XPA;PARP1;DDB2;RPA1
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),0.7860973415969431,1.259659598760309,0.24444444444444444,0.8190362678988534,1.0,1/5,6.62%,MYO1E
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),0.7860973415969431,1.259659598760309,0.24444444444444444,0.8190362678988534,1.0,1/5,6.62%,MYO1E
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.6663979100695776,-1.2596484166266415,0.18333333333333332,0.8851692019791031,1.0,8/17,19.10%,PARP1;TERF2IP;RPA1;PRKDC;WRN;SP100;MRE11;XRCC6
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.7278892768508977,1.259562859537896,0.17777777777777778,0.8169739547670892,1.0,4/7,26.02%,RHOA;CDC42;EZR;OPHN1
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.5593549832011748,1.2592760751527157,0.20454545454545456,0.8157495330461998,1.0,10/30,18.61%,MAP3K7;PHF20L1;PHF20;APBB1;LEF1;EP300;JADE2;HAT1;MEAF6;JADE1
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.7094170864943299,-1.2591263975530096,0.24074074074074073,0.8855925598482352,1.0,4/7,20.55%,PLPP3;PTS;CALM1;PRKG2
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.7532126899638026,-1.258871332063391,0.21428571428571427,0.8844830175222249,1.0,3/8,17.47%,SLC38A1;SLC6A20;SLC1A1
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.7275907075134189,1.258413222234768,0.2619047619047619,0.8170935657232509,1.0,2/6,11.69%,MTARC2;PPA2
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),-0.7727350776668714,-1.2582842999941877,0.3125,0.8854149755310299,1.0,4/7,15.51%,CYP1B1;TEX2;ST3GAL6;SPTLC1
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.8377085492663553,1.258223669359902,0.1951219512195122,0.8129074682825197,1.0,3/5,16.20%,NRXN1;NLGN4Y;NLGN2
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.8377085492663553,1.258223669359902,0.1951219512195122,0.8129074682825197,1.0,3/5,16.20%,NRXN1;NLGN4Y;NLGN2
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),-0.7337202936784608,-1.2581221127412254,0.1935483870967742,0.8818143424246131,1.0,1/10,1.41%,SLC4A4
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),-0.7337202936784608,-1.2581221127412254,0.1935483870967742,0.8818143424246131,1.0,1/10,1.41%,SLC4A4
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.6696640224395283,-1.25753100011078,0.15384615384615385,0.8831068709982832,1.0,10/22,17.15%,ANXA1;ADAMTS12;ERAP1;N4BP1;BIRC2;IL1R1;APOE;UFL1;APPL2;TMSB4X
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.4862700665118539,1.2567305228116756,0.11764705882352941,0.816937901954401,1.0,14/54,11.36%,HSPA1A;BCL9;HIPK2;LEMD3;ZEB2;PPM1A;BCL9L;ZBTB7A;SMAD7;PMEPA1;ITGA3;PPARA;MTMR4;ADAM17
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.6125332410057986,1.256227003202015,0.18181818181818182,0.8163642745798153,1.0,8/19,20.18%,RHOA;LRRC7;CDC42;PARD3;LIN7A;LIN7C;PARD3B;EZR
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.7293429127015306,-1.2562133140400655,0.2,0.8879690199706645,1.0,1/12,0.63%,COL15A1
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.8116997450312914,-1.2555510051571526,0.1694915254237288,0.889431655532196,1.0,1/5,2.57%,SUPT6H
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),-0.755673527458087,-1.2552025581261044,0.25806451612903225,0.8889048952546467,1.0,1/9,1.01%,ARHGAP24
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.6901320310711715,1.2551764854836225,0.18181818181818182,0.8187386529759251,1.0,2/12,2.63%,CSPG4;CHST3
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),-0.7477855189844278,-1.2551531543856003,0.19298245614035087,0.8869512523612413,1.0,4/11,6.66%,ANXA1;ADAM9;SLIT2;ZFP36L2
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),-0.8228761660197458,-1.2551081482832764,0.20689655172413793,0.8850784149555235,1.0,2/6,10.52%,LIMA1;PLEKHH2
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),0.7318816479619104,1.2551016361095984,0.21739130434782608,0.816575221420792,1.0,1/11,1.32%,CNOT7
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.5684219053894983,1.2550206820345837,0.14285714285714285,0.8144840431995489,1.0,4/35,11.23%,INTS7;INTS2;ZNF143;ELL
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.6081949820456269,1.254914351768836,0.20454545454545456,0.8124942815260469,1.0,7/14,21.86%,OPCML;NXPH1;GRIN1;CKB;NLGN2;GRIA2;GRM5
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),-0.5874357712452664,-1.254892984428501,0.21212121212121213,0.8841155939504861,1.0,10/33,12.75%,PLXNC1;RIPOR2;FBLN1;ADAM22;GCNT2;SPOCK1;TBCD;JAM3;CYP1B1;PLXNA2
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.5374464176572974,1.2546351048864035,0.2222222222222222,0.8111397032511425,1.0,4/40,6.18%,HSPA1A;BACH1;EPAS1;HIF3A
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.5684988608108038,1.2545464923245802,0.14,0.809289395572273,1.0,4/34,11.23%,INTS7;INTS2;ZNF143;ELL
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.522159992052234,1.2542711322051898,0.09090909090909091,0.8079517145616647,1.0,8/49,5.74%,TRPC6;VAPB;PML;BCL2;ATP2B4;PDZD8;PTH1R;PACS2
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.5496354750138359,1.2542198649513752,0.11363636363636363,0.8058265483413953,1.0,4/31,5.50%,TRPC6;GABRB1;SLC12A2;SLC26A3
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.7251531304687124,-1.2539633133657229,0.18518518518518517,0.8869179676999495,1.0,1/11,0.38%,CLU
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.7280830670633153,1.2538174668811235,0.2391304347826087,0.8028421637650259,1.0,2/6,9.08%,EIF4ENIF1;AGO2
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.7280830670633153,1.2538174668811235,0.2391304347826087,0.8028421637650259,1.0,2/6,9.08%,EIF4ENIF1;AGO2
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.6160763784384676,1.2533629302696647,0.125,0.802647366861051,1.0,5/22,7.73%,HSPA1A;SMAD7;GNL3L;SPOPL;MARCHF7
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),-0.5860568459021154,-1.25300325774426,0.14545454545454545,0.889801179481711,1.0,2/36,0.88%,PRAG1;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.6763894503252728,-1.2526573185633068,0.2037037037037037,0.8895635905688051,1.0,6/13,24.56%,RPS20;DDX5;RPL37;RPS7;RPL23;PLA2R1
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.6427727022416005,1.2526015889719044,0.15,0.8038512645029497,1.0,5/16,10.59%,TRPC6;SNX4;KIF5B;CACNB2;P2RX4
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),-0.7363165009170547,-1.2523108793517694,0.1509433962264151,0.8894445468335767,1.0,3/7,14.93%,JAM2;RNF8;BBS4
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.6337286356944233,-1.251993001983213,0.19672131147540983,0.8888341642491895,1.0,8/20,19.10%,PARP1;TERF2IP;RPA1;PRKDC;WRN;SP100;MRE11;XRCC6
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.5253394553423878,-1.251894189931559,0.078125,0.8871984997116786,1.0,17/97,7.75%,IGFBP5;NR4A2;SPRY1;SULF2;NKD1;DKK3;APCDD1;SFRP4;RACK1;GLI3;GPC3;ADAMTS12;IFT122;BMP5;CD47;THBS1;DCN
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.7812265377087991,-1.251846121527131,0.08771929824561403,0.8854540803125616,1.0,1/9,4.89%,CENATAC
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.6641248436814915,-1.2518182122875814,0.15517241379310345,0.8835086550321108,1.0,8/18,23.72%,RPL23A;RPL5;RPL6;RPL11;RPS14;EIF2A;RPL24;RPS28
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.9027723831131712,-1.2517633696141044,0.11320754716981132,0.8816420768305524,1.0,1/5,0.77%,AK5
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.7676042020208174,-1.2517483246335113,0.07547169811320754,0.8796223178088042,1.0,1/10,0.38%,CLU
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.8111936263700215,-1.2517210162620513,0.16129032258064516,0.8776352004921649,1.0,1/5,0.88%,TGFB2
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.7733397102792752,-1.251390077293861,0.16666666666666666,0.8774774231963367,1.0,2/5,4.65%,GPC3;NR4A3
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.7250520396757774,-1.2512313004408164,0.21052631578947367,0.876355087734514,1.0,2/7,8.97%,CEMIP;HEXB
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.5787130756087379,1.250917271578511,0.2,0.8075163582049163,1.0,3/19,8.57%,MGRN1;MARCHF7;RAD18
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,-0.596128628560895,-1.2508428001396383,0.19298245614035087,0.8760634797533423,1.0,10/30,16.33%,CLU;ACTG1;LSS;ANXA5;ALCAM;LGALS3;PLSCR1;S100A11;LPL;SREBF2
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.5732783818809298,-1.250222736341309,0.11666666666666667,0.8771457795216283,1.0,7/53,8.69%,GBP2;TGFB2;WARS1;STAT1;EIF3J;CD47;BRCA1
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",-0.8416854062841065,-1.2498936820241817,0.18181818181818182,0.8768080422828398,1.0,1/6,1.68%,NRP1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.5515173400440047,1.249803949902025,0.21621621621621623,0.8100317331379462,1.0,7/23,19.92%,CNOT7;RC3H2;CNOT6;DCP1A;DIS3;CNOT4;PAN3
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.7129270452202994,-1.2495008261236322,0.25862068965517243,0.8766084938873687,1.0,3/9,12.40%,DDX60;BIRC2;UFD1
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),-0.7369885476356719,-1.2494606586953116,0.1509433962264151,0.8748197465885462,1.0,6/12,17.47%,SLC6A20;SLC25A13;SLC7A2;SLC1A2;SLC1A3;SLC1A1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.6033559773008669,1.2492941962460162,0.2,0.8098767753643029,1.0,5/26,3.83%,HSPA1A;HSPB1;BCL2;TMBIM6;BCL2L1
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),-0.8217928347629084,-1.2489943561466668,0.3,0.8728272501061959,1.0,1/5,2.04%,PHLDB2
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),-0.8217928347629084,-1.2489943561466668,0.3,0.8728272501061959,1.0,1/5,2.04%,PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.7840791732467725,-1.2488757385442544,0.20408163265306123,0.8693001528955389,1.0,1/7,2.21%,FBLN1
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.7840791732467725,-1.2488757385442544,0.20408163265306123,0.8693001528955389,1.0,1/7,2.21%,FBLN1
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.7841547731455301,-1.2485823039227504,0.10606060606060606,0.8685367865140965,1.0,3/6,11.41%,IFITM3;GSN;PPIA
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.759221166387157,-1.2478716229826987,0.16,0.8698604467198099,1.0,4/6,20.13%,DDX18;WDR12;ZNHIT6;RPL35
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.7601657566493367,-1.2475486339340525,0.13333333333333333,0.8697028019992689,1.0,1/8,1.14%,COLEC12
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.6995334648336043,-1.2474725295524443,0.25,0.8681186006657473,1.0,2/12,3.19%,VEGFA;ANXA1
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.7218967818754178,-1.2473321994536406,0.16129032258064516,0.8670311253309827,1.0,6/13,22.02%,UCHL5;NUB1;EPHA4;APOE;PRKACA;PSMD14
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.6308352439356848,-1.247319394130614,0.19298245614035087,0.8651271995226232,1.0,4/21,6.90%,AFG3L2;ERAP1;ADAM9;APH1B
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.777024071093397,-1.2470415287817822,0.2,0.864605176415189,1.0,1/6,0.79%,DDX60
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.46582895893924364,1.246477582991219,0.041666666666666664,0.8193680635800182,1.0,8/75,4.99%,ADGRB3;CACNA1B;LSAMP;CSRNP3;FILIP1;KALRN;OPCML;CNTN1
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.7172577396223132,1.2464054022425288,0.225,0.817379163270292,1.0,2/11,1.35%,GJC1;CACNA1C
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.6150344991539511,1.2459761839415293,0.18421052631578946,0.8168901808315577,1.0,2/14,8.85%,INTS7;TIPRL
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),-0.5623088781719516,-1.2457468568685182,0.15151515151515152,0.8688368807692917,1.0,8/47,9.13%,FGF1;VEGFA;NRP1;RIN2;PLPP3;THBS1;SASH1;BCAS3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.7943917279740815,-1.2456529835966748,0.20754716981132076,0.8674709598801403,1.0,1/6,2.20%,RAD51B
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.5241531865338613,1.245481952146225,0.1111111111111111,0.8166323285766365,1.0,4/31,4.36%,JPH2;VAPB;ATP2B4;PTH1R
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,-0.5995057905610863,-1.2453684679666293,0.2,0.8668811857351205,1.0,12/34,20.15%,SHROOM3;KIAA1217;RPL23A;NR2F1;ATP1B1;WNK2;SLC7A2;EFNB2;DDAH1;HES1;MARK1;LRIG3
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),-0.7953862764849111,-1.2452335555372527,0.2222222222222222,0.8655916498043182,1.0,1/9,1.68%,NRP1
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.8367740055759476,1.2448228118744789,0.24390243902439024,0.8170023451897117,1.0,3/5,15.74%,RAP1A;RAPGEF2;RAPGEF1
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.6450950482097493,-1.2444105759335204,0.27450980392156865,0.8675711713427632,1.0,3/16,15.50%,NR4A2;THRB;PTMA
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.44851936569535544,1.244029548362798,0.038461538461538464,0.8181938327582863,1.0,8/79,5.42%,TRPC6;KCNC2;SLC6A16;CACNA1C;ATP2B4;SLC12A2;KCNH7;ATP6V1H
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),-0.8300472641554628,-1.2428843434736414,0.15789473684210525,0.873671897456264,1.0,1/5,0.59%,KCNMB1
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.7555239887893657,1.2422403217026385,0.2631578947368421,0.8226071451996243,1.0,1/5,8.61%,GLUD1
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.48954586957377416,1.2421870018353007,0.16666666666666666,0.8205007922784212,1.0,6/60,7.92%,CSF1R;PIP5K1B;ARF1;LCLAT1;MTMR1;INPP4B
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.6325331689757736,-1.2420141244864225,0.19047619047619047,0.8757335625780998,1.0,4/28,8.53%,TGFB2;ENPP2;SASH1;BMPER
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.4954028663732287,1.2414863628855441,0.16666666666666666,0.8212505391442373,1.0,14/43,21.09%,PISD;ZEB2;CLEC16A;MAVS;SURF4;PAK2;EP300;SCARB2;TJP1;PDE4DIP;MYO5A;EZR;ARMH3;PDE2A
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.7336642339237166,-1.2414804164289557,0.21052631578947367,0.8725289462180014,1.0,4/9,17.74%,MIS18BP1;ITGB3BP;NASP;RBBP7
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.7336642339237166,-1.2414804164289557,0.21052631578947367,0.8725289462180014,1.0,4/9,17.74%,MIS18BP1;ITGB3BP;NASP;RBBP7
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.7336642339237166,-1.2414804164289557,0.21052631578947367,0.8725289462180014,1.0,4/9,17.74%,MIS18BP1;ITGB3BP;NASP;RBBP7
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.660488990080758,-1.2405003922054645,0.24528301886792453,0.8746181160681251,1.0,3/12,13.46%,DDX60;SASH1;PLSCR1
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),-0.5612865576157456,-1.2400969905160661,0.13846153846153847,0.8745417877693297,1.0,7/42,6.75%,TGFB2;NR4A2;VEGFA;GLI2;TENM4;TGFBR1;SPOCK1
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.7610533471664863,-1.2397108734849283,0.31746031746031744,0.8743797347210346,1.0,1/5,2.98%,STAT1
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.5544760112077901,1.2391213769906577,0.15384615384615385,0.8292710111869656,1.0,7/30,6.22%,PPM1L;ST3GAL2;VAPB;SGPL1;VAPA;HACD2;CERS6
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.7776420143383299,-1.23845106634771,0.23333333333333334,0.8792418973628835,1.0,3/7,12.99%,ALDH3A2;NGF;PMP22
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),-0.5674085531993285,-1.2382213203113608,0.1111111111111111,0.8784062004039686,1.0,10/45,9.83%,TWIST1;FGF1;VEGFA;PKM;THBS1;F3;SASH1;BMPER;BRCA1;ADAM12
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.700115399227941,1.238179994029153,0.19607843137254902,0.8308893080094519,1.0,2/6,20.82%,GAS6;KDR
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.7707425584545584,-1.2380265360724252,0.19230769230769232,0.8776169087849948,1.0,4/8,16.91%,THBS1;PDCD4;ANO6;RGCC
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.5194021728000063,1.2378833919033352,0.16216216216216217,0.8296773007518338,1.0,7/37,11.36%,NCK2;ERBB4;NRG2;CBL;EGFR;RPS6KA5;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.7997801334178329,1.2377155042134993,0.2631578947368421,0.8279703309626085,1.0,2/5,17.56%,SLC27A1;ABHD5
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.5330286410555397,1.237626018465825,0.15151515151515152,0.8260502503613285,1.0,4/30,9.14%,CSF1R;IRS2;IRS1;RHOA
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),-0.680914374617511,-1.237346768231132,0.14754098360655737,0.8791770716139995,1.0,3/20,8.18%,NRP1;HSP90AB1;ALCAM
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.7954624917180513,-1.2370139202013382,0.26,0.8789641234349018,1.0,1/5,2.20%,RAD51B
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.7825419787354566,1.236491693502172,0.11320754716981132,0.8262483185404453,1.0,1/6,0.10%,CSPG4
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.7825419787354566,1.236491693502172,0.11320754716981132,0.8262483185404453,1.0,1/6,0.10%,CSPG4
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.7914747073386623,-1.2364376649279636,0.21818181818181817,0.8800261780588787,1.0,2/8,5.49%,RACK1;TENM4
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.6051828606900113,-1.236394033143778,0.1774193548387097,0.8783291131003477,1.0,2/27,2.21%,NRP1;FBLN1
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.6304050401539156,-1.2356932751294527,0.19047619047619047,0.8799587972220775,1.0,10/21,23.58%,AFG3L2;ATP5PF;HSPA9;MICOS10;ATP5MC2;ATP5F1E;DMAC2L;SPG7;ATP5ME;ATP5F1C
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.7160375691812311,1.235573012608065,0.2,0.8279039105686045,1.0,4/8,26.02%,RHOA;CDC42;EZR;OPHN1
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.6957154134289564,-1.2353372243837968,0.2222222222222222,0.8796827092966635,1.0,1/14,2.98%,STAT1
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.8025911053019565,-1.2352363530427277,0.21666666666666667,0.8782920787965035,1.0,1/7,1.70%,PRDX1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.6982461156211759,1.234685383880415,0.1891891891891892,0.8297981099712701,1.0,5/7,24.29%,AXL;GAS6;HLA-E;AP1G1;IL18
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.6634772733123736,1.2346134942754168,0.21739130434782608,0.8281454038550522,1.0,4/14,14.81%,CTNND2;ARF1;ITGA3;CDC42
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),-0.6000201331355968,-1.2344528431871624,0.13114754098360656,0.8801003850491947,1.0,6/29,13.30%,PARP1;AFDN;RACK1;HSP90AB1;DZIP1L;UFL1
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.7417373948766675,1.2342774385538264,0.2777777777777778,0.8272671011199257,1.0,2/8,12.72%,CNTN4;NPTN
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.7047500956368495,-1.2342240081584896,0.2711864406779661,0.8792178956272971,1.0,8/19,17.02%,CDC37;ERAP1;N4BP1;HSP90AB1;BIRC2;PARP9;PLSCR1;APPL2
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.7236245829747543,-1.2341706948105582,0.21153846153846154,0.8774816163272884,1.0,1/9,0.88%,TGFB2
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),-0.6893692787959911,-1.2340372184056074,0.2222222222222222,0.876316291056073,1.0,4/17,8.18%,NRP1;SLIT2;HSP90AB1;ALCAM
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.5561056015293977,-1.2335312277911847,0.2,0.8747694811746604,1.0,16/38,19.92%,SLC4A4;SLC2A3;LEPR;SLC38A1;ABCB1;SLC24A3;SLC6A20;SLCO1C1;SLC7A2;SLC6A13;SLC1A2;SLC1A3;SLC1A1;SLC44A1;SLC16A12;SLC2A1
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.5561056015293977,-1.2335312277911847,0.2,0.8747694811746604,1.0,16/38,19.92%,SLC4A4;SLC2A3;LEPR;SLC38A1;ABCB1;SLC24A3;SLC6A20;SLCO1C1;SLC7A2;SLC6A13;SLC1A2;SLC1A3;SLC1A1;SLC44A1;SLC16A12;SLC2A1
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.6004474853551601,1.2335274481301084,0.24,0.8277570737564697,1.0,1/13,0.66%,CACNA1B
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.6635461201667603,-1.2330295203008461,0.1896551724137931,0.8753179092257585,1.0,4/19,1.65%,TGFB2;RIPOR2;ARHGAP24;SPRY1
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.7676719958778921,1.23293911777044,0.17647058823529413,0.8277276478292706,1.0,4/10,18.03%,MYO1E;MYO1D;MYO1B;MYO5A
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),-0.7264979179548139,-1.2325505710374292,0.1935483870967742,0.8756777606559655,1.0,3/11,10.78%,SFRP4;TGFBR1;SPEF2
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),-0.7534787704346024,-1.2322854531482146,0.16666666666666666,0.8753959095013815,1.0,3/8,5.09%,TGFB2;GLI3;GLI2
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.7898358466507925,1.2321105705449191,0.18421052631578946,0.8288378215099045,1.0,4/6,17.36%,AXL;MAVS;GAS6;DHX9
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),0.7176757489004839,1.2316632149281772,0.2727272727272727,0.8287245445839551,1.0,4/10,5.49%,NOTCH1;TNFRSF1B;DAAM2;TNFRSF21
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.7475927866473251,-1.2316013869279248,0.2857142857142857,0.876578375331521,1.0,2/9,4.65%,IGFBP5;NR4A3
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.4888724942319055,1.2314147203629606,0.16666666666666666,0.8278292078481466,1.0,21/70,23.12%,DPP10;RAB40C;EMP2;TESC;PACS2;EHD2;CACNB2;RAP1A;ARL3;RAPGEF2;GAS6;LIN7A;LIN7C;MYO5A;ANK2;RAB10;EZR;FCHO2;ROCK1;SMURF1;FLNA
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.7309007687329421,-1.2309568612023067,0.15789473684210525,0.8780848871402318,1.0,2/10,9.90%,CD55;IL1R1
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.6471059502188551,1.2304283086351582,0.20930232558139536,0.8298725631725679,1.0,7/15,19.79%,ATP2B4;RYR2;GRIN1;ERO1A;GRIN2B;RYR3;SLC8A1
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.4781532356742143,1.2298473917107369,0.1875,0.830187045759452,1.0,7/78,6.51%,HSPA1A;HSPB1;EIF4ENIF1;HSPA8;RC3H2;METTL14;PUM2
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.6763708514404498,-1.2294646968380178,0.24561403508771928,0.8832583006975421,1.0,6/15,15.17%,TERF2IP;SUPT6H;MSH6;THOC1;SPIDR;ZRANB3
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.565435650908803,1.2288373095054335,0.25,0.8315710279399644,1.0,6/27,12.74%,CNTN4;GPRC5B;ZFHX3;HEYL;RHOA;BIN1
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),-0.6198485022541015,-1.2283487720276556,0.22807017543859648,0.8867308410243323,1.0,3/19,5.81%,FSIP2;IFT122;TCTN1
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.529940788642104,-1.2280235982321326,0.18333333333333332,0.8866331643625948,1.0,8/52,9.80%,CLU;TGFB2;VEGFA;ANXA5;THBS1;PROS1;FN1;PHACTR2
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.722196967537282,1.2279627241723157,0.2857142857142857,0.8326807674423384,1.0,1/11,0.72%,HSPB1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.7247665901931939,-1.22795645255254,0.19298245614035087,0.8851288251774939,1.0,2/11,8.69%,SNW1;BRCA1
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.6111929659034223,-1.2275337621814182,0.19298245614035087,0.8851162923950078,1.0,5/22,15.74%,TWIST1;CD47;HLA-B;IL16;LPL
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.5181118513562307,-1.227515403885695,0.11267605633802817,0.8832964413156369,1.0,17/76,14.49%,GLCE;VEGFA;NT5E;PKM;EXT1;GPC3;ENO1;VCAN;DCN;PGK1;PPIA;GLRX;PAM;DLD;LDHA;NASP;SLC25A13
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.7906296003843064,1.2271715233370732,0.15,0.8341843895455193,1.0,4/8,14.23%,CAB39;NEDD4L;BIN1;COMMD1
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.6395028782546878,-1.227144757627107,0.23214285714285715,0.882922984947072,1.0,1/18,0.38%,CLU
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.6963324334723542,-1.226830679198329,0.21818181818181817,0.8826724156427778,1.0,4/8,12.64%,RIPOR2;SLIT2;JAM3;DAPK2
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),-0.5966027137777111,-1.2267783699171764,0.14035087719298245,0.8811312555382399,1.0,3/32,5.73%,PRAG1;VEGFA;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),-0.6798914036061773,-1.2265205657103015,0.19672131147540983,0.8807041533660261,1.0,3/17,8.69%,TET1;SNW1;BRCA1
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.7728593886616705,-1.2260457273691523,0.22448979591836735,0.8812435419732142,1.0,2/6,2.12%,PARP1;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.596997042903656,1.2257722154858208,0.23529411764705882,0.8377528743273804,1.0,4/17,9.19%,SMARCA4;ZBTB7A;HEYL;HDAC1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.7257499282881892,-1.225615568205183,0.20634920634920634,0.8810586512928292,1.0,2/6,19.09%,RPS7;PRKN
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),-0.8362488348887699,-1.2255887959051894,0.15789473684210525,0.8794933980701212,1.0,2/5,5.73%,TGFB2;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.564523494735338,-1.2253729281616625,0.18333333333333332,0.8786936082190168,1.0,13/48,13.60%,CLU;TGFB2;VEGFA;WARS1;RACK1;GPC3;SLF1;TGFBR1;ABCB7;LGALS3;RPS3;APOE;SPIDR
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),-0.7636445929371575,-1.225164393583975,0.25925925925925924,0.8776578683701389,1.0,2/8,8.69%,TGFB2;BRCA1
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),-0.7879890237494577,-1.2250919217531449,0.2857142857142857,0.8761687868627945,1.0,3/7,19.92%,NR4A3;PRKAG2;SLC2A1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.7438129549387889,1.2247355448082782,0.1590909090909091,0.8399248731595689,1.0,4/8,18.33%,RYR2;NEDD4L;KCNQ1;ANK2
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.7678515246945472,-1.2243436702484345,0.22033898305084745,0.8775843698936302,1.0,1/5,2.89%,AFDN
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.5590581239149255,1.2241706443588445,0.17857142857142858,0.8401295133138907,1.0,6/26,6.19%,TNFRSF10B;BCL2;TNFRSF1B;SORT1;BCL2L1;CASP8AP2
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.7540814491838033,-1.2241668184141719,0.2830188679245283,0.8766958753193878,1.0,2/5,20.24%,BTG1;BCL2L11
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.667065602148357,-1.2240390954938092,0.23636363636363636,0.8755143810303364,1.0,5/14,14.13%,PKM;ENOSF1;ENO1;PGK1;LDHA
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.7293514606288599,1.2236573850318273,0.14583333333333334,0.8403858460960366,1.0,1/8,0.10%,CSPG4
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),-0.7903529208838351,-1.2236076773919125,0.3064516129032258,0.8758176488218877,1.0,1/5,5.12%,PER2
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.5763101135549529,-1.2235635931758806,0.203125,0.8742291279753889,1.0,6/36,8.61%,STAT1;CDC37;RACK1;HSP90AB1;OTULIN;BIRC2
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.6785948787803269,1.2235293989228933,0.32558139534883723,0.8387471836605488,1.0,2/9,4.43%,KCNC2;GUCY1B1
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.7444301436885334,1.2233392777035534,0.27906976744186046,0.8352069008840703,1.0,2/6,8.87%,IRS2;IRS1
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.7444301436885334,1.2233392777035534,0.27906976744186046,0.8352069008840703,1.0,2/6,8.87%,IRS2;IRS1
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.6529480465477833,1.2229782546496617,0.24390243902439024,0.8346117090183424,1.0,5/12,12.64%,GNAI1;MGRN1;PEX5L;PDE3A;RAPGEF2
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.5003457886830303,-1.2229147711265564,0.0821917808219178,0.8752216433123886,1.0,14/69,9.93%,FGF1;IGFBP5;GBP2;KIAA1217;COL3A1;COL1A1;COL1A2;PLPP3;FMO2;F3;COL12A1;DCN;FN1;NTN4
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.6698407160238118,1.2229028438792187,0.19148936170212766,0.8327958113817382,1.0,2/14,2.63%,CSPG4;CHST3
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.5088564763035262,1.2224502231291619,0.17647058823529413,0.8317681641258097,1.0,8/39,12.40%,NEURL1B;EIF4ENIF1;IPO8;IPO11;RALA;HK1;RYR2;IPO9
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.6474271568140387,1.2220644700892793,0.20454545454545456,0.8313415002891608,1.0,1/14,0.03%,HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.5204117539241666,-1.222042188202793,0.18181818181818182,0.8774458737739567,1.0,17/88,9.02%,PDGFD;TWIST1;FGF1;VEGFA;SEMA3C;CEMIP;ACTG1;SEMA6D;RACK1;COL1A1;TGFBR1;ADAM9;GCNT2;THBS1;F3;LAMB1;SEMA3D
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.6587064404507212,1.221878529728876,0.13333333333333333,0.8301934221071451,1.0,3/11,10.81%,NOTCH1;ERBB4;BMPR1A
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.5224427036117923,1.2215099941913328,0.2222222222222222,0.8297212602138285,1.0,4/37,8.90%,VAPB;VAPA;SEC23A;PPP6C
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.526812148649809,1.2213804458255861,0.22580645161290322,0.8280686757937088,1.0,9/46,4.99%,NOL4;ADGRB3;CACNA1B;LSAMP;CSRNP3;CNTN4;CTNND2;MEG3;CNTN1
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.6966339052505442,1.2211613290183307,0.20588235294117646,0.8268859680053054,1.0,5/9,22.20%,RAD21;PDS5B;MAU2;RB1;POGZ
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.5236676212588968,1.2201647399736657,0.1935483870967742,0.8286514059210619,1.0,4/35,9.14%,CSF1R;IRS2;IRS1;RHOA
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.7651791211500756,1.2200629420921318,0.27450980392156865,0.8269626605556025,1.0,2/5,10.25%,MGRN1;PDE3A
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.7755773939502195,1.220031286088259,0.3617021276595745,0.8250531022193555,1.0,2/6,10.47%,ABCA1;PPARA
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.4855590081902965,-1.2197695465955278,0.1388888888888889,0.8867669131875615,1.0,21/139,14.63%,PRSS23;IGFBP5;KLHL13;DDB2;ELOB;GPC3;LAMC1;ESCO1;VCAN;FBXW2;LAMB1;FBXO22;FN1;NUB1;PSMC2;CALU;APOE;CCN1;WSB1;PSMD8;NAE1
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),0.7455803323878452,1.21941721440241,0.21052631578947367,0.8253370306264702,1.0,3/7,11.52%,HEY2;MYOCD;TMEM204
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.6211824687416451,-1.2193719793359241,0.2033898305084746,0.8868297489260956,1.0,4/28,7.07%,PRAG1;COL3A1;ARHGEF3;NOTCH2
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),-0.7115011863833185,-1.21883278078755,0.2037037037037037,0.8876527110798181,1.0,3/12,4.60%,ST6GALNAC3;SPTLC3;ST3GAL5
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),-0.47048503144304954,-1.2186563116139468,0.13333333333333333,0.8870325014359111,1.0,29/177,9.34%,PDGFD;PLXNC1;FGF1;SRGAP3;IGFBP5;VEGFA;SEMA3C;CEMIP;AFDN;ACTG1;SEMA6D;ANXA1;NKD1;ENPP2;RACK1;COL1A1;LDLRAD4;TGFBR1;TMSB10;ADAM9;GCNT2;THBS1;SLIT2;F3;SGK1;SASH1;LAMB1;SEMA3D;TMEFF2
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),-0.5622070191127965,-1.2185686994768796,0.19117647058823528,0.8857156619380362,1.0,7/47,8.90%,NACA;CDC37;SRP14;SRP54;PEX1;AP4E1;HPS4
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),-0.6905055473320996,-1.2185256909631115,0.203125,0.8841520975932703,1.0,1/16,0.47%,ABLIM1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.7509542183135796,1.2183422726616346,0.22448979591836735,0.8273169654603307,1.0,1/5,8.00%,FBH1
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.7476362870139244,1.2182795135368267,0.24,0.8254458197532081,1.0,3/5,15.03%,FHOD1;PLS3;SPIRE1
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),0.7492162601629808,1.2179713888582486,0.34782608695652173,0.8246174411069059,1.0,1/7,2.17%,TMEM30A
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),-0.6234513648644489,-1.2178059985510907,0.2,0.8856508282922086,1.0,3/21,4.33%,TWIST1;TGFB2;GLI3
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.6637372117865011,1.2178049667724296,0.20512820512820512,0.8211162105776423,1.0,1/13,1.86%,BCL2
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.6637372117865011,1.2178049667724296,0.20512820512820512,0.8211162105776423,1.0,1/13,1.86%,BCL2
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.6972972080649438,-1.217631177104573,0.18,0.8847306106441152,1.0,4/13,9.10%,CDC37;YBX3;BIRC2;PELI1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.7591624901917606,1.2175632115806247,0.24390243902439024,0.8198788634726982,1.0,2/6,16.84%,CNOT6;NBDY
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.6945933510322531,1.2174659526166713,0.24489795918367346,0.8182480196790685,1.0,2/10,6.43%,WTIP;DLG5
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),-0.7304313819748582,-1.2174408208157943,0.2,0.8838718214081499,1.0,2/6,10.59%,COL1A1;COL4A6
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.6847932659775171,1.2173816306054668,0.2916666666666667,0.8167246632792189,1.0,2/7,14.81%,CTNND2;CDC42
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.4263951842905258,1.217012875094954,0.1111111111111111,0.8161279735512211,1.0,18/139,7.14%,HSPA1A;NOX4;H2AC6;NOTCH1;ZBTB7C;CNOT7;PML;NCK2;TOB1;APC;CTBP2;ERBB4;PTPRK;DLC1;TBX3;TESC;DLG5;NACC2
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.5142703890415596,1.2168891343667099,0.15555555555555556,0.8147657325714548,1.0,11/38,16.75%,OPA3;SMARCD3;NFYC;IRS2;TGS1;PPARA;ELOVL6;NCOA2;CCDC3;PANK2;FDFT1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.7136412972188557,1.216706959894932,0.3023255813953488,0.8136325634549185,1.0,1/8,2.79%,PISD
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.7872666037736487,1.216066091420509,0.15789473684210525,0.8143303241322118,1.0,4/5,18.50%,OAZ2;MAOA;AMD1;SLC22A3
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.6526033676748206,1.215942423291423,0.2,0.8128590412389192,1.0,8/11,25.65%,CBL;FBXW7;ADAM17;AFAP1L2;ARAP1;HIP1;AGT;CCDC88A
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.6985250245983667,-1.2156802515156422,0.23529411764705882,0.8888426319640018,1.0,1/10,0.98%,MT2A
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.6985250245983667,-1.2156802515156422,0.23529411764705882,0.8888426319640018,1.0,1/10,0.98%,MT2A
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.7673600821503275,1.2153062549504918,0.2826086956521739,0.8133834604302419,1.0,2/5,9.61%,PAPSS2;PAPSS1
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.4693825020516106,1.2148249864024456,0.2,0.8133910238449115,1.0,29/93,23.12%,DPP10;RAB40C;EMP2;TESC;PACS2;EHD2;AP3D1;NRXN1;SYNE3;CACNB2;RAP1A;ARL3;NUP54;RAPGEF2;LRRC7;GAS6;ARL5A;NLGN2;LIN7A;LIN7C;MYO5A;ANK2;RAB10;EZR;FCHO2;ROCK1;SAV1;SMURF1;FLNA
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.7456479870259883,-1.214508921339856,0.20967741935483872,0.8927881820888328,1.0,1/8,0.38%,CLU
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.5724619683901103,1.2143839049921097,0.16326530612244897,0.813154192273983,1.0,10/27,24.08%,MICALL2;SNX4;EHD2;VPS50;RAB14;VPS26A;EPS15;SNX3;VPS35L;VPS26C
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.6163851275350786,-1.2141328469803891,0.25,0.8927423053457365,1.0,9/31,12.56%,AKR1C2;VEGFA;STAT1;AKR1C1;IFT122;PGK1;LGALS3;PTCH1;PPP2R3A
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.6211008862485661,1.2134663083714101,0.2777777777777778,0.8143080403964269,1.0,5/13,20.39%,UBE2N;FBXW7;BTRC;DCUN1D4;DCUN1D1
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),-0.7650125280491036,-1.2134341836084102,0.2545454545454545,0.8938222083356961,1.0,2/5,10.59%,COL1A1;COL4A6
prerank,GO_Biological_Process_2021__gland development (GO:0048732),-0.6137151209140786,-1.2134324972821584,0.22413793103448276,0.8920798648496617,1.0,5/20,5.73%,ANXA1;DKK3;GLI2;SRP54;TGFBR1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.5346925002927044,-1.2134070941142323,0.19696969696969696,0.8904013121352709,1.0,13/45,23.05%,TEFM;POLA1;RPA1;PSMC2;ORC3;ORC5;WRN;PSMD8;TOPBP1;PURA;UBA52;PSMD14;SSBP1
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.685813268260016,-1.2132203513392046,0.26785714285714285,0.8894500180377687,1.0,5/12,23.55%,AKR1C1;CYP27A1;NPC1;HSD17B4;OSBP
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),0.7584621108053409,1.2130833124730687,0.2608695652173913,0.8138269563419968,1.0,4/7,12.77%,AKAP8;UBE2N;MYOCD;MTHFR
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.7659420645801689,1.2130185400135627,0.2727272727272727,0.8120621474567976,1.0,2/6,5.81%,PACSIN2;EHD2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),-0.653443280118199,-1.2129478864564427,0.27450980392156865,0.8889945933043223,1.0,3/9,6.40%,IGFBP5;NRP1;SLIT2
prerank,GO_Biological_Process_2021__limb development (GO:0060173),-0.6412889955989135,-1.2126671956085726,0.2037037037037037,0.8886542911797201,1.0,4/15,10.60%,GLI3;IFT122;SMOC1;PTCH1
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.8216188798355737,1.2124659675986014,0.25806451612903225,0.8122179588038962,1.0,2/5,16.15%,FBXW7;SLC27A1
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.7062119411815513,-1.2124267324040523,0.25,0.8881267330166489,1.0,4/10,17.74%,MIS18BP1;ITGB3BP;NASP;RBBP7
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,-0.525152945795138,-1.2118976687990184,0.16666666666666666,0.8888057301565696,1.0,22/76,13.20%,IGFBP5;COL6A3;VEGFA;PAMR1;DKK3;THBS2;COL3A1;ADAMTS12;COL1A1;COL1A2;COL6A1;PLPP3;COL12A1;PDZRN3;DCN;LAMA4;FN1;COL6A2;TPM2;C1S;CCN1;SVEP1
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),-0.6117752310169473,-1.2118705547345352,0.23529411764705882,0.887209195174164,1.0,3/21,13.99%,NPRL3;MTM1;TMEM39A
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.7415447844793625,-1.2115410024797917,0.3018867924528302,0.8872873976895151,1.0,3/6,18.35%,RPS21;WDR12;EXOSC10
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.6408758356711468,-1.211407442894383,0.20689655172413793,0.8862238382866588,1.0,6/25,6.77%,TWIST1;TGFB2;COL1A1;TGFBR1;GCNT2;OLFM1
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),-0.6857440648690152,-1.2111767943662233,0.22413793103448276,0.8854444967940696,1.0,3/13,16.96%,ELMO1;ABI2;FARP2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.673560657149128,1.2108212401618512,0.1875,0.8165510709646988,1.0,3/10,10.81%,NOTCH1;ERBB4;BMPR1A
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.7126112512169773,1.2107774361642842,0.2647058823529412,0.8148163476441633,1.0,3/7,7.84%,LEMD3;SMAD7;ACVR2A
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.4954818351414699,1.2103607103806475,0.24390243902439024,0.814411789865659,1.0,11/48,13.09%,EBF4;ZBTB7C;RALGPS1;NDRG2;KALRN;ZNF704;AGAP1;C2ORF72;ADCY5;KCNQ1;SORBS2
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),0.5874898263213938,1.2103065968718183,0.24390243902439024,0.8127140621900144,1.0,1/15,0.63%,SRSF12
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.8036472699174559,-1.2102168933884763,0.25,0.8877439072363841,1.0,3/5,13.12%,VEGFA;THBS1;PDCD10
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.747809161705776,-1.2101604477078378,0.328125,0.8863506555492321,1.0,2/7,5.34%,TGFB2;ADM
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),-0.7772627402232763,-1.2101010260642224,0.21153846153846154,0.8849998417894748,1.0,4/6,14.12%,GPC3;SLIT2;ROBO2;FOXC1
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.7375214641987682,1.2098210832293048,0.3023255813953488,0.8124837316510148,1.0,3/5,20.28%,EPOR;RASSF1;CCND3
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.7276270138928859,1.209441709960886,0.1875,0.8119680060048183,1.0,4/10,22.39%,MAP2K2;MAP2K1;EZR;SNX3
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.5219276427773907,1.2093059595618392,0.21428571428571427,0.8106448932946245,1.0,7/34,9.14%,GJC1;CDH2;GJA4;CTNND2;CDH10;SMAD7;RHOA
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),0.7406172224053982,1.208910391853003,0.28,0.8102308133276928,1.0,3/7,9.91%,TNFRSF21;DLG5;CEBPB
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,0.7268185992625167,1.2085706963021259,0.2608695652173913,0.8096052668540251,1.0,3/7,19.41%,GPRC5C;RHPN2;SMAD5
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.587937474416993,-1.2081663762574482,0.24193548387096775,0.8915685818085325,1.0,10/40,14.52%,PLXNC1;ARHGAP15;VAV3;EPHA3;RALBP1;EPHA5;EPHA4;PLXNA2;WRN;FGD6
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.7574968600639653,-1.208028898122973,0.24561403508771928,0.888899477685001,1.0,6/8,23.58%,ATP5PF;ATP5MC2;ATP5F1E;DMAC2L;ATP5ME;ATP5F1C
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.7574968600639653,-1.208028898122973,0.24561403508771928,0.888899477685001,1.0,6/8,23.58%,ATP5PF;ATP5MC2;ATP5F1E;DMAC2L;ATP5ME;ATP5F1C
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.46651286026972166,1.2080119366457605,0.08823529411764706,0.8098104410330405,1.0,16/72,12.11%,ADGRB3;INF2;WTIP;CDH2;EMP2;PDZD8;BCL9L;CHN1;ADGRA2;ARHGAP44;ARHGAP35;CAMSAP1;BCL6;NEDD4L;SEMA4D;PAK2
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.5621178759607562,1.207890111222932,0.17647058823529413,0.8084807384155515,1.0,4/19,5.41%,VAPB;ACADVL;CTDSP2;GFPT1
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),0.7476056213307954,1.2078353760972282,0.30952380952380953,0.8067803685586759,1.0,1/5,1.07%,NOTCH1
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.5167751107383014,1.2075685201918738,0.14285714285714285,0.8061918425983526,1.0,10/30,12.64%,ADGRB3;GNB1;ADCY9;PTH1R;ADCY3;GPR161;ADGRL2;ABCA1;ADCY5;RAPGEF2
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.7086104007737613,1.2075563693315108,0.2857142857142857,0.8043637431820299,1.0,2/8,15.30%,NPTN;GRIN2B
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),-0.7544614635436655,-1.2074700978453448,0.19607843137254902,0.8896919347292911,1.0,2/10,4.07%,CTSL;SFRP4
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.6102173302545115,1.2074629709384814,0.22448979591836735,0.802894698351568,1.0,3/16,12.64%,NOTCH1;RHOA;RAPGEF2
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.6881754318321087,-1.2074092662092315,0.21818181818181817,0.8883107573973745,1.0,3/13,13.30%,TGFB2;GPM6A;UFL1
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.6497301915563434,-1.2073806337546085,0.21212121212121213,0.8867878863980202,1.0,8/15,23.58%,AFG3L2;ATP5PF;ATP5MC2;ATP5F1E;DMAC2L;SPG7;ATP5ME;ATP5F1C
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.46665512446902413,1.2071452227148138,0.1111111111111111,0.8021556001150215,1.0,15/60,13.03%,ARRDC2;NDRG2;MCAM;OPCML;GPRC5B;GFAP;MOBP;TMEM63A;NRXN1;PEX5L;TNR;ADCY5;SEMA4D;MBP;MYO1D
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.7791429837166466,1.206801491129504,0.3,0.8013965509804238,1.0,2/6,7.23%,SLC12A2;HCN2
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.8423058323556653,-1.2065927299018895,0.21153846153846154,0.888954318041699,1.0,3/5,12.99%,TENM4;EPB41L3;PMP22
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.6781700761062921,-1.2065469296932994,0.21311475409836064,0.8875274054645211,1.0,3/15,10.52%,LIMA1;SLIT2;PLEKHH2
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.49899685463840093,-1.206436700376926,0.16216216216216217,0.886288405144036,1.0,39/97,24.13%,RPL30;RPL19;RPL23A;RPL5;RPL34;RPLP1;RPL15;RPS25;RPL27;RPL35A;RPL36;RPL37A;RPL6;RPL10A;DDX52;RPL11;RPL37;RPL13A;WDR12;RPS24;EXOSC10;RPS14;RPS7;TUT7;RPL7A;RPL28;RPL35;UBA52;RPL23;RPLP2;MPHOSPH10;WDR43;RPL8;INTS8;LAS1L;RPL24;RPS28;INTS10;RPL31
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.6746358873622676,-1.2061785572805812,0.19402985074626866,0.8858923198770032,1.0,5/18,5.61%,CYP3A5;PDXDC1;ENPP2;ERAP1;CPQ
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.7534262244753116,1.205490732329831,0.2553191489361702,0.8042180028801617,1.0,2/5,13.68%,TMEM30A;SCARB2
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.6861601500764635,1.2053367309944816,0.2391304347826087,0.8030405693997401,1.0,2/9,8.85%,MFHAS1;TIPRL
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),-0.5721093046565295,-1.2051323089355537,0.23728813559322035,0.8891174802167432,1.0,1/28,0.64%,FGF1
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.7739126273336178,-1.2050086804252027,0.29411764705882354,0.8879369012640311,1.0,4/6,12.86%,ANXA1;TSHR;CALCRL;CHRM3
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.52264933864546,-1.2045299667537037,0.13513513513513514,0.8885004443647426,1.0,29/76,16.12%,ABCA8;KCNMB1;COL15A1;IGFBP5;COL6A3;PAMR1;C7;THBS2;COL3A1;COL1A1;FBLN2;COL1A2;COL6A1;PLPP3;COL12A1;DCN;LAMA4;MGP;TPM2;CYP1B1;PMP22;C1S;SVEP1;SH3D19;FAM114A1;ASPN;PRRX1;TPM1;UACA
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.5160487643139716,-1.203807771795452,0.21666666666666667,0.8902014913108381,1.0,11/47,12.72%,CLU;IGFBP5;RACK1;EPRS1;BTG2;NCL;SAMD4A;DHX36;LARP1;RPS3;APOE
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.5410222915799091,-1.2031516471370314,0.22058823529411764,0.891246258534705,1.0,3/52,0.88%,PDGFD;TWIST1;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.5528204716907417,-1.203004827111628,0.18309859154929578,0.8903768386819783,1.0,4/52,4.43%,CLU;HECW2;NKD1;GPC3
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.549094171543911,-1.2029571367568324,0.18181818181818182,0.8889169904195364,1.0,8/41,11.41%,WARS1;TERF2IP;FBLN1;PLPP3;SLIT2;DNAJC10;PRKDC;PPIA
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),-0.7827782409252952,-1.2024335112478752,0.2,0.8896710654149804,1.0,3/7,11.29%,IGFBP2;PRKAR1A;RPS3
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.7335048225056433,1.2023951031189393,0.30612244897959184,0.8123897906990417,1.0,3/8,15.22%,FBH1;CECR2;KPNB1
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.7578894764995927,1.2020818226505168,0.3090909090909091,0.8116146746134493,1.0,2/5,4.44%,PDGFA;C1QTNF1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.6867541005788755,1.2020766359964108,0.35,0.8098531113969732,1.0,4/10,11.87%,TNFRSF10B;BCL2;CEBPB;ERO1A
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),0.7860348160391388,1.2010746037034004,0.3191489361702128,0.811246235446963,1.0,1/5,10.70%,IWS1
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.6603366924029592,1.2007539823228504,0.24390243902439024,0.8107079993072406,1.0,3/8,8.84%,CACNA1C;HCN2;CACNB2
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),-0.7659315971041837,-1.2003133135386987,0.25,0.8970896528635566,1.0,1/5,2.21%,FBLN1
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.4978546059749139,-1.200286009114816,0.17567567567567569,0.8956255312139458,1.0,20/120,9.11%,PDGFD;FGF1;TGFB2;VEGFA;NRP1;SEMA3C;CEMIP;ACTG1;SEMA6D;ENPP2;RACK1;COL1A1;TGFBR1;ADAM9;GCNT2;THBS1;F3;LAMB1;SEMA3D;FN1
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.6986599455962128,1.2002569695281662,0.29411764705882354,0.8103093535293028,1.0,6/8,21.33%,CLTC;PICALM;SGIP1;EPS15;HIP1;FCHO2
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.6674293552832196,1.1999354577967885,0.23809523809523808,0.8099809207252711,1.0,3/13,14.53%,UBE2N;MAP3K7;RNF34
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.6080254147138968,1.199793718647568,0.2692307692307692,0.8087204717584328,1.0,3/15,10.81%,NOTCH1;ACVR2A;BMPR1A
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),-0.7204974187198241,-1.1996123767164202,0.29411764705882354,0.8967024942813343,1.0,2/11,4.33%,TWIST1;GLI3
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.722234506247694,1.199581977693852,0.2708333333333333,0.8077154540997706,1.0,1/7,1.07%,NOTCH1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.6303226152626813,1.1994836391636048,0.2222222222222222,0.8062388262129339,1.0,1/16,0.16%,JPH2
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.5186947061807374,-1.1993989520720358,0.22077922077922077,0.8957791629572883,1.0,14/65,10.27%,TGFB2;MT2A;AKR1C2;FBLN1;PGRMC1;ADH5;GCNT2;PROS1;GABARAPL1;PTS;SSR3;HSD11B1;IL1R1;ACO2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.6110518792794131,1.1993509791172599,0.2222222222222222,0.8050400757840138,1.0,4/15,11.04%,TRPC6;CACNB2;P2RX4;GRIN1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.5492787964468342,-1.1993410609562052,0.19047619047619047,0.8944143900707796,1.0,7/53,5.42%,CLU;VEGFA;WARS1;SVIP;RACK1;GSN;SLF1
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.6818205437901229,1.1990651357043802,0.3488372093023256,0.8041399512034779,1.0,2/8,10.07%,PPP2R1A;SH2B3
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.7148654903929625,1.1984990170593588,0.2857142857142857,0.8045723921271354,1.0,2/9,11.65%,BCL2;NEDD4L
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.6546922895444474,-1.1982444358407995,0.22916666666666666,0.8973347063501168,1.0,2/10,5.57%,SRP14;SRP54
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.7439209825964656,1.1982142488119947,0.28,0.8038569612302535,1.0,3/6,17.34%,EGFR;RBPJ;MVB12B
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.7362313070381253,1.1981847319178323,0.22857142857142856,0.8003994341149879,1.0,3/7,20.98%,NLGN4Y;NLGN2;PTPRD
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.7362313070381253,1.1981847319178323,0.22857142857142856,0.8003994341149879,1.0,3/7,20.98%,NLGN4Y;NLGN2;PTPRD
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.8070173021546271,-1.198133456552689,0.3333333333333333,0.8960252470244664,1.0,1/5,8.69%,BRCA1
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.6352531822927922,-1.1976603956051644,0.2653061224489796,0.8965431699634256,1.0,3/22,3.32%,PRDX1;TXNRD1;FTL
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),-0.6323268588246417,-1.1974812450611994,0.26229508196721313,0.8955931481050267,1.0,5/13,10.60%,RACK1;GLI3;GPC3;IFT122;PTCH1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),-0.8019018761794141,-1.1973349474964754,0.24,0.8946112926677139,1.0,3/5,19.10%,LGALS3;PRKDC;XRCC6
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.740903294699321,-1.1972742774047385,0.2909090909090909,0.8931753790452063,1.0,5/9,17.47%,SLC25A13;SLC6A13;SLC1A2;SLC1A3;SLC1A1
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.7271446447880427,-1.1968877158668823,0.36363636363636365,0.8915290494370844,1.0,3/5,18.61%,CTSL;PPIA;CD4
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.7271446447880427,-1.1968877158668823,0.36363636363636365,0.8915290494370844,1.0,3/5,18.61%,CTSL;PPIA;CD4
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),-0.8330604609468393,-1.1963532523396634,0.1346153846153846,0.8927146600861195,1.0,1/6,8.69%,BRCA1
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.5616176434952896,-1.1962585745572296,0.21875,0.8916069448625181,1.0,11/43,18.24%,VEGFA;SFRP4;AKR1C1;THBS1;SLCO1C1;MAPK14;APOE;ANXA2;CHCHD2;EIF4G1;MT3
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),-0.6756448739809146,-1.1960926274523005,0.26229508196721313,0.8906252848049352,1.0,1/11,1.41%,SLC4A4
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.7819280201928837,-1.1958956053237093,0.2542372881355932,0.8898734755886072,1.0,1/5,5.23%,ERAP1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.6642415685863609,-1.1958184363774667,0.3191489361702128,0.88872458698514,1.0,2/10,4.65%,IGFBP5;NR4A3
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),-0.7620504825016524,-1.1956353243535962,0.2413793103448276,0.8880482236109485,1.0,3/7,8.04%,AK5;NMNAT2;NMNAT3
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),-0.7357353407100785,-1.1951184848411336,0.3191489361702128,0.8885173135330514,1.0,2/7,6.40%,BMP5;SLIT2
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),0.6365169432341775,1.1950678012969378,0.30952380952380953,0.8096322000176736,1.0,4/15,7.48%,BCL2;BCL2L1;BNIP3;SLC25A4
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.6228339777153107,1.1949930962481532,0.20930232558139536,0.8081991770282174,1.0,1/11,2.79%,PISD
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.7957191368737611,-1.1946328742770334,0.22641509433962265,0.8892267799953354,1.0,1/5,2.25%,PGRMC1
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.7851215040388573,-1.1943730425297092,0.23636363636363636,0.887433913065851,1.0,1/5,8.36%,GABARAPL1
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.7851215040388573,-1.1943730425297092,0.23636363636363636,0.887433913065851,1.0,1/5,8.36%,GABARAPL1
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),-0.7914673045412355,-1.1941427998694862,0.3488372093023256,0.8869721404828592,1.0,1/5,0.64%,FGF1
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.6950211792096979,-1.1939857570819603,0.2647058823529412,0.8861686545093824,1.0,2/14,7.01%,GNA14;SCN7A
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.7051288349905807,1.193918178553308,0.23255813953488372,0.8097287488960172,1.0,2/7,6.26%,PPM1A;PPP2CB
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.632261684904434,-1.1932076437129275,0.27586206896551724,0.8876300331616429,1.0,4/14,16.91%,THBS1;PDCD4;ANO6;RGCC
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),-0.7226083412640862,-1.1927560773043753,0.24074074074074073,0.8881112114974274,1.0,1/7,1.62%,VEGFA
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),-0.5714037631983174,-1.1917141705065697,0.2807017543859649,0.8910839185624051,1.0,2/20,1.62%,PDGFD;VEGFA
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),-0.75113932122815,-1.1916668486489388,0.3050847457627119,0.8898356440412085,1.0,1/6,0.43%,TWIST1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),-0.7208147096153632,-1.1916433329639653,0.25862068965517243,0.888472597893739,1.0,2/8,4.65%,TWIST1;NR4A3
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),-0.555821960494079,-1.191310500872913,0.2542372881355932,0.8885752343358496,1.0,7/35,13.12%,TGFB2;RACK1;ADAM9;MYO18A;BCAS3;PPIA;PDCD10
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.6937447842340584,-1.1910734507297476,0.2835820895522388,0.888033102800264,1.0,4/10,18.90%,ALDH3A2;PEX1;PEX3;ACBD5
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),-0.7031673381614011,-1.190684014384334,0.27586206896551724,0.8882207892220927,1.0,2/7,10.60%,TGFBR1;PTCH1
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.6448912165667192,-1.1905794197036532,0.21875,0.8870220654766429,1.0,3/17,6.53%,CLU;CD47;HSP90AB1
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),-0.8143486055454152,-1.1902227765273798,0.2653061224489796,0.8854285571817775,1.0,3/5,8.18%,NRP1;SLIT2;ALCAM
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),-0.8143486055454152,-1.1902227765273798,0.2653061224489796,0.8854285571817775,1.0,3/5,8.18%,NRP1;SLIT2;ALCAM
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.6349343067475895,1.1901493786638053,0.21052631578947367,0.8209005370120631,1.0,1/14,1.86%,BCL2
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.6990395273175416,-1.190126476277186,0.27586206896551724,0.8843753270490943,1.0,3/12,5.61%,XPNPEP1;ERAP1;CPQ
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.6195278836328998,1.18988798453995,0.275,0.8200280643596054,1.0,2/12,1.35%,JPH2;CACNA1C
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.764919355346078,-1.1898612005229399,0.2549019607843137,0.8838460008339557,1.0,1/6,0.56%,CD55
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),0.6544924693475477,1.1896059114805924,0.24444444444444444,0.819424355997317,1.0,3/10,6.35%,BCL2;TNFRSF21;BNIP3
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),-0.7811639656108471,-1.1894084686033282,0.2962962962962963,0.8843572747764874,1.0,1/6,6.59%,RSRC1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.6679941856409679,-1.1893785493522815,0.3269230769230769,0.883210934084725,1.0,6/10,29.45%,DERL1;UFD1;SELENOS;SEL1L;NPLOC4;VCP
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.5403549747630991,-1.189228710327472,0.1896551724137931,0.8824191559039937,1.0,9/45,10.97%,XPA;PARP1;DDB2;MSH6;XPC;GEM;GATAD1;HMGN1;FAM50A
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.4994709717212081,1.1888880926338408,0.21875,0.819837026305148,1.0,7/45,9.14%,GJC1;CDH2;GJA4;CTNND2;CDH10;NRXN1;RHOA
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),-0.6504383892795084,-1.1885396566280917,0.25,0.883847031894427,1.0,4/12,15.45%,ANXA1;RPS3;CYP1B1;NET1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.5078284227754019,-1.1883735725905464,0.10294117647058823,0.883090148611459,1.0,20/85,9.37%,EMCN;ABCA8;CD55;COL15A1;FHL2;C7;PROCR;COL3A1;COL1A2;FMO2;SGK1;SHROOM4;DCN;LAMA4;GPM6A;BIRC2;SEMA3D;CALCRL;MGP;SLCO1C1
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),-0.6301686280651335,-1.1882529048274084,0.26153846153846155,0.8820534338180598,1.0,1/19,0.47%,ABLIM1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.6428241687009544,-1.188095277406573,0.16666666666666666,0.8797918774688029,1.0,3/19,6.26%,CLU;TWIST1;THBS1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.6428241687009544,-1.188095277406573,0.16666666666666666,0.8797918774688029,1.0,3/19,6.26%,CLU;TWIST1;THBS1
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.7824548716071733,-1.1877939567141507,0.14754098360655737,0.879542812094609,1.0,2/7,4.17%,AKR1C2;AKR1C1
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.5846076753273525,-1.1876242726266704,0.25757575757575757,0.8787335925672897,1.0,8/32,12.72%,CLU;LIMA1;SLIT2;TBCD;PLEKHH2;FGF13;HDGFL3;APOE
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),-0.5974837561581744,-1.187530761386437,0.2535211267605634,0.8775976613615603,1.0,7/27,12.09%,TGFB2;ADAMTS12;BMP5;PDCD4;DDX5;SMAD6;TGFBR3
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.6938261424082398,-1.1874497648866886,0.3492063492063492,0.8765477764159307,1.0,2/10,3.02%,GNA14;CMKLR1
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),-0.5923230913518919,-1.1869813542493408,0.24074074074074073,0.8771595049406694,1.0,5/23,5.73%,TGFB2;VEGFA;SULF2;GLI2;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.7871515914536963,-1.1867657452688292,0.29411764705882354,0.8764252717860578,1.0,1/5,1.25%,JAM2
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.7121172734008184,-1.1865575363879342,0.2037037037037037,0.8759389235804799,1.0,2/10,8.69%,SNW1;BRCA1
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.6824978299018524,1.186328095985738,0.30434782608695654,0.827175524591404,1.0,2/8,11.15%,KDM7A;PHF8
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.4705371072421779,1.1859726707152205,0.12903225806451613,0.8269335622660342,1.0,8/59,11.02%,CSF1R;ERBB4;PTGES3;UBE2N;HMBOX1;AXL;EGFR;FBXW7
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.43287124755252676,1.1851014466044487,0.1724137931034483,0.8281379686024638,1.0,19/55,23.29%,ABL2;GFAP;HSPA8;PACSIN2;NRG3;SEMA4D;RAP1A;RAPGEF2;TJP1;RASGRP2;RAPGEF1;PICALM;CHPT1;HIP1;RUFY1;PTPN11;ROCK1;PTPN1;TSC2
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.6787693255267883,-1.1845448991192469,0.16981132075471697,0.8829843233677547,1.0,3/13,9.90%,ZFPM1;CD47;IL1R1
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),-0.7235098146079387,-1.1844490990791283,0.2542372881355932,0.8818526740592434,1.0,2/10,4.62%,DYNC2LI1;IFT122
prerank,PanglaoDB_Augmented_2021__Glomus Cells,-0.5116940593515554,-1.1842580821708542,0.18181818181818182,0.881196913203945,1.0,13/71,11.60%,IGFBP5;ARNT2;SEMA6D;DKK3;NTM;COL6A1;PLPP3;SLIT2;PDZRN3;NR2F1;IL1R1;BOC;LIMCH1
prerank,PanglaoDB_Augmented_2021__Leydig Cells,-0.5001000411119072,-1.184246717355263,0.16666666666666666,0.8797632009464263,1.0,16/70,8.39%,ABCA8;IGFBP5;PAMR1;KIAA1217;FBLN1;ALDH1A1;THBS2;COL3A1;COL1A1;COL1A2;PLPP3;FMO2;COL12A1;PDZRN3;DCN;SASH1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),-0.7713090210875331,-1.1842347999955236,0.27586206896551724,0.8783991549968568,1.0,1/7,2.07%,NT5E
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.7129663005127593,-1.1841499778745888,0.3018867924528302,0.8771368265119718,1.0,4/8,28.41%,PRKDC;RPS14;RPS28;RPS27L
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.6336197608982548,1.183723646654258,0.2608695652173913,0.8318722122146623,1.0,4/9,22.36%,AGO2;PRKRA;DHX9;CELF1
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.6595284993933871,1.1829904396166828,0.2894736842105263,0.8331483445388767,1.0,3/6,16.15%,CDS2;ABCA3;SLC27A1
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.6216464175189672,-1.1828127156165533,0.21311475409836064,0.881247801280752,1.0,6/25,15.74%,AGPAT4;LSS;AGPAT5;GNPAT;PAM;LPL
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),0.7300185782026052,1.1827638991363802,0.2982456140350877,0.8320254121525377,1.0,1/6,5.07%,MYH9
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),-0.7263576033885557,-1.1819898531645925,0.26785714285714285,0.8834400373896731,1.0,2/9,6.66%,ANXA1;ZFP36L2
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.6260925040591743,1.1817664895942939,0.28205128205128205,0.8336867328153135,1.0,3/12,11.47%,APC;CDKN1A;MYOCD
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.7234388846695896,-1.1813052507178352,0.2641509433962264,0.8847707480815139,1.0,5/12,22.28%,SLC6A20;ATP1B1;SLC7A2;TRPM7;PKD2
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),-0.7647176425454179,-1.180370028977161,0.2692307692307692,0.8877545636663189,1.0,3/6,12.72%,DKK3;BMP5;APOE
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.6654835647406054,-1.1800700597432314,0.26229508196721313,0.8875796940836573,1.0,3/16,8.85%,IFITM3;MDFIC;TRIM13
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),-0.5435996365239079,-1.1800202385373855,0.1864406779661017,0.8863628454041507,1.0,9/40,11.69%,TWIST1;FGF1;VEGFA;THBS1;F3;SASH1;BRCA1;ADAM12;CYP1B1
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.5544362277357184,-1.1798977144548308,0.2542372881355932,0.8853101162812587,1.0,8/34,8.58%,ISM1;TGFB2;EPN1;STAT1;THBS2;THBS1;DCN;PGK1
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.6204450721671257,-1.1791744206266792,0.2542372881355932,0.8868826651713497,1.0,5/16,12.62%,CD55;CD47;THBS1;THRB;EPB41L2
prerank,PanglaoDB_Augmented_2021__Tanycytes,-0.5082504419226577,-1.1789436271193756,0.27692307692307694,0.8863113467265732,1.0,15/74,7.94%,IGFBP5;TGFB2;COL23A1;PAMR1;MEGF10;SEMA6D;DKK3;NTM;ADM;PLPP3;SLIT2;VCAN;SCN7A;PDZRN3;COL11A1
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.5055840402328529,1.1784710619247216,0.2,0.8431638103516974,1.0,3/31,1.89%,CSPG4;CNOT7;PDGFA
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),-0.7672269488005412,-1.17821655863598,0.3448275862068966,0.8875743738069416,1.0,1/5,1.68%,NRP1
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.685607415433776,-1.1781683428698688,0.2830188679245283,0.8863992603230526,1.0,5/17,14.00%,LSS;FAXDC2;HSD11B1;PRKAG2;CYP27A1
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.5056941171793506,1.1780402048565142,0.21951219512195122,0.8428919431110918,1.0,7/41,10.03%,JPH2;MYH11;TINAGL1;EHD2;ITGA3;EGFR;PXN
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),-0.6337573552171178,-1.1777294365364812,0.3076923076923077,0.8867368345345135,1.0,1/13,1.22%,RIMS1
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.8065362147516476,1.177711689640732,0.24444444444444444,0.8423191034311777,1.0,4/5,19.39%,APOLD1;CEBPB;PRKX;KLF7
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),-0.7082416937812108,-1.177501779751519,0.2982456140350877,0.8862487477788666,1.0,2/9,1.91%,AFG3L2;SLC8B1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.6337422717974369,-1.177263114225314,0.2459016393442623,0.8855880986538809,1.0,3/18,12.03%,SUPT6H;HMGN1;THOC1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.684328024366863,1.1770738514475514,0.2962962962962963,0.8426961534773169,1.0,2/9,5.45%,PTP4A3;CORO2B
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.6876797638581698,1.1765556158756088,0.26666666666666666,0.8429212100379107,1.0,2/7,10.01%,ENOX2;SDHB
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),-0.6794345727294419,-1.1765358031003355,0.30357142857142855,0.8875375282168467,1.0,3/11,5.09%,TGFB2;GLI3;GLI2
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),-0.6023955145307509,-1.175754231681817,0.22950819672131148,0.8892281764702689,1.0,2/19,0.88%,TWIST1;TGFB2
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,-0.5973505347310117,-1.1757305558629985,0.24193548387096775,0.8879514846246331,1.0,9/28,13.03%,THSD4;ABCA8;C7;PLPP3;FAXDC2;COL12A1;ELOVL2;S100A6;C1S
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.5968490630142422,1.1753468228124704,0.2631578947368421,0.8447108033973684,1.0,2/13,12.35%,ABL2;PLAA
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.7652859301670757,-1.174737485086529,0.36538461538461536,0.890469676642336,1.0,3/6,12.42%,LSS;FAXDC2;PRKAG2
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.7012700420855308,-1.1739976619424828,0.23076923076923078,0.892194568748599,1.0,6/8,28.95%,SMG6;RAD17;SRPX2;PSEN1;SMG7;BARD1
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),-0.7626133442703333,-1.173151542903463,0.32653061224489793,0.894180463921454,1.0,1/5,1.68%,NRP1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),-0.7437439148904846,-1.173102870074487,0.3333333333333333,0.8928727121936005,1.0,3/7,12.00%,NR4A3;AZIN1;ANO6
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),-0.6675762508787161,-1.172930870475264,0.288135593220339,0.8921942923572026,1.0,1/12,2.39%,MYO10
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.5983811976234794,-1.172676922859553,0.22807017543859648,0.8916896808196328,1.0,5/25,5.73%,LAMA1;VEGFA;NRP1;ADM;TGFBR1
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.602454589646945,1.172566558109283,0.2972972972972973,0.8526777032337458,1.0,1/11,0.37%,MYH11
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.6605487976294524,1.1718226482655176,0.25,0.853585495997689,1.0,1/10,3.21%,CDH10
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),0.7281898368351924,1.1713802098978208,0.30434782608695654,0.8531042552069134,1.0,1/5,2.26%,CNTN4
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.6319875692810977,-1.1712748181090697,0.26153846153846155,0.8964211640574847,1.0,4/16,11.81%,ABCA8;AGPAT4;AGPAT5;GNPAT
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.557291577910029,1.1709668675397549,0.23809523809523808,0.8527951412540892,1.0,2/15,6.13%,CNOT7;CNOT6
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.6528620023262375,1.1700758155567395,0.37209302325581395,0.8543975135366095,1.0,4/10,15.50%,PUM2;RAD18;CSNK2A1;SMC5
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.7155058186229565,-1.1696702501435579,0.2857142857142857,0.901946387806228,1.0,5/7,24.08%,SLIT2;ANO6;NBL1;LYN;CXCL12
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.4294736687494151,1.169407829632245,0.14285714285714285,0.8549342618335605,1.0,10/59,5.36%,ADGRB3;CACNA1B;LSAMP;CSRNP3;KALRN;OPCML;SLC12A2;TTLL7;CNTN1;LIFR
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.6700040959755742,-1.1693030143728071,0.3333333333333333,0.9016926767994418,1.0,3/12,4.62%,LAMA1;VEGFA;IFT122
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.6691084890676963,1.1691901346777396,0.24528301886792453,0.8542005454902961,1.0,3/10,16.03%,HEY2;BMPR1A;RBPJ
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.4973903746862054,1.1691653911091562,0.16666666666666666,0.8525627524914166,1.0,5/35,10.47%,PDK4;HSPA8;CLEC16A;ZFYVE1;PPARA
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.755618262081864,-1.16914876124856,0.3157894736842105,0.9006800438630542,1.0,4/7,23.29%,LPCAT2;PLA2G4C;PNPLA8;LPCAT3
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),-0.7738585218684778,-1.1688178569537846,0.3148148148148148,0.9006923050601602,1.0,1/6,1.62%,VEGFA
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),-0.7285351633646113,-1.1688104210210577,0.35185185185185186,0.8992980701572727,1.0,4/5,26.93%,SLC6A20;SLC6A13;SLC16A12;MGST1
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.6521788355304212,1.1686559441650108,0.1951219512195122,0.8528473373945996,1.0,7/10,19.38%,LIFR;SH2B3;MAVS;TLE5;CBFB;DHX9;MAP2K5
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),0.6991076524942329,1.1685973290970066,0.2857142857142857,0.8513870239805905,1.0,2/6,11.47%,SOX6;MYOCD
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.5172939932904805,-1.168362333094672,0.23728813559322035,0.9000686025849856,1.0,11/55,11.07%,CD55;SLC4A4;CMKLR1;GPC3;ADM;F3;BTG2;SLC11A2;CALCRL;IL1R1;NAMPT
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.685781956010678,1.167691887608758,0.23404255319148937,0.8526372898944553,1.0,3/7,9.10%,NOTCH1;HEY2;HEYL
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.7456412529685796,1.1673273600170915,0.34146341463414637,0.8521248883401258,1.0,2/5,15.50%,RAD18;SMC5
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),-0.7837476699634669,-1.1672842816500635,0.30357142857142855,0.9030090657837181,1.0,1/5,1.96%,PARP1
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),-0.6607524765967041,-1.1672510576852384,0.21875,0.9017869774940253,1.0,3/17,11.60%,ACTG1;EPHA3;LIMCH1
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.6360325071655376,-1.167228526805519,0.2909090909090909,0.9004305069207177,1.0,2/16,1.04%,ABCA8;SPTLC3
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),-0.6133920453761539,-1.1666846505238322,0.2459016393442623,0.9013630999275819,1.0,8/24,21.58%,PARP1;GSN;HSP90AB1;EPHA5;GOSR1;PRKN;DYNC1H1;LYN
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.5543541227851266,-1.1662517658664087,0.27692307692307694,0.9014353968745721,1.0,4/28,9.08%,XPA;UVSSA;HMGN1;RPA1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.6731907827783381,-1.1657905680748823,0.25,0.901981341749343,1.0,3/9,10.14%,VEGFA;JAM3;LGALS3
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),-0.4952291069541886,-1.165609435831765,0.19444444444444445,0.9014114268043721,1.0,19/100,13.23%,LAMA1;PLXNC1;VEGFA;NRP1;SEMA3C;LRTM1;SEMA6D;UNC5D;EPHA3;GLI2;SLIT2;NOTCH2;ALCAM;SEMA3D;NTN4;EPHA5;EPHA4;PLXNA2;ROBO2
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.7420657946274105,-1.1653843499450796,0.3230769230769231,0.901087107181354,1.0,3/6,19.04%,NKD1;CSNK1D;WNT5B
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.6257596844386881,1.164947043591588,0.28888888888888886,0.8593616330993804,1.0,3/13,5.58%,NOTCH1;EPOR;IRS2
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),-0.7285403013124523,-1.1647563380616444,0.30357142857142855,0.9021939922650346,1.0,2/8,17.10%,AGBL1;AGBL4
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.6512675233225684,1.1643211228527925,0.21428571428571427,0.8600255924054375,1.0,2/10,14.89%,PRELID2;ABCA3
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.6416236372473566,1.1641760926747398,0.2702702702702703,0.8589814786216425,1.0,5/13,15.50%,PML;TBX3;CDKN1A;MAP2K1;SMC5
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.6336809968667444,1.164076817433128,0.34782608695652173,0.8576094650471685,1.0,8/11,25.65%,CBL;AFAP1L2;ARAP1;RBPJ;HIP1;RTN4;AGT;CCDC88A
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),-0.5044560167949514,-1.163778167472173,0.1891891891891892,0.9049228898123486,1.0,10/54,10.39%,NR4A2;NR4A1;PARP1;PKM;NR4A3;EPRS1;TSHR;RHOQ;PRKAR1A;PRKDC
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.5537378055792467,1.1635613123612203,0.29411764705882354,0.8573408041243287,1.0,7/23,11.07%,PML;BCL2;TNFRSF1B;HIPK2;BCL2L1;MSH2;MCL1
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),-0.7322533811458432,-1.1632234181592005,0.40350877192982454,0.905610856449331,1.0,3/7,14.98%,LPCAT2;GNPAT;PLA2G4C
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.7346431758183505,-1.1630799770474929,0.2549019607843137,0.9047974272230319,1.0,1/6,1.62%,VEGFA
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.47592383948484157,1.1626442612269239,0.16666666666666666,0.8588097322401002,1.0,5/37,9.14%,MYOM2;OBSCN;EPB41L5;MYH9;RHOA
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),-0.6926900667942887,-1.1626108229434715,0.2727272727272727,0.904803030058967,1.0,6/11,21.72%,CYP1B1;PLA2G4C;GPX4;PTGR1;PNPLA8;MGLL
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.6999856996149937,-1.1625933483922535,0.2698412698412698,0.9034196682245906,1.0,1/12,1.22%,RIMS1
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.6855963797373014,1.162527735396163,0.2926829268292683,0.8575288032323656,1.0,3/7,22.39%,CORO2B;NDFIP2;SNX3
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),-0.717955121256225,-1.162084362386312,0.3508771929824561,0.9042564474961656,1.0,1/6,4.07%,SFRP4
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),-0.5579762993295947,-1.1619658674538136,0.3220338983050847,0.903284560597239,1.0,4/30,7.23%,TGFB2;TM7SF3;ADAM9;MYO18A
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.698057550825074,1.1616454810073793,0.3191489361702128,0.8585591055419529,1.0,1/9,0.63%,SRSF12
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.5437062642818812,-1.1614886167987362,0.20588235294117646,0.9036982009441853,1.0,12/64,17.18%,COLEC12;CTSL;ADM;AP2A2;AP4E1;CALCRL;SNAP91;APOE;HSPH1;SNX9;GPR107;LMBRD1
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.6212694491845502,-1.1613653846567014,0.21052631578947367,0.9014055278476744,1.0,2/12,16.76%,CMTR1;GTF2H1
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.6212694491845502,-1.1613653846567014,0.21052631578947367,0.9014055278476744,1.0,2/12,16.76%,CMTR1;GTF2H1
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.6913942900176234,1.1600648455956484,0.3170731707317073,0.8623183938515915,1.0,1/8,2.47%,EIF4ENIF1
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.7274627190973103,-1.1599397008405838,0.32786885245901637,0.9057093644400805,1.0,3/7,15.94%,ABCB7;NUBPL;HSPA9
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),-0.712999573183409,-1.1587529805134447,0.3157894736842105,0.9091337710327836,1.0,3/7,18.21%,ANXA1;CYB5R4;EDN3
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),-0.7401913757262109,-1.1583775268535035,0.23636363636363636,0.9092072408103289,1.0,1/9,1.41%,SLC4A4
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.6915000467412139,-1.1583684415791071,0.39215686274509803,0.9050767639118282,1.0,2/6,7.96%,SVIP;ERLEC1
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.6915000467412139,-1.1583684415791071,0.39215686274509803,0.9050767639118282,1.0,2/6,7.96%,SVIP;ERLEC1
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",-0.6915000467412139,-1.1583684415791071,0.39215686274509803,0.9050767639118282,1.0,2/6,7.96%,SVIP;ERLEC1
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.6456918658627627,1.1575915910794392,0.36363636363636365,0.8689955114035011,1.0,4/10,10.81%,NOTCH1;HEY2;HEYL;BMPR1A
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.599291181292094,-1.1575192460151824,0.21666666666666667,0.9068753356943094,1.0,6/18,13.68%,TERF2IP;SLF1;RPA1;CTCF;MRNIP;TNKS2
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.6256282050458345,-1.1569010226874514,0.29508196721311475,0.9077212647048336,1.0,8/22,19.09%,AKR1C1;THBS1;BRCA1;CYP1B1;MAPK14;ARF4;MT3;PRKN
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),-0.6820487914655717,-1.1566344101037969,0.31666666666666665,0.9074563221581096,1.0,3/10,11.05%,PKM;YBX3;DHX36
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.6500860162372871,-1.1563003085083177,0.26666666666666666,0.9076643455147941,1.0,4/12,12.93%,XPA;PARP1;RPA1;WRN
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),-0.5803936313337147,-1.1560694227962434,0.27692307692307694,0.9074150209582679,1.0,5/25,13.12%,TGFB2;MID1;PPIA;TGFBR3;PDCD10
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.5074402809961347,1.156067911127182,0.16666666666666666,0.8721666063406784,1.0,7/40,3.98%,SLC35F1;CSRNP3;CTNND2;OPCML;NXPH1;GFAP;MGAT5
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.510486936183623,1.1555268956415188,0.21621621621621623,0.8725265780894153,1.0,5/34,12.38%,WTIP;IPO8;PUM2;AGO2;NUP54
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.6492549021169587,-1.1552772484638238,0.27586206896551724,0.9086080986975817,1.0,2/11,7.64%,LIMA1;BAIAP2L2
prerank,MSigDB_Hallmark_2020__Angiogenesis,-0.6068953720018342,-1.1551477622042485,0.234375,0.9077118061325677,1.0,4/19,6.67%,VEGFA;NRP1;COL3A1;VCAN
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.7764012130042381,-1.155068333861397,0.26229508196721313,0.9069502040992181,1.0,2/5,1.32%,MLPH;FOXQ1
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),-0.779954070471785,-1.1550307492214071,0.32727272727272727,0.9057076151661472,1.0,4/6,17.47%,SLC25A13;SLC1A2;SLC1A3;SLC1A1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.728552733936182,-1.154348755226114,0.38095238095238093,0.9066621424913193,1.0,4/8,22.65%,PHLDB2;RGCC;DAG1;CLASP2
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.560028469780588,1.1542401827158486,0.3181818181818182,0.8753316139041196,1.0,3/11,16.43%,TESC;LEF1;ZFP36L1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.7903561785454675,-1.153700363966752,0.3225806451612903,0.9077160216967198,1.0,3/5,11.05%,PKM;YBX3;DHX36
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.6868036626447624,-1.1535174785286113,0.34545454545454546,0.9071047501480646,1.0,3/11,14.08%,VEGFA;LARS1;RRAGB
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.5042976842187538,1.1534319990744493,0.21621621621621623,0.8763147023858933,1.0,5/25,5.31%,ADGRF5;ZBTB7C;ERBB4;DNAH9;TACC2
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.5920776827481362,-1.1530455909801223,0.288135593220339,0.907645324318169,1.0,7/22,18.64%,RPL5;RPS25;RPL35A;RPL11;WDR12;RPS24;RPS7
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.6844538813193319,-1.1530236254219215,0.29508196721311475,0.9063237328332244,1.0,3/9,11.69%,SULF2;BRCA1;CYP1B1
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.6195715230131125,-1.152808865227355,0.2807017543859649,0.9060801049457125,1.0,4/22,13.57%,WARS1;EPRS1;NARS1;LARS1
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.7859828967970812,-1.1527615509101985,0.2830188679245283,0.9049966368640673,1.0,1/5,1.36%,ZFPM1
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.6399905923037942,1.1526552521767317,0.2727272727272727,0.877192391745854,1.0,3/9,16.12%,PDK4;PPARA;PANK2
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.6858211001629463,-1.152417328801913,0.32608695652173914,0.9049438198707376,1.0,1/10,0.38%,CLU
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.6798911896818863,-1.1523462202029617,0.29411764705882354,0.9025589909558344,1.0,1/8,1.22%,RIMS1
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.6798911896818863,-1.1523462202029617,0.29411764705882354,0.9025589909558344,1.0,1/8,1.22%,RIMS1
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.48618434375900993,1.1518183178072496,0.21428571428571427,0.8789178717332854,1.0,3/53,1.51%,HSPA1A;NOX4;SERPINB6
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),-0.6508839995613083,-1.1515192628129864,0.36231884057971014,0.9045557922424279,1.0,1/12,1.22%,RIMS1
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.6495392510885506,-1.1512885486689977,0.3148148148148148,0.9043169209203297,1.0,2/10,7.64%,LIMA1;BAIAP2L2
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.8040086515478738,1.1505885851330029,0.34146341463414637,0.8816479873379732,1.0,3/5,18.61%,JADE2;MEAF6;JADE1
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,0.6710699996900329,1.1505832277637724,0.3673469387755102,0.8799260186127037,1.0,2/8,3.45%,MYH11;EMP2
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.5368307507931819,-1.1504283740298384,0.29508196721311475,0.9060179722114968,1.0,5/34,12.30%,NACA;SRP14;ALDH3A2;SSR1;PEX3
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.49108855788617695,-1.1503051070297248,0.2028985507246377,0.9051465413315436,1.0,10/58,11.29%,GBP2;STAT1;ADAMTS12;ZFP36L2;YBX3;BIRC2;BRCA1;ASAH1;PSMC2;RPS3
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),-0.7480916429145991,-1.1501450579043582,0.35185185185185186,0.9043492783076721,1.0,5/10,17.47%,SLC22A6;SLC25A13;SLC1A2;SLC1A3;SLC1A1
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.5752419637777243,1.1501123468299856,0.2857142857142857,0.8800644637209107,1.0,7/16,16.15%,ATP2B4;ACADVL;FBXW7;RAPGEF2;NFKB1;EP300;SLC27A1
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.6730855571662737,1.1496052315110912,0.30434782608695654,0.8802828090054118,1.0,2/8,11.02%,NOTCH1;FBXW7
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),-0.6403115513537492,-1.1495350726488054,0.29577464788732394,0.9053563386388017,1.0,1/11,1.56%,MDFIC
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.5802583588343377,-1.1494547041689147,0.2631578947368421,0.9044468553561579,1.0,9/19,22.30%,BRCA1;UIMC1;RAD17;MRNIP;NAE1;TOPBP1;MRE11;DONSON;BABAM2
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),-0.7968636823850752,-1.1493738740199155,0.288135593220339,0.9034402093056924,1.0,1/5,8.69%,BRCA1
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.7232409560454176,1.1491339681396116,0.43243243243243246,0.8804200236658339,1.0,1/6,3.77%,SORT1
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.7600132687429131,-1.1486161124434804,0.2786885245901639,0.9051703774678806,1.0,3/5,12.93%,POLA1;PPIA;WRN
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),-0.6814524564358587,-1.1486008413515996,0.3333333333333333,0.903895462463783,1.0,3/9,22.01%,ENO1;TPM1;PPP1R12B
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),-0.4994586634521584,-1.148514967384362,0.2328767123287671,0.9029649951155438,1.0,12/57,11.07%,CIRBP;TGFB2;RPS4X;RPL5;PLD1;GLI2;NMD3;THBS1;UPF3A;SAMD4A;PRKDC;NAMPT
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.783221485581461,1.148502768553969,0.3225806451612903,0.8805967700338048,1.0,3/5,19.35%,NEDD4L;COMMD1;PICALM
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.5019985788282119,-1.14827999291816,0.24,0.902448360434949,1.0,27/91,16.92%,IGFBP5;SLC2A3;PRDX1;TXNRD1;WARS1;EPRS1;UCHL5;EIF2S2;ENO1;BTG2;PGK1;RPA1;ADD3;SSR1;PSMC2;NAMPT;PPIA;GLRX;CCT6A;BHLHE40;HSPA4;LDHA;SQSTM1;USO1;HSPA9;GTF2H1;CYB5B
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.5880563939110536,-1.1479434405008133,0.35714285714285715,0.9022021950449275,1.0,5/18,13.60%,PARP1;TERF2IP;FUS;MRNIP;SPIDR
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),-0.7152747510732473,-1.1479105578515845,0.3076923076923077,0.9010379071102403,1.0,2/8,9.11%,TGFB2;FN1
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.7666937128419098,-1.1478455383152815,0.3,0.899961677145459,1.0,1/6,1.36%,ZFPM1
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),-0.6998930246713253,-1.1473782749641381,0.3333333333333333,0.9002557805313807,1.0,2/8,5.77%,PARP1;ENO1
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.7575764458034027,-1.146997399736911,0.4,0.9004927370878463,1.0,2/5,16.96%,JAM3;FARP2
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.7050848305145507,-1.146874441717157,0.28846153846153844,0.8998435741107554,1.0,1/7,10.60%,PTCH1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.722355602349326,-1.1467523834547884,0.3793103448275862,0.8989576922130539,1.0,1/8,2.61%,HECW2
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.7341845414886107,1.1464620160309795,0.3541666666666667,0.8834225649465154,1.0,1/5,9.08%,AGO2
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.7341845414886107,1.1464620160309795,0.3541666666666667,0.8834225649465154,1.0,1/5,9.08%,AGO2
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.6841379792916197,1.1464482504021247,0.3333333333333333,0.8817602339743943,1.0,1/10,0.63%,SRSF12
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.6804934539783224,-1.1456846820644737,0.32653061224489793,0.9017040396943399,1.0,3/11,14.36%,DDB2;KDM2B;RNF8
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),-0.7340981704475636,-1.145230795867281,0.3090909090909091,0.9024973298372173,1.0,2/5,10.67%,BMP5;ASAH1
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.45651843899761113,1.1452167167219287,0.25806451612903225,0.8841394662506185,1.0,4/39,4.72%,CSPG4;ST3GAL2;CHST3;PAPSS2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.5638221056944269,-1.1452060092219782,0.29850746268656714,0.9013319707229414,1.0,8/31,18.70%,SGK1;GPM6A;SNX2;NGF;EPB41L3;MINK1;DTNBP1;NBL1
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.5290373839970003,1.1446071438236296,0.21951219512195122,0.8842875378208298,1.0,3/27,6.35%,NOTCH1;HEY2;BNIP3
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.6420961434937493,1.144241194679521,0.35135135135135137,0.8838013933186432,1.0,4/8,21.51%,SORT1;VTA1;CHMP4B;LYST
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),0.7596812336375384,1.1441756074394704,0.36538461538461536,0.8822301064695582,1.0,2/5,6.35%,BNIP3L;BNIP3
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),-0.737378500697551,-1.1439655939681044,0.3275862068965517,0.9048724985266092,1.0,1/7,0.88%,TGFB2
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),0.6054488997750069,1.143516963954546,0.23809523809523808,0.8828938486895307,1.0,2/15,5.98%,TRPC6;IREB2
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.6484333189734258,-1.1434782147744489,0.3225806451612903,0.9053095170436648,1.0,5/15,17.98%,SLC7A14;SLC38A1;SLC6A20;SLC7A2;SLC7A11
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.7335148328683581,-1.1434029636737761,0.3,0.9043955917015446,1.0,3/5,11.79%,RIPOR2;ADAM9;MAPK14
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.6134311312945362,1.1431689182985485,0.29545454545454547,0.8821965647118227,1.0,4/15,16.49%,BRD2;UBN1;SART3;HAT1
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.5913073547584722,-1.142970595847795,0.2833333333333333,0.9044291011097532,1.0,4/25,13.57%,WARS1;EPRS1;NARS1;LARS1
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.4574654783320641,1.1426238852865007,0.17857142857142858,0.8827006394330402,1.0,9/55,6.50%,LDB3;NOTCH1;CACNA1C;HEY2;ERBB4;RBM20;MICAL2;PCSK5;HDAC9
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.5050742530332376,1.141601681926344,0.14705882352941177,0.884477688611693,1.0,7/35,10.96%,CACNA1C;RCAN2;CAMKK2;EGFR;RYR2;P2RX4;MCU
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.7393804690533907,-1.1408154652654199,0.39285714285714285,0.9111224629691446,1.0,2/6,18.08%,RPS3;PRKCH
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.747844031175215,-1.1402046274996127,0.36666666666666664,0.9120469243192824,1.0,1/6,1.51%,SLC2A3
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),-0.7010796540487529,-1.1400868112656155,0.34615384615384615,0.9111839762958068,1.0,2/6,4.65%,LEPR;NR4A3
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.5337567745581139,1.139930404412682,0.21212121212121213,0.8877553975112695,1.0,5/31,9.08%,CNOT7;TOB1;EIF4ENIF1;METTL14;AGO2
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.6111817934234994,1.1396566298211868,0.3157894736842105,0.8869369589321288,1.0,1/10,0.16%,JPH2
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,0.4948736143435534,1.1396181580301292,0.1875,0.88534150350175,1.0,6/47,2.66%,TRPC6;CSF1R;NOTCH1;CDH2;GJA4;APC
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),-0.5649789476168248,-1.1394443265926524,0.25757575757575757,0.9123544237589433,1.0,10/34,17.81%,CDKL1;DYNC2LI1;HTT;TBC1D2B;TCHP;TBC1D22A;BBS4;SDCCAG8;DCDC2;TBC1D8
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.756843203955747,-1.1392777449795477,0.41379310344827586,0.9116866301445833,1.0,3/6,11.31%,NCKAP5;FGF13;HDGFL3
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.6142396592418782,-1.1392062211516583,0.3548387096774194,0.9105936319709612,1.0,6/20,10.07%,TGFB2;LDLRAD4;BMP5;TGFBR1;BMPER;SMAD6
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.6199296723050952,1.1389015165256697,0.37209302325581395,0.8860879658412466,1.0,1/10,1.86%,BCL2
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),-0.7510456012650533,-1.13879311429503,0.32,0.9110583257972491,1.0,3/6,12.72%,THBS1;ST3GAL4;APOE
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.6058547767738547,1.1385752802548907,0.2926829268292683,0.8854327113017116,1.0,3/12,11.81%,PPP2R1A;SH2B3;SEMA4D
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.726322063169085,-1.1384576369018,0.3333333333333333,0.9113843295815842,1.0,1/7,8.69%,BRCA1
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.6106624686988227,-1.1375746441250985,0.3484848484848485,0.9134791677584781,1.0,5/16,13.54%,TUBGCP5;CCDC57;FGF13;HDGFL3;CSNK1D
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.567365927904146,-1.1373392239568283,0.23728813559322035,0.9131158741930095,1.0,1/21,0.38%,CLU
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.4590355911444523,1.1355628951002503,0.21875,0.8935067032023553,1.0,15/66,13.91%,HSPA1A;NOX4;PTPRK;PYROXD1;CAMKK2;ERCC6L2;VKORC1L1;EGFR;ARNT;PXN;SLC25A24;ERO1A;CAT;PRDX6;FOXO3
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),0.6580431125005282,1.1355000535793678,0.2619047619047619,0.8919496089477574,1.0,2/7,17.04%,GSTA4;GSTP1
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.6148048620348973,-1.1354377759320757,0.27450980392156865,0.9197443668338793,1.0,2/11,2.07%,GBP2;NT5E
prerank,GO_Biological_Process_2021__eye development (GO:0001654),-0.5956055411631,-1.135382217237085,0.3333333333333333,0.9187312396975411,1.0,2/23,0.88%,LAMA1;TGFB2
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.7329524469712421,1.1353688629362506,0.4423076923076923,0.8906301799847549,1.0,1/6,0.10%,CSPG4
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.7506546956070596,1.1351241654359514,0.3170731707317073,0.8897206449719224,1.0,1/5,6.26%,PPP2CB
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.6081756370897627,1.1346961850175652,0.3181818181818182,0.8894111980810063,1.0,1/14,0.10%,CSPG4
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.44450932801476606,1.1346525364124407,0.26666666666666666,0.887950143720407,1.0,9/55,9.85%,ADGRB3;CACNA1B;LSAMP;CNTN4;OPCML;NRXN1;RNF152;CTNNA2;TNR
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.7429447214775171,-1.1345082760782426,0.3333333333333333,0.9209951067322882,1.0,1/5,0.88%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),-0.7343892117718921,-1.1340399299785244,0.375,0.9213726402410961,1.0,1/5,0.43%,TWIST1
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.5927793707131354,1.1338924669383925,0.3333333333333333,0.8885272711793888,1.0,1/10,2.01%,PDK4
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),0.6363574409149573,1.133833391985946,0.36363636363636365,0.8872263968137629,1.0,2/10,2.05%,NOTCH1;TNFRSF1B
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.7213041131598523,-1.1337308952051257,0.3728813559322034,0.921232156828892,1.0,2/7,11.05%,TGFB2;DHX36
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.6388353740414027,1.1336070884369318,0.29545454545454547,0.8862551351417876,1.0,3/10,13.33%,WDR33;PCF11;CPSF2
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),-0.7547738096924006,-1.1334164433141924,0.375,0.920996966190403,1.0,3/5,12.72%,NRP1;RALBP1;APOE
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.5129354445045726,1.1332750527968423,0.2765957446808511,0.8858023701376277,1.0,7/32,13.62%,CNOT7;PML;HIPK2;CNOT6;CDKN1A;USP10;EP300
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.69928616974156,-1.1332102918498566,0.3389830508474576,0.9205317973388277,1.0,1/11,2.61%,HECW2
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.6217090190729962,-1.1331660682865803,0.296875,0.9194447226199755,1.0,1/12,6.38%,POLA1
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.6818479436864975,1.1328864096854743,0.425,0.8855987371182018,1.0,2/7,10.07%,PPP2R1A;SH2B3
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.6872663569140469,-1.132097939535097,0.39655172413793105,0.92210818651707,1.0,2/8,7.78%,TEFM;FASTKD2
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),-0.746392556572969,-1.13201009895667,0.4032258064516129,0.9210489591103821,1.0,1/5,2.57%,SUPT6H
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.6855278896532375,-1.1319092042311003,0.3448275862068966,0.9201680486327578,1.0,4/9,18.90%,PIK3R4;SQSTM1;NBR1;ACBD5
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),-0.7052110550349873,-1.131848766752315,0.40350877192982454,0.9191952572702122,1.0,2/8,7.17%,SLC47A1;RALBP1
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.48931526098188016,1.1318472608688066,0.24324324324324326,0.8876759399277867,1.0,2/32,1.35%,CACNA1B;CACNA1C
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,-0.5081490561461155,-1.1316704353114213,0.3333333333333333,0.9184673256881652,1.0,14/50,9.46%,ABCA8;FGF1;SLC4A4;KIAA1755;SEMA6D;ENPP2;NTM;ADM;SGCD;COL1A2;PLPP3;DCN;LAMA4;HEPH
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.7645459248861952,1.1316422472173238,0.3333333333333333,0.886748913657627,1.0,2/6,8.49%,OGA;STT3B
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.6194284162864939,-1.1312857436732187,0.2857142857142857,0.9185475526428722,1.0,5/13,12.72%,SLC47A1;SLC4A4;HSD11B1;SLC22A6;APOE
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.522690236089124,-1.1311867444514887,0.29411764705882354,0.917580995991972,1.0,13/47,11.28%,CIRBP;RPS4X;PKM;RPL5;PLD1;THBS1;FASTKD2;YBX3;UPF3A;SAMD4A;PRKDC;DHX36;LARP1
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.5374257348747206,-1.1309486745549175,0.3,0.9171932511540462,1.0,3/35,6.66%,ZFPM1;CMKLR1;ZFP36L2
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.6194970328531929,-1.1302316242870376,0.36363636363636365,0.918840437574684,1.0,7/14,20.10%,PARP1;PARP6;PARP9;ARF4;TNKS2;PARP8;PARP14
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),-0.6609939334049546,-1.1294636958040705,0.3793103448275862,0.9203227683845796,1.0,2/9,11.66%,GSN;ABI2
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,-0.48149032490484406,-1.1294020082725478,0.2727272727272727,0.9192923475188891,1.0,10/81,7.15%,IGFBP5;ARNT2;FBLN1;SEMA6D;DKK3;NTM;GLI2;SLIT2;DZIP1;PDZRN3
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),-0.6057469877166441,-1.1293487367128048,0.35,0.9182114343596941,1.0,3/16,8.07%,TGFB2;IFT122;KDM2B
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.4989494617981761,1.127890491392814,0.3235294117647059,0.8970514412534016,1.0,9/29,11.04%,JPH2;CACNA1C;ABL2;C1QTNF1;SELENOT;RYR2;P2RX4;ADCY5;GRIN1
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.6368248721723575,-1.1277700330591378,0.32786885245901637,0.9225098165768335,1.0,5/12,29.45%,RPA1;UFD1;UBA52;NPLOC4;VCP
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.5811482100731871,1.1273578797883348,0.2894736842105263,0.896696456670003,1.0,1/17,0.66%,CACNA1B
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.5508441411362061,-1.127130527638218,0.3220338983050847,0.9233943415039861,1.0,7/30,17.34%,LEPR;AKR1C1;GPC3;HSD11B1;PLSCR1;PHLDA1;SAMD5
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.6795641546736302,-1.126819180342125,0.35714285714285715,0.9233474483943364,1.0,1/10,1.56%,MDFIC
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),-0.7780587723793035,-1.1267947056685794,0.3548387096774194,0.9222006314843587,1.0,1/5,4.65%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),-0.6215755473434181,-1.126685099332452,0.29411764705882354,0.9214142855238325,1.0,5/17,13.59%,KCNMB1;KCNMA1;ANO6;ATP1B1;WNK2
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.6665090738443684,-1.1264414461871215,0.3392857142857143,0.9196235711447586,1.0,3/11,8.58%,PKM;ENO1;PGK1
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.6665090738443684,-1.1264414461871215,0.3392857142857143,0.9196235711447586,1.0,3/11,8.58%,PKM;ENO1;PGK1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),-0.7754605571353628,-1.1258387639115683,0.36065573770491804,0.9206102856557303,1.0,2/5,15.61%,EPHA4;ANXA2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),-0.7782703446787094,-1.125617116068295,0.32558139534883723,0.9203700590774041,1.0,2/5,13.97%,MAPK14;IL16
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),-0.6538522773316513,-1.1254892694484142,0.36,0.9197097879636721,1.0,1/7,4.89%,CENATAC
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,-0.48385533934841674,-1.1249845827402412,0.2972972972972973,0.9203904425359922,1.0,15/67,9.11%,IGFBP5;COL6A3;PAMR1;DKK3;THBS2;COL3A1;NTM;COL1A1;COL1A2;COL6A1;PLPP3;COL12A1;DCN;LAMA4;FN1
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.43883915074711344,1.1245979213256998,0.3333333333333333,0.9042082362669761,1.0,7/38,10.86%,TNFRSF1B;RBM20;RC3H2;RRP1B;MITF;GRSF1;HNRNPF
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.6487179806780281,-1.124583803738855,0.3181818181818182,0.920780821108404,1.0,3/12,21.77%,RPA1;UBA52;POLK
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.6150216515069398,-1.1245758684484186,0.3230769230769231,0.9195989053869053,1.0,2/16,5.77%,SLC4A4;ENO1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.732970892979151,-1.1243838542366513,0.34,0.9189693546005904,1.0,3/6,19.10%,CD47;PRKDC;XRCC6
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.6024705437957975,-1.1242764274776669,0.2631578947368421,0.9181325475710818,1.0,6/19,15.45%,ANXA1;ADAM9;RPS3;CYP1B1;PDCD10;NET1
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.7112575532645321,-1.124241827661282,0.37254901960784315,0.9170110667141654,1.0,2/7,10.39%,TERF2IP;PRKDC
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),-0.7232034115542286,-1.1240961682027577,0.42592592592592593,0.9163614367873126,1.0,5/6,27.16%,SLIT2;ROBO2;FOXC1;PKD2;FGFR2
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.65091893550749,-1.1235609549538716,0.33962264150943394,0.9170662186773496,1.0,2/8,8.97%,CEMIP;HEXB
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),-0.48502103172820415,-1.1234345414197688,0.2898550724637681,0.9162493827745151,1.0,15/72,14.63%,CLU;TM7SF3;STAT1;SEPTIN4;SGK1;BIRC2;DDX42;NDRG1;ASAH1;BCL2L14;RPS3;DAPK2;WRN;SRA1;NAE1
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.6476304020552778,1.1233520853900454,0.375,0.9065150391037397,1.0,2/9,6.42%,LRCH1;RRP1B
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),-0.5968588240667084,-1.1232364059133682,0.2631578947368421,0.9159535968059561,1.0,3/17,6.75%,TGFB2;ANXA1;SPOCK1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),0.5833482136842499,1.122945831140299,0.2682926829268293,0.9064266859458279,1.0,4/17,9.67%,HSPA1A;TESC;ACVR2A;ARNT
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),-0.7564745893584703,-1.1222582167155981,0.3392857142857143,0.9184309237558377,1.0,1/5,10.22%,ZC3H14
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.6896804796929438,-1.1221245921542937,0.3829787234042553,0.9177578401152858,1.0,4/14,14.00%,PER2;FAXDC2;PRKAG2;CYP27A1
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.5207915547519587,1.1218247198834976,0.21951219512195122,0.9084021806630161,1.0,2/27,1.80%,CSF1R;DGKH
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.5667150875878734,1.1217198441487144,0.37142857142857144,0.9070186794895506,1.0,7/15,26.69%,ABCA1;TMEM167A;CANX;ARFGAP3;RAB10;MIA2;RAB12
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.5995916078391126,-1.1217011881914745,0.3018867924528302,0.9182235440546681,1.0,4/13,17.74%,MIS18BP1;ITGB3BP;NASP;RBBP7
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),-0.43653596553563156,-1.1216997547332386,0.2236842105263158,0.9170105671140412,1.0,36/185,13.46%,CLU;TWIST1;FGF1;CIRBP;RPS4X;RIMS1;VEGFA;WARS1;AFDN;ACTG1;RPL5;CALCOCO1;SFRP4;PLD1;GSN;TGFBR1;THBS1;F3;OLFM1;SLC24A3;BRCA1;FN1;UPF3A;DDX5;SAMD4A;PRKDC;DHX36;NGF;CTCF;RPS3;HNRNPLL;MAPK14;KRAS;EEF2;PDCD10;PLSCR1
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.4607339884819315,1.1208019037157433,0.325,0.9079766184667707,1.0,7/41,13.62%,TDG;DEK;PHF2;MTF2;AEBP2;DDX21;EP300
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),-0.646856013335821,-1.1204740220225446,0.3728813559322034,0.9200662030215769,1.0,1/16,0.64%,FGF1
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),-0.7095838427088816,-1.1204068302733705,0.38596491228070173,0.9190599060103255,1.0,1/6,0.43%,TWIST1
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.7286163952429354,-1.1200972129087754,0.375,0.9189687868181163,1.0,2/5,20.48%,CD47;SELENOS
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.6396888307768636,1.1195765667066422,0.39473684210526316,0.9105170081925712,1.0,1/10,3.45%,EMP2
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.45823248557511415,1.1193367587752405,0.2777777777777778,0.9097517713755925,1.0,10/48,9.48%,NOL4;CSRNP3;CNTN4;RCAN2;KALRN;CNTN1;NRXN1;C2ORF72;GABRB3;LCORL
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.5433726776621288,-1.119286879051183,0.3150684931506849,0.9207390751225389,1.0,13/40,13.52%,SLC47A1;KCNMB1;SLC4A4;SLC8B1;KCNMA1;SCN7A;SGK1;SLC11A2;SLC6A20;FGF13;ANO6;SLC41A1;ATP1B1
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),-0.6622491434136986,-1.1189690883149568,0.4032258064516129,0.920569078673068,1.0,4/12,15.61%,ENO1;NPRL3;MTM1;ANXA2
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.6904870397378033,-1.1188526650760158,0.34375,0.919733824013353,1.0,3/8,15.13%,FBLN1;TGFBR3;SP100
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.6316151012439686,-1.1185333688263117,0.3076923076923077,0.9195272326350279,1.0,1/6,2.98%,STAT1
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.695171913366291,1.1184105718773725,0.3,0.9114990234555467,1.0,4/6,20.63%,SETD7;METTL21A;SMYD3;SETD3
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),-0.7326033999872255,-1.1182601086856565,0.42,0.9190530422961629,1.0,5/8,21.06%,SLC4A4;CA5B;CYB5R4;CA4;CA2
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),-0.6991169419902195,-1.1182079184254488,0.3898305084745763,0.9180190083007748,1.0,6/8,28.54%,LAMB1;NTN4;FLRT2;PXDN;LAMB2;NID2
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),-0.6515593639733769,-1.1177749627434739,0.3492063492063492,0.9184522223340894,1.0,4/12,6.66%,LEPR;ANXA1;GLI3;ZFP36L2
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),0.7231258466223582,1.117635154479265,0.4222222222222222,0.9110846987514232,1.0,3/5,18.48%,SELENOT;EEFSEC;TRNAU1AP
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),0.7231258466223582,1.117635154479265,0.4222222222222222,0.9110846987514232,1.0,3/5,18.48%,SELENOT;EEFSEC;TRNAU1AP
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),0.7087293244410046,1.1174865404918002,0.38095238095238093,0.9098616504434113,1.0,2/6,14.81%,CD44;CDC42
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),-0.7578584206470194,-1.117226607351718,0.4,0.9192022744564319,1.0,3/6,22.28%,GLI2;VIT;PKD2
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.5482565300029233,1.1168843370015364,0.32558139534883723,0.9101565137490789,1.0,2/16,5.49%,CMTM8;TNFRSF21
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.7249812961798767,-1.1166588725634146,0.34545454545454546,0.9203949497366045,1.0,3/6,23.29%,PLA2G4C;PNPLA8;LPCAT3
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.7298905751644635,-1.1164928013363302,0.3269230769230769,0.9196436281299545,1.0,3/7,7.07%,TGFB2;ZFPM1;NOTCH2
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),-0.7461836469363061,-1.1163855143429038,0.32653061224489793,0.916390416223163,1.0,1/5,5.42%,SLF1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),-0.7461836469363061,-1.1163855143429038,0.32653061224489793,0.916390416223163,1.0,1/5,5.42%,SLF1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),-0.7461836469363061,-1.1163855143429038,0.32653061224489793,0.916390416223163,1.0,1/5,5.42%,SLF1
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.5662753503752083,-1.116150979444955,0.3148148148148148,0.9160519930181968,1.0,5/26,5.23%,NR4A2;NR4A1;NR4A3;PER2;ERAP1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.5738524373151951,-1.1157696379691944,0.37254901960784315,0.9162059902672905,1.0,2/16,5.00%,TERF2IP;MSH6
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),0.7846375852090564,1.1156254636553837,0.35714285714285715,0.912403370219491,1.0,1/5,3.74%,VAPA
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.5889333708530273,1.1155945700321197,0.3,0.9108166610027583,1.0,3/17,5.26%,PTPRK;EMP2;GGA2
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.5604893809127747,-1.1146838003168156,0.35135135135135137,0.9186756961214624,1.0,5/25,12.09%,IGFBP5;STAT1;ANXA1;EIF2B3;TGFBR3
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.5309866960358846,-1.1145526384417774,0.3137254901960784,0.9180087838380648,1.0,9/31,14.49%,MT2A;KCNMA1;ADAM9;THBS1;SLC11A2;NDRG1;PAM;PLSCR1;SLC25A13
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.5867066551458443,-1.1143191145940206,0.30158730158730157,0.9174942480369015,1.0,9/31,13.67%,AKR1C2;CTSL;AKR1C1;NR4A3;SLIT2;BCAS3;THRB;ROBO2;SRA1
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.6221357912844269,1.1140839581854427,0.4166666666666667,0.9141192138530304,1.0,3/12,12.59%,MTFR1;WASHC5;DNM2
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.6128163925207966,-1.113945424587927,0.3387096774193548,0.9172694314983917,1.0,4/9,19.09%,ABCB7;BRCA1;MT3;PRKN
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.7030608579351032,1.1135436933950547,0.3953488372093023,0.9140928790467017,1.0,4/6,29.27%,HLA-E;AP1G1;PIK3R6;LAMP1
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.574304085580837,-1.1135258350907695,0.3333333333333333,0.9175335875734247,1.0,6/26,9.42%,RIPOR2;CEMIP;COL1A1;EYA1;COL11A1;CACNA1D
prerank,MSigDB_Hallmark_2020__Myogenesis,0.40810659334728094,1.1133816773287022,0.2631578947368421,0.9129140836589882,1.0,14/83,5.37%,LDB3;MYH11;MYOM2;NOTCH1;PTP4A3;SORBS3;CKMT2;PKIA;MEF2D;ADCY9;GNAO1;DTNA;MYH9;TAGLN
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.6548368255641717,1.113177791045971,0.36363636363636365,0.9118672889024239,1.0,3/6,25.20%,MAP2K2;DYRK1A;MARK3
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.6125125828979898,-1.1130740571119684,0.352112676056338,0.9176219699772717,1.0,8/14,29.18%,RPS25;DDX52;RPS24;RPS14;RPS7;RPS28;RPS27L;RPS6
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.6464922332793267,1.1130630541526132,0.30434782608695654,0.9106236568305627,1.0,5/6,13.62%,PML;DEK;CDKN1A;LEF1;EP300
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),-0.7028471341205165,-1.1130588933043373,0.4117647058823529,0.9165109951001754,1.0,3/5,26.66%,APPL2;SELENOS;PID1
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.6018574984930274,1.1129001243596692,0.38461538461538464,0.909584580412628,1.0,6/15,18.33%,CACNA1C;CACNB2;KCNQ1;BIN1;CTNNA3;ANK2
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.5173923940444781,1.1128579445978135,0.3125,0.9081131747641964,1.0,8/26,13.01%,NOTCH1;HIPK2;LEMD3;SMAD7;ACVR2A;BMPR1A;UBE2D1;RBPMS2
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.7428234442887831,1.1127048090641787,0.30952380952380953,0.9054211543107529,1.0,2/5,15.54%,ADAM17;WNK1
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.7428234442887831,1.1127048090641787,0.30952380952380953,0.9054211543107529,1.0,2/5,15.54%,ADAM17;WNK1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.7292221850603354,-1.112685139867126,0.4375,0.9165630327505264,1.0,1/5,11.02%,FGF13
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.5402246424209676,1.112334231089809,0.3333333333333333,0.9048502049704196,1.0,5/23,13.62%,CNOT7;PML;CNOT6;CDKN1A;EP300
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.5753029964424259,1.1122351051579022,0.27906976744186046,0.9035055678547681,1.0,2/16,3.19%,CSF1R;ERBB4
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.6613264682648262,-1.1122293713535205,0.4166666666666667,0.9169014966237143,1.0,1/7,0.93%,RIPOR2
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),-0.6055005962653348,-1.1111233647779553,0.3275862068965517,0.9181226455384558,1.0,2/15,4.62%,TGFB2;IFT122
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),-0.6055005962653348,-1.1111233647779553,0.3275862068965517,0.9181226455384558,1.0,2/15,4.62%,TGFB2;IFT122
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.4337665577225161,-1.1110861940469583,0.2318840579710145,0.9170801507311338,1.0,28/153,13.30%,PDGFD;FGF1;TGFB2;RPS4X;AKR1C2;VEGFA;MEGF10;STAT1;TET1;NR4A3;LAMC1;BMP5;TSHR;TGFBR1;CD47;GCNT2;THBS1;PTGFR;LAMB1;FN1;SSR1;NAMPT;S100A6;TGFBR3;KRAS;CCN1;PDCD10;UFL1
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.6145778760490194,-1.1094958755595161,0.3584905660377358,0.9213333262328609,1.0,4/15,13.97%,BACH2;WDFY4;RALGPS2;IL16
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),-0.5366291991477736,-1.1091001639324112,0.31343283582089554,0.9215397979070321,1.0,9/36,15.32%,TGFB2;VEGFA;TNFRSF19;MID1;SASH1;MAP3K4;PDCD10;MINK1;GADD45B
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.5078021315395784,1.1079414997576924,0.2571428571428571,0.9157974123533673,1.0,3/21,8.85%,MFHAS1;DLC1;TIPRL
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.6409646416246325,1.1079305906193664,0.35,0.9142946028989081,1.0,2/6,18.91%,PARD3;SKI
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.6977410144991512,1.107852404775342,0.42857142857142855,0.9113762672439899,1.0,3/5,22.06%,IRS1;GKAP1;PTPN11
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.6977410144991512,1.107852404775342,0.42857142857142855,0.9113762672439899,1.0,3/5,22.06%,IRS1;GKAP1;PTPN11
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.6881898251187272,1.1077479677500848,0.42,0.9102108015390361,1.0,2/7,6.38%,GRID1;GRID2
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),0.6474432042531373,1.1074810130878159,0.30434782608695654,0.9091564745260635,1.0,1/10,0.21%,CSF1R
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),-0.7173289216382732,-1.1063128234756516,0.38181818181818183,0.9299681126145665,1.0,1/5,2.61%,HECW2
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.547993541973778,-1.1057903729029694,0.3728813559322034,0.9303607271986637,1.0,2/22,4.07%,VEGFA;SFRP4
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.5391321453785929,1.1057810453788441,0.2777777777777778,0.9129353746774969,1.0,4/22,7.06%,HSPA1A;SMAD7;GNL3L;SPOPL
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),0.481920384507268,1.1056836422504797,0.25,0.9116664991936003,1.0,5/22,10.83%,UBE2N;WDR33;MSH2;RAD18;USP10
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.6088961429170201,1.1053155076727097,0.42105263157894735,0.9113432709553814,1.0,4/11,27.41%,METTL14;CELF1;ROCK1;YTHDF2
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.693267056970673,1.1049371180956495,0.44642857142857145,0.910967962564251,1.0,3/8,14.63%,GNL3L;SAE1;EGR1
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.6252360104114613,-1.1048472257761597,0.3137254901960784,0.9324913366621974,1.0,7/11,23.50%,DDX18;RPL10A;WDR12;ZNHIT6;RPL7A;RPL35;LAS1L
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.6542086116000742,1.104490926296117,0.4666666666666667,0.9108594290787718,1.0,1/5,1.78%,CDH2
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.5496537303891762,-1.1044408942168495,0.3620689655172414,0.9327689200203497,1.0,4/23,7.94%,ABLIM1;EYS;COL1A1;COL11A1
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),-0.6572586981860922,-1.1044118302620076,0.4098360655737705,0.9316064502510768,1.0,1/9,1.56%,MDFIC
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.6710663350316541,-1.1044016448241842,0.3469387755102041,0.9305329118051519,1.0,2/8,17.02%,BIRC2;APPL2
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),0.453751929290093,1.1043041706571628,0.3125,0.9098501450144382,1.0,3/46,1.28%,CSF1R;NOX4;MFHAS1
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),-0.7111102697709579,-1.1041149337103973,0.43859649122807015,0.9303210589146592,1.0,1/7,1.01%,ARHGAP24
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.6199853081149982,-1.1038531990776805,0.41818181818181815,0.9299871790148879,1.0,1/14,0.88%,TGFB2
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.6306358166496713,-1.1033983292879277,0.34545454545454546,0.9304375282450993,1.0,3/13,3.35%,MLPH;ANXA1;PGR
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),-0.7497269650615869,-1.1032901146633345,0.3148148148148148,0.9297742583122788,1.0,3/6,13.84%,IFITM3;TRIM13;LARP7
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.5063209703380345,-1.1032437169606217,0.3424657534246575,0.9287585593376527,1.0,12/41,11.65%,KCNMB1;TGFB2;NR4A2;IGFBP2;FGGY;IFI44L;SGK1;PTGFR;BTG2;PLAG1;EPHA5;THRB
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.557777789043232,-1.1032025993962786,0.4032258064516129,0.9277453964403661,1.0,6/22,10.67%,ANXA1;COL3A1;COL1A1;COL1A2;ADAM9;ASAH1
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),-0.7124995584938698,-1.1029426293003382,0.4117647058823529,0.927453348001475,1.0,1/6,0.43%,TWIST1
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.6408276729157047,1.1024776553069617,0.37777777777777777,0.9138361142128222,1.0,1/5,6.95%,USP7
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),-0.5215911620813004,-1.1024658756930035,0.3709677419354839,0.9277215842012982,1.0,7/31,13.23%,PLXNC1;VEGFA;SLIT2;SNW1;NGF;PLXNA2;ROBO2
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.6229167716912603,1.102130745300887,0.41304347826086957,0.9132654191828856,1.0,4/10,15.22%,KPNA4;CBLB;NUP54;KPNB1
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.6007278894582865,1.1016951378371311,0.42857142857142855,0.9131712956847042,1.0,2/11,3.34%,PDK4;ACADVL
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),0.6303733208250784,1.101563919725399,0.4489795918367347,0.9121298426547266,1.0,1/9,7.12%,MAPKBP1
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.6805979919054466,-1.1014939624384177,0.4032258064516129,0.9297872285650586,1.0,2/9,8.69%,SUPT6H;BRCA1
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.6712164926327376,-1.100846266365788,0.41509433962264153,0.9310104903316236,1.0,1/6,0.98%,MT2A
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),-0.676527100806334,-1.1007792704457016,0.4576271186440678,0.930037175639232,1.0,2/7,4.46%,CTSL;ADAMTS12
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),-0.6962793421102167,-1.1004486903195014,0.4153846153846154,0.9299740726825344,1.0,1/8,0.88%,TGFB2
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.42394550652222207,1.100241425736139,0.24324324324324326,0.9148585724650024,1.0,14/74,13.68%,TRIM4;TOB1;SORT1;ARF1;FUBP1;ADNP;NFKBIZ;MTMR1;TOB2;PRDM10;MTMR4;SART3;UBAP2;SCARB2
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),0.5287173662409449,1.1000596211139984,0.32558139534883723,0.91367787149529,1.0,10/16,28.18%,MAVS;IRF3;DHX9;RIOK3;PTPRS;TRAF3;PTPN11;DDX3X;RNF216;TBK1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.6413949865392772,-1.099565927305402,0.38461538461538464,0.9315310537816189,1.0,3/10,11.69%,SULF2;BRCA1;CYP1B1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.4470073043816109,-1.0993797838159622,0.23880597014925373,0.9310315937074148,1.0,26/145,13.46%,CLU;TWIST1;FGF1;RIMS1;VEGFA;WARS1;AFDN;ACTG1;RPL5;CALCOCO1;SFRP4;GSN;TGFBR1;F3;OLFM1;SLC24A3;BRCA1;FN1;DHX36;NGF;CTCF;RPS3;MAPK14;KRAS;PDCD10;PLSCR1
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),-0.7036249591973358,-1.098774769975666,0.34545454545454546,0.9318357566303089,1.0,1/5,0.93%,RIPOR2
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.7130198082401461,1.0986312510339582,0.4,0.9161852461857085,1.0,2/5,21.37%,RHOA;CHMP4B
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.6636491098576601,-1.0981174409778633,0.42857142857142855,0.9315856032235746,1.0,1/6,0.93%,RIPOR2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.6636491098576601,-1.0981174409778633,0.42857142857142855,0.9315856032235746,1.0,1/6,0.93%,RIPOR2
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.6069771055392911,-1.097619637292304,0.4166666666666667,0.9322659706600469,1.0,4/13,16.33%,ABCA8;PTCH1;APOE;SREBF2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.7339822140035552,1.097429536352509,0.425,0.9180740903842959,1.0,2/6,15.54%,ADAM17;WNK1
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.4949817724278476,1.0973696458076727,0.358974358974359,0.9168069325272951,1.0,4/31,7.23%,KCNC2;SLC12A2;KCNH7;HCN2
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.6728250149357122,-1.0970246612982169,0.27586206896551724,0.9332806637908925,1.0,1/9,2.57%,SUPT6H
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.5238606177818121,1.0966961652688088,0.3125,0.9173854758597847,1.0,2/21,3.91%,HSPA1A;RBM20
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),-0.6464063373970778,-1.0964535612341326,0.40350877192982454,0.9339452966032448,1.0,4/11,3.14%,VEGFA;NRP1;SEMA3C;SEMA6D
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.4777481403595692,1.0963174402596763,0.2857142857142857,0.9170949305227143,1.0,10/49,8.49%,ST3GAL2;GALNT18;MGAT5;TRAK1;GFPT1;RPN2;NUS1;B3GNT2;OGA;STT3B
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.5716281416776336,-1.0959934765162764,0.3448275862068966,0.9343808610249607,1.0,5/18,10.67%,ST6GALNAC3;SPTLC3;PLPP3;NSMAF;ASAH1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.61526662225,-1.0959761853452257,0.43137254901960786,0.9332969672123083,1.0,3/13,12.72%,ABCA8;PTCH1;APOE
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.5892192842083115,-1.095942646599566,0.3880597014925373,0.9322276647332048,1.0,8/21,13.84%,IFITM3;STAT1;N4BP1;TRIM13;PPIA;PLSCR1;SRPK1;LARP7
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.7005608832927605,-1.0954277831827344,0.37735849056603776,0.932699510849985,1.0,2/8,13.99%,MTM1;TMEM39A
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),-0.7268342332507225,-1.0952947251417051,0.48148148148148145,0.9320504685829993,1.0,2/6,16.25%,SCN7A;SCN2A
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.6301648766515306,-1.0951968032642336,0.3770491803278688,0.9311531579810127,1.0,2/10,19.10%,WRN;XRCC6
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.6331996879527931,1.0951134188135947,0.38461538461538464,0.9197833484459884,1.0,2/10,11.47%,APC;MYOCD
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.5736172428672234,-1.0950890307859065,0.3230769230769231,0.9303055630895791,1.0,5/21,10.07%,CLU;SVIP;LDLRAD4;JAM3;SMAD6
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.6983592690494402,1.0949439873670619,0.41304347826086957,0.9186946576883938,1.0,3/5,25.22%,RHOA;ETS1;TRAF6
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),-0.5621415088345377,-1.0948497581991938,0.3333333333333333,0.9299110377875155,1.0,6/26,12.09%,TGFB2;BMP5;PDCD4;DDX5;SMAD6;TGFBR3
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),-0.6448286361963492,-1.0947020746119545,0.43859649122807015,0.9293515102106435,1.0,1/11,0.38%,CLU
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.7113591892919988,-1.0945538991936754,0.39344262295081966,0.9275033339018991,1.0,1/5,5.12%,PER2
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.7113591892919988,-1.0945538991936754,0.39344262295081966,0.9275033339018991,1.0,1/5,5.12%,PER2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.5179352246910598,-1.093928532752832,0.3235294117647059,0.9283779115196413,1.0,5/29,12.72%,TGFB2;STAT1;THBS1;TGFBR3;APOE
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.620713058706201,1.0938865144678045,0.4146341463414634,0.9201117343542623,1.0,4/9,19.79%,CACNA1C;RYR2;ANK2;SLC8A1
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.5521835726797022,-1.0934309612466264,0.390625,0.9289672484218549,1.0,7/27,13.25%,RACK1;GLI3;GPC3;IFT122;UCHL5;PTCH1;ARMC9
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.5826439043889493,1.0932811327483456,0.35135135135135137,0.9189244525055902,1.0,5/11,16.43%,CNOT7;TOB1;AGO2;CPEB3;ZFP36L1
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.5826439043889493,1.0932811327483456,0.35135135135135137,0.9189244525055902,1.0,5/11,16.43%,CNOT7;TOB1;AGO2;CPEB3;ZFP36L1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.557916254266858,-1.0931845109072356,0.31666666666666665,0.9286714551490083,1.0,8/20,15.24%,PARP1;SLF1;FUS;PRKDC;MRNIP;PARP9;SPIDR;MGMT
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.6412540909603426,-1.0931299509141912,0.35,0.9277408711927825,1.0,4/9,20.50%,APOE;LPL;PNPLA8;RORA
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),-0.5203034824696158,-1.0924769924681144,0.31746031746031744,0.9289635858126503,1.0,11/39,28.89%,CSE1L;STRADB;THOC1;SRSF7;SRSF5;U2AF2;NEMF;NCBP1;TPR;SRSF11;POLDIP3
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),-0.6619519909619587,-1.0922756175074793,0.3620689655172414,0.9284927591193275,1.0,3/9,12.00%,NT5E;HSP90AB1;ANO6
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.6546352050764025,1.0918285551430136,0.4090909090909091,0.921707692945236,1.0,2/6,12.74%,CACNB2;BIN1
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.6584873771046191,-1.0917938369374394,0.4230769230769231,0.9290666945145439,1.0,3/12,8.58%,PKM;ENO1;PGK1
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.7573253198705718,-1.0917929935258004,0.38333333333333336,0.927964417810351,1.0,3/5,24.24%,SPIDR;DDI2;FMR1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),-0.6940486705105785,-1.0916831515627634,0.43103448275862066,0.9270987435226375,1.0,3/7,14.95%,YBX3;MAPK14;ANGEL2
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),-0.562636636058304,-1.091506358902401,0.4,0.9265622955491207,1.0,3/21,6.53%,PARP1;GPC3;HSP90AB1
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.6243032219045704,-1.0911028804903424,0.4166666666666667,0.9269840824618527,1.0,2/14,18.14%,GOSR1;NAPG
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.6886447505810029,1.0910425190175876,0.3829787234042553,0.9224761328538725,1.0,1/6,1.28%,MFHAS1
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.5200531835820272,-1.0908545113114578,0.2714285714285714,0.9267054887458479,1.0,9/35,18.66%,POLA1;BRCA1;RPA1;RAD17;ORC3;ORC5;WRN;TOPBP1;MRE11
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.648135214910335,-1.0905935582355508,0.423728813559322,0.9264508438187193,1.0,3/10,9.98%,SLC2A3;ST6GAL1;CSGALNACT1
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.6396479512576982,1.0904320811391517,0.40476190476190477,0.9227115179094278,1.0,4/8,20.95%,TMTC1;LARGE1;TMTC4;DPM1
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),0.6811865552176753,1.0903198983538918,0.40425531914893614,0.9201097410770607,1.0,2/5,5.85%,AP3M1;AP3D1
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),0.6811865552176753,1.0903198983538918,0.40425531914893614,0.9201097410770607,1.0,2/5,5.85%,AP3M1;AP3D1
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),-0.6422841210376835,-1.0901129277695671,0.43137254901960786,0.926766600710063,1.0,3/10,10.67%,ANXA1;ADAM9;ASAH1
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.6977303061480267,1.089970155187968,0.4090909090909091,0.9194623710845132,1.0,2/5,26.74%,CHMP4B;MARK4
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.6082057257718577,-1.089907748879687,0.4426229508196721,0.9262221223672983,1.0,4/10,21.61%,RPL5;RPL11;RPS7;RPL23
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.6414290458490002,-1.089336736641732,0.3787878787878788,0.9268390232150867,1.0,1/8,2.37%,CEMIP
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.5318413914751593,-1.0886851800560546,0.4262295081967213,0.9280454024524385,1.0,4/37,9.11%,PDGFD;TGFB2;DCN;FN1
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.45250641394727803,-1.0886698480786206,0.2903225806451613,0.9269805426979367,1.0,22/90,15.61%,MT2A;SLC2A3;VEGFA;EXT1;AKAP12;XPNPEP1;GPC3;ADM;ENO1;GCNT2;F3;DCN;PGK1;NDRG1;GLRX;PAM;BHLHE40;CCN1;WSB1;LDHA;BTG1;ANXA2
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.46849644508913124,-1.0883929110294361,0.2857142857142857,0.9267504997377263,1.0,18/71,16.52%,CLU;TGFB2;SAT1;IFITM3;ANXA1;GSN;BTG2;DCN;BRCA1;PDCD4;LGALS3;TGFBR3;TIMP2;SQSTM1;MGMT;GADD45B;GPX4;EMP1
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.5739494708462399,1.088385495752399,0.3076923076923077,0.922489271001312,1.0,3/16,10.47%,PDK4;ACADVL;PPARA
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.5852892852395163,1.0877172441116605,0.34782608695652173,0.9229942656790358,1.0,2/10,2.10%,ATP2B4;PKIA
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.6450443750924126,-1.0872909735124983,0.42592592592592593,0.9292343126191908,1.0,2/13,2.74%,KCNMB1;KCNMA1
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.4597261582544504,1.08691713441286,0.358974358974359,0.9235145495466816,1.0,14/44,14.55%,ADGRB3;CACNA1B;CTNND2;OPCML;NXPH1;PRKG1;GRID2;NRXN1;CTNNA2;GRIN1;CNTNAP2;CADPS;SHISA6;GNG4
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),-0.5575279941444107,-1.0861879341448364,0.4339622641509434,0.9317122605351735,1.0,4/18,5.73%,TGFB2;VEGFA;NRP1;TGFBR1
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.5204568365045755,1.0861212720092672,0.40540540540540543,0.9245913972017643,1.0,2/21,1.86%,TRPC6;BCL2
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.6917774123370046,-1.085430761657733,0.3333333333333333,0.9329288175000355,1.0,4/5,30.35%,HSPA4;BCL2L11;TOMM70;HSP90AA1
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.7124524025213439,-1.0848864176418933,0.40625,0.9331415553437417,1.0,3/5,20.48%,ATG10;TMCO1;SELENOS
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.6837133136112227,-1.084822059679209,0.40384615384615385,0.9321701501673298,1.0,2/7,13.68%,MAP3K4;TNKS2
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.5885346168871188,-1.0848105277372542,0.33962264150943394,0.9310862462578707,1.0,1/13,2.98%,STAT1
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.48470497696952825,-1.0847286666617797,0.3333333333333333,0.9301653925043568,1.0,9/54,8.55%,MDFIC;SULF2;NKD1;APCDD1;SFRP4;RACK1;GPC3;OTULIN;PTK7
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.7468384965113216,-1.0846030371281525,0.4909090909090909,0.9294871742667592,1.0,1/5,1.62%,VEGFA
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),-0.6509858898371119,-1.0844661433230751,0.42857142857142855,0.9288562957590747,1.0,4/11,8.77%,NT5E;HINT1;PRTFDC1;ACAT1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.6626317033052364,-1.0840811677006583,0.3469387755102041,0.9291751241333506,1.0,2/7,6.40%,IGFBP5;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.5363688920220943,1.0829408398637606,0.3170731707317073,0.9337210337765173,1.0,2/14,13.75%,RAB27A;CADPS
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),-0.48192713310445634,-1.0826796250109385,0.3088235294117647,0.9329964230345603,1.0,11/52,13.55%,CIRBP;RPS4X;RPL5;PLD1;THBS1;ATG10;UPF3A;SAMD4A;PRKDC;EEF2;VGLL4
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.5769184987851006,-1.0821871914395904,0.3870967741935484,0.933674406320084,1.0,4/15,14.93%,IFT122;TTC8;CSNK1D;BBS4
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),-0.7153716433121904,-1.0817782201926924,0.4186046511627907,0.9339637353445709,1.0,3/5,23.13%,EIF2B3;MT3;CDK6
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),-0.5324955450296356,-1.0816424128498978,0.3620689655172414,0.9332630900058677,1.0,2/27,1.68%,VEGFA;NRP1
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.5637058510262283,-1.0813120903696405,0.375,0.9332228409896044,1.0,1/12,2.37%,CEMIP
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.4227907795988401,1.0809627052614537,0.3103448275862069,0.938386182239009,1.0,6/51,7.06%,HSPA1A;UBQLN1;UBE2N;SMAD7;GNL3L;SPOPL
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),-0.431994137811915,-1.080336759730118,0.27631578947368424,0.9349978628361155,1.0,12/121,6.77%,TWIST1;TGFB2;VEGFA;LEPR;CMKLR1;COL1A1;PER2;TSHR;TGFBR1;ENO1;GCNT2;OLFM1
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.38947111402599605,1.0794658418000405,0.4,0.9414200208694498,1.0,15/89,11.53%,HSPB1;TNFRSF10B;CXXC5;SLC44A2;GPRC5B;VAPA;PPM1A;UBE2N;MAP3K7;MAPKBP1;RHOA;PELI2;USP10;MID2;MAVS
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.5464374426907856,1.0794628949073268,0.35714285714285715,0.9398892566078734,1.0,4/15,18.33%,CACNA1C;RYR2;CTNNA3;ANK2
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.6212020061870557,-1.0794226958702196,0.39622641509433965,0.9367914296974088,1.0,5/11,19.87%,TRMT1L;TARBP1;NSUN2;NSUN6;TRMT44
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),-0.4670991013725367,-1.0793667997363041,0.36363636363636365,0.9358757024883319,1.0,12/77,10.39%,CLU;CIRBP;RPS4X;RPL5;PLD1;GLI2;NMD3;THBS1;HSP90AB1;UPF3A;SAMD4A;PRKDC
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),-0.6798879245504179,-1.078912844121122,0.36,0.9359682815533115,1.0,1/7,1.06%,UAP1
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.6334514430054948,1.078796828349515,0.43902439024390244,0.9404609451539357,1.0,1/7,1.07%,NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.6513128343642027,1.0787876720370297,0.391304347826087,0.9389869552681491,1.0,1/7,2.10%,PKIA
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),0.648520826152378,1.0786713065230957,0.46808510638297873,0.9377518933964103,1.0,1/8,0.21%,CSF1R
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.5669157573977466,1.0782390038784913,0.42857142857142855,0.9375227343295421,1.0,3/13,3.83%,HSPA1A;TMBIM6;BCL2L1
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.54963110543255,-1.077558732846169,0.3684210526315789,0.9394709503912225,1.0,4/20,2.98%,NR4A1;VEGFA;NRP1;STAT1
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.6013625441257721,1.0775277305912732,0.3333333333333333,0.9383279540062562,1.0,1/9,0.66%,CACNA1B
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.6003378584969229,1.0769560079562863,0.3902439024390244,0.9385313690664869,1.0,3/11,9.37%,PDK4;TNFRSF1B;MITF
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.5372302237491573,1.0769499055030929,0.4186046511627907,0.9370723301863536,1.0,7/16,24.09%,MAP3K7;LEF1;JADE2;MEAF6;JADE1;KAT6A;KAT2B
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.6402192989765632,1.076724401057194,0.3888888888888889,0.9361488976054364,1.0,2/8,14.08%,PCF11;XRN1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.7041198425803237,-1.076501488735106,0.46938775510204084,0.9417135212905314,1.0,1/5,8.69%,BRCA1
prerank,MSigDB_Hallmark_2020__UV Response Dn,-0.45992259797691143,-1.0764143315698491,0.36231884057971014,0.9409315379059693,1.0,27/108,16.71%,IGFBP5;NRP1;KCNMA1;FHL2;COL3A1;COL1A1;LAMC1;COL1A2;PLPP3;F3;AMPH;NOTCH2;PTGFR;COL11A1;ADD3;SYNJ2;MAPK14;TGFBR3;BHLHE40;PMP22;CCN1;CELF2;MGMT;ANXA2;CDC42BPA;LPAR1;SYNE1
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.5540206973122009,-1.076402840532022,0.3698630136986301,0.9399150356034343,1.0,6/27,9.42%,RIPOR2;CEMIP;COL1A1;EYA1;COL11A1;CACNA1D
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),-0.7001771218670826,-1.076375237345617,0.4230769230769231,0.9378778138611202,1.0,1/5,16.19%,SLC1A2
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),-0.7001771218670826,-1.076375237345617,0.4230769230769231,0.9378778138611202,1.0,1/5,16.19%,SLC1A2
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.6474198439527036,-1.076360960912115,0.4,0.9368122456743884,1.0,1/9,1.19%,IFITM3
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),-0.5307150126712633,-1.0761347800474992,0.3709677419354839,0.9364100245131289,1.0,8/38,11.66%,NRP1;LAMC1;TBCD;LAMB1;FN1;TMEFF2;NTN4;ABI2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.7015651042885768,1.0755281454984476,0.4318181818181818,0.9364443293672811,1.0,3/5,29.27%,HLA-E;AP1G1;LAMP1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),0.7015651042885768,1.0755281454984476,0.4318181818181818,0.9364443293672811,1.0,3/5,29.27%,HLA-E;AP1G1;LAMP1
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),-0.7225144089876947,-1.0754159084309542,0.3673469387755102,0.9375863619039935,1.0,3/6,7.07%,TGFB2;ZFPM1;NOTCH2
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),-0.6323825603390383,-1.0750366746388127,0.41379310344827586,0.9376871005492387,1.0,2/10,1.68%,VEGFA;NRP1
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),-0.6719600024516932,-1.0750041204983423,0.4888888888888889,0.9367047648751718,1.0,2/5,20.50%,PTCH1;RORA
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),0.6095029680904693,1.0749012113486223,0.4,0.9370123885871133,1.0,1/8,4.35%,GNAI1
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),0.37700506659817906,1.0746963491545212,0.24,0.9362103410753797,1.0,32/147,14.93%,HSPA1A;HSPB1;BCL2;BNIP3L;TMBIM6;BCL2L1;FMN2;TBX3;API5;ARHGAP10;BNIP3;RAF1;AXL;CD44;HDAC1;CBL;TNFAIP8;EGFR;KLHL20;MCL1;SEMA4D;PAK2;NAA38;CAT;HDAC2;LEF1;NFKB1;ZFAND6;RPS6KB1;MECOM;GAS6;TJP1
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),-0.5918978855743693,-1.0745562083666929,0.39655172413793105,0.9370515930529805,1.0,7/13,27.16%,ACTG1;KDM2B;DAG1;ARHGAP12;VCL;TBX18;FGFR2
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.4841231206217323,1.073778218950567,0.37142857142857144,0.9377151397804032,1.0,5/36,10.28%,CSF1R;MAP2K2;RHOA;CAB39;CDKN1A
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",0.6553642716117402,1.0736827166633658,0.5,0.9364379664861611,1.0,1/8,0.63%,SRSF12
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.5832191028320607,1.0728303636957592,0.44,0.9372813476814463,1.0,4/10,11.82%,ANPEP;EGFR;ARHGEF10L;KCNQ1
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.4261958429781123,-1.0720834392910676,0.29577464788732394,0.9440135326730923,1.0,23/118,16.76%,XPA;PARP1;RAD51B;DDB2;MSH6;XPC;POLA1;EYA1;BTG2;BRCA1;RPA1;UIMC1;INO80;RAD17;PRKDC;WRN;PARP9;RNF8;ZRANB3;MGMT;ASCC3;TOPBP1;GTF2H1
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.4161989358700846,1.0720519160859512,0.3023255813953488,0.9379091030445719,1.0,9/55,12.61%,OPA3;SMARCD3;NFYC;IRS2;TGS1;OAZ2;PPARA;ELOVL6;NCOA2
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.5194381052986209,1.0716358280305598,0.42857142857142855,0.9376516988318263,1.0,8/20,10.64%,GUCY1A1;PANK3;ADCY9;GUCY1B1;PAPSS2;ADCY3;PAPSS1;ADCY5
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.6091360376718274,-1.0716062374643216,0.4117647058823529,0.9441509929214359,1.0,6/12,29.45%,DERL1;UFD1;SELENOS;SEL1L;NPLOC4;VCP
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.4425019652461503,-1.0713892215911387,0.30434782608695654,0.943699175751088,1.0,29/90,16.46%,IGFBP5;CMKLR1;PROCR;COL3A1;COL1A1;COL1A2;CPQ;COL6A1;PLPP3;APH1B;COL12A1;DCN;LAMA4;FN1;CALCRL;NTN4;SMAD6;ITGBL1;SMOC1;CYP1B1;NXN;PMP22;C1S;SVEP1;SH3D19;FAM114A1;ITPRID2;UACA;LMCD1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.6673909745805752,1.0706489863425959,0.3829787234042553,0.939044358954656,1.0,3/6,23.13%,EGFR;KDR;DYRK1A
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.4445355756222003,1.070616521648071,0.3157894736842105,0.9376936441324293,1.0,10/46,11.36%,MFHAS1;TNFRSF1B;GNB1;ADCY9;PTH1R;MYH9;ADCY3;PPARA;ADCY5;ADAM17
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.3192667289204292,1.070608094429827,0.0,0.9362332390160126,1.0,116/774,11.98%,CSF1R;DACH1;EBF4;MXD4;GATAD2A;TENM2;NOTCH1;ZBTB7C;SATB2;CSRNP3;KLF15;CXXC5;PPARGC1B;BCL9;ATP2B4;SP4;NCK2;HEY2;SOX6;BACH1;HDX;MED24;CTBP2;SMARCD3;NCOA5;HIPK2;NCOA3;MEF2D;ACTR2;RFX3;EPAS1;KLF13;ZNF721;DEK;SOX13;ZEB2;PPM1A;NFYC;TRAK1;RNF14;BBS7;SMARCA4;TBX3;ZNF710;ZNF704;BCL9L;ZBTB7A;SMAD7;HIF3A;RRP1B;HDAC9;BRD2;VEZF1;ZNF611;KLF12;SOX5;ZNF546;KDM7A;NACC2;LCOR;HMBOX1;ZFHX3;KLF9;ACVR2A;MED23;ZNF143;PHF2;ZBTB16;PHF20L1;USP16;ZNF586;CBX6;AGO2;HEYL;HDAC1;PHF20;MITF;ARID1B;LCORL;EGFR;EBF1;THRA;ARNT;BRWD1;RAD21;CEBPB;APBB1;CTDSP1;CDKN1A;RBL1;MTF2;ZNF160;PPARA;AEBP2;PRDM10;GABPB1;BMPR1A;MBD2;ZNF609;RPS6KA5;GRIN1;SMARCA1;ZFY;PHF8;ZNF251;MEIS2;BCL6;MYOCD;MAVS;ZNF208;NEDD4L;ARID1A;SEMA4D;FHOD1;PKNOX1;UBE2D1
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.5865170243556909,1.0704733520656513,0.425,0.9351024702429764,1.0,3/10,9.77%,MCM9;MSH2;RAD21
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),-0.6436538796448205,-1.0701147507484237,0.390625,0.9462342619669625,1.0,3/9,18.90%,ALDH3A2;PEX3;ACBD5
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.3825830352746393,1.0701029253299386,0.25,0.9347865857681176,1.0,11/70,9.85%,ADGRB3;LSAMP;CHL1;OPCML;GFAP;ZEB2;CDC42EP4;NRXN1;CTNNA2;EGFR;TNR
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),-0.7106693869279654,-1.0699729861446248,0.4918032786885246,0.9457034946295001,1.0,3/5,22.73%,EPHA4;APOE;PTN
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.5885568506847535,1.0695741327055488,0.46153846153846156,0.9334298677143242,1.0,4/9,18.61%,PHF20;JADE2;MEAF6;JADE1
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.5885568506847535,1.0695741327055488,0.46153846153846156,0.9334298677143242,1.0,4/9,18.61%,PHF20;JADE2;MEAF6;JADE1
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.4464565859483356,-1.0693772515808213,0.3939393939393939,0.9461817324479068,1.0,9/55,14.74%,GBP2;ADAMTS12;CD47;PELI1;IL1R1;PSMC2;PSMD8;MAP3K8;SQSTM1
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.5431915140818336,1.0689224033075004,0.4,0.9339256082650063,1.0,6/17,17.04%,CNOT7;SH2B3;SLIT3;CCDC3;GAS6;GSTP1
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.5631050723652467,1.0688959972855683,0.37142857142857144,0.9325815039876116,1.0,3/13,10.64%,ADCY9;ADCY3;ADCY5
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),-0.5795566826448221,-1.068777061962115,0.38095238095238093,0.9469907530759301,1.0,5/22,10.84%,ADH5;ALDH3A2;HADHA;ACAT1;CYP4V2
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.674918260858895,-1.0687182483156887,0.4166666666666667,0.9461183909320848,1.0,4/8,19.06%,ENPP2;PLA2G4C;GPCPD1;PNPLA8
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.5744076086920957,-1.0686426775593356,0.4307692307692308,0.9442583021042924,1.0,6/20,15.74%,LIMA1;AKR1C1;SOAT1;APOE;NPC1;LPL
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.5744076086920957,-1.0686426775593356,0.4307692307692308,0.9442583021042924,1.0,6/20,15.74%,LIMA1;AKR1C1;SOAT1;APOE;NPC1;LPL
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.5577939970180942,1.0685956013298266,0.41304347826086957,0.9319822009378123,1.0,3/17,15.54%,ATP2B4;P2RX4;WNK1
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.6457850949722131,-1.0684850988172767,0.3793103448275862,0.9436893035052933,1.0,3/11,8.63%,ARHGAP24;SLIT2;TCHP
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.5422151304591818,1.0675891243720026,0.3902439024390244,0.9332334174136792,1.0,1/17,0.21%,CSF1R
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.5128915643751074,-1.067458835184364,0.359375,0.9463335611864043,1.0,3/28,11.24%,PIGG;ATG10;HHAT
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.6445780792344883,1.067107307385361,0.3953488372093023,0.933084371752845,1.0,2/7,18.33%,KCNQ1;ANK2
prerank,PanglaoDB_Augmented_2021__Myoblasts,0.41419624715383196,1.0668688422409744,0.34375,0.9324710511002183,1.0,8/68,5.81%,CSPG4;JPH2;CHST3;TIMP3;C1QTNF1;PRKG1;TBX3;EHD2
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.588316878085804,1.0666680386295033,0.40476190476190477,0.9316036194847115,1.0,4/11,19.79%,CACNA1C;RYR2;ANK2;SLC8A1
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),-0.6807125502955305,-1.0666198872978563,0.43137254901960786,0.9477852156921913,1.0,2/6,19.63%,SRP54;CLMP
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.6904708817990324,-1.0663796067462723,0.4915254237288136,0.9475324528859107,1.0,3/8,21.77%,RPA1;UBA52;POLK
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.5969497017112303,1.0661152093565363,0.45,0.931873156838276,1.0,8/11,37.30%,ADAM17;MEF2C;AKT3;PLCG1;FGF2;SP1;COL4A3;FLT1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.5979959493693225,-1.0656841399649153,0.41935483870967744,0.9486506170468725,1.0,2/14,6.53%,CDC37;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),0.6229533157669609,1.0653738519427811,0.4,0.9329234724178864,1.0,3/9,15.54%,RHOA;ADAM17;WNK1
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,-0.47963348816193907,-1.0653225200581316,0.3424657534246575,0.9487259683894551,1.0,12/55,9.19%,COL15A1;IGFBP5;COL6A3;PAMR1;C7;THBS2;COL3A1;COL1A1;COL1A2;COL12A1;DCN;MGP
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.6087999264182328,1.0652426306463432,0.38461538461538464,0.9317726737142247,1.0,3/8,18.91%,SORT1;MYOCD;SKI
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),0.6240991733723782,1.0651263842513472,0.46511627906976744,0.930545905197283,1.0,2/7,19.43%,P2RX4;RYR3
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),0.554715044237512,1.0651251483907247,0.4222222222222222,0.9291164952046604,1.0,2/11,2.05%,NOTCH1;TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),-0.5523991460634485,-1.064997454492391,0.4098360655737705,0.9487136443810568,1.0,6/21,9.13%,RIPOR2;NRP1;MYO10;RHOQ;GPM6A;BCAS3
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),-0.7371217825093753,-1.0647921489344525,0.4603174603174603,0.9482970826645664,1.0,3/5,12.24%,GSN;SGK1;MAGED2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.6353403673600524,-1.0647453377690594,0.47540983606557374,0.9473466716584339,1.0,3/6,21.62%,CYP1B1;PDCD10;STK24
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),-0.6392995051652538,-1.0647284492954197,0.46,0.9463329719053222,1.0,3/10,12.72%,ABCA8;PTCH1;APOE
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.630660527444047,1.0647033471751162,0.38461538461538464,0.9288170589539751,1.0,2/8,3.30%,PML;HIPK2
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.5314066530591953,-1.0637178732716246,0.36065573770491804,0.9484686112931171,1.0,9/36,17.81%,MYO10;CDKL1;DYNC2LI1;PLD1;TBC1D2B;TBC1D22A;SDCCAG8;DCDC2;TBC1D8
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),-0.461201491876311,-1.0634622750838671,0.36363636363636365,0.9480868102109326,1.0,13/75,12.42%,TWIST1;WARS1;TERF2IP;FBLN1;RACK1;LDLRAD4;PLPP3;SLIT2;DNAJC10;SMAD6;PRKDC;PPIA;PRKAG2
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),-0.49943110459366064,-1.063403315002867,0.3770491803278688,0.9472386497336506,1.0,10/37,19.09%,TGFB2;FOXQ1;KDM2B;RETREG1;NGF;APOE;NAE1;MT3;EPHA7;PRKN
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),-0.6498527503779578,-1.0616150239628952,0.4339622641509434,0.9511460966899956,1.0,4/8,22.28%,PTCH1;ROBO2;BASP1;PKD2
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.633136122454357,-1.0614244483202537,0.4117647058823529,0.9507192303747136,1.0,4/7,16.49%,PARP1;PARP6;TNKS2;PARP8
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),-0.5828327567008963,-1.0613064895290745,0.453125,0.9499684350528935,1.0,2/18,6.53%,HTT;HSP90AB1
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.48712398330214385,-1.061128152292743,0.34328358208955223,0.949392377673626,1.0,4/57,1.97%,FGF1;TGFB2;VEGFA;PRRC1
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.5074700937227132,-1.0610726281667353,0.3333333333333333,0.9484610223392455,1.0,2/33,2.90%,TGFB2;ACTG1
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.6539520102001651,-1.0609418706123357,0.4423076923076923,0.9479094902350139,1.0,1/10,0.88%,TGFB2
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.5603040487545028,-1.060935640283181,0.4,0.9468847952639325,1.0,5/16,18.24%,LSS;SOAT1;APOE;CYP27A1;MT3
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.5541692699261377,-1.060918761387416,0.4117647058823529,0.9458731293040525,1.0,6/21,18.30%,SPRY1;PDCD4;SPRY3;APOE;SPRY4;PIK3CB
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.6068514342157455,-1.0603616785903633,0.4074074074074074,0.9465633963841515,1.0,1/11,1.22%,RIMS1
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),-0.667590651075994,-1.0601475714263413,0.45454545454545453,0.9461023451821344,1.0,1/6,4.97%,GSN
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.6228723921580928,-1.0599800256988645,0.375,0.9455671694085577,1.0,5/12,18.66%,MMS22L;THOC1;WRN;ZRANB3;MRE11
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.6034229267088358,1.0598865180181338,0.4482758620689655,0.9409918620544289,1.0,2/9,7.36%,ST3GAL2;B3GNT2
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.6750803440808026,-1.05981419263623,0.4576271186440678,0.9451082239468035,1.0,1/5,8.42%,HLA-B
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.5830981751604055,1.0596753169689828,0.40476190476190477,0.9401694271171996,1.0,1/11,5.89%,MAP3K7
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),-0.7096772922489362,-1.059453189980757,0.42857142857142855,0.9453143323561182,1.0,2/5,9.53%,SHROOM3;JAM3
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.4339052526058828,1.0593314259759985,0.36363636363636365,0.9397755838448353,1.0,16/39,19.81%,NOTCH1;HIPK2;LEMD3;SMAD7;ACVR2A;ITGA3;BMPR1A;UBE2D1;RBPMS2;PCSK6;RBPJ;TRIM33;SKI;SMAD5;SKIL;SMAD2
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,0.6258327398227136,1.0589655453586333,0.37209302325581395,0.9393986980141672,1.0,2/10,2.05%,CSF1R;TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.6058236972902464,1.058771303267764,0.4411764705882353,0.9384723143743456,1.0,4/11,10.59%,SMAD7;C12ORF57;RYR2;P2RX4
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.617729284982661,1.0586057544601148,0.4146341463414634,0.9374073672245072,1.0,2/8,5.47%,CWC27;FKBP5
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),-0.52714927574832,-1.0585958122200707,0.38333333333333336,0.9470071101087277,1.0,2/22,2.89%,VAMP4;AFDN
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),-0.586806629444235,-1.0575588440619361,0.43548387096774194,0.9487068707581778,1.0,4/10,22.73%,EPHA4;APOE;SQSTM1;PTN
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.3555866760906463,1.0569738220885965,0.20689655172413793,0.940988403194283,1.0,26/200,11.42%,DACH1;GATAD2A;NOTCH1;CNOT7;PML;HEY2;PHC1;CTBP2;ATP8B1;PTPRK;HSPA8;RFX3;SOX13;SMARCA4;TBX3;ZBTB7A;HDAC9;NACC2;HMBOX1;ZBTB16;HEYL;HDAC1;THRA;MBD2;RPS6KA5;BCL6
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.6839380485525053,-1.0567985163729052,0.4230769230769231,0.9502214355431491,1.0,2/7,20.36%,HSP90AB1;CALM1
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.6960920536945712,-1.056715936990909,0.44,0.9494186766733281,1.0,4/6,13.27%,NMNAT2;NMNAT3;NAMPT;PARP9
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.5545931034205199,-1.0564649005236875,0.4074074074074074,0.9493207034633779,1.0,9/23,22.30%,BRCA1;UIMC1;RAD17;PRKDC;MRNIP;TOPBP1;MRE11;DONSON;BABAM2
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),-0.6876630845323406,-1.0561682648549342,0.4576271186440678,0.9492229437026869,1.0,2/5,7.25%,AKR1C2;PTGFR
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.504905189068748,-1.0557728496814243,0.3870967741935484,0.9493060873307017,1.0,8/36,15.74%,DDX60;CD47;THBS1;SASH1;PDCD4;PLSCR1;IL16;LPL
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),-0.7048952346149371,-1.0557005866076417,0.5344827586206896,0.9484865790448553,1.0,1/5,3.19%,ANXA1
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.579036732911019,-1.0556536581962326,0.39344262295081966,0.9476476388047597,1.0,4/17,13.59%,HECW2;FGF13;GLRX;WNK2
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.5568850699984876,1.0552836809040564,0.4411764705882353,0.9440417677795152,1.0,4/16,6.06%,PTPRK;CD151;DLC1;ARHGEF7
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.4218055826720884,1.0552817886636419,0.25806451612903225,0.9426135654076854,1.0,17/52,20.08%,SORCS1;SORT1;HSPA8;ARF1;SNAP23;KLHL20;EXOC6;ARL3;DNM2;COMMD1;MYO1B;RAB14;MYO5A;AP1G1;CLTC;EPS15;RAB10
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),0.5661608435423855,1.05514944537085,0.4772727272727273,0.9415331834275723,1.0,4/16,12.59%,ATP2B4;NUS1;EGFR;DNM2
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.635335597441417,1.0550705067726447,0.4358974358974359,0.9404092894992492,1.0,2/8,8.23%,SYNE3;SYNE2
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.5826005409896687,-1.0548233740397843,0.43103448275862066,0.9490988821823239,1.0,6/14,18.66%,ANXA1;DHX36;WRN;ZRANB3;ASCC3;MRE11
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),-0.6938713861882007,-1.0543481545100324,0.4583333333333333,0.9496686086435108,1.0,2/6,21.96%,NAMPT;SPTLC2
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.3884411288183086,1.0541829522460169,0.28,0.9415926761110158,1.0,27/105,13.11%,KCNC2;ABL2;PDK4;TNFRSF1B;ATP2B4;PTPRK;NCOA3;GNB1;GUCY1B1;SLC26A3;TESC;LCOR;HCN2;CAMKK2;ERCC6L2;AXL;IRS1;RHOA;EGFR;PXN;PDE3A;P2RX4;KCNQ1;RAP1A;PLAA;RAPGEF2;NFKB1
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),-0.5507078785336961,-1.0541439491875835,0.4666666666666667,0.9493913942926518,1.0,5/25,5.09%,TGFB2;ZFPM1;GLI3;IFT122;GLI2
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),0.6155054314819997,1.053994298775703,0.4772727272727273,0.9406430508179703,1.0,1/9,0.21%,CSF1R
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.3262364184678958,1.0537818104531287,0.14285714285714285,0.9398049180430046,1.0,139/738,14.68%,DACH1;EBF4;MXD4;GATAD2A;WTIP;NOTCH1;ZBTB7C;CNOT7;SATB2;PTP4A3;CSRNP3;PML;KLF15;PPARGC1B;ATP2B4;SP4;HEY2;PHC1;SOX6;BACH1;HDX;MED24;CTBP2;ATP8B1;SMARCD3;ERBB4;FOXN2;HIPK2;PTPRK;MEF2D;HSPA8;RFX3;EPAS1;KLF13;ZNF721;DEK;PPP2R1A;SOX13;ZEB2;PPM1A;NFYC;TRAK1;RNF14;BBS7;SMARCA4;TBX3;TESC;ZNF710;ZNF704;ZBTB7A;SMAD7;HIF3A;HDAC9;BRD2;VEZF1;ZNF611;KLF12;SOX5;ZNF546;KDM7A;NACC2;LCOR;CAMKK2;HMBOX1;ZFHX3;KLF9;MED23;MAP2K2;ZNF143;PHF2;ZNF562;ZBTB16;PHF20L1;USP16;ZNF586;HEYL;HDAC1;PHF20;MITF;ARID1B;LCORL;EGFR;EBF1;THRA;ARNT;BRWD1;RAD21;CEBPB;APBB1;CTDSP1;CDKN1A;MTF2;ZNF160;PPARA;AEBP2;MBD2;ZNF609;RBM23;RPS6KA5;SMARCA1;ZFY;PHF8;ZNF251;MEIS2;BCL6;MYOCD;ZNF208;CDK17;ARID1A;PKNOX1;ZNF81;ZNF398;CEP290;DNM2;NCOA2;HDAC2;NSD2;LEF1;ZBTB11;ACTA2;YAF2;NFKB1;RNF10;TBX15;PURB;APBB2;AFAP1L2;EP300;BBX;BTRC;MAP2K1;FOXO3;ZNF213;ZNF782;MECOM;TRIP4;EGR1;GAS6;NFIA
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.7006042157381642,-1.0536424992666695,0.49056603773584906,0.9498645334306052,1.0,1/6,8.69%,BRCA1
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.5686675584206342,-1.053426877730964,0.45454545454545453,0.9494400270482863,1.0,9/25,15.42%,SLC7A14;SLC38A1;AKR1C1;SLCO1A2;SLC6A20;SLCO1C1;SLC22A6;SLC7A2;SLC6A13
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),-0.44022085034505826,-1.0533590476783918,0.38028169014084506,0.9486476368473574,1.0,17/120,12.16%,LAMA1;AFG3L2;NRP1;SEMA3C;LRTM1;SEMA6D;UNC5D;EPHA3;GLI2;SLIT2;HSP90AB1;NOTCH2;SEMA3D;NTN4;EPHA5;S100A6;EPHA4
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.4128814806377671,1.0531884092713657,0.34375,0.9401160648946225,1.0,9/56,4.99%,RASL12;SORCS1;CHL1;NDRG2;RCAN2;GPRC5B;DAAM2;GFAP;CNTN1
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,-0.4586380050190451,-1.052622080141781,0.3787878787878788,0.9496884399872311,1.0,13/72,7.15%,PDGFD;IGFBP5;SPRY1;ARNT2;MEGF10;SEMA6D;KCNIP1;DKK3;FAT3;GLI3;NTM;SLIT2;PDZRN3
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.61387473308243,-1.0524706016217946,0.4423076923076923,0.9491288061676263,1.0,1/12,0.43%,TWIST1
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),-0.6417982726964149,-1.052237979535063,0.46,0.9488014450129962,1.0,3/12,19.33%,AFDN;ANO6;NUP107
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),-0.6803320086516501,-1.0519802970900742,0.5,0.9484852789663436,1.0,1/7,11.81%,GNPAT
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.4465878197250859,-1.051498478083729,0.36363636363636365,0.94899775912815,1.0,14/69,14.36%,PARP1;RAD51B;MMS22L;POLA1;EYA1;BRCA1;RPA1;UIMC1;INO80;PRKDC;WRN;PARP9;SPIDR;RNF8
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),-0.6395207257579829,-1.051429810735707,0.47619047619047616,0.948179530598682,1.0,3/10,14.28%,BMP5;SGCD;SVIL
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.5990282803802982,1.0511931810006232,0.44,0.9440161659296535,1.0,3/12,10.64%,EBF4;C2ORF72;ADCY5
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.6409886649420906,-1.051123737468454,0.43636363636363634,0.9482101652787264,1.0,1/8,2.57%,SUPT6H
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,-0.437234511164989,-1.050990482557016,0.36,0.9475721279210312,1.0,18/95,8.49%,PDGFD;ABCA8;KCNMB1;COL15A1;IGFBP5;COL6A3;PAMR1;FHL2;DKK3;THBS2;COL3A1;COL1A1;FBLN2;SGCD;COL1A2;COL12A1;DCN;LAMA4
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.46567214840658677,-1.0509246531559076,0.375,0.9466954301367446,1.0,11/78,10.60%,TWIST1;ZFPM1;SPRY1;ADAMTS12;LDLRAD4;BMP5;TGFBR1;ZFP36L2;PDCD4;SMAD6;PTCH1
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.44057290219655054,-1.0505563880587903,0.3561643835616438,0.9466337285173904,1.0,10/81,7.17%,SRGAP3;ARHGAP24;ARHGAP15;RASGRF2;VAV3;ARHGEF3;ARHGAP28;SLIT2;RHOQ;RALBP1
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.5214756871913614,1.0505322718579464,0.3783783783783784,0.9444591424005255,1.0,3/18,9.50%,TIMP3;FMN2;EGFR
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.6533123544213768,1.0503217520579544,0.425,0.9436511726553104,1.0,1/9,0.72%,HSPB1
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),-0.62148074717358,-1.050055641628794,0.4117647058823529,0.9470303552826983,1.0,3/12,10.60%,TGFB2;GLI3;PTCH1
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.5544539484591174,-1.0493331947859048,0.36923076923076925,0.9478942485988705,1.0,8/15,25.84%,DERL1;UFD1;SEC13;SELENOS;LMAN1;SEL1L;NPLOC4;TECPR2
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.5371811136325166,-1.0493079009188793,0.4,0.9469378075004546,1.0,1/19,0.14%,ABCA4
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,-0.42348202197748297,-1.0491920935884214,0.375,0.9462844297979021,1.0,15/93,12.61%,SHROOM3;FBLN1;MYO10;PRTG;LAMC1;GLI2;MID1;PTK7;LAMB1;ADGRA3;COL4A6;COL4A5;PRDM5;ANO6;NXN
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),0.5508234641992771,1.0489604627819469,0.3673469387755102,0.9465118735493812,1.0,2/12,2.81%,SERPINB6;TIMP3
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.6025095049123833,-1.0489480435223224,0.5,0.9460886904997865,1.0,5/16,23.55%,PER2;CYP27A1;LPL;HSD17B4;OSBP
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),-0.5903657446294429,-1.048624412159216,0.4444444444444444,0.9460798166274534,1.0,3/12,13.54%,TUBGCP5;CCDC57;CSNK1D
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),-0.6159223498300972,-1.0484914139538104,0.45,0.9455328979886263,1.0,2/11,14.93%,CSNK1D;BBS4
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.5738200445003614,1.0483351130676257,0.4888888888888889,0.9471798817034159,1.0,4/9,17.82%,CACNA1C;ADGRV1;CAP2;GNAI3
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.600512102778802,-1.0478306841928446,0.4642857142857143,0.9466306286925253,1.0,5/9,16.92%,SPTLC3;ASAH1;CYP1B1;SPTLC1;CYB5B
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.444692338745195,1.0478260529051964,0.4482758620689655,0.9470165356857833,1.0,5/56,6.56%,CSPG4;CHST3;MCAM;EHD2;ENAH
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.6092787651955703,1.0472023167356332,0.4782608695652174,0.9475744615773559,1.0,4/9,19.02%,PDK4;IRS1;FOXO3;SCD
prerank,PanglaoDB_Augmented_2021__T Cells,-0.5430273195171222,-1.0468604233541392,0.43333333333333335,0.9485830551317871,1.0,5/19,9.18%,IFIT3;SEMA6D;DKK3;GEM;CREM
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.529963947821667,1.0466956916142225,0.4,0.9473038227385473,1.0,2/10,8.29%,ARF1;CTNNA2
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.6561992916541945,-1.0466818643759976,0.46,0.9480145965467897,1.0,1/7,5.18%,SRP14
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3617110684535821,1.0466056712849952,0.3333333333333333,0.94620829623177,1.0,34/176,14.68%,WTIP;NOTCH1;PTP4A3;PML;PDGFA;PPARGC1B;SOX6;BACH1;FOXN2;RFX3;PPP2R1A;SOX13;NFYC;RNF14;ZFHX3;MED23;ZNF143;ZNF562;MITF;CEBPB;APBB1;MTF2;RPS6KA5;ZNF398;DNM2;NCOA2;NSD2;ZBTB11;YAF2;APBB2;EP300;FOXO3;TRIP4;NFIA
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.5679895421578195,-1.0463819488712827,0.39215686274509803,0.9477873598851583,1.0,1/11,2.37%,CEMIP
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.49326018044622844,1.0462853070583136,0.42105263157894735,0.9456503840311798,1.0,3/30,10.30%,SRSF12;ZBTB7A;SMU1
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.45019559010267335,1.0457271902987006,0.37142857142857144,0.9456886889950551,1.0,5/35,4.44%,TRPC6;CACNA1C;ABL2;ATP2B4;C1QTNF1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),0.4524332194378161,1.0455819530252746,0.3548387096774194,0.9447069422816784,1.0,11/45,11.87%,TNFRSF10B;PML;BCL2;TNFRSF1B;HIPK2;BCL2L1;BNIP3;CEBPB;CDKN1A;MCL1;ERO1A
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.6618011475941232,-1.0454665451745675,0.4727272727272727,0.9494750738998147,1.0,2/8,5.09%,GLI3;GLI2
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.6460944191683371,1.045415673179306,0.41304347826086957,0.9438344871269513,1.0,4/6,24.46%,KCNQ1;GAS6;PPM1E;MEF2C
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.4699842297427852,-1.0454078576351507,0.36065573770491804,0.9485990107468794,1.0,7/35,14.34%,AFG3L2;CTSL;F3;APH1B;PTCH1;C1RL;AEBP1
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),-0.6684772434322642,-1.0453962891661743,0.5,0.9476426202969567,1.0,1/5,1.62%,VEGFA
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.617100964822453,-1.045045941850314,0.49122807017543857,0.9474885521074047,1.0,3/8,24.74%,TUT7;UBA52;TUT4
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),-0.6707793279814676,-1.0446627892869234,0.4666666666666667,0.9476012983355196,1.0,1/7,2.12%,TERF2IP
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.45856243742681724,1.0446546782358372,0.37142857142857144,0.9445431333113234,1.0,4/28,6.35%,DENND3;PISD;BNIP3L;BNIP3
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.5745756603964058,1.0445375986257224,0.43243243243243246,0.9435522288275887,1.0,1/8,5.42%,ATP6V1H
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.5570642550965536,-1.0441486518437597,0.4423076923076923,0.9480721701612865,1.0,7/27,17.15%,CMKLR1;OTULIN;PRMT2;G3BP2;CYP1B1;UFL1;TMSB4X
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.6098005487431429,1.044087433458641,0.5,0.9431695785419241,1.0,5/10,21.00%,ATL2;RTN3;REEP3;RAB10;RTN4
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.4902701692299916,-1.043641778886464,0.3770491803278688,0.9483579484147305,1.0,7/26,25.33%,PSMC2;ORC3;ORC5;PSMD8;UBA52;PSMD14;PSMA3
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.4611096066049794,-1.0430487963128474,0.375,0.9489496535928827,1.0,13/61,9.54%,FGF1;IGFBP5;ARNT2;MEGF10;NTM;LAMC1;TMEM132C;ASPA;SCN7A;PDZRN3;SLC22A17;SLCO1C1;NDRG1
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.5825499716079368,-1.0424160846357537,0.4,0.9499892221056413,1.0,2/15,6.37%,PIK3R4;AP2A2
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),-0.6064706479043744,-1.0420086764619463,0.4918032786885246,0.9504352429319213,1.0,5/13,19.83%,ALDH3A2;PEX1;PEX3;ACBD5;LONP2
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),-0.4981194232517096,-1.0414763256085158,0.37037037037037035,0.9510738586481721,1.0,9/27,15.24%,PARP1;SLF1;EYA1;BRCA1;UIMC1;RPS3;SPIDR;RNF8;MGMT
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.7142899569750245,1.0410234218599403,0.5609756097560976,0.9503287798780321,1.0,2/5,16.20%,NRXN1;NLGN2
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.5712368814498943,1.0406013007151766,0.4146341463414634,0.9498166370198974,1.0,5/13,9.91%,TNFRSF1B;NCK2;TNFRSF21;DLG5;CEBPB
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.543062109415508,1.0405468898461099,0.43137254901960786,0.9485224704517157,1.0,4/18,10.96%,INF2;BNIP3;RALA;MCU
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.6181437340487129,1.0401989434794707,0.4222222222222222,0.948300316100265,1.0,2/7,5.47%,CWC27;FKBP5
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.6007435869344028,-1.0398979435338522,0.4915254237288136,0.9542345240795611,1.0,2/10,12.42%,CEMIP;PRKAG2
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,-0.458287641365189,-1.039838187350931,0.43661971830985913,0.9534448507603858,1.0,14/65,10.38%,TWIST1;IGFBP5;FBLN1;COL3A1;GLI3;COL1A1;LAMC1;GLI2;COL6A1;SLIT2;COL12A1;LAMB1;EBF2;BOC
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),-0.6583448137628752,-1.0397379708354004,0.45614035087719296,0.9526669729400211,1.0,1/8,1.22%,RIMS1
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.5206349339105708,-1.039453790647976,0.4098360655737705,0.952499303996808,1.0,3/25,3.37%,KCNMB1;KCNMA1;KCNIP1
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.5947989042478117,-1.039448769126477,0.44642857142857145,0.9515213668798171,1.0,4/14,14.49%,PER2;ENO1;PGK1;SLC25A13
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),-0.6070765887810198,-1.0390966214047601,0.4897959183673469,0.9516082875991808,1.0,4/15,9.53%,JAM2;ACTG1;LAMC1;JAM3
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.6732411551115729,-1.0390169656228974,0.41509433962264153,0.9508153085655735,1.0,1/6,0.98%,MT2A
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.43244658218707865,-1.0386483910889936,0.3972602739726027,0.9509027796643327,1.0,16/94,5.79%,ABCA8;COL15A1;IGFBP5;COL6A3;VEGFA;PAMR1;NT5E;THBS2;COL3A1;COL1A1;FBLN2;ADM;SGCD;COL1A2;COL6A1;PLPP3
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.47958306569245696,1.0385350595927263,0.40476190476190477,0.9516244314839267,1.0,3/24,10.83%,INTS7;TIPRL;USP10
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),-0.7060664543743955,-1.0382701683721274,0.5471698113207547,0.9509698883781409,1.0,1/5,4.36%,TEFM
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.42182704539886523,1.0377083588533516,0.45454545454545453,0.9520735109960816,1.0,10/59,12.24%,GALNT18;MOCS1;CHST3;CDC42EP4;FKBP5;KCTD3;ADGRL2;EGFR;SMARCA1;PLS3
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.5272342717041921,-1.0375313261922285,0.42857142857142855,0.9519239351989887,1.0,1/24,0.43%,TWIST1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.5786116263402039,-1.0373799259114347,0.4528301886792453,0.9513252312268958,1.0,2/9,6.00%,NR4A3;CD47
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.40233470467447063,1.0371883303647356,0.3783783783783784,0.9519670183608234,1.0,4/55,5.97%,HSPA1A;UBE2N;MAP3K7;ZBTB7A
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),-0.5800253101237016,-1.037144308848424,0.4642857142857143,0.9511905044699973,1.0,2/11,11.21%,VEGFA;POMZP3
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.5279957164096039,1.0371349874210656,0.5142857142857142,0.9506641456512409,1.0,3/13,9.14%,GPRC5B;HEYL;RHOA
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),-0.6605076972114623,-1.0371316737380285,0.47058823529411764,0.9492754897566679,1.0,1/6,2.57%,SUPT6H
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),-0.6605076972114623,-1.0371316737380285,0.47058823529411764,0.9492754897566679,1.0,1/6,2.57%,SUPT6H
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),-0.5871603114573559,-1.0370472710542853,0.4696969696969697,0.9485215049733318,1.0,4/17,9.03%,SLC47A1;SLC38A1;SLC11A2;SLC6A20
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.6852845576583299,-1.036846077726634,0.4791666666666667,0.9481998572853018,1.0,3/5,19.10%,ZFP36L2;PRKDC;XRCC6
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.6386597242808913,-1.0362352547997342,0.45,0.9490498185233328,1.0,2/8,7.70%,TERF2IP;SMG6
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.6824192021337271,-1.0361187365086295,0.5087719298245614,0.9485683225347342,1.0,1/7,1.03%,AFG3L2
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),-0.4396700247899177,-1.035621881161551,0.4225352112676056,0.9490166627948209,1.0,23/102,18.70%,TWIST1;TGFB2;RIPOR2;CMKLR1;COL1A1;RIN2;TGFBR1;GCNT2;HSP90AB1;OLFM1;BOC;DHX36;NGF;MAPK14;CCN1;FOXC1;BTG1;LPL;RGCC;ACVR1;PRKCH;EDN3;NBL1
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),0.6789507199582405,1.035619836929403,0.47368421052631576,0.953353214077377,1.0,1/8,0.21%,CSF1R
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.5877109370782059,-1.035465552711707,0.37254901960784315,0.9484563647244705,1.0,2/12,7.89%,SLIT2;TBCD
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.699492592917566,1.0354320102796828,0.46938775510204084,0.9525741413417883,1.0,2/5,20.69%,GRIN1;GRIA2
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),-0.4764612977211367,-1.0352322445159687,0.43283582089552236,0.948086588222768,1.0,17/67,21.33%,TGFB2;NR4A2;NRP1;PER2;SPOCK1;GPM6A;FGF13;BHLHE40;SDCCAG8;DCDC2;CCK;WNT5B;HES1;MARK1;AUTS2;ADGRL3;ASTN2
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.5584727664178228,-1.0352209100488987,0.46774193548387094,0.9471201391012362,1.0,2/17,2.98%,IGFBP5;STAT1
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.5698125838430868,-1.0349228991942756,0.45161290322580644,0.9470409385180033,1.0,3/11,10.60%,GLI3;GLI2;PTCH1
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.553894724058237,-1.0349076263901988,0.40350877192982454,0.9461470774030544,1.0,4/19,11.28%,CIRBP;FUS;DHX36;LARP1
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.5716805145946733,1.0348586830440223,0.42857142857142855,0.9527654199519948,1.0,6/12,25.86%,PHF20;JADE2;MEAF6;JADE1;MSL2;OGT
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.691533813070927,-1.0343903936898124,0.5102040816326531,0.9465355839886141,1.0,2/7,6.29%,CMKLR1;HTT
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),-0.6714760807351786,-1.034103536662569,0.4375,0.9463183846559559,1.0,1/6,1.70%,PRDX1
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.49060561006199,1.034017215617973,0.3409090909090909,0.9538038812523127,1.0,8/23,14.12%,SMARCA4;HDAC1;ARID1B;MBD2;SMARCA1;ARID1A;HDAC2;CECR2
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),-0.595743072458415,-1.0339322187698594,0.4576271186440678,0.9459332134206262,1.0,1/13,1.41%,SLC4A4
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.45077468797906256,1.0339009693417196,0.3548387096774194,0.9527601985128308,1.0,5/29,2.95%,NOL4;CACNA1B;CSRNP3;CTNND2;OPCML
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.5595396688918928,1.0336967485198056,0.4444444444444444,0.9520309371002412,1.0,2/18,5.85%,AP3M1;AP3D1
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.5765928565913929,1.033438423789968,0.42857142857142855,0.9514962769204988,1.0,2/10,5.68%,CSF1R;CAMK1D
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.6444879131303622,-1.033186804615048,0.5,0.9472015513239088,1.0,2/6,20.24%,UFL1;BCL2L11
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.5739211624114512,-1.0331165437702976,0.46296296296296297,0.9464900093493299,1.0,1/16,0.14%,ABCA4
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.6418550083510678,-1.0325609583334436,0.46296296296296297,0.9471823785788448,1.0,4/8,20.50%,APOE;LPL;PNPLA8;RORA
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.5742612937715948,1.0322240732996644,0.4146341463414634,0.9529890208378038,1.0,2/11,8.23%,SYNE3;SYNE2
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.6026931747414191,-1.032209347678031,0.532258064516129,0.9470840219539484,1.0,5/12,17.73%,EIF2S2;EIF2B3;EIF4H;EIF2S3;EIF4G1
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.516932412618802,1.032138133390101,0.42424242424242425,0.9518638684127866,1.0,3/14,10.64%,ADCY9;ADCY3;ADCY5
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.46927964527807403,-1.0316499644983355,0.4782608695652174,0.9479616704872682,1.0,11/62,12.09%,TGFB2;COL3A1;BMP5;COL1A2;TGFBR1;ADAM9;GCNT2;PDCD4;DDX5;SMAD6;TGFBR3
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.6472543365063642,-1.0315381208301186,0.48148148148148145,0.9472423846876061,1.0,4/10,14.13%,PKM;ENO1;PGK1;LDHA
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.7270886359082838,-1.031482387829429,0.45614035087719296,0.9463769958902958,1.0,3/5,19.70%,HEXB;OMD;OGN
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.5283605935799955,1.0310750952699597,0.4418604651162791,0.9533370838357479,1.0,4/14,14.81%,CDH2;CTNNA2;MYOCD;CDC42
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.5892237477146398,-1.0309918900343742,0.4745762711864407,0.9466827475763752,1.0,2/10,1.36%,TGFB2;ZFPM1
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.5727489661132315,1.0307699057072688,0.47619047619047616,0.9528772305933598,1.0,3/12,11.02%,ATP2B4;CDKN1A;FBXW7
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),-0.49587270144875606,-1.0303290265887495,0.4406779661016949,0.9476848922725826,1.0,4/34,10.14%,ZFPM1;NR4A3;THBS1;LGALS3
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.4775142177163124,1.0301111856709284,0.36585365853658536,0.9532126619138581,1.0,5/16,16.20%,GRID2;DLG5;NRXN1;CLSTN2;NLGN2
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.45597579457658177,1.029974817653826,0.3541666666666667,0.9523872323194961,1.0,6/26,15.11%,PACSIN2;MYH9;EHD2;UGCG;BIN1;STX2
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),0.569911515642544,1.0291726698569015,0.4,0.9533088692342456,1.0,2/10,10.97%,VAPA;YTHDC2
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.5415442756934313,1.0288364494718478,0.4444444444444444,0.9527052534925553,1.0,6/19,12.83%,NOTCH1;HEY2;GNAI1;ADAM17;HDAC2;LEF1
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),0.6076381096909834,1.0287151151252205,0.46,0.9516501228711474,1.0,2/10,10.97%,VAPA;YTHDC2
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),-0.44858627684998004,-1.028562309246175,0.4461538461538462,0.951646784481163,1.0,7/62,7.83%,NR4A2;NR4A1;PGR;NR4A3;NOTCH2;SNW1;NR2F1
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.5450873930568317,1.0283936595534857,0.4864864864864865,0.9511819499751025,1.0,4/14,15.56%,UBE2N;SMG1;MCL1;WRNIP1
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),-0.3755395470899313,-1.0280790843721976,0.40217391304347827,0.9521226821795468,1.0,57/455,14.85%,PRAG1;PRSS23;IGFBP5;TGFB2;KLHL13;PARP1;DDB2;ANXA1;CDKL1;ELOB;COL3A1;GPC3;ST3GAL5;LAMC1;PIK3R4;PPM1H;TGFBR1;GCNT2;THBS1;VCAN;STRADB;SGK1;UBL5;ATG10;PARP6;FBXW2;LAMB1;FBXO22;FN1;FAM20A;MTM1;PRKDC;NUB1;ST3GAL4;PSMC2;GLRX;CALU;PRKAG2;PPP2R3A;DAPK2;APOE;CHRM3;CCN1;PARP9;WSB1;UFL1;NEK1;ARF4;CSNK1D;WNK2;SRPK1;TNKS2;PSMD8;NPC1;NAE1;MINK1;PPP2R2A
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.5396140680086772,1.027513827363526,0.43243243243243246,0.952027193037449,1.0,4/15,18.33%,CACNA1C;RYR2;CTNNA3;ANK2
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.5597059555053003,1.0275080048934315,0.4878048780487805,0.9506863096669737,1.0,5/13,24.09%,PHF20L1;PHF20;EP300;KAT6A;KAT2B
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.6260902904056099,-1.027399606242788,0.5079365079365079,0.9530380635947597,1.0,2/10,1.32%,MLPH;FOXQ1
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),-0.6801515734973999,-1.027399135740146,0.5102040816326531,0.9511319874675702,1.0,3/5,9.10%,YBX3;BIRC2;PELI1
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.6801515734973999,-1.027399135740146,0.5102040816326531,0.9511319874675702,1.0,3/5,9.10%,YBX3;BIRC2;PELI1
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.5349519915285766,1.0263966785254524,0.5,0.9525329822982732,1.0,7/18,13.62%,RNF14;SMARCA4;ZBTB7A;HEYL;HDAC1;NCOA2;EP300
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.5668264416790565,-1.0261775511269893,0.4375,0.9538216012265093,1.0,2/15,10.83%,CTSL;ALPK1
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.6156241218241111,1.0258552309402735,0.4634146341463415,0.9526323785669245,1.0,2/6,17.36%,AGO2;DHX9
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),-0.5067877060723113,-1.0257149794995242,0.4,0.9541662241673423,1.0,5/16,12.75%,NRP1;SEMA3C;SEMA6D;SEMA3D;PLXNA2
prerank,MSigDB_Hallmark_2020__heme Metabolism,0.3846225450338102,1.0254835368575432,0.36363636363636365,0.9520501347692271,1.0,8/87,6.90%,BCAM;MFHAS1;BACH1;BNIP3L;EPOR;TNS1;VEZF1;KDM7A
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.4950954450264644,1.0250164257282837,0.40425531914893614,0.9519327777141722,1.0,3/18,13.80%,MAP3K7;NFKB1;BTRC
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.5225821372483772,1.024946873508023,0.4,0.9508037941550055,1.0,1/17,1.09%,MOB1B
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.43295702606710607,1.024452004979624,0.47058823529411764,0.9507462508367603,1.0,6/39,8.16%,ST3GAL2;GALNT18;C1GALT1;TRAK1;B3GNT2;OGA
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.3310690337013561,1.0244275966282685,0.42857142857142855,0.949535574282822,1.0,42/266,11.47%,HSPA1A;CSF1R;NOX4;H2AC6;NOTCH1;ZBTB7C;CNOT7;PML;BCL2;PDGFA;NCK2;TOB1;APC;CTBP2;PGF;ERBB4;PTPRK;EMP2;DLC1;TBX3;LIFR;TESC;IRS2;CNOT6;DLG5;NACC2;MARCHF7;RAF1;ELN;RNF139;IRS1;RHOA;HDAC1;EGFR;SH2B3;CDKN1A;BMPR1A;ZNF609;ADAM17;MEIS2;BCL6;MYOCD
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),-0.6752838581438991,-1.024263300264634,0.4925373134328358,0.957324646274681,1.0,2/7,17.21%,SLC38A1;SLC1A3
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.4388102147663981,-1.024230224689456,0.4583333333333333,0.9564197807067658,1.0,10/82,8.53%,PDGFD;FGF1;TGFB2;VEGFA;NRP1;DENND2B;GCNT2;NOTCH2;MID1;BMPER
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.6356051271389014,-1.0241880836112323,0.5,0.9555458738461032,1.0,1/7,0.38%,CLU
prerank,PanglaoDB_Augmented_2021__Mast Cells,-0.4397449619426541,-1.0241467836438485,0.3815789473684211,0.9546931237052781,1.0,22/99,9.90%,ABCA8;CD55;COL15A1;ST6GALNAC3;MLPH;SLC4A4;ALDH1A1;LIMA1;EXT1;ENPP2;GSN;SGCD;RIN2;COL1A2;PLPP3;FMO2;SHROOM4;DCN;GPM6A;CALCRL;HSD11B1;IL1R1
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.48211737338546096,1.0238624963242369,0.4418604651162791,0.9499406325706494,1.0,4/19,12.64%,ADGRB3;NEDD4L;SEMA4D;RAPGEF2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.49504549579160834,1.0234106479975615,0.4722222222222222,0.949855777710156,1.0,8/28,13.92%,DPP10;ATP2B4;GNAI1;KIF5B;ITGA3;EGFR;PTPN9;EFCAB7
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.3987552937514338,1.0231326117816453,0.34210526315789475,0.9494983925729564,1.0,11/68,14.90%,DPP10;RAB40C;EMP2;TESC;PACS2;EHD2;CACNB2;RAP1A;RAPGEF2;GAS6;NECTIN3
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.4172002878712365,1.0229663038118677,0.36363636363636365,0.9484395253346325,1.0,7/48,12.64%,CSF1R;ERBB4;AXL;EGFR;CDKN1A;RAP1A;RAPGEF2
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.6349266083311712,-1.0227259970467861,0.5192307692307693,0.9573243754864003,1.0,3/9,4.43%,RNF213;SFRP4;GPC3
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),0.6256503743826862,1.0225853503193927,0.48717948717948717,0.9482139387840267,1.0,4/8,16.35%,ZNF609;PLAA;RAPGEF2;SEMA6A
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.5725787410214956,1.0221134485775556,0.45714285714285713,0.9483177965804223,1.0,2/11,7.23%,SLC12A2;HCN2
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.5440549892615911,1.0221112123293892,0.4375,0.9470222421586368,1.0,4/12,19.83%,SORT1;KLHL20;RAB14;EPS15
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.49667264844158504,-1.0220150414419424,0.5,0.9582545865268053,1.0,3/29,10.07%,ANXA1;PELI1;SMAD6
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.5886001457105964,-1.0219829243683274,0.49056603773584906,0.9574113680618568,1.0,1/9,1.91%,SLC8B1
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),-0.5791879232277815,-1.0219229800293455,0.5185185185185185,0.9566568602364015,1.0,1/11,2.57%,SUPT6H
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.6081679781633098,-1.0215156352502879,0.4925373134328358,0.9569183177457624,1.0,4/10,13.97%,FHL2;SEMA6D;HSD11B1;IL16
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.6768557234452408,-1.021480124287952,0.5254237288135594,0.9550772545479307,1.0,1/6,6.37%,AP2A2
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.6768557234452408,-1.021480124287952,0.5254237288135594,0.9550772545479307,1.0,1/6,6.37%,AP2A2
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.5998538490660281,1.0214763054059055,0.5,0.9475409129785641,1.0,2/8,8.87%,IRS2;IRS1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.6683065626026905,-1.0213879591972428,0.5106382978723404,0.9544050894547796,1.0,1/6,8.42%,HLA-B
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),-0.6405581826880801,-1.0212679614516194,0.5818181818181818,0.9538016138125741,1.0,3/6,20.55%,PTS;CALM1;PRKG2
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.5785078303761034,-1.0212396791993943,0.43333333333333335,0.9529589736731681,1.0,6/19,14.95%,CIRBP;YBX3;FUS;LARP1;MAPK14;ANGEL2
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),-0.5325961951019562,-1.0212014260502214,0.40625,0.9521371999317109,1.0,8/21,19.96%,PLXNC1;SLIT2;NGF;PLXNA2;ROBO2;ZFYVE27;PLXND1;GOLGA4
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.5105496640402237,1.0210255429095418,0.4523809523809524,0.9474032318409136,1.0,4/16,11.82%,ATP2B4;GNB1;RYR2;KCNQ1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",-0.43668818762984085,-1.0209387699758063,0.42028985507246375,0.951921538872171,1.0,7/71,7.83%,NR4A2;NR4A1;PGR;NR4A3;NOTCH2;SNW1;NR2F1
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),-0.6180183433137413,-1.0205571596741072,0.5,0.9520130464731633,1.0,2/8,6.66%,ANXA1;ZFP36L2
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),-0.3912110143514708,-1.020403461439926,0.4125,0.9513765686038228,1.0,24/204,9.11%,PDGFD;FGF1;DDX60;TGFB2;AKR1C2;VEGFA;TERF2IP;TNFRSF19;RACK1;SEPTIN4;TGFBR1;GCNT2;THBS1;HSP90AB1;F3;RHEB;RPS20;DCN;SASH1;BIRC2;TRIM13;PDCD4;PELI1;FN1
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.63324891761076,-1.0201992412451106,0.4444444444444444,0.9509805129050782,1.0,2/10,5.12%,TWIST1;PER2
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.6460337950666286,-1.0199238206392456,0.49019607843137253,0.9509006348751972,1.0,3/5,10.67%,PDXDC1;ENPP2;ASAH1
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.597716960544745,1.0193544792479146,0.425531914893617,0.9506071301202123,1.0,3/9,9.19%,NOTCH1;HDAC9;HDAC1
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.5968952325172684,-1.0192383370596465,0.5454545454545454,0.9517375509655014,1.0,3/13,12.51%,PARP1;FUS;MRNIP
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),0.6288228545169725,1.0191788831028377,0.5208333333333334,0.9498266898627542,1.0,5/6,29.66%,PCSK5;SPCS2;SPPL3;SEC11A;HM13
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.3743123663034723,1.019093965150846,0.375,0.9487364556216776,1.0,30/155,13.62%,WTIP;NOTCH1;PTP4A3;PML;PPARGC1B;SOX6;BACH1;FOXN2;RFX3;PPP2R1A;SOX13;NFYC;RNF14;ZFHX3;MED23;ZNF143;ZNF562;MITF;CEBPB;APBB1;MTF2;RPS6KA5;ZNF398;DNM2;NCOA2;NSD2;ZBTB11;YAF2;APBB2;EP300
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),-0.6594436355710052,-1.018787167845747,0.4666666666666667,0.9521435780157932,1.0,1/7,3.13%,TET1
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.5113225122921344,-1.0185894958208506,0.5076923076923077,0.9518531460914649,1.0,6/27,12.72%,FOXQ1;KDM2B;RETREG1;NONO;NGF;APOE
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.6196821319633969,1.018361712257658,0.5,0.9497589657017693,1.0,5/5,38.08%,PICALM;ALS2;RAB22A;RAB5A;AP2M1
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.4410947250186336,1.0179822565826546,0.41379310344827586,0.9495626317216205,1.0,5/42,8.87%,PDK4;APC;ATP6V1H;IRS2;IRS1
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.5398187653861433,-1.0171902471888894,0.5087719298245614,0.9551524684720926,1.0,7/15,22.30%,BRCA1;UIMC1;MRNIP;TOPBP1;MRE11;DONSON;BABAM2
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6111087379132834,1.0170739131777085,0.45454545454545453,0.9506941854702955,1.0,3/8,25.91%,ADAM17;AKT3;PLCG1
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),-0.5132991200220667,-1.0168638166662152,0.453125,0.9551354949184583,1.0,8/28,13.60%,PARP1;RAD51B;MMS22L;BRCA1;RPA1;INO80;WRN;SPIDR
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),-0.5416276394069032,-1.0167927665456982,0.5409836065573771,0.9542918916247228,1.0,7/20,17.69%,SLC4A4;SLCO1A2;CA5B;SLCO1C1;SLC22A6;CYB5R4;CA4
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),-0.6444625141435238,-1.0166847268335828,0.5344827586206896,0.9536777512695781,1.0,1/6,8.77%,ACAT1
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.42563475833912223,1.0164136565006197,0.36363636363636365,0.9510188665936697,1.0,3/41,2.09%,TRPC6;CACNA1C;ATP2B4
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.578040507358158,-1.0163467202774024,0.5283018867924528,0.9535958749735558,1.0,5/11,18.32%,BEX3;BIRC2;NGF;MT3;EPHA7
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.41392616572241164,-1.0162483943892557,0.43478260869565216,0.9528793846106205,1.0,15/79,15.46%,NKD1;IGFBP2;RNF213;DKK3;APCDD1;SFRP4;RACK1;GLI3;TLE4;PSMC2;NXN;APOE;VGLL4;PSMD8;TCF7L2
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),-0.5524107162017345,-1.0157077327566564,0.5,0.9534042032808555,1.0,2/20,4.59%,PHLDB2;EPHA3
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.6396243137314809,1.0156014962422888,0.4909090909090909,0.9520186125777123,1.0,2/6,15.22%,CECR2;KPNB1
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.5982183298829814,-1.0155549900046819,0.43636363636363634,0.9528500356160013,1.0,4/13,14.49%,PER2;ENO1;PGK1;SLC25A13
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.6149894233602659,-1.0154296120724349,0.5666666666666667,0.9522685996394228,1.0,1/10,2.37%,CEMIP
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),0.5787184114204469,1.015339649191521,0.4716981132075472,0.9514827577867553,1.0,3/7,9.91%,TNFRSF21;DLG5;CEBPB
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.47651570024478046,-1.015236574447302,0.4657534246575342,0.9518392889222014,1.0,4/40,2.37%,PDGFD;FGF1;VEGFA;CEMIP
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.498839922872875,1.0151395896914581,0.47619047619047616,0.950836007001123,1.0,8/16,24.46%,RAP1A;RAPGEF2;PDLIM5;TJP1;RAPGEF1;CBFB;ROCK1;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.3940667054713503,1.0146926229433446,0.4444444444444444,0.9509343341633711,1.0,12/65,11.53%,TNFRSF10B;CXXC5;SLC44A2;GPRC5B;VAPA;PPM1A;UBE2N;MAP3K7;RHOA;PELI2;MID2;MAVS
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),-0.5367763989242769,-1.0146785776505687,0.49206349206349204,0.9524479416947199,1.0,6/27,9.93%,NRP1;LAMC1;LAMB1;FN1;TMEFF2;NTN4
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.6100936865491072,1.0145193083617543,0.5853658536585366,0.9502060434779388,1.0,2/6,19.49%,RNF139;PRNP
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.5911842613151805,-1.0145184351261987,0.4696969696969697,0.9521511576934345,1.0,2/8,12.72%,OLFM1;APOE
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.4128299093487825,1.014437879904249,0.3103448275862069,0.9492139707524816,1.0,4/56,3.74%,CSF1R;CNTN4;MICALL2;VAPA
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),-0.5592381163119136,-1.0143298957189486,0.48214285714285715,0.9518643558609547,1.0,4/18,13.99%,TCHP;BRCA1;MTM1;TMEM39A
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.6696893812621432,-1.014073887429942,0.543859649122807,0.9516815201103407,1.0,3/6,18.96%,ENPP2;PLA2G4C;GPCPD1
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),0.5390502741866572,1.0140418990118611,0.43243243243243246,0.9488391757764794,1.0,1/13,0.40%,PRR16
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.6161821474082849,1.0140300485376417,0.5681818181818182,0.9476005388127102,1.0,3/7,12.77%,NOX4;MMUT;MTHFR
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.47241391084628115,-1.013841200224921,0.4098360655737705,0.9503316652053234,1.0,2/31,3.77%,SUPT6H;ELOB
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.47241391084628115,-1.013841200224921,0.4098360655737705,0.9503316652053234,1.0,2/31,3.77%,SUPT6H;ELOB
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.5320540456154128,1.013840367146122,0.5135135135135135,0.9468388758529771,1.0,5/12,20.20%,MAP2K2;MAP2K1;PDE4DIP;MYO5A;ARMH3
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.4067818171551515,1.0131281015283444,0.38461538461538464,0.9476373738477522,1.0,15/46,23.72%,CDH2;CTNND2;NRXN1;CACNB2;APBB2;CDC42;KIRREL3;NLGN2;GPHN;PTPRS;CYFIP1;PTPRD;GRM5;PPFIA2;ZC4H2
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.5402487072485258,-1.013067011531364,0.5,0.9515944545731528,1.0,2/16,10.07%,PELI1;SMAD6
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.4490383775370446,1.0125013769015083,0.42857142857142855,0.9479335771873223,1.0,7/38,5.71%,RASL12;ZBTB7C;RALGPS1;NDRG2;KALRN;SLC12A2;ZNF704
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),-0.4427822414651707,-1.012475257589955,0.45454545454545453,0.9520306832296836,1.0,10/53,12.16%,SRGAP3;IGFBP5;FBLN1;AFDN;LDLRAD4;SLIT2;TMEFF2;LIMCH1;CYP1B1;EPHA4
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.331401525297665,1.012461715582714,0.42105263157894735,0.9467999266838207,1.0,27/222,6.43%,HSPA1A;NOX4;H2AC6;NOTCH1;ZBTB7C;CNOT7;PML;BCL2;TNFRSF1B;NCK2;NDRG3;TOB1;APC;TP53TG5;CTBP2;ERBB4;PTPRK;BNIP3L;TMBIM6;DLC1;PPP2R1A;MYH9;SMARCA4;TNFRSF21;TESC;BNIP3;DLG5
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),-0.3949952132878983,-1.012302997733737,0.3972602739726027,0.9515585201147388,1.0,28/140,15.58%,CLU;TGFB2;RASGRF2;KCNMA1;VAV3;SFRP4;RACK1;ARHGEF3;SEPTIN4;TGFBR1;HTT;SLIT2;OLFM1;APH1B;PRMT2;NGF;RPS3;CYP1B1;PTRH2;ANO6;ITGB3BP;DAPK2;SQSTM1;BTG1;MTCH2;GADD45B;NET1;PHLDA1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.6610468860188298,1.0118675129143258,0.48,0.9473735736489163,1.0,3/5,17.04%,CCDC3;GAS6;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.6356894545074161,-1.0118539932434278,0.46774193548387094,0.9517883077821385,1.0,3/8,13.59%,GLRX;ATP1B1;WNK2
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.4638393359731316,-1.011827041499417,0.42857142857142855,0.9509250681151269,1.0,8/39,15.62%,SPRY1;FBLN1;SPRY3;PPIA;APOE;PEBP1;WNK2;SPRY4
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),-0.6520953058408441,-1.01156836646815,0.5357142857142857,0.9497720837756417,1.0,3/8,22.33%,LARS1;UBR2;SESN3
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),-0.6520953058408441,-1.01156836646815,0.5357142857142857,0.9497720837756417,1.0,3/8,22.33%,LARS1;UBR2;SESN3
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.5260942208218842,-1.0114287577796568,0.4918032786885246,0.9491925844704372,1.0,4/20,14.36%,XPA;MSH6;RPA1;RNF8
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.5100965070465554,-1.0111726843410853,0.44642857142857145,0.9490049059021372,1.0,3/19,9.05%,IGFBP5;NR4A3;PDCD4
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.6372841239145945,1.0107582807467566,0.5,0.9489142893832486,1.0,4/5,19.79%,CASP7;RYR2;RYR3;SLC8A1
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,-0.469370296668803,-1.0107566171664597,0.5,0.9494309840317424,1.0,16/57,11.68%,IGFBP5;COL6A3;DKK3;COL3A1;COL1A1;MRC2;GLI2;COL1A2;COL6A1;COL12A1;DCN;LAMA4;BMPER;COL13A1;COL6A2;TPM2
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),-0.4228528034591491,-1.010561978271434,0.4782608695652174,0.9490205932964773,1.0,10/79,10.60%,AFG3L2;CTSL;XPNPEP1;ADAMTS12;ERAP1;CPQ;F3;APH1B;FBXW2;PTCH1
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.49522608950952607,1.0104911692036296,0.5588235294117647,0.9481431609582481,1.0,3/16,3.19%,SEMA4B;CDH2;ERBB4
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.510597073992054,1.010200463511705,0.44680851063829785,0.9475534950092853,1.0,2/18,2.09%,NOTCH1;ATP2B4
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.6441818355277263,-1.0100006637266083,0.5490196078431373,0.9495200575059373,1.0,2/6,14.49%,ASPA;SLC25A13
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.449455768332977,1.009939087743261,0.5277777777777778,0.9470894382453473,1.0,10/23,26.79%,ATP2B4;RYR2;ATP2B1;ANK2;RYR3;SLC8A1;TRPC1;STIM1;AGT;ATP1B2
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.4510529287377076,1.0098706886538076,0.5121951219512195,0.9460485499431907,1.0,6/33,12.88%,MFHAS1;GRID2;MAPKBP1;CTNNA2;PPARA;CASK
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),-0.41068037158129395,-1.0098601638544564,0.39436619718309857,0.9489620813214451,1.0,15/103,10.60%,NR4A2;ARNT2;ADAM22;GSN;AFF2;DHX30;ALDH3A2;VCAN;SPOCK1;SHROOM4;GRIK1;MARCKS;PTS;SYNJ2;PTCH1
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.5842582796531662,-1.009482380745695,0.4918032786885246,0.9490532715612194,1.0,2/9,11.05%,STAT1;DHX36
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),0.3498826000544559,1.0090087485721682,0.45,0.9469897396816404,1.0,38/185,14.93%,HSPA1A;HSPB1;NOTCH1;BCL2;PDK4;BNIP3L;TMBIM6;BCL2L1;FMN2;TBX3;MAEA;API5;ARHGAP10;BNIP3;FZD3;MSH2;RAF1;AXL;CD44;HDAC1;CBL;DNAJB6;TNFAIP8;EGFR;KLHL20;MCL1;SEMA4D;PAK2;NAA38;CAT;HDAC2;LEF1;NFKB1;ZFAND6;RPS6KB1;CSNK2A1;GAS6;TJP1
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.6470868381082031,1.0080806991955868,0.49019607843137253,0.9479970643424835,1.0,2/6,1.07%,MYH11;NOTCH1
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.4875148561407871,1.0080124752866286,0.41304347826086957,0.9469316962636606,1.0,5/26,13.62%,CNOT7;PML;CNOT6;CDKN1A;EP300
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.5900395482942555,1.0077829192250574,0.4634146341463415,0.9463483209907089,1.0,1/9,3.40%,NCOA3
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),0.6163099552367117,1.007627260273675,0.56,0.9455340568712125,1.0,3/5,20.24%,GTF3C2;SPIN1;TAF1B
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.4537084055476864,1.0076240967656707,0.5142857142857142,0.9442850026349229,1.0,6/35,9.93%,HSPA1A;TNFRSF1B;BNIP3L;BNIP3;RAD18;INPP5A
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.6364452873481068,-1.006702063481706,0.5,0.9553324904488124,1.0,2/8,20.36%,HSP90AB1;CALM1
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.5804757619238438,-1.0065152134331599,0.5,0.9549831459858108,1.0,2/16,13.57%,VAV3;LARS1
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.4946588859109904,-1.0064889854735615,0.5636363636363636,0.9541728398290907,1.0,2/29,2.89%,NACA;AFDN
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.5852116677334595,1.0062965737015888,0.41509433962264153,0.9467347098891374,1.0,1/6,1.07%,NOTCH1
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.5992004509397428,-1.0062898250994012,0.5,0.9538160264485519,1.0,3/12,11.90%,ACAT1;FAR2;PAM
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.5353033453590524,1.0062487188720952,0.4878048780487805,0.9455963125923966,1.0,9/15,25.79%,PTPN9;UBASH3B;PTPRZ1;PTPRS;PTPRQ;PTPN11;PTPN1;TNS2;DUSP1
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.4304398934896691,-1.0057156712290953,0.4594594594594595,0.9546394091044417,1.0,14/74,9.54%,SAT1;TM7SF3;HINT1;DDB2;PROCR;RACK1;XPC;TSPYL2;BTG2;PRMT2;RPS12;TSC22D1;RPL36;NDRG1
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.37167932821742306,1.005450670538647,0.5185185185185185,0.9463377828394425,1.0,12/87,8.69%,PIP5K1B;DGKB;DGKH;SLC44A2;PISD;ARF1;CDS2;LCLAT1;MTMR1;DGKG;INPP4B;DGKE
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.3750670695277352,1.005194476601529,0.37142857142857144,0.9457597875468611,1.0,10/71,5.00%,RASL12;DACH1;ADGRF5;GJA4;HEY2;TIMP3;SMARCD3;EPAS1;C1QTNF1;TNS1
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.6485352491108478,-1.0050836467903903,0.5714285714285714,0.9553507636322229,1.0,3/5,24.86%,APOD;LRP1;PTPN2
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.6259896523252378,-1.004806249778997,0.49206349206349204,0.9551594070636006,1.0,2/9,4.17%,AKR1C2;AKR1C1
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),0.6389455898298538,1.0040242457432302,0.5681818181818182,0.947326551353265,1.0,2/5,19.43%,P2RX4;RYR3
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),-0.6442814510436896,-1.0036777891767257,0.5849056603773585,0.9570726950198778,1.0,3/5,20.55%,PTS;CALM1;PRKG2
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.4927744619734263,-1.0030796985420143,0.39285714285714285,0.9578715607155889,1.0,3/30,5.20%,KLHL13;DCDC1;PIK3R4
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",-0.6946640938683426,-1.0028685117966423,0.5357142857142857,0.9575774868861486,1.0,2/5,9.98%,EXT1;CSGALNACT1
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.6092839309463453,-1.0027071063548738,0.5714285714285714,0.957064049070251,1.0,3/8,15.94%,ABCB7;NUBPL;HSPA9
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.644123500506793,-1.0026357146030116,0.4909090909090909,0.9563501731707962,1.0,1/7,4.94%,FTH1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),-0.6554828330139106,-1.0024941210801237,0.5471698113207547,0.9559120139832581,1.0,1/8,2.61%,HECW2
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.3889048438064557,1.0022405452767702,0.42105263157894735,0.9508264357194472,1.0,6/55,5.20%,HSPA1A;PML;NDRG3;TP53TG5;PPP2R1A;SMARCA4
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.47191111997337515,1.0020194705912215,0.4634146341463415,0.9500960123976923,1.0,6/21,16.20%,GRID2;DLG5;NRXN1;CLSTN2;PDLIM5;NLGN2
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.5223683128727464,1.0016662519123818,0.45,0.9499484986714685,1.0,8/18,14.12%,CACNA1B;PHC1;FRAS1;GRID2;GABRB3;LEF1;CNTNAP2;CECR2
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.4919677861997352,1.0016611576650756,0.4358974358974359,0.9487488389938602,1.0,5/20,16.12%,PDK4;ARF1;PPARA;RNF34;PANK2
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.3853633130268839,-1.0013578776078926,0.4155844155844156,0.9579509207548831,1.0,20/161,11.29%,TWIST1;GBP2;RIPOR2;MT2A;VEGFA;LEPR;STAT1;ANXA1;ADAMTS12;EPRS1;COL1A2;CD47;F3;ZFP36L2;YBX3;BRCA1;FN1;IL1R1;ASAH1;RPS3
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.5018577299458442,-1.0012609206091068,0.4482758620689655,0.9572747331254134,1.0,3/23,7.94%,ABLIM1;COL1A1;COL11A1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.4599489664272391,1.001195141443298,0.475,0.9486169427331699,1.0,9/33,13.11%,CSF1R;MED24;MED23;MITF;THRA;CEBPB;CDKN1A;LEF1;NFKB1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.5161502185465161,-1.0010801430287326,0.5178571428571429,0.9568004565006556,1.0,2/26,3.19%,RAD51B;ANXA1
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.5842344990829571,1.0010640157092707,0.4878048780487805,0.9477047767725651,1.0,3/10,17.56%,ABCA1;PPARA;ABHD5
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.4575688533942615,-1.000727615529768,0.453125,0.9568282174973692,1.0,8/41,11.41%,WARS1;TERF2IP;FBLN1;PLPP3;SLIT2;DNAJC10;PRKDC;PPIA
prerank,GO_Biological_Process_2021__heart process (GO:0003015),0.6173200269460556,1.000708018523765,0.4782608695652174,0.9473057543097754,1.0,2/5,9.83%,NOX4;SGCZ
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.5523557406058789,1.0006864431810767,0.4791666666666667,0.946115758766027,1.0,8/12,22.30%,HACD2;ELOVL6;ELOVL5;ACSL3;SCD5;ACSL1;SCD;TECR
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.5529631197575686,1.0004573843978166,0.46153846153846156,0.9453980768712573,1.0,2/9,8.85%,MGAT5;TIPRL
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.5715119486691865,-1.0002738092338173,0.5384615384615384,0.9571472348043999,1.0,2/9,13.27%,STAT1;PARP9
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.677233576626294,0.9998785993575908,0.5777777777777777,0.9458471070838363,1.0,1/5,1.84%,KLF15
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),-0.5439079245675292,-0.9996342354022231,0.4807692307692308,0.9578203591606598,1.0,5/15,9.13%,RIPOR2;NRP1;RHOQ;GPM6A;BCAS3
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),0.43674872916919494,0.9991984085721685,0.45714285714285713,0.9462682319266341,1.0,8/46,10.38%,BCAM;PTPRK;EMP2;DLC1;ARHGEF7;ITGA3;CD44;ITGA7
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.5284910625330613,0.9984805095435523,0.425531914893617,0.9470621950331715,1.0,2/7,7.35%,EMP2;HMBOX1
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),-0.4953974414454763,-0.9984412734561178,0.49295774647887325,0.9598733701033039,1.0,8/25,18.48%,GLI2;TSPYL2;ESCO1;RAD17;ORC3;ORC5;S100A11;SMC3
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),-0.6605436688318469,-0.9983968141642509,0.55,0.9591356204049729,1.0,2/5,14.12%,COL13A1;FOXC1
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.6128520802530442,0.9982460594636823,0.5111111111111111,0.9464403570839076,1.0,1/8,1.07%,NOTCH1
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.6739273800109116,-0.9979330210604824,0.5254237288135594,0.9593606147739238,1.0,3/8,12.09%,TGFB2;TGFBR1;TGFBR3
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.511225414169796,0.9977564387955252,0.48148148148148145,0.9465926874309765,1.0,4/14,15.74%,SORT1;RAP1A;RAPGEF2;RAPGEF1
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5585221096233028,0.997688259145025,0.5,0.9455074509633414,1.0,2/13,5.89%,UBE2N;MAP3K7
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.6180750749973848,-0.997649498728536,0.56,0.9592861736559372,1.0,3/8,13.67%,BRCA1;BCAS3;SRA1
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.5161547580150979,-0.9975577959720907,0.46153846153846156,0.9586505996767313,1.0,2/22,4.04%,SLC2A3;TPK1
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.5374633981382452,0.9973481643011419,0.4523809523809524,0.9451291546228938,1.0,3/11,5.58%,BCL2;TNFRSF21;IRS2
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.5959792224490876,0.997019720928221,0.5238095238095238,0.9446589479181661,1.0,4/7,18.32%,NRXN1;NLGN4Y;NLGN2;GPHN
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.5095851841389467,0.9969631068801628,0.5,0.9435803645901666,1.0,1/19,0.03%,HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.508775285770436,-0.9967547652791289,0.4915254237288136,0.9599969204499451,1.0,4/22,11.08%,VEGFA;THBS1;BEX3;NGF
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.4775209107477583,0.9963737982371605,0.5384615384615384,0.9440794870193903,1.0,8/18,25.83%,IRS2;ABCA1;FBXW7;ABHD5;PRKAA2;DDX3X;NR1D2;USF2
prerank,PanglaoDB_Augmented_2021__Enterocytes,0.4932918963497637,0.9961611215719908,0.5142857142857142,0.9434009401156754,1.0,4/17,8.13%,SLC35F1;SLC26A3;PMEPA1;ANPEP
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.32330915897863005,0.9952237748475662,0.45454545454545453,0.9442026401558781,1.0,40/285,12.27%,HSPA1A;DACH1;MXD4;GATAD2A;TENM2;NOTCH1;CXXC5;HEY2;BACH1;CTBP2;NCOA5;SOX13;ZEB2;PPM1A;SMARCA4;TBX3;ZBTB7A;SMAD7;HDAC9;KLF12;NACC2;LCOR;HMBOX1;ZFHX3;ZBTB16;CBX6;HDAC1;MITF;THRA;CEBPB;APBB1;MTF2;PPARA;MBD2;MEIS2;BCL6;NEDD4L;SEMA4D;UBE2D1;ZNF398
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),-0.6263190947607595,-0.9950558943590478,0.6140350877192983,0.96348228392531,1.0,3/6,5.73%,VEGFA;NRP1;TGFBR1
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.6264598775011991,0.9949951927591755,0.5263157894736842,0.942573903897218,1.0,3/6,34.91%,ROCK1;ADCY6;SCPEP1
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.6264598775011991,0.9949951927591755,0.5263157894736842,0.942573903897218,1.0,3/6,34.91%,ROCK1;ADCY6;SCPEP1
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.395487095362829,0.9944309130343476,0.4166666666666667,0.9429790773214692,1.0,4/41,3.26%,CSPG4;ST3GAL2;CHST3;GPC5
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.540429253368683,-0.9939845595176575,0.5357142857142857,0.964426834473662,1.0,3/14,4.97%,CTSL;LAMC1;GSN
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.540429253368683,-0.9939845595176575,0.5357142857142857,0.964426834473662,1.0,3/14,4.97%,CTSL;LAMC1;GSN
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),-0.5223855592430785,-0.9937023680179795,0.5517241379310345,0.9641949447692444,1.0,4/15,13.23%,PHLDB2;THBS1;BCAS3;ROBO2
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),0.5182989936288123,0.9936487290086465,0.5,0.9436590334045725,1.0,3/15,10.47%,FMN2;EGFR;PPARA
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),-0.648793357065583,-0.9935181917615933,0.5396825396825397,0.9637294124618325,1.0,3/6,27.77%,PTCH1;PKD2;ALDH1A2
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.6354165217746671,0.9931212271679786,0.6136363636363636,0.9437601045875336,1.0,1/5,9.08%,AGO2
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.6081245029808076,-0.9931133573443331,0.5636363636363636,0.9640652394831327,1.0,3/8,12.51%,PARP1;FUS;MRNIP
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),-0.6502409497625183,-0.9929947173967002,0.5370370370370371,0.9634838633561,1.0,1/5,2.07%,NT5E
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.5775163700313029,0.9920268197151947,0.45454545454545453,0.9456426049287999,1.0,5/9,29.79%,EP300;NAA25;KAT2B;NAA11;CREBBP
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.6596485980547373,-0.9919645779434874,0.5166666666666667,0.9652018908099129,1.0,2/5,17.65%,COX4I1;AFG1L
prerank,MSigDB_Hallmark_2020__Notch Signaling,0.5349987825041813,0.9916681638391961,0.5,0.9454399763602789,1.0,3/16,9.10%,NOTCH1;NOTCH3;HEYL
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.5747048161051557,0.9912912781668087,0.5652173913043478,0.9451594551064101,1.0,6/11,33.17%,ATXN3;MINDY2;OTUD7A;OTUD7B;USP8;USP25
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),-0.6316772543094802,-0.9907869952298162,0.5576923076923077,0.967311426589407,1.0,1/7,8.53%,BMPER
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.6582516243704971,0.9904627543748952,0.5434782608695652,0.9462108446526792,1.0,2/6,9.99%,CNTN4;ARHGAP35
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.5348200746588645,0.990412975043867,0.5,0.9451479860239603,1.0,4/12,10.64%,ADCY9;ADCY3;RAF1;ADCY5
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.5238288971436492,0.9900882571561547,0.4418604651162791,0.9446345660803643,1.0,2/12,10.56%,CACNA1C;RYR2
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),-0.5727900621030244,-0.9892497547765252,0.5344827586206896,0.9704745365598353,1.0,2/8,10.56%,VEGFA;EPHA5
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.5309808693737272,-0.9892087854946425,0.5967741935483871,0.9696745408637916,1.0,2/22,4.62%,DYNC2LI1;IFT122
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.47488068631676106,-0.9890791146769609,0.49295774647887325,0.9690280751000657,1.0,5/36,15.48%,CLU;BAIAP2L2;RPS3;APOE;SNX9
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),0.5883819311452501,0.988914096324059,0.5348837209302325,0.9465927712051709,1.0,2/8,11.08%,PML;MID2
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),-0.6230902240306108,-0.9888855677823755,0.5357142857142857,0.9686508962787512,1.0,1/6,6.90%,APH1B
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.5739507958368103,-0.9886685181029526,0.5396825396825397,0.9683190501573732,1.0,5/11,23.68%,PER2;PRKAG2;CALM1;PYGB;PGM2L1
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),-0.6539632093767584,-0.98865982592226,0.5217391304347826,0.967452581478175,1.0,2/6,16.06%,BBS4;NINL
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.47944313206797007,-0.9886009885755874,0.5147058823529411,0.9667213790267345,1.0,11/44,19.33%,CLU;CSE1L;ALDH3A2;PEX3;APOE;HSPA4;SEC13;HIKESHI;APPL2;ACBD5;NUP107
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),-0.49013992975582704,-0.9878281994990109,0.5238095238095238,0.9678702989124103,1.0,8/30,13.60%,PARP1;RAD51B;MMS22L;BRCA1;RPA1;INO80;WRN;SPIDR
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.5090233135782458,0.9877509517868274,0.56,0.9483772457420986,1.0,2/15,2.81%,SERPINB6;TIMP3
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),0.6300225752742371,0.9877484011243057,0.5,0.946039219043025,1.0,4/5,24.94%,GSTA4;GSTP1;ESD;MGST3
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),0.6300225752742371,0.9877484011243057,0.5,0.946039219043025,1.0,4/5,24.94%,GSTA4;GSTP1;ESD;MGST3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.5100499791651825,0.9874467811093589,0.5111111111111111,0.9457736931865981,1.0,2/13,3.19%,NOTCH1;ERBB4
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.41696028202704827,0.9865519549913049,0.46153846153846156,0.9467362780757456,1.0,7/49,9.50%,BCL2;DPP10;ATP2B4;TCAF1;KIF5B;ITGA3;EGFR
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.4771241081836574,-0.9864819989290937,0.39344262295081966,0.9702181002139376,1.0,1/27,0.14%,ABCA4
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3898421887945062,0.9864018481586408,0.5357142857142857,0.9458769442456838,1.0,8/86,5.97%,HSPA1A;PPARGC1B;HIPK2;UBE2N;SMARCA4;CAMK1D;MAP3K7;ZBTB7A
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.5822014817209248,-0.9863841118520827,0.5636363636363636,0.9695841454822536,1.0,4/7,39.33%,LRPPRC;RHOT1;OPA1;UBB
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.46274639895992886,-0.985788776395245,0.45614035087719296,0.9702922128554067,1.0,5/41,10.60%,AFG3L2;LMF1;F3;APH1B;PTCH1
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.5787695810270382,-0.9856191903980064,0.47368421052631576,0.9697214454619104,1.0,4/10,17.93%,PDCD4;MAPK14;APPL2;APOD
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),0.5980472577399776,0.9855218906363024,0.5454545454545454,0.9469787709383837,1.0,3/7,6.35%,HSPA1A;BCL2L1;BNIP3
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),-0.6372909267417766,-0.9854610328238488,0.5636363636363636,0.968308486363599,1.0,2/5,15.26%,MGMT;ASCC3
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),-0.6372909267417766,-0.9854610328238488,0.5636363636363636,0.968308486363599,1.0,2/5,15.26%,MGMT;ASCC3
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),-0.6805761809038389,-0.9852530450809146,0.5471698113207547,0.9671039562882726,1.0,1/5,19.09%,PRKN
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),-0.6805761809038389,-0.9852530450809146,0.5471698113207547,0.9671039562882726,1.0,1/5,19.09%,PRKN
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),-0.6569812450469584,-0.9851017943550381,0.5686274509803921,0.9666534647495353,1.0,2/5,26.05%,FBXL7;RBX1
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),0.46252458830595045,0.9849012298359624,0.46808510638297873,0.9473183921881829,1.0,2/23,3.26%,CSPG4;GPC5
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.6100241752405521,-0.9846334538612053,0.5625,0.9670243985426087,1.0,2/8,13.30%,RETREG1;UFL1
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),-0.6082531316315063,-0.9840149139059615,0.5555555555555556,0.9675886107140228,1.0,1/8,5.73%,TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.33504781681307966,0.9837074463127526,0.45,0.9491999141624143,1.0,46/207,14.63%,NOTCH1;PML;HEY2;MED24;SMARCD3;ERBB4;HIPK2;RFX3;PPM1A;RNF14;SMARCA4;TESC;CAMKK2;ZFHX3;MAP2K2;ZBTB16;USP16;HDAC1;MITF;ARID1B;EGFR;CEBPB;APBB1;PPARA;RBM23;SMARCA1;PHF8;MYOCD;ARID1A;ZNF398;CEP290;DNM2;HDAC2;LEF1;ACTA2;YAF2;NFKB1;RNF10;AFAP1L2;EP300;BTRC;MAP2K1;FOXO3;MECOM;TRIP4;EGR1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.56638872798243,0.981785917716011,0.48936170212765956,0.9526432711321864,1.0,3/9,18.83%,GNL3L;XRN1;TENT4B
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),0.6031974566142879,0.9815553611861582,0.55,0.9520384256150913,1.0,2/7,9.77%,PML;RAD21
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),-0.5675557854592603,-0.9811716735174713,0.5245901639344263,0.9738416867034962,1.0,2/10,6.40%,SLC8B1;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),-0.4074586502249642,-0.9808811183790602,0.4533333333333333,0.9738619447949304,1.0,11/112,8.39%,FGF1;TGFB2;RIMS1;NRP1;SULF2;UCHL5;TGFBR1;HTT;F3;SNW1;SASH1
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.5038555090994417,0.9807870947411278,0.42857142857142855,0.9528824305930674,1.0,3/15,10.64%,ADCY9;ADCY3;ADCY5
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.40144801835090504,0.980770562709525,0.55,0.9517287057908678,1.0,5/40,6.02%,HSPA1A;UBQLN1;RNF14;BBS7;SMAD7
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.5478436481352187,0.9800748768661648,0.48717948717948717,0.9510121640316382,1.0,2/9,11.65%,SLC12A2;NEDD4L
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.5478436481352187,0.9800748768661648,0.48717948717948717,0.9510121640316382,1.0,2/9,11.65%,SLC12A2;NEDD4L
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.5863487291040551,-0.9795681186619378,0.5,0.9760801689423658,1.0,4/10,11.69%,TGFB2;ADAM9;JAM3;CYP1B1
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.5121262292159997,-0.9795650293692374,0.5245901639344263,0.9752287513171057,1.0,2/20,9.64%,TGFB2;DDX5
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.441112956924518,0.9795232661779255,0.45454545454545453,0.9511140473321982,1.0,6/37,5.07%,ARRDC2;TMEM30A;SLC44A2;SLC12A2;SNX4;MYH9
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.3823044633449283,-0.9793873305885374,0.42857142857142855,0.9748878839001753,1.0,25/144,13.54%,PDGFD;FGF1;TGFB2;VEGFA;NRP1;TERF2IP;CEMIP;LEPR;ENPP2;RACK1;BMP5;TGFBR1;FAXDC2;HSP90AB1;RALBP1;FAM20A;NGF;PPIA;LIMCH1;PRKAG2;MRNIP;KRAS;CCN1;PDCD10;CSNK1D
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),-0.426261098507514,-0.9793758918157178,0.45588235294117646,0.9740390651261651,1.0,8/74,6.61%,FGF1;AKR1C2;RACK1;TGFBR1;GCNT2;THBS1;HSP90AB1;F3
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),-0.6369739147110272,-0.9793700360968739,0.5576923076923077,0.9731742479585341,1.0,2/5,8.20%,SLC11A2;ABCB7
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.6170693833237926,-0.9793518458989605,0.4915254237288136,0.9723459911199405,1.0,3/5,32.61%,TBX18;FGFR2;ZIC1
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.43119397089993877,0.9793280260454732,0.5142857142857142,0.9504009884407582,1.0,9/45,9.18%,DENND3;NOTCH1;RALGPS1;DLC1;EPOR;IRS2;ARHGAP44;RAF1;MADD
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.6354717728317603,0.9791718912956577,0.6,0.9495371169727972,1.0,2/5,11.58%,BNIP3;ZDHHC6
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),0.4041283083075931,0.9790791366357998,0.4117647058823529,0.9486626697649445,1.0,10/45,11.02%,HSPA1A;RNF185;RNF14;BBS7;SMAD7;TMEM259;ATXN3;ZER1;RNF180;FBXW7
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),-0.6701476839545254,-0.9789050053469818,0.5714285714285714,0.9725773360924542,1.0,2/5,16.91%,ZFP36L2;RGCC
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.4568177114256232,-0.9782409334538633,0.4918032786885246,0.9734373284547019,1.0,13/38,28.89%,THOC1;SRSF7;SRSF5;RFTN1;CKAP5;TGFBR2;U2AF2;FMR1;FLOT1;NCBP1;TPR;SRSF11;POLDIP3
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.6243107946607453,-0.9780300660047215,0.5185185185185185,0.9731348062747996,1.0,3/7,22.28%,G3BP2;TMSB4X;PKD2
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.640863708855728,-0.9777325014111757,0.5172413793103449,0.9729985301533743,1.0,2/5,18.66%,RAD17;MRE11
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),0.6359978970573534,0.977503058150935,0.5510204081632653,0.9512273783800923,1.0,3/5,20.05%,SARS1;AARS1;YARS2
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),-0.5249605257006854,-0.977358098964449,0.5,0.9730019144456197,1.0,5/15,9.11%,NRP1;SEMA3C;SEMA6D;SEMA3D;FN1
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),-0.5061421450371998,-0.9770563281330911,0.5079365079365079,0.972796353171192,1.0,2/20,1.38%,ANO2;GABRB2
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),-0.6246034399144333,-0.9770480043762457,0.5660377358490566,0.9719561994904097,1.0,2/6,5.77%,GSN;ENO1
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.4309201821261836,0.9768838154882252,0.40476190476190477,0.9516197181254187,1.0,3/29,2.36%,NOL4;GALNT18;CTNND2
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.6420118267999793,-0.9768776656100874,0.5660377358490566,0.9706884550740117,1.0,1/5,20.95%,UBA52
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.6420118267999793,-0.9768776656100874,0.5660377358490566,0.9706884550740117,1.0,1/5,20.95%,UBA52
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),-0.6060299311760164,-0.9768016018641037,0.6078431372549019,0.9699651853727752,1.0,1/9,5.65%,BORCS5
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.5494790796759297,0.9767764584548375,0.5588235294117647,0.950758584425129,1.0,2/13,6.42%,LRCH1;RRP1B
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.5052048359363969,0.9766832893101224,0.5116279069767442,0.9496973773068377,1.0,3/16,10.28%,INTS7;RHOB;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.5534701683365532,-0.9763625942645443,0.5254237288135594,0.9702052573011358,1.0,3/14,11.28%,CIRBP;FUS;LARP1
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.44503014956666226,0.9760818381782652,0.4411764705882353,0.9500649065410793,1.0,3/21,12.21%,APC;RHOB;ARL3
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.4557321880200165,-0.9757822513461998,0.5074626865671642,0.9707133482684054,1.0,13/62,14.89%,RPL23A;RPL5;EIF2S2;HSP90AB1;PRPF6;RPL6;PRKDC;SNRNP200;SRSF10;EIF4H;SRPK1;CELF2;RPL11
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.6110923360699727,-0.9757592712592696,0.5185185185185185,0.9690644249845152,1.0,2/6,21.29%,ACAT1;ACBD6
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.6110923360699727,-0.9757592712592696,0.5185185185185185,0.9690644249845152,1.0,2/6,21.29%,ACAT1;ACBD6
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.5160064717951386,0.9756867645353252,0.4418604651162791,0.9498264820820946,1.0,1/14,0.03%,HSPA1A
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.5858199626898472,-0.9755627656001592,0.5423728813559322,0.9687430693828413,1.0,2/7,9.08%,PARP1;RPA1
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),-0.4544564948552485,-0.9750911820025066,0.5230769230769231,0.9690349339752071,1.0,5/52,4.78%,AFG3L2;RIMS1;ELOB;EPRS1;LAMC1
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.670169030429715,-0.9749786472277886,0.5833333333333334,0.9683865625923714,1.0,1/5,8.42%,HLA-B
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.5119580386540192,-0.9749150671558409,0.5227272727272727,0.9677048799660574,1.0,2/23,2.21%,SPRY1;FBLN1
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.634424713643777,0.9748826006635327,0.5471698113207547,0.9504951188945885,1.0,1/6,6.35%,BNIP3
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.42360385201607803,-0.974797758123315,0.5072463768115942,0.9671620961386279,1.0,6/70,6.02%,FSIP2;GBP2;XPA;COL1A1;IFT122;ALDH3A2
prerank,PanglaoDB_Augmented_2021__Macrophages,0.4908776861403312,0.9741551307146454,0.525,0.9513255998239645,1.0,2/19,2.05%,CSF1R;TNFRSF1B
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),-0.5527152983214408,-0.9738645621695204,0.5689655172413793,0.9676773116160807,1.0,3/11,9.13%,PHLDB2;THBS1;BCAS3
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),-0.5527152983214408,-0.9738645621695204,0.5689655172413793,0.9676773116160807,1.0,3/11,9.13%,PHLDB2;THBS1;BCAS3
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.4269336177401257,-0.9734933198507746,0.5079365079365079,0.9679342402482908,1.0,11/66,12.16%,SRGAP3;IGFBP5;PHLDB2;AFDN;COL3A1;LDLRAD4;SLIT2;TMEFF2;LIMCH1;CYP1B1;EPHA4
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.4859264241064961,-0.9734884760695132,0.47619047619047616,0.9670930055537947,1.0,1/22,0.69%,SERTAD2
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.5773516644610053,-0.9733518033736921,0.543859649122807,0.9665445707354283,1.0,1/10,2.61%,HECW2
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.476825461410065,0.9732921206121121,0.42857142857142855,0.9521666219846272,1.0,5/16,19.81%,PUM2;AGO2;PRKRA;ZC3H7B;SMAD2
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.43681492166661273,0.9732055398085079,0.5555555555555556,0.9511866983328376,1.0,4/30,3.83%,HSPA1A;BCL2;TMBIM6;BCL2L1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.5098743506825718,0.9731988051806594,0.5142857142857142,0.9500588026868774,1.0,8/18,26.02%,CDH2;NRXN1;NLGN2;GRM5;SYT1;MEF2C;DGKI;OPHN1
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),-0.4525880786701254,-0.9731614238139805,0.5,0.9661255099029523,1.0,8/49,12.09%,TGFB2;COL3A1;COL1A2;TGFBR1;ADAM9;GCNT2;SMAD6;TGFBR3
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.6435229564285447,0.9723018907044851,0.6136363636363636,0.951136066057715,1.0,2/5,14.65%,AXL;GAS6
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.6005388867480546,-0.9720956480288242,0.5714285714285714,0.9678113065426257,1.0,1/8,8.69%,BRCA1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.5719697093722608,0.9718654688635429,0.5121951219512195,0.9511233404202994,1.0,1/6,3.34%,ACADVL
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.5151409154586162,-0.9718037505842548,0.576271186440678,0.9676055173342072,1.0,6/26,10.14%,AKR1C2;VEGFA;ANXA1;AKR1C1;PGK1;LGALS3
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.5630330936333061,0.9717478681865922,0.5454545454545454,0.9503116970992752,1.0,2/7,9.50%,ARHGAP6;EGFR
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.46247431609745904,-0.9716300444413152,0.5,0.9671268592756607,1.0,1/32,0.38%,CLU
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.5423665949649721,-0.9709826564940497,0.48333333333333334,0.968013987270331,1.0,6/15,18.66%,TERF2IP;HSP90AB1;RPA1;PPIA;ANKRD28;MRE11
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),-0.47860591719057877,-0.970929761104415,0.5076923076923077,0.9673227208049265,1.0,3/32,4.43%,HECW2;NKD1;GPC3
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.6535026124323982,-0.970879183176298,0.6226415094339622,0.965824679750203,1.0,2/5,11.65%,CTSL;THRB
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.6535026124323982,-0.970879183176298,0.6226415094339622,0.965824679750203,1.0,2/5,11.65%,CTSL;THRB
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.6177244856199124,0.9707974392899564,0.6,0.9516840012426866,1.0,3/6,24.24%,DCP1A;DHX9;DDX3X
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),-0.5446008396367389,-0.9704855380583272,0.54,0.9658342251305424,1.0,2/10,13.55%,APOE;VGLL4
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.5920811055560037,-0.970477970242959,0.5,0.9650113569751552,1.0,5/12,19.70%,IGFBP5;PDCD4;TPM1;APOD;OGN
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.4816421944295477,0.9697185054188325,0.4838709677419355,0.9531401730465416,1.0,7/18,22.59%,SAMD8;FOXO3;PICALM;EIF4E;CYFIP1;GRM5;ROCK1
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.3590349126026284,0.9693725444334709,0.4827586206896552,0.9526275569003975,1.0,8/101,6.08%,VAPB;ATL2;ATP8B1;VAPA;LEMD3;AP3D1;ARHGEF7;FAM174B
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.587592350251704,0.9691305905298003,0.5531914893617021,0.9522031378681322,1.0,2/5,15.54%,PPARA;WNK1
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.5722312431195007,-0.9691305793455623,0.5833333333333334,0.9674232624793833,1.0,7/13,35.26%,CSNK1D;BBS4;GOLGB1;HOOK3;NUDCD3;CEP192;DCTN2
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.39421069974629175,-0.9681491929052447,0.5822784810126582,0.969059382546276,1.0,20/110,17.04%,ABLIM1;PTPDC1;RTTN;IFT122;GSN;SCLT1;TCTN1;ARMC2;DZIP1;CCDC57;CEP126;TTC8;DZIP1L;ARMC9;NEK1;ARF4;BBS4;ABLIM3;DYNC2H1;DCDC2
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.4395235649312659,0.9679923692239343,0.5428571428571428,0.9536038075917129,1.0,1/35,0.16%,JPH2
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.4569696606145483,0.9677018218309711,0.5,0.9531048732310621,1.0,9/26,21.66%,PHF20;APBB1;LEF1;EP300;JADE2;HAT1;MEAF6;JADE1;MSL2
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.372950716836449,0.9673615498709827,0.4594594594594595,0.9529537435824363,1.0,12/66,14.31%,SATB2;SMARCD3;SMARCA4;ZBTB7A;HDAC1;BRWD1;MTF2;SMARCA1;ARID1A;SETD7;HDAC2;MECOM
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.4896835534879357,-0.9672862048287593,0.5161290322580645,0.9700742271274629,1.0,2/23,4.43%,CLU;GPC3
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.526422503839945,0.9671332744513801,0.5121951219512195,0.9523207752330819,1.0,4/13,12.77%,NOX4;MMUT;GLUD1;MTHFR
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),-0.5047777870640788,-0.9671052158125653,0.4827586206896552,0.96964836405167,1.0,4/21,6.61%,VEGFA;NRP1;THBS1;F3
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,0.5127651924327152,0.9670016872509908,0.5918367346938775,0.9515781753184086,1.0,3/14,2.73%,CSF1R;ADGRF5;DDX3Y
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.6438694518120447,-0.966965378197438,0.5869565217391305,0.969189410095601,1.0,1/6,0.38%,CLU
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.6205757226383163,0.9669380878765146,0.5588235294117647,0.9505906557088333,1.0,4/5,18.90%,RPS6KB1;ACSL3;SLC27A1;ACSL1
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.597446936149586,0.9666802926070869,0.5454545454545454,0.950172205489938,1.0,1/5,11.02%,FBXW7
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.572249735278558,0.9664512519032379,0.5128205128205128,0.9496932254191363,1.0,1/5,9.99%,ARHGAP35
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),-0.6455689536178639,-0.9663031912977028,0.53125,0.9695086281498537,1.0,3/5,23.42%,TGFBR1;RORA;TGFBR2
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.5948253076883175,0.9662283140057305,0.5666666666666667,0.9491293502159761,1.0,2/7,11.82%,NEDD4L;KCNQ1
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,0.596844211281062,0.9656177476084814,0.5833333333333334,0.9493647546314823,1.0,2/6,11.42%,TNFRSF1B;BCL6
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),-0.5050773268456086,-0.9654234017298363,0.5409836065573771,0.9708741591192956,1.0,2/20,1.38%,ANO2;GABRB2
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.4237971751834643,0.9653118019114846,0.4117647058823529,0.9490723585692081,1.0,12/34,20.76%,BACH1;PPP6C;CDKN1A;PHF8;CDK17;RPS6KB1;BRD4;CACUL1;CUL4A;ACVR1B;EIF4E;RB1
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),-0.6123648080018507,-0.9649591167366599,0.5862068965517241,0.9712082413024798,1.0,3/7,9.98%,ST6GAL1;EXTL2;CSGALNACT1
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.4912159323247252,0.9648563678219391,0.5555555555555556,0.9490133467499124,1.0,10/22,25.86%,IRS1;RPS6KB1;GKAP1;KANK1;PTPN11;SIK2;PTPN1;TSC2;TNS2;OGT
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.45648598735357077,-0.9647111758156506,0.5522388059701493,0.9710529294295922,1.0,2/37,4.46%,CTSL;ADAMTS12
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),-0.5615395984749114,-0.9645312223304916,0.5423728813559322,0.9706536872553561,1.0,1/11,2.90%,ACTG1
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.6152885186941344,-0.9644126835573864,0.5833333333333334,0.9701121055373204,1.0,2/6,24.24%,SLIRP;FMR1
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),0.6009375030761539,0.9643776768145199,0.5,0.948881080081376,1.0,1/5,10.11%,HK1
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),-0.5918310862341515,-0.9642495539325848,0.5555555555555556,0.9696891417956036,1.0,3/9,23.55%,CYP27A1;HSD17B4;OSBP
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.5548933992397731,0.9639865327028939,0.5434782608695652,0.9486391644488515,1.0,5/7,36.57%,CBFB;ZMIZ1;ABL1;SOD1;ZBTB1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.4651368976663748,-0.9639135921538039,0.578125,0.9696616538223398,1.0,7/31,18.32%,VEGFA;THBS1;BEX3;NGF;UACA;MT3;EPHA7
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.5526182957644814,-0.9637096191171945,0.6065573770491803,0.9684497607288685,1.0,3/9,14.28%,GSN;ADD3;SVIL
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.5526182957644814,-0.9637096191171945,0.6065573770491803,0.9684497607288685,1.0,3/9,14.28%,GSN;ADD3;SVIL
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.42724401254229977,0.9635295717699289,0.4473684210526316,0.9486052801620164,1.0,6/39,9.50%,DPP10;ATP2B4;BCL2L1;KIF5B;ITGA3;EGFR
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.5546961784215829,-0.9635132286896971,0.5507246376811594,0.9679961644887854,1.0,1/16,1.56%,MDFIC
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),-0.5255080005249224,-0.9632028842276634,0.6181818181818182,0.9679116306429223,1.0,1/15,2.18%,GRIA4
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.4704049253762362,0.963121203982706,0.5121951219512195,0.9483764494662754,1.0,3/20,4.04%,KCNC2;CACNA1C;RFX3
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.3561972858257902,0.9630297723863355,0.4827586206896552,0.9475881175712766,1.0,8/81,5.29%,HSPA1A;PML;BCL2;NDRG3;TP53TG5;PPP2R1A;SMARCA4;NRG3
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),-0.428797874198328,-0.9629882760927844,0.5441176470588235,0.9676516196396294,1.0,7/59,6.61%,FGF1;AKR1C2;TGFBR1;GCNT2;THBS1;HSP90AB1;F3
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.5013438920647006,-0.9628759806694493,0.53125,0.9671748028350955,1.0,2/16,6.00%,ANXA1;CD47
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.5606027677938643,0.9628461637650746,0.5434782608695652,0.9469840475491104,1.0,1/7,10.70%,IWS1
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),0.4857218777757096,0.9627506286427219,0.5111111111111111,0.9460048657626676,1.0,7/12,28.18%,MAVS;IRF3;DHX9;RIOK3;PTPN11;DDX3X;TBK1
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),0.5472441615504553,0.9624012441621339,0.5526315789473685,0.9458044253575347,1.0,1/5,4.65%,UBQLN1
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.37988333098009025,0.9622770734042829,0.5757575757575758,0.9450591585707564,1.0,9/64,5.17%,ADGRB3;LSAMP;CACNA1C;CSRNP3;CNTN4;OPCML;FMN2;RAB27A;PRKG1
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.44644493160438836,0.9622225187383363,0.4666666666666667,0.9441219810231443,1.0,2/26,1.07%,EPN2;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),-0.570198050974591,-0.9620206963079435,0.54,0.9683518342619241,1.0,2/9,6.61%,VEGFA;F3
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.435312372807931,-0.9616284911574743,0.5076923076923077,0.9684591404669706,1.0,10/44,12.72%,IGFBP5;RACK1;EPRS1;BTG2;NCL;SAMD4A;DHX36;LARP1;RPS3;APOE
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.5014201484452718,-0.9615231498183205,0.5178571428571429,0.9678411702792343,1.0,4/17,19.09%,BRCA1;APOE;MT3;PRKN
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),-0.5246174443075826,-0.9610511622868457,0.5818181818181818,0.9681236021783493,1.0,4/20,10.30%,PLPP3;PIP4P2;MTM1;SYNJ2
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.5101766425145838,-0.9607963371104199,0.59375,0.9678064980165907,1.0,5/19,19.67%,SLC38A1;SLC6A20;SLC6A13;SLC1A1;SLC16A12
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.43134495336973144,0.9607711208820777,0.4444444444444444,0.9465357459640374,1.0,5/30,10.47%,VAPB;CNOT7;NELFA;AXL;PPARA
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),0.6097418730309785,0.9607704421296884,0.6046511627906976,0.9454299799056682,1.0,2/6,10.11%,RALA;HK1
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.5392276226611519,-0.9604796721879076,0.5441176470588235,0.967830771778445,1.0,2/14,13.30%,BRCA1;UFL1
prerank,PanglaoDB_Augmented_2021__Pinealocytes,-0.5487653969480769,-0.960423272095967,0.559322033898305,0.9670991530570292,1.0,5/14,14.79%,SLC7A14;CREM;PDE10A;HCN1;MCF2L2
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),-0.535972740432658,-0.959615286777812,0.5192307692307693,0.9681613615679371,1.0,2/9,5.09%,VEGFA;GLI2
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.622362395541849,-0.9590068611078503,0.5531914893617021,0.9686827895812511,1.0,2/7,16.06%,BBS4;NINL
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.5851820486662321,-0.9590053303557661,0.6428571428571429,0.9678777455242993,1.0,2/7,6.03%,TAMM41;HADHA
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),-0.39781939892947893,-0.9589006825779506,0.527027027027027,0.9672892913756286,1.0,18/104,13.54%,FGF1;SLC4A4;VEGFA;NRP1;LEPR;RACK1;EPHA3;FAXDC2;THBS1;RALBP1;FAM20A;EPHA5;PPIA;LIMCH1;EPHA4;KRAS;CCN1;CSNK1D
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.49381181550610026,-0.9588677267276553,0.5272727272727272,0.9665694994935248,1.0,7/20,27.32%,NUP58;SEC13;NUP107;RANBP2;NUP133;SSB;TPR
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.6182364974639905,0.9588632047994727,0.625,0.9487894154330915,1.0,2/5,13.62%,PPARA;EP300
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.5132828088788917,-0.9585167047960022,0.59375,0.9665533565600343,1.0,5/19,21.77%,POLA1;RPA1;WRN;UBA52;POLK
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),-0.6251023247286085,-0.9584133449287952,0.6379310344827587,0.966000541840172,1.0,1/6,18.67%,PARG
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.5471671946886216,-0.9583274983695668,0.5306122448979592,0.9653249119017084,1.0,2/12,6.90%,ADAM9;APH1B
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.6065886650190648,-0.9580390571577129,0.5740740740740741,0.9650460849795501,1.0,3/8,19.57%,RSRC1;DDX5;DDX17
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.5491041859560633,-0.9580282058350105,0.5087719298245614,0.9642735668776181,1.0,3/11,11.29%,ANXA1;IGFBP2;RPS3
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.6174599588711188,-0.9579651687710192,0.5208333333333334,0.9635764121667241,1.0,3/5,13.46%,F3;ANO6;PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.3624098453655034,-0.9579189350657394,0.5443037974683544,0.9629790970080463,1.0,23/198,11.07%,PDGFD;FGF1;TGFB2;RPS4X;COLEC12;AKR1C2;VEGFA;TET1;BMP5;TSHR;TENM4;TGFBR1;CD47;GCNT2;THBS1;HSP90AB1;PTGFR;TRIM13;FN1;INO80;SSR1;DHX36;NAMPT
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.3938042269890138,0.9570448800086436,0.47058823529411764,0.9519241726565566,1.0,5/48,3.19%,CSF1R;NOTCH1;MFHAS1;PDGFA;ERBB4
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.6235687804370544,-0.956282304833794,0.6086956521739131,0.9657838969397006,1.0,2/5,27.74%,CD46;STAT3
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.5497009744321169,-0.956282170540006,0.5689655172413793,0.9649723138330285,1.0,2/10,11.05%,STAT1;DHX36
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.38455127794106175,0.9561433992340521,0.5,0.9529699125512597,1.0,10/55,13.62%,PHC1;UBE2N;HDAC9;PHF20L1;USP16;HDAC1;PHF20;RPS6KA5;HDAC2;EP300
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.5387927158214213,-0.9558809587481388,0.6346153846153846,0.9650068426135325,1.0,2/15,4.97%,WASHC3;GSN
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),-0.6491933293472498,-0.9554233055460926,0.5769230769230769,0.9653609015516917,1.0,2/5,23.97%,TRERF1;NEDD4
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),-0.5485982636618556,-0.9553176868864578,0.6326530612244898,0.9647727817070342,1.0,3/17,11.02%,NKD1;PTCH1;FGF13
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.4954365641429291,-0.9547248638978016,0.5333333333333333,0.9651673478136341,1.0,7/19,27.32%,NUP58;SEC13;NUP107;RANBP2;NUP133;SSB;TPR
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.5229147304887091,-0.9544914225911935,0.46875,0.9649482039842232,1.0,5/15,24.48%,HMGN1;THOC1;ZNF326;WDR43;ERCC6
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.46285749492510536,-0.9543925564884068,0.4852941176470588,0.9643210686220184,1.0,6/32,15.14%,TUBGCP5;GOLGA8A;INO80;RPS3;CSNK1D;GOLGA8B
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.587938909035547,0.9542603144153684,0.65625,0.9531402019074645,1.0,1/6,1.15%,PANK3
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.587938909035547,0.9542603144153684,0.65625,0.9531402019074645,1.0,1/6,1.15%,PANK3
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.587938909035547,0.9542603144153684,0.65625,0.9531402019074645,1.0,1/6,1.15%,PANK3
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.587938909035547,0.9542603144153684,0.65625,0.9531402019074645,1.0,1/6,1.15%,PANK3
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.4099878486991585,0.9541220515138498,0.4864864864864865,0.9523002256258272,1.0,9/39,16.92%,EIF4ENIF1;KPNA4;IPO8;CBLB;IPO11;NUP54;IPO9;KPNB1;TNPO3
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.5332620119026398,0.9540387756782474,0.5384615384615384,0.9514621914858816,1.0,2/11,7.36%,ST3GAL2;B3GNT2
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),-0.5068045948647555,-0.9535514824832397,0.5423728813559322,0.9654412931923875,1.0,1/13,4.30%,RACK1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.452497043330193,0.9534469007899922,0.5,0.9518077360917303,1.0,7/25,15.06%,MGAT5;GFPT1;RPN2;STT3B;PMM2;UBE2J1;UGGT1
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),-0.5666864647972771,-0.953415687467111,0.5964912280701754,0.9649860172367654,1.0,2/9,3.19%,TGFB2;ANXA1
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),-0.46306393998707873,-0.952620961483088,0.5396825396825397,0.965818683249694,1.0,5/39,5.21%,VEGFA;LEPR;CMKLR1;PER2;TSHR
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.3856167384108517,0.9525508093373163,0.5277777777777778,0.9526889746942824,1.0,7/53,5.20%,HSPA1A;NOTCH1;PML;NDRG3;TP53TG5;PPP2R1A;SMARCA4
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.3636848980738592,-0.9524501845281138,0.5949367088607594,0.9654045512756898,1.0,32/217,15.45%,FGF1;SRGAP3;AKAP7;ARHGAP24;VEGFA;ARHGAP15;RASGRF2;CMKLR1;RPL5;AKAP12;VAV3;ARHGEF3;ARHGAP28;RHOQ;SGK1;RALBP1;BIRC2;BRCA1;RPA1;RAD17;PRKAR1A;MAPK14;PRKAG2;DAPK2;WRN;UFL1;RRAGB;MINK1;SQSTM1;RPL11;ARHGAP20;NET1
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.4701835370625047,0.9521660949796191,0.5151515151515151,0.9524130787203745,1.0,2/18,7.99%,TNFAIP8L1;RNF152
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.570251447424323,-0.9518012583836242,0.5892857142857143,0.9661622837540446,1.0,1/9,5.73%,TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.4998197992499666,0.9516710912272912,0.59375,0.9525184444709766,1.0,4/16,12.67%,RAB27A;PPARA;GRIN1;HDAC2
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.439640499907638,0.9516113775361085,0.4878048780487805,0.9515305239105166,1.0,5/20,10.49%,GUCY1A1;GUCY1B1;ELN;SGCZ;CYB5R3
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.4734861641904171,-0.9514571393309933,0.5555555555555556,0.9662442649079251,1.0,5/35,16.86%,PLPP3;HTT;COG4;ARF4;NBAS
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.45014697352544414,-0.9510606606442993,0.45901639344262296,0.9664154257734315,1.0,2/27,4.30%,ZFPM1;RACK1
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.5262360758148388,-0.9504938330445954,0.5535714285714286,0.9668296891096999,1.0,3/11,14.00%,SOAT1;APOE;CYP27A1
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.37664958176522917,-0.9504100390768572,0.5466666666666666,0.966213782507953,1.0,20/165,14.36%,HERC6;DZIP3;DDB2;HECW2;RNF213;RNF19A;FBXO38;SASH1;BIRC2;BRCA1;FBXW2;FBXO22;PELI1;ARIH2;PSMC2;WSB1;UBE3D;TNKS2;PSMD8;RNF8
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),-0.36892624098324156,-0.9503919045648817,0.6219512195121951,0.9654450079725986,1.0,31/191,17.04%,ABLIM1;CIRBP;TUBGCP5;PTPDC1;GOLGA8A;IFT122;GSN;SCLT1;TCTN1;DZIP1;CCDC57;GABARAPL1;CEP126;HPS4;INO80;RPS3;TTC8;VPS36;DZIP1L;ARMC9;NEK1;ARF4;CSNK1D;BBS4;PLA2G4C;GOLGA8B;ABLIM3;ATG14;DYNC2H1;FARP2;DCDC2
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.4990346619249485,0.9500684979944309,0.5348837209302325,0.9538677084009418,1.0,2/11,6.42%,ARF1;RRP1B
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),0.45075959420594,0.949869491815644,0.5581395348837209,0.9532361163191821,1.0,3/23,10.47%,MFHAS1;MAPKBP1;PPARA
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.5456397948142645,0.9492422531020018,0.5121951219512195,0.9537426194540526,1.0,2/9,3.83%,TNFRSF10B;BCL2L1
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.5134596611528663,0.9488809532927551,0.5555555555555556,0.9536093304293184,1.0,5/9,22.30%,HACD2;ELOVL6;ELOVL5;ACSL1;TECR
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.4116142622925385,-0.9487344562705401,0.5223880597014925,0.9684568114750988,1.0,11/62,15.98%,SHROOM3;ELMO1;GSN;SHROOM4;BAIAP2L2;MARCKS;ABI2;TPM2;SVIL;TPM1;RHOBTB3
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),-0.5560200304182102,-0.948513496762278,0.576271186440678,0.9680998404200435,1.0,5/8,28.28%,ASPA;DLD;AASS;PHYKPL;ALDH7A1
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.5331166020840094,-0.9479511026991582,0.5714285714285714,0.9686079493702764,1.0,3/11,5.73%,TWIST1;VEGFA;TGFBR1
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),-0.406764390845522,-0.947887936215907,0.5833333333333334,0.9678962462347585,1.0,8/84,12.72%,PRAG1;EPHA3;SPOCK1;TANC2;PTK7;ABI2;EPHA4;APOE
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.4873921249234,0.9478165920904863,0.5319148936170213,0.9549175348827652,1.0,4/14,12.56%,IWS1;RPS6KA5;MYOCD;GLYR1
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),-0.3627922599037429,-0.9476766715432325,0.5394736842105263,0.9676293483702886,1.0,17/197,13.65%,PRAG1;TGFB2;CDKL1;FGGY;PIK3R4;TGFBR1;STRADB;SGK1;PGK1;FAM20A;PRKDC;PRKAG2;DAPK2;NEK1;CSNK1D;WNK2;SRPK1
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.4336650676846994,-0.9476164611826473,0.5,0.9669679831444874,1.0,9/45,14.69%,IGFBP5;GABRB2;TSHR;SLIT2;BRCA1;LARP1;LARS1;RRAGB;HCN1
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.4832699153224027,0.9471791632876186,0.5625,0.9555737779830851,1.0,2/19,2.23%,NOTCH1;HEY2
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.38921304672272533,-0.9470866310725716,0.5555555555555556,0.9674995077510495,1.0,19/101,13.38%,CIRBP;IGFBP5;RPS4X;RPL5;RACK1;EPRS1;PLD1;THBS1;BTG2;NCL;UPF3A;SAMD4A;PRKDC;DHX36;LARP1;RPS3;EIF4H;EEF2;EIF1B
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.6499490393646232,-0.946569067075303,0.6041666666666666,0.9679014196552272,1.0,2/5,10.03%,RACK1;NSMAF
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),-0.5083643177869474,-0.9462217987476201,0.5423728813559322,0.9678122639543989,1.0,3/16,6.14%,EXT1;GPC3;GCNT2
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.344718133099583,0.9459713717859943,0.59375,0.957277485949196,1.0,10/80,10.38%,CSPG4;JPH2;CHST3;TIMP3;LIFR;ENAH;NOTCH3;HEYL;EGFR;ITGA7
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),0.5013845312756212,0.9458459243864179,0.5121951219512195,0.9565285998160282,1.0,4/13,15.06%,RNF185;AMFR;RNF139;UGGT1
prerank,PanglaoDB_Augmented_2021__Osteocytes,-0.4324331210086509,-0.9457779516664213,0.5072463768115942,0.9680847323129405,1.0,20/55,24.01%,MYO10;GLI3;ADAMTS12;COL1A1;GLI2;SLIT2;MID1;COL4A6;NXN;TPM1;EFNB2;FBXL7;FSTL1;CDH11;RAI14;STC1;ROR1;PTN;RND3;PXDN
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.6321395143571904,-0.9457185196756916,0.62,0.9674096576341823,1.0,1/5,2.12%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.6273862155525947,0.9451964450432516,0.6585365853658537,0.9572278074062199,1.0,3/5,14.65%,AXL;RAPGEF2;GAS6
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.5787721726513564,0.9448605501664875,0.6046511627906976,0.956809565041949,1.0,1/6,0.83%,MOCS1
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),-0.6087249445005207,-0.9447324399207181,0.6181818181818182,0.9687807000078427,1.0,2/5,10.39%,MSH6;PRKDC
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.5183704623954891,-0.9447177392296814,0.5573770491803278,0.9680260313581955,1.0,6/16,19.84%,FTL;ABCB7;HEPH;MT3;PRKN;TF
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.5760743679336978,0.9447050783576276,0.5882352941176471,0.9562632138666023,1.0,3/8,8.52%,CSF1R;MYH9;AXL
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.5008333701949497,-0.9446393780374215,0.5714285714285714,0.9666004018755057,1.0,7/18,27.32%,NUP58;SEC13;NUP107;RANBP2;NUP133;SSB;TPR
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.5008333701949497,-0.9446393780374215,0.5714285714285714,0.9666004018755057,1.0,7/18,27.32%,NUP58;SEC13;NUP107;RANBP2;NUP133;SSB;TPR
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.43826614901969074,0.9446305737372893,0.5348837209302325,0.9554134005902877,1.0,2/18,3.13%,CSF1R;PGF
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.4330869024627534,0.9444901992860597,0.5757575757575758,0.9546357481268833,1.0,9/27,20.76%,PPP6C;CDKN1A;PHF8;RPS6KB1;CACUL1;CUL4A;ACVR1B;EIF4E;RB1
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),-0.5329331484633054,-0.9440358313679816,0.58,0.9672562068677402,1.0,4/18,16.47%,TGFB2;SMOC1;FOXC1;CPAMD8
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.4667602300070986,0.9438105699735932,0.5405405405405406,0.9549238957413545,1.0,4/17,15.06%,RNF185;AMFR;RNF139;UGGT1
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.3731387406669883,0.9435541879069638,0.5681818181818182,0.9545222991609189,1.0,10/51,16.33%,BCAM;EPAS1;CDC42EP4;GPRC5C;ARHGEF10L;MYO1D;SCARB2;DOCK1;CMTM4;MAOA
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),-0.5269722993723295,-0.9434665455071058,0.55,0.9677272417504167,1.0,6/19,22.83%,PIK3R4;PRKAG2;ATG14;SESN3;ITFG2;SZT2
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),0.5366370736837921,0.9433519931291448,0.4523809523809524,0.9538182837517661,1.0,4/8,35.79%,EIF2AK4;EIF2S1;HERPUD1;EIF2AK3
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.42867098351813465,0.9432056631555028,0.47368421052631576,0.953150815373551,1.0,9/25,24.46%,ADGRV1;SLC25A24;RASGRP2;RYR3;SYT17;SYT1;ADD1;PRKAA2;MEF2C
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),-0.6349238149686907,-0.9429625920348809,0.6607142857142857,0.9681576053211214,1.0,3/7,22.33%,LARS1;RRAGB;SESN3
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),0.4679001984748177,0.9426015564621837,0.425,0.9533927769085898,1.0,2/17,4.65%,SNAP29;UBQLN1
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.3587827898572958,0.9423015808619657,0.56,0.9530063365715313,1.0,10/67,6.50%,LDB3;NOTCH1;CACNA1C;ERBB4;MEF2D;DLC1;RBM20;MICAL2;PCSK5;HDAC9
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.5652598709356486,-0.9422893685868103,0.5967741935483871,0.9688264807035707,1.0,2/9,13.65%,SUPT6H;SRPK1
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.4377455553179631,0.9420397540871156,0.47619047619047616,0.9525510810765258,1.0,6/23,14.81%,NDRG2;GLUD1;RHOA;MBP;CKB;CDC42
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.6067571914705769,-0.9414515531003751,0.625,0.9700758786342415,1.0,1/6,7.68%,ABCB1
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.31242580176802415,0.9413724684351984,0.6551724137931034,0.9531873313733592,1.0,21/193,10.84%,VAPB;WTIP;ATL2;MTFR1;ATP8B1;FMNL3;PDZD8;VAPA;SORT1;PACSIN2;MICAL2;ARHGEF7;FAM174B;ARHGAP10;RAB31;SYNE3;BRWD1;KLHL20;GABPB1;CAMSAP1;RANBP10
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.5550925440349062,0.9408271899357694,0.5714285714285714,0.9532659365238126,1.0,2/8,2.23%,MYH11;HEY2
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.42632212860619684,0.9398687672555434,0.5675675675675675,0.9544208323170769,1.0,3/27,10.28%,INTS7;RHOB;CDKN1A
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.6470702214651094,-0.9394638012144989,0.6037735849056604,0.973297522825796,1.0,1/5,14.36%,RNF8
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.3849916336661252,0.9389570616586741,0.4827586206896552,0.955445962854331,1.0,6/60,6.29%,PDE1C;EPN2;CNTN4;SGPL1;TESC;AGAP1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),-0.5650475612036612,-0.938952165795354,0.5517241379310345,0.97371399416639,1.0,1/7,3.19%,ANXA1
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),-0.5161410382802831,-0.9387636770383092,0.6290322580645161,0.9734144801267846,1.0,2/16,1.38%,ANO2;GABRB2
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.5309573359594304,0.9386960082931689,0.5102040816326531,0.9549096815322161,1.0,3/8,16.43%,ZBTB16;MEIS2;ZFP36L1
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.5564714709303282,0.9384353949653954,0.5681818181818182,0.9544207418880875,1.0,3/8,14.61%,PPARGC1B;ARID1A;TRIP4
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.5294994282420649,-0.9376067819682592,0.5737704918032787,0.9751087447503478,1.0,3/13,19.09%,ACTG1;ASAP3;PRKN
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.35121869705461667,0.9365165406773022,0.5333333333333333,0.9577010097269664,1.0,7/80,5.81%,CSPG4;HSPB1;CHST3;TIMP3;EPAS1;RASAL2;EHD2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.4561850802231812,-0.9362854742226463,0.5573770491803278,0.9773080934979398,1.0,5/31,13.12%,VEGFA;TERF2IP;HSP90AB1;NGF;PDCD10
prerank,PanglaoDB_Augmented_2021__Platelets,-0.4429918473725204,-0.9361039704634059,0.582089552238806,0.9768716068512628,1.0,3/37,6.26%,SLC2A3;VEGFA;THBS1
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),-0.6023003150938007,-0.9358475236453921,0.6326530612244898,0.9766259581044366,1.0,1/5,3.87%,FGGY
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),0.6016107022755521,0.9350227940134885,0.5471698113207547,0.9600416243948939,1.0,1/5,20.18%,EZR
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),0.4256635214678547,0.9350223989431249,0.6,0.9589737249239321,1.0,5/39,8.79%,KCNC2;HPRT1;ATL2;NACC2;USP16
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),-0.592851389234326,-0.9348419968421547,0.5740740740740741,0.9781221524737906,1.0,3/6,22.73%,KDM2B;APPL2;PTN
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.6019991481934197,0.9344217646377627,0.5869565217391305,0.9592404450563627,1.0,1/6,1.35%,CACNA1C
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.4881041116633562,-0.934170633995267,0.5192307692307693,0.9785877214123533,1.0,4/19,3.19%,NR4A1;VEGFA;NRP1;ANXA1
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),0.5705636432617073,0.9337603812606696,0.5813953488372093,0.9596098223659364,1.0,2/5,14.81%,AXL;CDC42
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.5664966146400459,-0.9337461025467619,0.5686274509803921,0.9788470628901272,1.0,1/7,9.64%,DDX5
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.44877357418734065,-0.9335361541980916,0.5555555555555556,0.978647990277702,1.0,4/41,3.27%,ELMO1;VEGFA;NRP1;VAV3
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.520986265659079,-0.9330996645353221,0.6153846153846154,0.978962094688192,1.0,4/17,5.31%,DDX60L;GBP2;SAMD9L;WDFY4
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),-0.578453568126111,-0.932556227127935,0.6206896551724138,0.9793781803682607,1.0,3/6,18.24%,LEPR;BBS4;MT3
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),-0.596494026698741,-0.9317970475532829,0.5849056603773585,0.9802662363884065,1.0,1/5,1.30%,LMF1
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.5118353989366813,-0.9315668759045044,0.5714285714285714,0.979932854688352,1.0,1/18,1.68%,NRP1
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.6241766936459768,0.9305798843092566,0.58,0.9654445231339681,1.0,2/5,5.07%,CSF1R;MYH9
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),-0.5800152377883727,-0.9300124176248008,0.6333333333333333,0.9826908261186662,1.0,2/10,13.35%,HTT;GPATCH2
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.556760165611581,-0.9299800972799561,0.5961538461538461,0.9819788296633625,1.0,3/9,15.75%,PER2;CELF2;TPM1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.540381578068127,0.9297477227202803,0.5227272727272727,0.9662411874703435,1.0,3/7,38.15%,HLA-E;TP53BP1;RIF1
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.3398686336707181,0.9290650522036087,0.5952380952380952,0.9666816332446432,1.0,15/89,11.07%,WTIP;TNFAIP8L1;BCL2;ATP2B4;BCL2L1;PPM1A;MGRN1;DLG5;MAPKBP1;DGKG;SH2B3;PDE3A;PPARA;USP10;MCL1
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),-0.500334634736429,-0.9289776681789328,0.6166666666666667,0.9833644694556555,1.0,6/12,12.09%,TGFB2;SPRY1;TGFBR1;OLFM1;PDCD4;TGFBR3
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.5297602811495427,-0.9287381601110514,0.5517241379310345,0.982225043100338,1.0,3/14,9.08%,TERF2IP;HSP90AB1;RPA1
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.5297602811495427,-0.9287381601110514,0.5517241379310345,0.982225043100338,1.0,3/14,9.08%,TERF2IP;HSP90AB1;RPA1
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),-0.45178565774315366,-0.9284316271904552,0.5714285714285714,0.9822911847102965,1.0,12/28,16.59%,SLC4A4;SCN7A;SGK1;SLC24A3;SLC6A20;FGF13;ANO6;ATP1B1;HCN1;SLC6A13;SCN2A;SLC9B2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.4805038292643122,-0.9283473337422166,0.5573770491803278,0.9816762833690121,1.0,3/20,5.42%,TWIST1;TERF2IP;SLF1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.38250105884805313,0.9283419774408471,0.5428571428571428,0.9670639985022712,1.0,8/41,11.02%,HSPA1A;RNF14;BBS7;SMAD7;RNF139;ZER1;RNF180;FBXW7
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),-0.544340199413254,-0.9277775244408818,0.6037735849056604,0.982251097105196,1.0,3/9,5.73%,TGFB2;BMP5;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.4197989954888622,-0.9277225717946572,0.5384615384615384,0.9815903256446972,1.0,7/55,9.11%,ZFPM1;CMKLR1;ANXA1;N4BP1;THBS1;PDCD4;FN1
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.46094138210021807,-0.9272936172802388,0.5636363636363636,0.9817426521518654,1.0,1/26,0.38%,CLU
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.4485394695904405,-0.9267120723520782,0.546875,0.9821131872828984,1.0,7/21,20.48%,RACK1;THBS1;EIF2B3;TCF7L2;LPL;PRKACA;SELENOS
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.47316535372900254,-0.926524453765274,0.5517241379310345,0.9817035680707372,1.0,5/24,6.77%,TGFB2;ZFPM1;VEGFA;TGFBR1;OLFM1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.537790805909186,0.9261780219142386,0.5660377358490566,0.9711191612504234,1.0,6/8,22.30%,HACD2;ELOVL6;ELOVL5;ACSL3;ACSL1;TECR
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),-0.5742302503995909,-0.9260442821207046,0.5714285714285714,0.9820190175169979,1.0,2/6,13.59%,ATP1B1;WNK2
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),0.36509650948805367,0.9260135230837916,0.5405405405405406,0.9705612986518602,1.0,12/64,16.41%,BCL2;RC3H2;UBE2N;TNFRSF21;MAP3K7;NFKBIZ;PAK2;NFKB1;BTRC;WNK1;CD38;PIK3CD
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.5042465767424616,0.925802450987306,0.53125,0.9698794441787494,1.0,2/14,6.38%,TENM2;GRID2
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.49576455926820395,0.92550140409176,0.5365853658536586,0.9694719980598022,1.0,5/13,23.37%,SLC44A2;CSNK2A1;SLC27A1;CHPT1;LPIN1
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.3529051816615598,0.9251866157455173,0.6129032258064516,0.9692471862436722,1.0,13/69,20.92%,ADARB2;METTL14;AGO2;HNRNPUL1;HNRNPF;RBMX;RBMS2;PAPOLG;DHX9;HNRNPK;POLR2B;HNRNPH1;PCBP1
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.5645903306187637,0.9247512189010527,0.5882352941176471,0.9693065231693959,1.0,2/6,12.59%,ATP10A;DNM2
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),-0.5335301287639328,-0.9246576458705195,0.639344262295082,0.9843342481330049,1.0,4/15,12.16%,TANC2;DHX36;ABI2;EPHA4
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),-0.5731390565005029,-0.9245235646036207,0.5964912280701754,0.9839860550215821,1.0,1/5,1.62%,VEGFA
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),-0.4458235252098534,-0.9244362794298775,0.5666666666666667,0.983343124681801,1.0,8/38,14.36%,DDB2;RNF213;RNF220;BRCA1;TRIM13;NFX1;UBE3D;RNF8
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.4411505610448814,0.9243256299570294,0.5714285714285714,0.9689917156699983,1.0,2/26,3.30%,MFHAS1;HIPK2
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.36890029973818783,0.9242108720640724,0.5769230769230769,0.9681794582536817,1.0,8/53,9.91%,TNFRSF10B;BCL2;NIBAN1;RNF185;UBQLN1;TMEM259;RNF139;CEBPB
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.44309967175217907,-0.9239153738792159,0.6060606060606061,0.9838814425055772,1.0,5/39,11.08%,TGFB2;RIMS1;TGFBR1;INO80;NGF
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.5952024617467326,-0.9227310346949299,0.6296296296296297,0.98563698615105,1.0,6/8,29.34%,LGALS3;STC1;PKD2;CXCL12;FYN;PDGFRB
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.5168911576725689,-0.9220317805625602,0.6363636363636364,0.98631992305738,1.0,6/17,16.91%,ZFP36L2;BTG2;FOXC1;BTG1;ANGEL2;RGCC
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.43309497289288856,0.9220098775421012,0.5227272727272727,0.9720961261237078,1.0,4/25,5.07%,CSF1R;PML;DEK;MYH9
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.5323598416683235,-0.9219908635393119,0.6065573770491803,0.9856461966513443,1.0,3/10,14.66%,NR4A1;IL16;MAP3K8
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),-0.5673988713600798,-0.9219688538131657,0.5714285714285714,0.9841085967909724,1.0,2/6,13.84%,CCT6A;LARP7
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),-0.5673988713600798,-0.9219688538131657,0.5714285714285714,0.9841085967909724,1.0,2/6,13.84%,CCT6A;LARP7
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.5496890843243946,-0.9217375778241608,0.6551724137931034,0.983901886127453,1.0,2/9,11.29%,LGALS3;RPS3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.5943593409152282,0.9216300734163205,0.6590909090909091,0.970774828970335,1.0,1/5,4.35%,GNAI1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.5943593409152282,0.9216300734163205,0.6590909090909091,0.970774828970335,1.0,1/5,4.35%,GNAI1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.44921330211556737,0.9213030986898945,0.5526315789473685,0.9694142503439579,1.0,5/15,15.06%,MGAT5;RPN2;STT3B;UBE2J1;UGGT1
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.44921330211556737,0.9213030986898945,0.5526315789473685,0.9694142503439579,1.0,5/15,15.06%,MGAT5;RPN2;STT3B;UBE2J1;UGGT1
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),-0.5733186425174917,-0.9211202715156349,0.6078431372549019,0.9845140001930981,1.0,4/6,24.74%,ZNF91;TUT7;UBR2;TUT4
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.5553175272575682,-0.9201783081991816,0.6129032258064516,0.9861204569656461,1.0,1/9,0.38%,CLU
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.5249578882129197,0.9201768287724069,0.6041666666666666,0.970216748015857,1.0,1/7,11.58%,ZDHHC6
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.5249578882129197,0.9201768287724069,0.6041666666666666,0.970216748015857,1.0,1/7,11.58%,ZDHHC6
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.4827547752473002,0.9201042099199045,0.6060606060606061,0.9693653238744081,1.0,3/15,11.82%,CACNA1C;HCN2;KCNQ1
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.4374875996176596,-0.9198114670979208,0.576271186440678,0.9861053850963303,1.0,3/37,5.50%,ZFPM1;RACK1;ARHGAP28
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.4209908835984551,-0.9196301901657472,0.6417910447761194,0.9858053108490078,1.0,12/48,16.91%,NRP1;PHLDB2;ACTG1;ARHGAP28;TGFBR1;CD47;TMEFF2;LIMCH1;TPM1;LPAR1;ASAP3;RGCC
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.4587112380790709,-0.9194073401532261,0.5942028985507246,0.9855441962270461,1.0,11/37,19.49%,SEPTIN4;JAM3;RAD17;ZC3H14;TLE4;SNAP91;PEBP1;HSPA4L;TOPBP1;GMCL1;CSNK2A2
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,-0.3995306719530531,-0.9182872560756659,0.6307692307692307,0.9873139902339745,1.0,5/62,7.15%,SHROOM3;IGFBP5;KIAA1217;PLPP3;PDZRN3
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),-0.5415622914306454,-0.9180154783775935,0.5588235294117647,0.9871058960780883,1.0,1/8,4.65%,NR4A3
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.5510132088042037,-0.9178504006037013,0.609375,0.9866293576420886,1.0,3/9,19.19%,DCN;PIK3CB;JCAD
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.43231702827031504,-0.9174534431877921,0.5882352941176471,0.9866906885714496,1.0,6/36,7.28%,TGFB2;BMP5;TGFBR1;THBS1;HSP90AB1;SNW1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.4731314132638474,0.9174492142002637,0.5526315789473685,0.9739866369452345,1.0,2/14,1.62%,CSF1R;ABL2
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),-0.3608158537572733,-0.916784563965508,0.5540540540540541,0.9874726334102264,1.0,23/126,15.58%,CLU;RASGRF2;KCNMA1;VAV3;SFRP4;RACK1;ARHGEF3;SEPTIN4;HTT;SLIT2;OLFM1;APH1B;PRMT2;NGF;CYP1B1;ANO6;ITGB3BP;DAPK2;SQSTM1;MTCH2;GADD45B;NET1;PHLDA1
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,-0.41127343400794486,-0.9167256898014382,0.6142857142857143,0.9867824173490369,1.0,13/53,15.37%,PRTG;GLI3;GLI2;SLIT2;DZIP1;EYA1;NR2F1;MID1;ZFHX4;BOC;NXN;FOXC1;HSPA12A
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),-0.5742538952429586,-0.9165475371943513,0.5692307692307692,0.986345901835107,1.0,2/5,13.59%,ATP1B1;WNK2
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),-0.5672138107851,-0.9165218744426036,0.5535714285714286,0.9833551451720374,1.0,1/7,0.91%,MLPH
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),-0.5672138107851,-0.9165218744426036,0.5535714285714286,0.9833551451720374,1.0,1/7,0.91%,MLPH
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),-0.5672138107851,-0.9165218744426036,0.5535714285714286,0.9833551451720374,1.0,1/7,0.91%,MLPH
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),-0.5672138107851,-0.9165218744426036,0.5535714285714286,0.9833551451720374,1.0,1/7,0.91%,MLPH
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.5730247820812068,0.9164633826466845,0.6521739130434783,0.975159937063781,1.0,2/8,11.23%,ZNF143;ELL
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.6086564885898305,0.9162495175758025,0.6571428571428571,0.9746638979115397,1.0,1/8,2.09%,ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.32908522456154393,0.9160027277039762,0.8461538461538461,0.9742359781642193,1.0,20/151,11.31%,HSPA1A;NOTCH1;CNOT7;ATP2B4;HEY2;TOB1;EIF4ENIF1;TMBIM6;HDAC9;MAP2K2;RNF139;AGO2;HDAC1;RBL1;MTF2;AEBP2;BMPR1A;RPS6KA5;FBXW7;TIPARP
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),-0.6104642474888164,-0.9159585365610609,0.660377358490566,0.9837846602383852,1.0,1/6,6.58%,ESCO1
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),-0.5192430532073595,-0.915325294727795,0.5517241379310345,0.9842287438041889,1.0,3/15,10.60%,TWIST1;SMAD6;PTCH1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.5736611524890235,-0.9152934304356781,0.6363636363636364,0.9835377465231069,1.0,2/7,11.05%,ZFP36L2;DHX36
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.35051816507539224,0.9146707576076383,0.7027027027027027,0.9763540130031692,1.0,13/62,13.28%,CDH2;CNTN4;SOX6;ADGRL2;ZFHX3;CTNNA2;SCYL2;GRIN1;SMARCA1;PHF8;MEIS2;RAPGEF2;CNTNAP2
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.4574486033999041,-0.9146301739885242,0.5483870967741935,0.9840345825882151,1.0,2/18,1.62%,ZFPM1;VEGFA
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.6087296487141644,0.9143907678596104,0.673469387755102,0.9758359903030333,1.0,4/6,12.64%,HEY2;EMP2;RAP1A;RAPGEF2
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),-0.6093513247907404,-0.9135980461112034,0.660377358490566,0.9855796519077191,1.0,2/8,10.47%,VEGFA;SAP30BP
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),-0.4353126306391407,-0.9129859906121535,0.640625,0.9861804656925254,1.0,5/43,5.21%,VEGFA;LEPR;CMKLR1;PER2;TSHR
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),0.5251335650834531,0.9122619187851778,0.5454545454545454,0.9796184897964679,1.0,2/7,4.44%,PDGFA;C1QTNF1
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),-0.47604988998753023,-0.9121260885948,0.5740740740740741,0.9872660855832808,1.0,3/18,12.72%,CENATAC;HSP90AB1;APOE
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),-0.5681222394502099,-0.9115491325040944,0.5666666666666667,0.9876143919710171,1.0,1/8,9.69%,INO80
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.5826821118369546,-0.9114421653089716,0.6785714285714286,0.9870376531723118,1.0,1/9,2.07%,NT5E
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),-0.4745415715570532,-0.9114403652730505,0.6290322580645161,0.9862876517717403,1.0,9/23,19.67%,SLC6A20;SLC25A13;SLC7A2;SLC6A13;SLC1A2;LRRC8B;SLC1A3;SLC1A1;SLC16A12
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),-0.5773777175469081,-0.9113768725329827,0.6607142857142857,0.9857279664697293,1.0,1/7,6.53%,HSP90AB1
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.4451008173414741,0.9109264605800441,0.6666666666666666,0.9814234791168372,1.0,2/26,1.67%,HSPB1;PML
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.3802796894277333,-0.9108773432831836,0.5507246376811594,0.9859327390745152,1.0,10/57,22.02%,VAV3;NR4A3;PSMC2;PSMD8;PIK3CB;JUN;PIK3R1;CALM1;LYN;PSMD14
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.5684873956161545,-0.9108208321801777,0.5892857142857143,0.9852684314664364,1.0,3/7,25.14%,CLASP2;LRP1;CST3
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.44506504219831555,0.9108156429976638,0.5526315789473685,0.9805682443153583,1.0,4/17,8.00%,BCL2;BCL2L1;NACC2;FBH1
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.5708865310570945,-0.9106799086365887,0.5882352941176471,0.9847863176546783,1.0,1/8,0.56%,CD55
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.3726847740229947,-0.9105897436777102,0.6212121212121212,0.9842144348460184,1.0,11/85,14.29%,CD55;VAMP4;ACTR10;PROS1;COG4;CNIH3;STX17;ARF4;TMED4;SEC13;GOSR1
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),0.5148734434205923,0.9104353974166287,0.6041666666666666,0.9801478429002481,1.0,3/11,11.61%,SRSF12;TGS1;SART3
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.5146410910889885,-0.9103999520336069,0.5686274509803921,0.9839072287952546,1.0,1/11,0.38%,CLU
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),0.36192688087426567,0.9102326693161541,0.5,0.9797394341868958,1.0,10/58,16.41%,RC3H2;UBE2N;TNFRSF21;MAP3K7;NFKBIZ;PAK2;NFKB1;BTRC;WNK1;PIK3CD
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.5905913667431588,0.9101592263819367,0.5434782608695652,0.9787890463226769,1.0,2/5,11.65%,SMAD7;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),-0.5991440563914292,-0.909962312027492,0.6166666666666667,0.9840448352980297,1.0,4/6,29.34%,RGCC;EDN3;PHIP;PDGFRB
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),-0.385674538999663,-0.9098496394950848,0.6338028169014085,0.9836253527937878,1.0,11/76,10.60%,SPRY1;ALDH1A1;PROCR;LDLRAD4;BMP5;ADM;N4BP1;RHEB;LAMA4;SMAD6;PTCH1
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.3891249262217693,0.9090152660778538,0.7073170731707317,0.9804081921457724,1.0,8/33,10.91%,PDGFA;DLC1;CORO2B;ARHGAP44;RHOA;RHOB;ARHGAP35;RICTOR
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),-0.6131815880911224,-0.909001082505777,0.6862745098039216,0.9846653129910266,1.0,1/5,0.88%,TGFB2
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.4733508229179291,-0.9085892519823338,0.6101694915254238,0.9849147256050016,1.0,7/22,21.59%,RACK1;MRPS25;EEF2;GTPBP2;GTPBP1;GFM1;MRPL3
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.4671389275277054,-0.90856119403111,0.6,0.9842402693634863,1.0,4/15,25.86%,CSNK1D;VPS13C;GCC2;ZDHHC15
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.4647557931038939,-0.908319143737266,0.6206896551724138,0.9839269569214548,1.0,1/22,1.22%,RIMS1
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.3596587072265784,0.9082101064297929,0.6923076923076923,0.9809183777416678,1.0,11/54,12.11%,SORBS3;PDGFA;DLC1;CORO2B;ARHGAP44;RHOA;RHOB;ARHGAP35;RICTOR;KATNBL1;PAK2
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),-0.5580074659636529,-0.9080245518192385,0.6666666666666666,0.9838090340638759,1.0,4/14,16.47%,TGFB2;SMOC1;FOXC1;CPAMD8
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.4018230646348262,0.9073385997947676,0.6486486486486487,0.9816593795001415,1.0,12/30,27.57%,UBQLN1;PACS2;AMBRA1;ATG2B;TMEM41B;ULK2;UBXN2A;PIK3C3;VMP1;WDR45B;ATG16L2;NSFL1C
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),0.5985780918458535,0.90723357419317,0.6041666666666666,0.9807771879831912,1.0,1/5,3.40%,NCOA3
prerank,PanglaoDB_Augmented_2021__Podocytes,-0.3637530097607745,-0.9069760730269965,0.6714285714285714,0.9851969305410005,1.0,17/125,11.89%,THSD4;ARHGAP24;VEGFA;KIAA1217;RASSF8;IQGAP2;LAMC1;ADM;PLPP3;COL12A1;PROS1;MID1;LAMB1;NTN4;PLEKHH2;LIMCH1;COL4A5
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),-0.44251458192072546,-0.9068674804334035,0.5967741935483871,0.9846964803179027,1.0,1/27,1.22%,RIMS1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.43801195456012354,0.9063899003304279,0.5348837209302325,0.9815387995248817,1.0,2/20,2.09%,NOTCH1;ATP2B4
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),-0.5125067425473284,-0.9063611361071194,0.5961538461538461,0.985064391498854,1.0,1/11,3.19%,ANXA1
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.3940823084299652,-0.9060516231379614,0.6617647058823529,0.984923538639133,1.0,8/61,9.96%,PRSS23;PGR;ALDH3A2;OLFM1;SGK1;SLC24A3;PDCD4;ADD3
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.4529118043948539,0.9059877898742055,0.631578947368421,0.9813961430898652,1.0,3/16,16.07%,DNAJC15;IMMP1L;IMMP2L
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.5244789307226735,-0.9059471545083047,0.6811594202898551,0.9843198956159778,1.0,2/17,7.68%,SLC38A1;ABCB1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.32415964864188224,0.9056060049588219,0.7241379310344828,0.9813747479954408,1.0,13/114,11.08%,HSPB1;ABL2;BCL2;GFAP;UBQLN1;ATP6V1H;BNIP3;RNF152;MTMR4;USP10;FBXW7;MCL1;MID2
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),-0.5055072980289843,-0.9055933361060791,0.6451612903225806,0.9843066828603831,1.0,1/12,2.89%,AFDN
prerank,MSigDB_Hallmark_2020__Androgen Response,-0.40621286059398753,-0.9053954996063845,0.6507936507936508,0.9840250587991989,1.0,7/62,9.54%,SAT1;UAP1;IQGAP2;AKAP12;SGK1;TSC22D1;NDRG1
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),-0.6312838039726024,-0.9052621905007604,0.6111111111111112,0.9835873987811514,1.0,2/5,22.01%,TPM1;PPP1R12B
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),-0.36200654603773685,-0.9051453976146053,0.6119402985074627,0.9830834003569136,1.0,15/89,13.54%,FGF1;VEGFA;TERF2IP;LEPR;SVIP;RACK1;FAXDC2;RALBP1;ATG10;FAM20A;PPIA;LIMCH1;KRAS;CCN1;CSNK1D
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),-0.4096980869223812,-0.905105606283837,0.6461538461538462,0.9824239423814789,1.0,8/38,16.96%,NRP1;ANXA1;GSN;PTK7;MINK1;DTNBP1;CDC42BPA;FARP2
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.5953720482064427,0.9046663608920466,0.7272727272727273,0.9823859394469541,1.0,1/7,1.75%,HPRT1
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.3614080412429209,0.9040284264219305,0.6153846153846154,0.9825500769558896,1.0,20/68,14.63%,GABRB1;CASP7;NCOA3;GNB1;GNAI1;ADCY3;SLC26A3;LCOR;HCN2;GABRB3;EGFR;PDE3A;P2RX4;ADCY5;TIPARP;KCNQ1;RAP1A;RAPGEF2;TFPI;EGR1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.5217516034280051,-0.903982564099563,0.6078431372549019,0.983861800435964,1.0,1/12,1.96%,PARP1
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.31652769525601404,0.903526546640447,0.7894736842105263,0.9826480992513948,1.0,31/151,19.65%,TBC1D4;HEY2;PTPRK;EMP2;ARF1;HERC2;GGA2;PACS2;AP3D1;GRID2;SNX13;RAB31;EGFR;TBC1D5;CNTNAP2;TRIM23;CEP68;STX2;GGA3;ARL5A;SEPTIN9;ARL6;RAB14;CNTLN;ANK2;ARFGAP3;CROCC;VPS26A;CLTC;NPHP1;ESAM
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.5309991120589409,-0.9034352469669266,0.6349206349206349,0.9841684037032367,1.0,1/11,5.36%,RMDN1
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.3945486975154904,-0.9023855669631602,0.6,0.9857511996657167,1.0,8/73,6.66%,NR4A1;VEGFA;NRP1;ANXA1;RACK1;ADAMTS12;TGFBR1;ZFP36L2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.5298564028531615,0.9019602939478361,0.6,0.9849686768250823,1.0,2/10,6.02%,NCK2;SMAD7
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),-0.5125147745757115,-0.9012676200750547,0.5892857142857143,0.9875095951462666,1.0,3/11,14.15%,SLC4A4;WNK2;FHL1
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),-0.48656817901707494,-0.9010452240107747,0.6166666666666667,0.9871457274771989,1.0,3/15,6.14%,EXT1;GPC3;GCNT2
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.5670895391968702,-0.9007251431077876,0.6,0.9869379281348243,1.0,3/5,28.28%,DMGDH;SLC44A1;ALDH7A1
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,-0.46180063417685935,-0.9004793306039602,0.6111111111111112,0.986774843290927,1.0,2/18,1.68%,VEGFA;NRP1
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.5679737777796372,0.9003099006255655,0.6595744680851063,0.9874265369199918,1.0,2/5,19.81%,ITGA3;SMAD2
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.33429009880929106,0.9000002124827612,0.7096774193548387,0.9870055517084991,1.0,13/69,16.41%,PANK3;PPM1A;GFPT1;INPP4B;INPP5A;HK1;PPA2;ITPK1;PAK2;PLAA;PANK2;IP6K1;PIK3CD
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.5209602319229354,0.8998125113306579,0.6444444444444445,0.9863562430239948,1.0,2/7,7.59%,CDS2;ZFYVE1
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.3138325095325775,0.899799734720185,0.7941176470588235,0.9853484929634458,1.0,24/128,15.30%,PDGFA;ERBB4;BCL2L1;RGL3;RASAL2;IRS2;MAP3K7;CAMKK2;NRG2;MAP2K2;RAF1;IRS1;EGFR;PPP1CC;GRIN1;PDE6D;MBP;RAPGEF2;NFKB1;LRRC7;BTRC;MAP2K1;RANBP9;GRIN2B
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.37496310495076784,-0.8997460064493275,0.6666666666666666,0.9876324242863312,1.0,9/92,11.65%,NR4A2;PARP1;SUPT6H;ELOB;TEFM;TSC22D1;DDX5;NFX1;THRB
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.36994688000658604,0.8992692345567753,0.5882352941176471,0.985628108692832,1.0,9/37,15.27%,UBQLN1;UBE2N;SMAD7;MARCHF7;FBXW7;UBE2D1;COMMD1;NDFIP2;DCUN1D4
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.34061640070854937,-0.8986355402162851,0.7066666666666667,0.9893384137598239,1.0,19/205,9.90%,TWIST1;GBP2;MT2A;IFITM3;VEGFA;IFIT3;LEPR;STAT1;ANXA1;XAF1;COL1A2;F3;MID1;HLA-B;BIRC2;PDCD4;PELI1;FN1;IL1R1
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.5137874369290435,-0.8981292678241573,0.5818181818181818,0.9898383688694347,1.0,2/11,13.27%,STAT1;PARP9
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),-0.5216587266271276,-0.8978950890076108,0.5849056603773585,0.9896071877941799,1.0,2/8,12.72%,APH1B;APOE
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.34366666188595885,-0.8976962633777481,0.7402597402597403,0.9892731474261733,1.0,14/199,6.90%,PDGFD;FGF1;ELMO1;VEGFA;NRP1;SULF2;ACTG1;VAV3;COL1A1;EPHA3;NR4A3;AP2A2;RHOQ;APH1B
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.4310414423866342,-0.8974539899323047,0.578125,0.9890280083849751,1.0,4/31,9.54%,TWIST1;VEGFA;PGK1;NDRG1
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),0.5309603190386467,0.8973213238504381,0.6046511627906976,0.9889645326558488,1.0,4/10,20.76%,PHF8;TTN;CSNK2A1;RB1
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.4561223196834193,-0.8969500995767997,0.5833333333333334,0.9892837804642584,1.0,6/21,13.60%,AKR1C2;PTGFR;BRCA1;PTCH1;LARP1;SPIDR
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.48138765795623284,0.8966425976713037,0.6530612244897959,0.9890875923346975,1.0,4/14,14.04%,DTNA;RYR2;KCNQ1;TTN
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.5129277748235145,-0.8965551084940586,0.5932203389830508,0.989311151064698,1.0,3/11,13.68%,SMG6;MAP3K4;TNKS2
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),-0.5223766667476321,-0.8965217762369692,0.7169811320754716,0.9885961477101499,1.0,3/13,10.67%,ANXA1;ADAM9;ASAH1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",0.4217489838537394,0.8963923144544689,0.5208333333333334,0.9886349429112623,1.0,3/19,13.33%,WDR33;PCF11;CPSF2
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),-0.5824262383859411,-0.8957314683571381,0.6851851851851852,0.9896448523096875,1.0,1/5,0.93%,RIPOR2
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.2993641016890167,0.8955930103041922,0.875,0.9897993220133442,1.0,30/244,11.42%,DACH1;GATAD2A;NOTCH1;CNOT7;PML;HEY2;PHC1;TOB1;EIF4ENIF1;CTBP2;ATP8B1;PTPRK;HSPA8;RFX3;SOX13;SMARCA4;TBX3;ZBTB7A;HDAC9;NACC2;HMBOX1;ZBTB16;RNF139;HEYL;HDAC1;THRA;CDKN1A;MBD2;RPS6KA5;BCL6
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.38197241416284966,-0.8955071728207584,0.6571428571428571,0.98948108152222,1.0,7/68,7.07%,CLU;CD55;IGFBP5;GSN;COL6A1;PLPP3;NOTCH2
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),-0.5639163130245386,-0.8954086519662215,0.5636363636363636,0.9889582261280802,1.0,3/5,27.24%,OTUD6B;PSMG2;POMP
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.4583927877005714,0.8950079795331296,0.65,0.9898344413042924,1.0,3/16,7.36%,ST3GAL2;C1GALT1;B3GNT2
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),0.4949920825917109,0.8948848540735626,0.575,0.9890252579095915,1.0,4/9,9.99%,CD151;CD44;RHOA;ARHGAP35
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),-0.5330706891717527,-0.8944564105768553,0.6206896551724138,0.990165509961354,1.0,2/10,4.97%,ELMO1;GSN
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.4761600220889913,-0.894062613017509,0.5925925925925926,0.990353186677002,1.0,2/18,6.27%,ANXA1;TSPYL2
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),-0.5160206152993565,-0.8938435411805574,0.6779661016949152,0.9900503568690463,1.0,1/14,1.22%,RIMS1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.45432830348221437,-0.8936622051873054,0.6470588235294118,0.9896017540036532,1.0,4/21,13.68%,MAP3K4;DHX36;CCT6A;TNKS2
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.4736175056476625,0.8934891388534779,0.6153846153846154,0.9909856723600802,1.0,3/10,10.47%,PDK4;ACADVL;PPARA
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.5537152443353806,-0.8934819852932794,0.6229508196721312,0.9892707158182995,1.0,2/7,10.14%,RIPOR2;LGALS3
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),-0.48933235943627496,-0.8932478249927431,0.609375,0.9889912751956467,1.0,1/15,0.75%,IGFBP5
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.4991615452408208,0.892912942458231,0.6341463414634146,0.991159852705869,1.0,2/13,5.89%,UBE2N;MAP3K7
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.47051200952739347,0.8926886007015015,0.6829268292682927,0.9905460317877068,1.0,2/13,1.35%,CACNA1B;CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.49802618391944103,0.8926081437053017,0.5833333333333334,0.9896532550472632,1.0,1/10,1.67%,PML
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),-0.3613718993762886,-0.8924681515109553,0.759493670886076,0.9897991978595274,1.0,24/142,17.04%,ABLIM1;NRP1;PTPDC1;IFT122;GSN;SCLT1;TCTN1;DZIP1;CCDC57;CEP126;TTC8;DZIP1L;ANO6;PMP22;ARMC9;NEK1;ARF4;FGD6;MINK1;BBS4;ABLIM3;EMP1;DYNC2H1;DCDC2
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.5964266695072941,-0.8923234088358127,0.6666666666666666,0.9893521215392621,1.0,4/8,9.37%,AKR1C1;SLCO1A2;RALBP1;SLCO1C1
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.4708416183582671,0.8918582074196613,0.5454545454545454,0.9904097012446142,1.0,3/14,10.51%,BCL2;IRS2;PPP2R3C
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.3609362265102779,0.8915688233886979,0.68,0.9898846241098846,1.0,6/53,7.72%,TENM2;CDH2;CNTN4;CDH10;GRID2;IGSF11
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),0.47823005506620603,0.8915549262420702,0.6190476190476191,0.9889201061755158,1.0,1/11,3.80%,DLC1
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.3387763282638104,0.8915503520080115,0.6923076923076923,0.9878931901774104,1.0,7/61,8.05%,BNIP3L;UBQLN1;ATP6V1H;MAP3K7;CLEC16A;BNIP3;SMG1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.46316086624587205,-0.8914640443767698,0.576271186440678,0.9903479556960479,1.0,4/21,11.08%,VEGFA;THBS1;BEX3;NGF
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.527562842834027,-0.8913929574350272,0.65,0.9897701213853858,1.0,2/13,18.21%,PER2;EDN3
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.4997638187210391,0.8913897748249625,0.6363636363636364,0.9872544111704658,1.0,1/8,3.77%,SORT1
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.5294049370244776,0.8913897533084663,0.6136363636363636,0.9862313496044861,1.0,2/13,2.09%,DPP10;ATP2B4
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),-0.5905416416831722,-0.8910022839434799,0.6333333333333333,0.9898404634224434,1.0,2/5,25.70%,PDCD10;GOLGA2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.444677116028353,0.8907309512491417,0.575,0.986537231236132,1.0,3/16,5.58%,BCL2;NCK2;IRS2
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.4506645984333419,0.8905798462511894,0.625,0.9859445927429347,1.0,3/16,9.50%,ERBB4;NRG2;EGFR
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.4484637574353517,0.8905070356948879,0.6,0.9850541920711904,1.0,6/19,12.11%,APC;MICALL2;MPP7;RHOA;PARD6G;PAK2
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.576112652465075,0.8904742927562539,0.6862745098039216,0.9841442950226943,1.0,2/5,9.37%,TNFRSF1B;MITF
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),0.5490604266465189,0.8898204635259629,0.6122448979591837,0.9845576276647873,1.0,1/7,0.63%,SRSF12
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),0.5566919429841174,0.8891424141550057,0.5609756097560976,0.9850765599843205,1.0,1/5,14.45%,GLRX3
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.5358679963535127,-0.8891373391864107,0.7045454545454546,0.9929268377892858,1.0,4/7,23.50%,PRKDC;WDR12;EXOSC10;LAS1L
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),0.47165468526431276,0.888879668235524,0.6097560975609756,0.9844565703368992,1.0,2/12,9.66%,SERPINB6;CAB39
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.515678229763576,0.8887356533874081,0.64,0.9837634925217902,1.0,3/10,20.02%,LRRC7;PARD3;PARD3B
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.5518379582290895,0.888612356811359,0.6666666666666666,0.9830187762873699,1.0,4/8,20.76%,PHF8;TTN;CSNK2A1;RB1
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),-0.5096263325350274,-0.8884840095128541,0.7241379310344828,0.9935176207714658,1.0,9/15,32.45%,LARS1;RRAGB;UBR2;SESN3;IPO5;FYN;CAPN2;RPTOR;SLC38A9
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),-0.5540092326172674,-0.8877070861259524,0.6557377049180327,0.9941946099294604,1.0,2/7,9.98%,EXT1;CSGALNACT1
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),-0.4258443608653742,-0.887677965608779,0.6451612903225806,0.9935580518857463,1.0,9/41,18.75%,TWIST1;DDX5;SMAD6;SMOC1;PTCH1;CCN1;ACVR1;NBR1;PRKACA
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.46610156928567836,-0.8875744800601233,0.7058823529411765,0.9929949006285776,1.0,2/22,1.92%,SPRY1;EPN1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.42960236056012663,0.8875246683777791,0.6,0.9842050481147948,1.0,4/17,12.37%,NOTCH1;NEXMIF;PPARA;MBP
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.5050333977297157,-0.8872546332956462,0.5555555555555556,0.9928308317135012,1.0,1/10,1.46%,TM7SF3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.42240869758575345,0.8870002130307933,0.6,0.9841603830695081,1.0,8/27,14.79%,DPP10;ATP2B4;CNST;KIF5B;ITGA3;EGFR;PTPN9;ACSL3
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.5408712614083895,0.8864282569243994,0.6956521739130435,0.9845072594293202,1.0,2/8,4.73%,HSPA1A;PTGES3
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.5824823223387439,0.8863830077036351,0.6585365853658537,0.9836062949023767,1.0,2/6,20.18%,KPNB1;EZR
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.5102516058459656,0.8858526097125867,0.6511627906976745,0.9837735406359516,1.0,3/6,13.81%,MAP2K2;EGFR;MAP2K1
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3988902083114638,0.8855059302355046,0.6097560975609756,0.9834025306072125,1.0,7/29,11.36%,GNB1;ADCY9;PTH1R;MYH9;ADCY3;ADCY5;ADAM17
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.4546150679332607,-0.8848546632707491,0.578125,0.9967116496254396,1.0,5/18,19.09%,GSN;HTT;DERL1;SERF2;PRKN
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.3645777038769977,0.8846998277787907,0.6052631578947368,0.9840648628317122,1.0,11/39,17.26%,RNF185;UBQLN1;AMFR;STT3B;RNF139;ATXN3;UBE2J1;UBE4A;UGGT1;UBE4B;RNF121
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.5310938032338752,0.8839621811524205,0.673469387755102,0.9846732168072424,1.0,2/8,9.14%,NOTCH1;RHOA
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.40042496061926747,-0.8839267324296672,0.6212121212121212,0.9978464982292392,1.0,15/54,21.58%,NR4A1;IGFBP2;OLFM1;BTG2;ABCB1;NUP58;SQSTM1;BTG1;CYB5B;CCK;EIF2S3;PRKACA;BCL2L11;CA2;LYN
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.5458037049590199,0.8838745100548732,0.6410256410256411,0.9838502722515214,1.0,2/6,9.40%,GFAP;DNAJB6
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.5015594893964317,-0.8835627747283995,0.6491228070175439,0.9978020264323907,1.0,1/11,1.22%,RIMS1
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.45170820730560385,0.882916163404358,0.5925925925925926,0.984583661415185,1.0,4/13,8.69%,DGKB;DGKH;DGKG;DGKE
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.503747476347121,0.8827515053138052,0.5384615384615384,0.9838464291499884,1.0,4/8,16.43%,PTPRK;KLF9;CASK;ZFP36L1
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),-0.455243956324466,-0.8823855103581023,0.6666666666666666,0.9992448281953497,1.0,1/16,2.98%,STAT1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),0.3471342604360321,0.8821209903303615,0.75,0.984274322982766,1.0,2/87,0.21%,HSPA1A;CSF1R
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.5314340509300353,0.8819921162354071,0.6511627906976745,0.982553875239283,1.0,2/6,20.89%,ATG2B;ULK2
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.5314340509300353,0.8819921162354071,0.6511627906976745,0.982553875239283,1.0,2/6,20.89%,ATG2B;ULK2
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.5621603597388776,0.8819552042165596,0.5909090909090909,0.9815917471405815,1.0,3/8,11.04%,RAB27A;PPARA;GRIN1
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.4936874756178183,0.881882351231039,0.6428571428571429,0.9807777339803724,1.0,3/8,13.81%,MAP2K2;EGFR;MAP2K1
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),0.31203562601338797,0.8818422577294078,0.7692307692307693,0.9798819214908574,1.0,29/161,13.25%,HSPA1A;SERPINB6;TNFRSF1B;TMEM30A;SNAP29;SLC44A2;ACTR2;VAPA;HSPA8;RAB27A;TMEM63A;CD58;GDI2;RAB31;ANPEP;SNAP23;CD44;RHOA;CAB39;CYB5R3;ADAM17;SURF4;RAP1A;CAT;CEP290;OSTF1;NFKB1;PRDX6;LRRC7
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.5090594952248808,-0.8815761182336803,0.6,1.0,1.0,2/11,2.90%,PRDX1;ACTG1
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),-0.5408547989707787,-0.8812757603778506,0.6444444444444445,1.0,1.0,1/9,3.85%,CMTR1
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.3537015024491805,0.8812746304984268,0.5714285714285714,0.9802070262032557,1.0,9/63,13.62%,HSPB1;PML;EMP2;PTGES3;ZBTB7A;EGFR;CDKN1A;NUP54;EP300
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),-0.5147864059631895,-0.8809694193142967,0.6060606060606061,1.0,1.0,2/12,20.28%,NCKAP5;SPAG16
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.3814147800853235,-0.8808892150820109,0.6515151515151515,0.9994881669371449,1.0,9/53,11.29%,IGFBP5;RACK1;EPRS1;BTG2;NCL;SAMD4A;DHX36;LARP1;RPS3
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.5124553445058764,0.8808793662421222,0.5952380952380952,0.9801567427616686,1.0,4/10,13.62%,SMARCA4;RRP1B;LEF1;EP300
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),-0.46420979314127014,-0.880630545047986,0.6491228070175439,0.9992125107655613,1.0,2/16,6.56%,NR4A3;RHOQ
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),-0.4483525788497156,-0.880261236094648,0.6231884057971014,0.9992535138536669,1.0,1/23,0.93%,RIPOR2
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.5134147115170913,0.8801827100653057,0.6153846153846154,0.9806992914063302,1.0,4/11,23.12%,NRXN1;LRRC7;SAV1;FLNA
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.3706367465887763,0.8786014866220819,0.71875,0.9829756017619693,1.0,5/35,12.45%,PPP2R1A;CEP70;CCP110;NDE1;CEP290
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.5325251984835442,-0.8785516563873699,0.5932203389830508,1.0,1.0,3/8,17.16%,EIF2S2;EIF4H;EIF2S3
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.34369427481146847,-0.8783828424520924,0.8082191780821918,1.0,1.0,28/246,11.39%,HERC6;KLHL13;DZIP3;DDB2;HECW2;RNF213;ELOB;UVSSA;RNF19A;RACK1;PDZRN3;MARCHF3;OTULIN;RNF220;SASH1;BIRC2;BRCA1;TRIM13;FBXW2;FBXO22;PELI1;KLHL7;ARIH2;PRKDC;NUB1;NFX1;PSMC2;DERL1
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),0.35245895629311713,0.8783628189037499,0.6410256410256411,0.9825283296224581,1.0,10/62,11.07%,CSF1R;PML;BCL2;TIMP3;BCL2L1;LIFR;RHOA;KLHL20;YTHDC2;MCL1
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.577299605975572,0.878043326041999,0.6170212765957447,0.9822789371752518,1.0,1/5,13.65%,NAA25
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),0.3838689679341731,0.8780341015501246,0.6842105263157895,0.9812946897432125,1.0,2/26,1.32%,VAPB;CNOT7
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.3694711261612759,-0.8776632772905082,0.7,1.0,1.0,15/91,14.21%,RPL34;RACK1;DDX18;EPRS1;EIF3J;EIF2S2;HSP90AB1;PGK1;RPL6;RPS3;PPIA;EIF4H;SRPK1;LDHA;PSMD8
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.5453481821400933,-0.8775864189285024,0.6964285714285714,1.0,1.0,2/9,5.49%,RIMS1;TENM4
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.4934396981002218,-0.8774384420465449,0.6964285714285714,1.0,1.0,7/19,20.76%,PER2;ENO1;PGK1;HECTD4;SLC25A13;APOD;CRY1
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.4129923108252789,0.8774269027069502,0.6410256410256411,0.9815436750685297,1.0,9/40,11.81%,CSF1R;PTH1R;TNS1;ZBTB7A;ANPEP;ABCA1;THRA;ARHGEF10L;SEMA4D
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),-0.319018707220889,-0.8772237588471287,0.8452380952380952,1.0,1.0,58/399,13.52%,CLU;TWIST1;FGF1;TGFB2;RIMS1;VEGFA;ARNT2;WARS1;TERF2IP;HINT1;AFDN;ACTG1;RPL5;PGR;CALCOCO1;PRDM6;ZNF331;SFRP4;RACK1;GSN;AFF2;TGFBR1;GCNT2;F3;OLFM1;NOTCH2;NFXL1;SLC24A3;YBX3;PLAG1;BRCA1;FUS;NONO;FN1;CREM;RPL6;YY1AP1;NFX1;FAM50A;DHX36;NGF;CTCF;LARP1;RPS3;HNRNPLL;SRSF10;MAPK14;PTRH2;PRDM5;BHLHE40;APOE;ZNF138;KRAS;PDCD10;PARP9;ZNF680;PLSCR1;ATP1B1
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.5192740960338417,0.8763307411991904,0.6666666666666666,0.982898156710437,1.0,3/9,11.79%,RNF14;PMEPA1;ARID1A
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),-0.38492947477643563,-0.8762260803854562,0.5584415584415584,1.0,1.0,19/70,22.91%,VAMP4;GOLGA8A;HTT;MYO18A;BCAS3;COG4;STX17;PDCD10;CSNK1D;TMED4;GOLGA8B;SYNE1;DYNC2H1;VPS51;PLEKHM2;LMAN1;GCC2;CLASP2;GOLGB1
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.5563762728661694,-0.8758012293020364,0.6557377049180327,1.0,1.0,1/6,10.64%,SPRY3
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.3735959095003056,-0.8757470978163036,0.6721311475409836,1.0,1.0,24/83,16.52%,IFITM3;SLC2A3;NRP1;NT5E;COL6A1;UCK2;ABCB1;ALCAM;GABARAPL1;NDRG1;PTCH1;ST3GAL4;PTRH2;BHLHE40;PLAGL1;PLSCR1;MAP3K8;GADD45B;SNX9;PHLDA1;SPRY4;PHTF2;GPX4;EMP1
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.498283204163815,-0.8748763030068195,0.6461538461538462,1.0,1.0,4/14,11.31%,LIMA1;PLEKHH2;FGF13;HDGFL3
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.38951151192378697,0.8747897307895501,0.6842105263157895,0.9851689522486636,1.0,9/29,22.20%,RAD21;PHF8;PDS5B;TTN;CSNK2A1;KPNB1;RB1;CHMP4B;POGZ
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),0.4047191705826202,0.874396262401455,0.6666666666666666,0.9850213265596296,1.0,6/22,11.60%,NOTCH1;EMP2;CORO2B;RHOA;ATXN3;RSU1
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),0.5250188983235743,0.8743141564430874,0.5945945945945946,0.9841938336399468,1.0,1/7,1.28%,MFHAS1
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.5294881868227093,0.8740901779389173,0.6666666666666666,0.9836871407573987,1.0,2/10,12.59%,MTFR1;DNM2
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.4238554278093911,0.8739854915507476,0.6382978723404256,0.9830683215449785,1.0,5/17,16.78%,GUCY1B1;PDE3A;RAPGEF2;CAP2;RIMS2
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.3657170919143672,-0.8739615434471678,0.6231884057971014,1.0,1.0,14/85,14.42%,TGFB2;VEGFA;TET1;PGR;RACK1;HSP90AB1;OLFM1;NOTCH2;SLC24A3;PTRH2;APOE;PDCD10;PARP9;RBL2
prerank,MSigDB_Hallmark_2020__Complement,-0.37199087897136673,-0.8736876831129796,0.6857142857142857,1.0,1.0,14/65,13.51%,CLU;CD55;CTSL;XPNPEP1;ANXA5;CPQ;ADAM9;F3;FN1;LGALS3;TIMP2;C1S;PLSCR1;CFH
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3545649501419255,0.8732921067292926,0.7741935483870968,0.9833651850481885,1.0,10/43,10.64%,ADGRB3;ADCY9;GNAI1;PTH1R;GNAO1;ADCY3;GPR161;ADGRL2;ABCA1;ADCY5
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.5499289304884821,-0.8728734874925899,0.6545454545454545,1.0,1.0,4/6,21.61%,RPL5;RPL11;RPS7;RPL23
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),0.4170981146711382,0.8724359163214424,0.5714285714285714,0.9839796597971159,1.0,2/29,5.89%,TNFRSF10B;MAP3K7
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.4477016262679185,-0.8723504673306621,0.6557377049180327,1.0,1.0,4/24,11.31%,WASHC3;GSN;FGF13;HDGFL3
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.4330776635180309,0.8719083891777608,0.5641025641025641,0.9842340127387288,1.0,5/20,11.89%,FMNL3;RHOA;RHOB;PPP2R3C;FHOD1
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.39153279467902247,-0.8717616377923633,0.6212121212121212,1.0,1.0,4/38,6.08%,IFITM3;IFIT3;STAT1;IFI44L
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.44640197697192513,0.8717367931175779,0.6944444444444444,0.9835146627560308,1.0,4/17,10.35%,APC;NACC2;CDKN1A;RBL1
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.45489600334402036,-0.8715579190758121,0.7058823529411765,1.0,1.0,6/17,12.64%,NR4A2;TGFBR1;BCL2L14;RPS3;PPIA;DAPK2
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),-0.5121526900654814,-0.8714770830211711,0.6349206349206349,1.0,1.0,3/11,12.09%,TGFBR1;SLIT2;TGFBR3
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),0.4725156516045661,0.8712501357971539,0.5853658536585366,0.9834414826724026,1.0,1/13,0.21%,CSF1R
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),-0.5245156106202276,-0.8709949200666569,0.5932203389830508,1.0,1.0,3/9,11.29%,SASH1;MAP3K4;RPS3
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.4169730987018145,-0.8702417681014426,0.6825396825396826,1.0,1.0,11/53,17.15%,CMKLR1;SFRP4;OTULIN;PRMT2;PTCH1;CYP1B1;BHLHE40;UFL1;SP100;TCF7L2;TMSB4X
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),-0.3841505182629654,-0.8696338576393295,0.6619718309859155,1.0,1.0,6/71,7.75%,TWIST1;SLC4A4;SVIP;TPCN1;ADAM9;DCN
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.3929241854047077,0.8695081782235685,0.7666666666666667,0.9858119670940616,1.0,2/29,4.89%,NCK2;CDC42EP4
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.41353898980141063,-0.8693765630516341,0.6470588235294118,1.0,1.0,15/55,19.33%,MMS22L;CSE1L;BRCA1;RPA1;PRKDC;CTCF;NASP;RBBP7;SPC25;ATAD2;PNN;SMC3;MRE11;XRCC6;NUP107
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.3773156779542409,0.8693497696469015,0.6571428571428571,0.9852668254257176,1.0,2/30,2.81%,BCL2;TIMP3
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),-0.449678832489667,-0.8689953143996535,0.6721311475409836,1.0,1.0,4/21,11.05%,PARP1;N4BP1;INO80;DHX36
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.4987729456438175,0.8688398532202156,0.6585365853658537,0.9853757998251326,1.0,3/10,14.04%,CDH2;RYR2;TTN
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.5337317389743428,0.8684271545485032,0.6590909090909091,0.9850054561539674,1.0,2/7,15.35%,EIF3B;CCT3
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.39320145279589314,0.8678017861283817,0.6764705882352942,0.985043187847981,1.0,5/27,11.47%,APC;EGFR;CDKN1A;ADAM17;MYOCD
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),-0.389902157373945,-0.8677418841382635,0.7066666666666667,1.0,1.0,7/60,6.66%,TGFB2;COL3A1;COL1A2;TGFBR1;ADAM9;GCNT2;ZFP36L2
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.41947709642052533,-0.8674884825810939,0.704225352112676,1.0,1.0,13/43,22.43%,VEGFA;TSPYL2;FUS;SSR1;EEF2;HSPA9;EIF4G1;EXOSC10;RPS14;ATP6V0D1;SERP1;PAIP1;PDIA6
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.4665574620181645,-0.8674619391705378,0.6909090909090909,1.0,1.0,2/10,2.89%,VEGFA;AFDN
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),0.505927144680475,0.8674260552643446,0.6774193548387096,0.9848163312164118,1.0,2/15,11.61%,BRD2;SART3
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),0.5502061029303233,0.8673820685955044,0.6904761904761905,0.9839191222048472,1.0,1/6,2.37%,SNAP29
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.4586037193746995,0.8670161160489456,0.6666666666666666,0.9837039690841956,1.0,6/15,25.36%,IRS1;RPS6KB1;KANK1;PTPN1;TSC2;TNS2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.45930496110788466,0.8667751086201126,0.625,0.9832965086007294,1.0,3/10,20.82%,PPARA;GAS6;KDR
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.555362842662495,-0.866587679474093,0.6610169491525424,1.0,1.0,4/7,24.83%,PRMT2;NSD3;NSD1;PRMT7
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),-0.5164193886105425,-0.8660195780310312,0.7083333333333334,1.0,1.0,1/7,3.19%,ANXA1
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.5577090292376137,0.8659491210096892,0.6458333333333334,0.9840349575088856,1.0,2/5,16.36%,BCL6;CBFB
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),-0.5385286819042286,-0.865820362520773,0.7017543859649122,1.0,1.0,4/8,18.70%,GLI2;PTCH1;ACVR1;NBL1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.42986186705439344,0.8657491944098339,0.6,0.98352673304938,1.0,3/21,3.83%,PML;BCL2;BCL2L1
prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.40965310143917866,-0.8653141200630031,0.5522388059701493,1.0,1.0,4/39,7.68%,PRDX1;SEMA3C;ALDH1A1;ABCB1
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),0.5531296008489226,0.8651883397678686,0.6666666666666666,0.9836465643157122,1.0,2/5,2.23%,NOTCH1;HEY2
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.5380050880217443,0.8644413785414551,0.6136363636363636,0.9841299054207052,1.0,4/5,45.94%,JAK2;PRLR;PTK2B;GHR
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.48559869958149615,0.8640805594105754,0.6666666666666666,0.9838451481682695,1.0,2/8,15.30%,GRIN1;GRIN2B
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.389270697920508,-0.8640330793952723,0.6533333333333333,1.0,1.0,4/42,6.53%,VEGFA;TERF2IP;RACK1;HSP90AB1
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.41258258323249536,0.8636666926471784,0.6818181818181818,0.98365170513181,1.0,5/18,10.81%,NOTCH1;HEY2;SMAD7;HEYL;BMPR1A
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.45525798633589365,-0.8626304507433294,0.6451612903225806,1.0,1.0,2/26,3.16%,CLU;RPL5
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),-0.5420630294791379,-0.8621461666159563,0.7209302325581395,1.0,1.0,1/8,3.85%,CMTR1
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),-0.4736497187254007,-0.8620493181368334,0.6481481481481481,1.0,1.0,5/16,15.32%,VEGFA;SASH1;MAP3K4;MINK1;GADD45B
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.3953813223396759,0.8612758057528719,0.6756756756756757,0.987377603832124,1.0,3/31,6.19%,TNFRSF10B;DLC1;CASP8AP2
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.44868487484810177,0.8612464005504112,0.6285714285714286,0.986476572446939,1.0,6/15,16.35%,NEXMIF;CTNNA2;ZNF609;PLAA;RAPGEF2;SEMA6A
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),0.46634904871352,0.8611125815513614,0.5897435897435898,0.98574822664668,1.0,1/8,1.28%,MFHAS1
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),0.47697231239246096,0.8610295613002353,0.7073170731707317,0.9849811161338546,1.0,4/9,20.74%,EIF4EBP2;AGO2;PAIP2;EIF2AK4
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.35162282310754933,-0.8610009516103142,0.8674698795180723,1.0,1.0,23/143,17.04%,ABLIM1;PTPDC1;DYNC2LI1;IFT122;GSN;SCLT1;TCTN1;DZIP1;CCDC57;BBOF1;CEP126;TTC8;DZIP1L;ARMC9;NEK1;ARF4;CSNK1D;BBS4;ABLIM3;NINL;DYNC2H1;SDCCAG8;DCDC2
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),-0.5507291353164955,-0.8608196826322613,0.7538461538461538,1.0,1.0,2/8,4.17%,AKR1C2;AKR1C1
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.4590825372719354,-0.8608170068244162,0.7166666666666667,1.0,1.0,4/15,13.46%,RACK1;CD47;PIP4P2;PLSCR1
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.4325388868961727,-0.8607835916530099,0.625,1.0,1.0,5/22,9.02%,SEMA3C;PDXDC1;SEMA6D;GPC3;SEMA3D
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.421287580840528,-0.8606921237291896,0.6142857142857143,1.0,1.0,7/30,14.95%,NR4A1;TSPYL2;BTG2;PDCD4;FOXC1;BTG1;ANGEL2
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.4640330374522118,0.8606128561411549,0.6428571428571429,0.9849380392870403,1.0,5/14,12.11%,APC;MICALL2;MPP7;PARD6G;PAK2
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,-0.37669910193583844,-0.8605557091770613,0.6619718309859155,1.0,1.0,18/69,17.93%,NRP1;CMKLR1;AKAP12;ST6GAL1;AVL9;ABCB1;ATG10;HSD11B1;ITGBL1;NGF;SNAP91;GLRX;EPB41L3;CFH;PRRX1;EMP1;SDCCAG8;APOD
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.5252256896807339,-0.8602468073954733,0.6909090909090909,1.0,1.0,1/6,12.72%,APOE
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),-0.34156276701641963,-0.860244315468038,0.6756756756756757,1.0,1.0,22/119,13.54%,FGF1;VEGFA;WARS1;TERF2IP;FBLN1;LEPR;RACK1;PLPP3;FAXDC2;TSPYL2;SLIT2;RALBP1;BMPER;FN1;DNAJC10;FAM20A;PRKDC;PPIA;LIMCH1;KRAS;CCN1;CSNK1D
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.40614886018117746,-0.860133968638907,0.6440677966101694,1.0,1.0,2/33,1.92%,SPRY1;EPN1
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.41319036529292086,0.8592353435254461,0.7045454545454546,0.9867698334950884,1.0,7/17,31.26%,MTF2;AEBP2;TASOR;EED;JARID2;EPC1;PHF1
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),-0.4272830312998155,-0.8591094945197407,0.6065573770491803,1.0,1.0,2/22,5.55%,ANXA1;SEPTIN4
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.5389774318384527,-0.8589340798542372,0.7580645161290323,1.0,1.0,3/8,11.58%,NT5E;PRPSAP2;FHIT
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.5255841128277803,-0.858796139627952,0.6984126984126984,1.0,1.0,1/7,0.93%,RIPOR2
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.341796712664486,-0.8586351215088024,0.7702702702702703,1.0,1.0,28/126,20.69%,AFG3L2;RIMS1;AFDN;ELOB;EPRS1;LAMC1;FN1;CNIH3;TLE4;REPS2;ANO6;CSNK1D;SEC13;TCF7L2;SNX9;USO1;HGSNAT;FARP2;CD2AP;ANKRD28;NAPG;ZNHIT6;HES1;MCFD2;FANCC;SLC2A1;FBXL7;TSPAN4
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.426536969907134,-0.8585380626489427,0.6206896551724138,1.0,1.0,2/26,10.39%,NRP1;PRKDC
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.4651672093165883,0.8582685432180323,0.6333333333333333,0.9880472039387485,1.0,1/10,1.35%,CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),-0.42134997272722646,-0.8581710268258648,0.640625,1.0,1.0,8/34,18.21%,TGFB2;ADAM9;MYO18A;PPIA;DTNBP1;RGCC;CD2AP;EDN3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),-0.41350511320641525,-0.8578545364032553,0.6875,1.0,1.0,2/26,8.26%,TGFB2;CCDC57
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.3913344416165092,0.8576203287134085,0.6976744186046512,0.9883214821639449,1.0,7/26,14.81%,CDC42EP4;ARHGEF1;ARHGAP6;RHOA;RHOB;GNA12;CDC42
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.5211902390186792,-0.8575204345876947,0.7222222222222222,1.0,1.0,1/9,8.42%,HLA-B
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.41505948239007406,0.8573177007916211,0.5833333333333334,0.9879954390458898,1.0,4/24,15.40%,PHC1;CCP110;YAF2;APAF1
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),-0.5093750694719117,-0.8570756562583293,0.639344262295082,1.0,1.0,6/12,30.61%,RGCC;CDC27;EDN3;PHIP;PDGFRB;ANAPC5
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.5625894854479405,-0.8568731663013542,0.6666666666666666,1.0,1.0,2/6,20.26%,BCL2L11;PIK3R1
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.5499627704227228,-0.8566070154212069,0.6666666666666666,1.0,1.0,3/5,38.84%,LYN;PRKCA;RDX
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),-0.3951268264125838,-0.8564427534201315,0.746031746031746,1.0,1.0,6/31,13.23%,PLXNC1;SLIT2;NGF;EPHA4;PLXNA2;ROBO2
prerank,PanglaoDB_Augmented_2021__Germ Cells,-0.46439190755426035,-0.8564109895778654,0.734375,1.0,1.0,4/18,13.62%,BRCA1;CREM;BCL2L14;UBE3D
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.567691063305123,-0.8562921414199517,0.7916666666666666,1.0,1.0,3/7,7.07%,TGFB2;ZFPM1;NOTCH2
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),-0.4711354216706542,-0.8562135257907182,0.6792452830188679,1.0,1.0,1/13,0.43%,TWIST1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3910439949901742,0.8559172552001882,0.6923076923076923,0.9898571472676966,1.0,7/29,11.36%,GNB1;ADCY9;PTH1R;MYH9;ADCY3;ADCY5;ADAM17
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5299834621690171,0.8554125148622493,0.7608695652173914,0.9898195905223832,1.0,3/7,17.04%,MAP2K2;MAP2K1;GSTP1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.436373312656395,0.8552797683876063,0.7435897435897436,0.9891142773976717,1.0,6/15,19.79%,SMAD7;RYR2;P2RX4;KCNQ1;ANK2;SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.37428774784952173,-0.8552687071304726,0.6666666666666666,1.0,1.0,4/38,4.59%,CLU;VEGFA;SVIP;EPHA3
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),-0.5048594947510637,-0.854935188288265,0.6440677966101694,1.0,1.0,4/14,11.29%,SASH1;PDCD4;MAP3K4;RPS3
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.36528340759276146,0.8549217048858798,0.6486486486486487,0.9887090630036779,1.0,11/40,13.01%,EPN2;NOTCH1;ATP2B4;HIPK2;LEMD3;SMAD7;ACVR2A;BMPR1A;UBE2D1;CASK;RBPMS2
prerank,GO_Biological_Process_2021__cognition (GO:0050890),-0.4763973150533812,-0.8548746993630244,0.6481481481481481,1.0,1.0,4/17,14.93%,SHROOM4;ST3GAL4;TTC8;BBS4
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.3475262440031152,0.8545006839989068,0.896551724137931,0.9886130292451332,1.0,4/37,4.36%,VAPB;ATP2B4;SLC12A2;PTH1R
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.48524424703825797,-0.8544952640176805,0.6491228070175439,1.0,1.0,4/14,15.17%,MMS22L;THOC1;WRN;ZRANB3
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),-0.5958959920897478,-0.8543460679106869,0.7647058823529411,1.0,1.0,4/5,40.07%,ERCC6;ERCC8;APTX;APLF
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.36237542531149597,-0.8540318952789618,0.7285714285714285,1.0,1.0,15/86,15.48%,PLXNC1;ARHGAP15;AFDN;VAV3;RACK1;EPHA3;RALBP1;BCAS3;EPHA5;EPHA4;PLXNA2;LARS1;FGD6;NET1;SNX9
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.489879632401146,0.853798804313676,0.6428571428571429,0.9892526544412987,1.0,2/6,20.92%,IGF2BP2;PCBP1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.4745996315364366,0.8537657218815374,0.5882352941176471,0.988401656648443,1.0,1/8,4.65%,UBQLN1
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.44127870394938234,-0.853650181066453,0.6530612244897959,1.0,1.0,3/20,6.26%,VEGFA;ANXA1;THBS1
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),-0.5424243898340732,-0.8534966265723902,0.7254901960784313,1.0,1.0,2/8,12.16%,GLI2;EPHA4
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),-0.4377347169954111,-0.8533551834122146,0.6666666666666666,1.0,1.0,3/25,7.73%,KCNMB1;KCNMA1;SLC24A3
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.5324461412993751,-0.8529281815105956,0.6825396825396826,1.0,1.0,1/8,1.43%,CYP3A5
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.349108892497516,0.8528246667453413,0.7142857142857143,0.9895759243239068,1.0,11/40,15.74%,ABL2;CAMK1D;RETREG3;ARHGAP35;RAP1A;RAPGEF2;NPTN;LRRC7;EP300;SCARB2;RAPGEF1
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),-0.4240928108954123,-0.8527637425169603,0.639344262295082,1.0,1.0,3/24,9.69%,TGFB2;TGFBR1;INO80
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),0.3036074908071219,0.8526976429070766,0.8461538461538461,0.9888352612127286,1.0,14/123,9.83%,VAPB;EPN2;SNAP29;ACTR2;VAPA;LEMD3;HSPA8;PACSIN2;AP3D1;EPS15L1;SNAP23;CBL;EGFR;SGCZ
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),-0.4900334189497299,-0.852242795696515,0.6875,1.0,1.0,2/11,5.49%,JAM2;TENM4
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),-0.5548450721047593,-0.8517898330830108,0.6792452830188679,1.0,1.0,1/5,1.36%,ZFPM1
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),-0.5002360481680247,-0.8514768060506723,0.7,1.0,1.0,2/13,6.26%,NRP1;THBS1
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),0.501808000975887,0.8512993132229774,0.6444444444444445,0.9906603142749774,1.0,1/6,23.32%,TSG101
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),-0.5592411809851281,-0.8511775571225353,0.6976744186046512,1.0,1.0,2/5,6.26%,VEGFA;THBS1
prerank,PanglaoDB_Augmented_2021__Microglia,0.40742524383973555,0.8511743429161164,0.5833333333333334,0.9899694874435221,1.0,2/20,2.05%,CSF1R;TNFRSF1B
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.46626872184861734,0.8511415316027298,0.6551724137931034,0.9891218722089477,1.0,5/13,14.16%,EIF4EBP2;SMG1;TIPRL;RICTOR;RPS6KB1
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.2708682543722504,0.851051359576592,0.9411764705882353,0.9883252380694145,1.0,52/391,13.11%,DACH1;MXD4;GATAD2A;TENM2;NOTCH1;CNOT7;PML;CXXC5;HEY2;PHC1;BACH1;CTBP2;ATP8B1;NCOA5;PTPRK;HSPA8;RFX3;SOX13;ZEB2;PPM1A;SMARCA4;TBX3;ZBTB7A;SMAD7;HDAC9;KLF12;NACC2;LCOR;HMBOX1;ZFHX3;ZBTB16;CBX6;HEYL;HDAC1;MITF;THRA;CEBPB;APBB1;MTF2;PPARA;MBD2;RPS6KA5;MEIS2;BCL6;NEDD4L;SEMA4D;UBE2D1;ZNF398;HDAC2;LEF1;YAF2;NFKB1
prerank,MSigDB_Hallmark_2020__Apical Surface,-0.45450341679366035,-0.8507173761326233,0.7213114754098361,1.0,1.0,3/14,8.69%,AKAP7;SULF2;BRCA1
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.4899262282156226,0.8496675724210377,0.6415094339622641,0.9901832638336915,1.0,3/10,12.66%,IRS2;HK1;PMM2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),-0.4917082467869889,-0.8490608933226454,0.7058823529411765,1.0,1.0,2/11,11.29%,ANXA1;RPS3
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),-0.49675621399052866,-0.8489117797896776,0.6727272727272727,1.0,1.0,1/15,1.22%,RIMS1
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.5182822518556679,0.84880775511579,0.5681818181818182,0.9908257579849131,1.0,1/7,4.12%,ARF1
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.42946273546607927,-0.8486439253819518,0.6911764705882353,1.0,1.0,2/18,12.72%,OLFM1;APOE
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.47189545445715786,0.8484600742694932,0.6875,0.9906598050929474,1.0,3/12,18.74%,MAPRE2;CAMSAP1;MAP1B
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.48419112247277396,0.8484321270384992,0.6046511627906976,0.9897270520863963,1.0,1/7,8.61%,GLUD1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),-0.43303871129651206,-0.8484187851415003,0.6774193548387096,1.0,1.0,5/23,20.79%,GRIA4;CNIH3;MINK1;GRIA3;DLG2
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),-0.3951168770734668,-0.8481731986326132,0.75,1.0,1.0,11/67,11.08%,PHLDB2;MEGF10;SUPT6H;EPHA3;TGFBR1;HSP90AB1;BIRC2;DDX5;LGALS3;SMOC1;NGF
prerank,PanglaoDB_Augmented_2021__Astrocytes,-0.37517753488749744,-0.8480968566957768,0.7333333333333333,1.0,1.0,6/59,5.05%,FGF1;SLC4A4;KCNIP1;DKK3;NTM;TMEM132C
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.43231537135030446,0.84766985324153,0.6756756756756757,0.99026989298402,1.0,5/21,12.96%,ADGRB3;CAMK1D;NEDD4L;SEMA4D;CSMD3
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.5230737942832618,-0.8475849148808566,0.7321428571428571,1.0,1.0,2/8,13.04%,PRMT2;PRMT3
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.5228022168221508,-0.8473187289590719,0.7454545454545455,1.0,1.0,1/12,6.29%,HTT
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.40911720943915963,-0.8470403072506691,0.6721311475409836,1.0,1.0,7/26,26.05%,PSMC2;FHL1;PSMD8;FBXL7;PSMD14;PSMA3;RBX1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.437736018791235,-0.846965738540888,0.74,1.0,1.0,2/24,1.92%,SPRY1;EPN1
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.42147603254313376,-0.8469015034640883,0.6417910447761194,1.0,1.0,3/29,9.16%,PIK3R4;ADM;CALCRL
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.44743389333203065,0.8465430139511386,0.6382978723404256,0.9916558908674753,1.0,2/8,10.88%,HDAC1;MBD2
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.4099987970627943,0.8463144303000114,0.6739130434782609,0.9911367344187755,1.0,2/20,8.29%,CTNND2;CTNNA2
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.36354342740752627,0.8460455485976534,0.7297297297297297,0.9907655251179576,1.0,3/31,4.48%,ABL2;CD151;PACSIN2
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.3909159259737395,0.8459139291450158,0.6521739130434783,0.9900328535026611,1.0,5/29,13.04%,KCNC2;ATL2;NACC2;MCU;UPB1
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),-0.46562026731765876,-0.8456463963320197,0.7272727272727273,1.0,1.0,4/21,17.18%,AP2A2;SNAP91;GPR107;LMBRD1
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.44954504392044686,0.8454654941349086,0.6666666666666666,0.9898883077678776,1.0,4/17,8.69%,DGKB;DGKH;DGKG;DGKE
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),-0.38734916684383464,-0.8454603742711233,0.7213114754098361,1.0,1.0,5/48,9.00%,HECW2;NKD1;GPC3;CENATAC;AZIN1
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),0.4052635646085453,0.845459325311768,0.717948717948718,0.9890113040471588,1.0,9/21,31.54%,SORT1;WASHC5;EPS15;CAV2;ALS2;RAB22A;ZFYVE16;WASL;USP8
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.37667082946765074,0.8450460561925892,0.7446808510638298,0.9890241643220549,1.0,5/33,11.36%,HSPB1;ATP2B4;NUS1;P2RX4;ADAM17
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.29754423432259486,0.8440172385138064,0.7407407407407407,0.9899146187933261,1.0,14/119,9.50%,TMEM131L;CTNND2;APC;GPC5;GPRC5B;DAAM2;SOX13;ZEB2;PPM1A;ADGRA2;AMFR;SCYL2;HDAC1;EGFR
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.5618434240198178,-0.8438724745498701,0.6666666666666666,1.0,1.0,1/5,10.19%,TSEN2
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.5618434240198178,-0.8438724745498701,0.6666666666666666,1.0,1.0,1/5,10.19%,TSEN2
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),-0.49077119562861576,-0.8433982256763272,0.6818181818181818,1.0,1.0,1/12,1.41%,SLC4A4
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.3575817239285321,0.843368677550128,0.717948717948718,0.9903552569700599,1.0,5/38,9.67%,NOTCH1;BACH1;EPAS1;HIF3A;ARNT
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.4945823459999304,-0.8433030005645644,0.639344262295082,1.0,1.0,2/10,6.40%,SFRP4;SLIT2
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.5131402846334069,0.8430205131299809,0.6415094339622641,0.9900650939067347,1.0,1/6,6.54%,VEZF1
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),-0.5825318736585499,-0.8429451152877241,0.7037037037037037,1.0,1.0,3/5,19.07%,IFT122;ACVR1;HES1
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.37594476016246026,-0.8428926773299348,0.6865671641791045,1.0,1.0,4/39,6.08%,IFITM3;IFIT3;STAT1;IFI44L
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.35660666248417777,0.8423752149410624,0.7878787878787878,0.9903005617628364,1.0,2/27,1.67%,TNFRSF10B;PML
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.46153681444640937,0.8423251681420786,0.6470588235294118,0.9894572600665092,1.0,1/9,0.37%,MYH11
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),0.43203351252991057,0.8422473697207562,0.7096774193548387,0.9886737752477781,1.0,5/24,15.30%,HPRT1;USP16;GRIN1;UPB1;GRIN2B
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),-0.5497650412535612,-0.8419234679232788,0.7272727272727273,1.0,1.0,2/7,5.73%,TGFB2;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.5751993063290982,0.841881477709402,0.6976744186046512,0.9883571890590795,1.0,1/5,11.61%,SART3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.43436818719063663,-0.8414487108568542,0.6440677966101694,1.0,1.0,2/17,4.65%,PARP1;NR4A3
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.3901695418069851,0.8414393513024085,0.7058823529411765,0.9881865064322322,1.0,2/17,8.05%,CLEC16A;SMG1
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,-0.3623703474917619,-0.8413839257750292,0.7727272727272727,1.0,1.0,13/81,11.66%,FBLN1;RASSF8;SEMA6D;AKAP12;NTM;GLI2;SLIT2;DZIP1;LAMA4;LAMB1;PDE10A;LIMCH1;ABI2
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),0.426205102323871,0.8412205949191982,0.6190476190476191,0.9875999777111112,1.0,1/16,1.67%,PML
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),-0.5227194348802975,-0.8410002148779973,0.7391304347826086,1.0,1.0,2/7,5.73%,TGFB2;TGFBR1
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),-0.507043221801881,-0.8407988704814888,0.6964285714285714,1.0,1.0,2/7,27.74%,CD4;STAT3
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),-0.507043221801881,-0.8407988704814888,0.6964285714285714,1.0,1.0,2/7,27.74%,CD4;STAT3
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.37232836970553523,-0.8403029928576009,0.6417910447761194,1.0,1.0,8/47,12.72%,TGFB2;SLC8B1;PER2;ADAM9;MYO18A;CACNA1D;PPIA;APOE
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.4346195974913838,-0.8401624558773896,0.6851851851851852,1.0,1.0,5/21,11.41%,MEGF10;ACTG1;PLPP3;FN1;PPIA
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.3123840974470347,-0.839859179591653,0.9090909090909091,1.0,1.0,33/383,11.07%,TWIST1;FGF1;TGFB2;ZFPM1;NR4A2;NR4A1;VEGFA;ARNT2;PARP1;SUPT6H;STAT1;TET1;PGR;CALCOCO1;GLI3;NR4A3;GLI2;BMP5;CEBPZ;RHOQ;PRPF6;SNW1;DCN;NR2F1;PLAG1;BRCA1;BCAS3;HSF2;INO80;NCOA7;PRKDC;DHX36;NAMPT
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),-0.5230023248153488,-0.8394822258511055,0.6811594202898551,1.0,1.0,3/7,8.04%,NMNAT2;PRPSAP2;NMNAT3
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),0.4892672389383409,0.8394055891312941,0.6851851851851852,0.9903697653553494,1.0,1/6,3.34%,ACADVL
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.30108754378255964,0.8393645743509275,0.88,0.9896084092368245,1.0,20/87,15.74%,RGS6;TBC1D4;TIAM2;ARHGEF7;SNX13;ABR;MMUT;MAPRE2;RSU1;TBC1D5;SEMA4D;RANGAP1;RAP1GDS1;RAP1A;RAPGEF2;DOCK11;ARAP1;RALGAPB;RASGRP2;RAPGEF1
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.502068822745149,0.8390347633278723,0.6666666666666666,0.9892248702287977,1.0,2/7,5.58%,BCL2;IRS2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.41416564020559626,-0.838803509912676,0.7058823529411765,1.0,1.0,9/25,27.70%,NMD3;CCT6A;PARP9;LARP7;PIK3R1;PSEN1;IPO5;TPR;WWTR1
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),-0.46799853833572513,-0.8386274582334471,0.631578947368421,1.0,1.0,1/9,0.88%,TGFB2
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),-0.5740381322248999,-0.8386152792631958,0.7450980392156863,1.0,1.0,1/5,12.35%,SLC41A1
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.5393119779539658,0.838512207865037,0.6341463414634146,0.9891023850907598,1.0,3/5,15.70%,CHST3;OGA;LARGE1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.4655572197881674,-0.838483571321454,0.7741935483870968,1.0,1.0,5/18,14.89%,UCHL5;N4BP1;HSP90AB1;FHIT;RPL11
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.45481302197128803,0.8379486789610399,0.5862068965517241,0.9892209575952872,1.0,4/13,15.06%,RNF185;ATXN3;ZER1;UGGT1
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.3970258330454813,0.8378877045918308,0.6756756756756757,0.9884346341086155,1.0,5/19,23.39%,KIFC2;RHOA;KPNB1;FLNA;LSM14A
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.4511875552534128,-0.8377096978804826,0.6451612903225806,1.0,1.0,4/18,21.59%,FASTKD2;MRPS25;GFM1;MRPL3
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.47574528311379305,0.8374098222408614,0.6341463414634146,0.9883516868983598,1.0,2/9,7.23%,CACNA1C;HCN2
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.4372449006223291,-0.8371480855055546,0.6612903225806451,1.0,1.0,9/24,21.11%,FTH1;SLC11A2;ABCB7;HEPH;ATP6V1E1;ATP6V1D;ATP6V0D1;TF;ATP6V0E1
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.5144077227206089,0.8371078580085735,0.7142857142857143,0.9879518854618597,1.0,1/7,4.62%,PPM1A
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.4570774456882456,0.8362712681610083,0.75,0.9887429035319962,1.0,4/11,17.36%,PDGFA;CDKN1A;GAS6;DHX9
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),-0.5211302635726544,-0.8361275849422097,0.7884615384615384,1.0,1.0,2/7,12.72%,SGK1;APOE
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.5517929284799281,0.8359705724578874,0.7254901960784313,0.9884297773673979,1.0,3/6,26.64%,ITGA3;PRNP;INSR
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.5858725447957385,0.8359141700170831,0.7083333333333334,0.9876190920753859,1.0,1/5,4.65%,UBQLN1
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.283390827022625,0.8358397049275684,0.9259259259259259,0.9868481909976474,1.0,12/159,8.02%,ARRDC2;NEURL1B;TBC1D4;ARF1;HERC2;SNX4;MYH9;GGA2;ATP6V1H;AP3D1;SNX13;RAB31
prerank,PanglaoDB_Augmented_2021__Principal Cells,0.43268480812790544,0.835796804389645,0.6875,0.9860022211322056,1.0,4/15,9.29%,ZBTB7C;GPRC5B;GPRC5C;PELI2
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.42785995690506673,-0.8354346241552925,0.6944444444444444,1.0,1.0,9/18,21.72%,ELOVL2;CYP1B1;PLA2G4C;GPX4;PTGR1;PNPLA8;HSD17B4;FADS2;MGLL
prerank,PanglaoDB_Augmented_2021__Alpha Cells,-0.3759450890129945,-0.8354179851944697,0.71875,1.0,1.0,5/49,3.37%,IGFBP5;ALDH1A1;SEMA6D;PGR;KCNIP1
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.3288651054211833,-0.8353417626507014,0.8076923076923077,1.0,1.0,24/153,15.24%,XPA;PARP1;RAD51B;DDB2;VAV3;MSH6;XPC;SLF1;POLA1;BTG2;BRCA1;RPA1;INO80;RAD17;PRKDC;RPS3;MAPK14;MRNIP;WRN;UFL1;SPIDR;RNF8;ZRANB3;MGMT
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),0.4655676488484164,0.8351081712339612,0.6666666666666666,0.9864665822124267,1.0,1/8,0.35%,ST3GAL2
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.5285459166871804,-0.8349654603290063,0.7213114754098361,1.0,1.0,3/7,17.04%,UCHL5;ARMC9;DCDC2
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.4987946291174456,-0.8349189976506527,0.7068965517241379,1.0,1.0,1/14,6.29%,HTT
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.40822552332199646,0.8345892905376466,0.6956521739130435,0.9866437590097339,1.0,2/18,5.07%,HSPB1;MYH9
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),-0.45505796505556223,-0.8345752609760189,0.7377049180327869,1.0,1.0,4/19,6.40%,TGFB2;ZFPM1;TGFBR1;SLIT2
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),-0.44475990816213157,-0.8345000076435672,0.746031746031746,1.0,1.0,4/22,6.40%,TGFB2;ZFPM1;TGFBR1;SLIT2
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),-0.4828223595765411,-0.8344723274247059,0.6530612244897959,1.0,1.0,3/9,12.32%,MTM1;SLIRP;NUBPL
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),-0.553852688136427,-0.8344242239274071,0.7619047619047619,1.0,1.0,2/8,13.52%,GSN;ATP1B1
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),-0.553852688136427,-0.8344242239274071,0.7619047619047619,1.0,1.0,2/8,13.52%,GSN;ATP1B1
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.3858179619886,-0.834030431179299,0.7746478873239436,1.0,1.0,10/52,17.02%,GBP2;XPA;COL1A1;CSE1L;WRN;SEC13;RPL11;BBS4;HIKESHI;APPL2
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),0.31228835505806185,0.83388285893643,0.7575757575757576,0.9869922464713828,1.0,15/56,15.74%,RGS6;ARHGEF7;SNX13;MMUT;MAPRE2;RHOA;RSU1;SEMA4D;RAP1GDS1;RAP1A;RAPGEF2;DOCK11;ARAP1;RASGRP2;RAPGEF1
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.5035631369951745,-0.8338532241492035,0.7192982456140351,0.9997007416847359,1.0,5/8,15.32%,VEGFA;SASH1;MAP3K4;MINK1;GADD45B
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),-0.41006808518755156,-0.833412550073972,0.746268656716418,0.9997380374077718,1.0,9/27,16.25%,SLC4A4;SCN7A;SLC24A3;SLC6A20;ANO6;ATP1B1;HCN1;SLC6A13;SCN2A
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.5842664690277932,-0.8328757762443814,0.8,0.9999993782036504,1.0,3/5,22.73%,EPHA4;STK24;PTN
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),-0.4730854363868064,-0.8328359260119034,0.6724137931034483,0.9993514161771275,1.0,5/16,14.08%,RHEB;GPR137C;LARS1;SEC13;RRAGB
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.48825004919059417,-0.8324741988630514,0.7014925373134329,0.9993625432650342,1.0,3/11,12.93%,RAD51B;RPA1;WRN
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.42378673053076205,0.8324608991598317,0.6756756756756757,0.9885785536584681,1.0,4/11,21.00%,AP3M1;SCARB2;GGA3;RTN4
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),-0.4794941926107048,-0.8317116904618801,0.7241379310344828,1.0,1.0,3/14,12.16%,TANC2;ABI2;EPHA4
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.3851544739733975,0.831517072664768,0.7674418604651163,0.9894195464435392,1.0,6/25,14.93%,CDH2;CDH10;SMAD7;PAK2;NECTIN3;TJP1
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),-0.3214253391456328,-0.8314347281929106,0.8414634146341463,0.9998580300849523,1.0,20/230,13.65%,PRAG1;TGFB2;CDKL1;EPHA3;PIK3R4;TGFBR1;STRADB;SGK1;FAM20A;PRKDC;ABI2;MAPK14;TGFBR3;EPHA4;PRKAG2;DAPK2;NEK1;CSNK1D;WNK2;SRPK1
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.4206266080681967,0.8313702138882401,0.7380952380952381,0.9887375353474446,1.0,3/14,8.74%,BCL9;SMAD7;ITGA3
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.4875113051669967,-0.8309653628919109,0.7222222222222222,1.0,1.0,2/14,4.97%,GPC3;GSN
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),-0.35814663236931565,-0.8304158827437783,0.7246376811594203,1.0,1.0,7/57,8.18%,FOXQ1;ARNT2;TNFRSF19;KAZN;DZIP1;NR2F1;ALCAM
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.46937781053633193,0.8304127306827783,0.717391304347826,0.9896718396994455,1.0,1/8,6.26%,PPP2CB
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.39888463608587144,0.8301830551721898,0.6521739130434783,0.9892376320967765,1.0,5/20,11.36%,ZBTB7A;HDAC9;MSH2;AXL;ADAM17
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),-0.4144121057143813,-0.8299081901878141,0.6896551724137931,1.0,1.0,12/37,16.09%,ANXA1;EYA1;BRCA1;TRIM13;UIMC1;INO80;MAPK14;MRNIP;SPIDR;RNF8;NET1;TOPBP1
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.3775462058781951,0.8298367705662698,0.6666666666666666,0.9889180163819054,1.0,8/32,17.26%,RNF185;UBQLN1;AMFR;STT3B;UBE2J1;UBE4A;UBE4B;RNF121
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),-0.4332854365659832,-0.8297641433970517,0.6949152542372882,1.0,1.0,2/21,8.52%,GRIA4;GRIK1
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.48852255314015525,0.8296722066696032,0.7317073170731707,0.988257913961211,1.0,2/8,3.77%,ADGRB3;SORT1
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.3687580027860897,0.8296509102108311,0.7777777777777778,0.9874002436883887,1.0,6/34,6.22%,PPM1L;VAPB;SGPL1;VAPA;HACD2;CERS6
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),-0.49761058469777675,-0.8292579580895652,0.7272727272727273,0.9998438349299007,1.0,2/11,14.07%,ACAT1;DLD
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),-0.49761058469777675,-0.8292579580895652,0.7272727272727273,0.9998438349299007,1.0,2/11,14.07%,ACAT1;DLD
prerank,GO_Biological_Process_2021__liver development (GO:0001889),-0.5177469994505287,-0.8291757948838528,0.7647058823529411,0.9992526569283476,1.0,2/7,12.09%,ANXA1;TGFBR3
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.5302173284963061,-0.8291474062435571,0.7192982456140351,0.9986230417224421,1.0,2/5,23.10%,VCL;KIFC3
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),-0.514439604202888,-0.829029172849379,0.7272727272727273,0.9981576120087454,1.0,1/8,3.19%,ANXA1
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.415989405032386,0.8284728959608291,0.7045454545454546,0.988463894154579,1.0,7/13,27.61%,PDE3A;RAPGEF2;CAP2;RIMS2;PDE2A;AKAP6;PDE7B
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.34971496960692566,-0.8283898879349577,0.7272727272727273,0.99870485539542,1.0,6/60,10.86%,TWIST1;VEGFA;ELOB;PGK1;NDRG1;PSMC2
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.3835895926267358,0.8283230777766917,0.7441860465116279,0.9878627065426018,1.0,5/22,13.11%,TNFRSF1B;AXL;RHOA;PLAA;NFKB1
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.3776836334999267,-0.8273167101334309,0.7428571428571429,1.0,1.0,8/46,15.48%,HECW2;NKD1;GPC3;ADAM9;APOE;VGLL4;SH3D19;SNX9
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.34820782499463,-0.8272327227701771,0.7727272727272727,0.9995624071246079,1.0,15/77,14.24%,PDGFD;SPRY1;NRP1;FBLN1;DENND2B;GCNT2;NOTCH2;BMPER;FN1;SPRY3;TGFBR3;APOE;CCN1;WNK2;APIP
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.5066180056249165,-0.8264773215533581,0.6481481481481481,1.0,1.0,1/6,5.00%,MSH6
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),-0.5204435543389783,-0.8264300426271544,0.6964285714285714,0.9997339174239526,1.0,1/6,1.62%,VEGFA
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),-0.5472017020601139,-0.8263456671797933,0.7307692307692307,0.9992370700463599,1.0,2/5,12.16%,SLIT2;EPHA4
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),-0.47544941290656295,-0.8262361657599667,0.6851851851851852,0.998818923583126,1.0,4/14,10.07%,TGFB2;ZFPM1;OLFM1;SMAD6
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.4065981140294732,0.8257723584141383,0.6097560975609756,0.9913216580307185,1.0,7/23,18.03%,TRAK1;MYO1E;KIF5B;NDE1;MYO1D;MYO1B;MYO5A
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.48370963759175567,-0.8256107410758807,0.6666666666666666,0.9992786919085165,1.0,1/7,3.18%,IQGAP2
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),0.4589287268915687,0.8255355609063199,0.6829268292682927,0.9908321322379404,1.0,3/11,16.28%,CD58;ITGA7;CTNNA3
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.4582370396349353,-0.8252948676000678,0.7833333333333333,0.9991208590089584,1.0,5/19,25.22%,RPA1;UFD1;UBA52;POLK;NPLOC4
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),-0.5370445797187855,-0.8250346193164894,0.7083333333333334,0.9988529005088022,1.0,1/6,5.98%,ADAM9
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.3407654105024912,0.8247378156054103,0.7777777777777778,0.9913893875934372,1.0,11/50,14.16%,CSF1R;NCOA3;ACVR2A;RHOA;SLIT3;BMPR1A;TIPARP;NCOA2;LEF1;PTPN9;RPS6KB1
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.3926089388271071,-0.8246504951616853,0.7916666666666666,0.9987539339878343,1.0,10/47,18.83%,RSRC1;PRPF6;FUS;NONO;WBP4;SRSF10;SRPK1;PRPF8;DHX8;SRSF7
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),-0.44757322192474946,-0.8245795312309476,0.7096774193548387,0.9981754529445968,1.0,4/17,11.79%,MEGF10;SUPT6H;BOC;MAPK14
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),-0.4077349488690249,-0.8240253745229774,0.6911764705882353,0.9984462788666062,1.0,5/21,19.96%,OLFM1;APOE;ZFYVE27;MT3;GOLGA4
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.36069783796293786,-0.8240241761528535,0.75,0.9977846179793519,1.0,18/81,22.68%,HECW2;XPC;ZFP36L2;INO80;PSMC2;CSNK1D;PSMD8;NINL;SDCCAG8;RGCC;APPL2;CDC27;PRKACA;UBA52;DYNC1H1;PSMD14;CKAP5;YWHAE
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.512947903858076,0.8240133539242815,0.76,0.9909583911650118,1.0,3/6,14.47%,HACD2;ELOVL6;ELOVL5
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.512947903858076,0.8240133539242815,0.76,0.9909583911650118,1.0,3/6,14.47%,HACD2;ELOVL6;ELOVL5
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.4163194298573401,0.8232074999114919,0.6923076923076923,0.9917489300252385,1.0,3/17,11.15%,KDM7A;PHF2;PHF8
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.4726599870438227,-0.8230426609412276,0.7222222222222222,0.9989027598779355,1.0,1/8,2.90%,ACTG1
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.5187771355202127,0.8228157416177447,0.7,0.9916273785922023,1.0,2/6,20.63%,SETD7;SETD3
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),-0.3413077748143414,-0.8221984431534036,0.8309859154929577,0.9997026592077172,1.0,8/75,13.01%,ELMO1;PLD1;ARHGEF3;COL1A2;G3BP2;ABI2;MAPK14;KRAS
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.4089779688261538,-0.8221085506610015,0.7142857142857143,0.9991836060672273,1.0,5/24,15.75%,MSH6;DNAJC10;PLSCR1;ATP1B1;TPM1
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),-0.4589192597291015,-0.8211223368975861,0.6825396825396826,1.0,1.0,2/15,5.73%,RACK1;TGFBR1
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.48343545112468594,0.8206998722662001,0.7058823529411765,0.9944794028250071,1.0,1/8,0.21%,CSF1R
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),-0.5103772860818728,-0.8206368436963124,0.7333333333333333,1.0,1.0,5/9,20.32%,RETREG1;GNAL;TTC8;BBS4;TRPA1
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.3797948644501289,0.8203671279730104,0.8,0.9941119460018185,1.0,8/27,17.79%,PML;DEK;UBE2N;EGFR;WRNIP1;RNF168;DHX9;BRCC3
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),-0.5186697569977197,-0.8203455856432956,0.7068965517241379,1.0,1.0,1/7,1.62%,VEGFA
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),0.39196203689176123,0.8198948004290681,0.675,0.9941945633485787,1.0,2/21,4.91%,UBQLN1;UBE2N
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.4189272515912184,-0.8198481726628832,0.6833333333333333,1.0,1.0,5/20,7.89%,FBLN1;GCNT2;THBS1;SPOCK1;TBCD
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),0.498527839981287,0.8197865117023242,0.7090909090909091,0.9934538612265742,1.0,2/6,2.23%,NOTCH1;HEY2
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.5107761208261432,0.8195703526089286,0.5873015873015873,0.9929107591982487,1.0,1/5,5.97%,ZBTB7A
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),-0.4363782152548612,-0.8193190992795534,0.7192982456140351,1.0,1.0,5/17,9.02%,SEMA3C;LRTM1;SEMA6D;SLIT2;SEMA3D
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.40021460017042504,-0.8190855023263104,0.75,1.0,1.0,2/24,6.90%,GSN;APH1B
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.41747684163576315,0.8186082551636669,0.7317073170731707,0.9936665235998681,1.0,3/13,9.10%,HEY2;PCSK5;HEYL
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.5600221741870598,-0.8174539891107754,0.7258064516129032,1.0,1.0,3/6,9.37%,AKR1C1;SLCO1A2;SLCO1C1
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),-0.3746699191369912,-0.8174429426324419,0.6825396825396826,1.0,1.0,6/38,12.09%,TGFB2;ZFPM1;ZFP36L2;NOTCH2;ARIH2;TGFBR3
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.43523170296086033,-0.8170522638145087,0.7666666666666667,1.0,1.0,3/17,14.02%,ERAP1;HLA-B;SEC13
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.3374872020841928,-0.8169380880983843,0.8472222222222222,1.0,1.0,10/107,7.64%,AFG3L2;RIMS1;LIMA1;ACTG1;ELOB;EPRS1;LAMC1;GSN;RHOQ;BAIAP2L2
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.5225096780375919,0.8169096620044993,0.78,0.995848241916649,1.0,1/7,16.23%,IP6K1
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.35769742265639154,0.816869358160918,0.8,0.9950714383961671,1.0,9/34,12.19%,KCNC2;CACNA1C;RFX3;IRS2;GLUD1;IRS1;ADCY5;MCU;RAP1A
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.47399046815095547,-0.8165661707701366,0.7037037037037037,1.0,1.0,1/10,1.62%,VEGFA
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.4605761895861727,-0.8164172102029883,0.711864406779661,1.0,1.0,2/14,2.74%,SHROOM3;KCNMA1
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.5063471368437436,-0.8161936176478257,0.7169811320754716,1.0,1.0,1/7,5.00%,MSH6
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.3240619998105875,0.8161386505113786,0.8214285714285714,0.9952458654326604,1.0,3/69,4.73%,HSPA1A;NCK2;PTGES3
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.4177439370745596,-0.8161012649707913,0.7068965517241379,1.0,1.0,2/16,11.29%,ANXA1;RPS3
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),0.469446426130634,0.8151716847080024,0.673469387755102,0.9961735770395979,1.0,4/6,23.76%,TTN;EZR;MYOM1;PRKACB
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.42904927433289886,0.8148868606405375,0.9047619047619048,0.9959284098521073,1.0,2/17,11.85%,RAB27A;WASHC5
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),-0.4588165718859857,-0.8144376309884409,0.6666666666666666,1.0,1.0,1/9,0.88%,TGFB2
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.3233009997846196,-0.8129843625523651,0.8533333333333334,1.0,1.0,21/188,11.39%,KLHL13;HECW2;RNF213;ELOB;UVSSA;RACK1;PDZRN3;EYA1;MARCHF3;OTULIN;ATG10;RNF220;BRCA1;TRIM13;KLHL7;ARIH2;PRKDC;NUB1;NFX1;NUP58;DERL1
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.45774622036035695,0.8128504680711918,0.6829268292682927,0.998766956540074,1.0,1/9,2.90%,MED24
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),-0.43801148733657913,-0.8127611473941696,0.7142857142857143,1.0,1.0,1/19,0.88%,TGFB2
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.4338778409249592,-0.8126956575028979,0.7619047619047619,1.0,1.0,1/20,1.41%,SLC4A4
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.39497683132277206,-0.812570790718713,0.7966101694915254,1.0,1.0,7/27,26.05%,PSMC2;FHL1;PSMD8;FBXL7;PSMD14;PSMA3;RBX1
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),-0.4961906390378476,-0.8125181339062428,0.7592592592592593,1.0,1.0,2/7,21.64%,ABI2;WASF2
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.35686466921415144,-0.8124258180846439,0.7866666666666666,1.0,1.0,12/47,23.00%,RMDN1;CEP126;ITGB3BP;SEC13;SPC25;NUP107;EML4;RANBP2;DYNC1H1;CKAP5;CLASP2;MECP2
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.44986599499536295,0.812005238697142,0.6571428571428571,0.999475600538655,1.0,1/7,15.91%,LTBP3
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.40845791422579997,0.81181301847585,0.75,0.9980363817365235,1.0,5/15,8.69%,DGKB;DGKH;LCLAT1;DGKG;DGKE
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.40845791422579997,0.81181301847585,0.75,0.9980363817365235,1.0,5/15,8.69%,DGKB;DGKH;LCLAT1;DGKG;DGKE
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),0.478284144197935,0.8115613195518272,0.6956521739130435,0.9976240775011359,1.0,2/10,11.23%,GTF3C2;ELL
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.5179750648330907,0.8115016193499215,0.7575757575757576,0.9968426934805574,1.0,2/5,20.89%,EIF2AK4;ULK2
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),0.4263585956183946,0.8107942954145649,0.7441860465116279,0.9972265896782373,1.0,2/15,2.23%,NOTCH1;HEY2
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.44465837705972755,0.8104721075466386,0.7692307692307693,0.9969822334950872,1.0,5/14,13.62%,SMARCA4;RRP1B;HDAC1;LEF1;EP300
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.42581287480089647,-0.8104609746513887,0.6833333333333333,1.0,1.0,4/19,11.29%,TERF2IP;SASH1;PDCD4;RPS3
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.408953910458706,0.810401759494218,0.7142857142857143,0.9962957200794563,1.0,3/13,16.43%,IRS1;PIK3CD;ZFP36L1
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.31664435767145405,0.8101638112419071,0.9230769230769231,0.995859167178481,1.0,8/65,8.87%,TBC1D4;PDK4;APC;ATP6V1H;IRS2;HDAC9;RAB31;IRS1
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.44594453603819895,0.809888454827597,0.6585365853658537,0.9953865746737394,1.0,3/13,9.50%,NCOA3;LCOR;EGFR
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),-0.42981152452009375,-0.8092896085180693,0.7241379310344828,1.0,1.0,7/16,16.17%,ST6GALNAC3;HEXB;GALC;ASAH1;ST3GAL4;ST3GAL6;SCCPDH
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.5287824314166311,0.8091354201169718,0.7924528301886793,0.9957608625463397,1.0,2/5,3.00%,NOTCH1;NEXMIF
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.3948673529312454,-0.8086099575670355,0.7857142857142857,1.0,1.0,4/31,14.21%,PRKDC;PSMC2;FOXC1;PSMD8
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.34969407513458556,-0.808394522282766,0.9,1.0,1.0,12/66,17.66%,XPC;BTG2;CCDC57;PSMC2;DYNLT3;SRA1;FOXC1;PSMD8;BTG1;ANGEL2;CDC27;PKN2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),0.5178026081011199,0.8083859400474807,0.7105263157894737,0.9961804245525347,1.0,3/5,21.11%,AXL;GAS6;MERTK
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.5057964350867464,0.8080736143155375,0.6923076923076923,0.9958832210611942,1.0,1/5,5.89%,MAP3K7
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.45841906428084034,0.8079405661058664,0.75,0.9951371365066748,1.0,3/12,14.74%,TMBIM6;GRIN1;CPEB3
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),-0.5425503929797765,-0.8070242910257363,0.723404255319149,1.0,1.0,1/5,5.98%,ADAM9
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.4569678596383213,-0.8069194838226523,0.7619047619047619,1.0,1.0,4/13,13.12%,ARHGAP24;TMEFF2;CCN1;PDCD10
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.3575172256649492,0.8062679937947498,0.9142857142857143,0.9972238873141563,1.0,14/33,27.57%,UBQLN1;PACS2;AMBRA1;ATG2B;TMEM41B;ULK2;UBXN2A;PIK3C3;TRAPPC8;SMURF1;VMP1;WDR45B;ATG16L2;NSFL1C
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.45356610065751335,-0.8053986202672377,0.6538461538461539,1.0,1.0,4/11,18.88%,WARS1;BMPER;SP100;PLXND1
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),0.5187908245947355,0.8053957401023045,0.8181818181818182,0.9979611043774662,1.0,2/5,24.54%,AKAP6;SUMO1
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.5159915265732046,0.8052281567126054,0.7083333333333334,0.9973889595391385,1.0,1/6,4.70%,TRAK1
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),0.4165418954514989,0.8047168632094679,0.6666666666666666,0.9975580987870293,1.0,3/18,13.04%,HPRT1;USP16;UPB1
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),0.4954747122656018,0.8041283198575313,0.7083333333333334,0.9976082350170774,1.0,1/6,22.01%,SENP2
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.47150720563647985,0.8032799723495789,0.7777777777777778,0.9982421567906762,1.0,3/10,19.49%,UBASH3B;ANK2;PRNP
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.3199550147230427,0.8031624182552797,0.7741935483870968,0.9974712525452649,1.0,12/62,19.83%,EMP2;SORT1;KLHL20;TBC1D5;MYO1D;HEATR5B;VPS50;RAB14;AP1G1;VPS26A;CLTC;EPS15
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),0.49410899358461113,0.8030819348273839,0.7758620689655172,0.996719920633692,1.0,3/5,8.74%,MCAM;MYO1E;ITGA3
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.29573028081639535,-0.8030160555491536,0.9666666666666667,1.0,1.0,50/484,13.46%,TWIST1;FGF1;SERTAD2;ZFPM1;NR4A2;MDFIC;NR4A1;VEGFA;ARNT2;PARP1;STAT1;TET1;PGR;CALCOCO1;GLI3;COL1A1;NR4A3;GLI2;BMP5;XPC;TGFBR1;CEBPZ;RHOQ;PRPF6;HIVEP3;SNW1;PRMT2;DCN;NR2F1;CREB3L2;HMGN1;PLAG1;BRCA1;BCAS3;HSF2;INO80;NCOA7;PRKDC;DHX36;NAMPT;CTCF;THRB;THOC1;ATF1;APOE;PLAGL1;CCN1;PARP9;ARF4;PLSCR1
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.32907397655544707,-0.8029525193311672,0.8333333333333334,1.0,1.0,21/123,16.91%,TGFB2;NR4A1;RACK1;PER2;TGFBR1;THBS1;TSPYL2;HSP90AB1;NOTCH2;BIRC2;BRCA1;PDCD4;YY1AP1;DYNLT3;PLAGL1;SRA1;GADD45B;TCF7L2;ADARB1;WDR12;RGCC
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.442227518969057,-0.8028405367531894,0.7037037037037037,1.0,1.0,2/14,5.98%,ERAP1;ADAM9
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.45358273837235596,0.8024980333587312,0.6511627906976745,0.9967979149789311,1.0,3/10,15.06%,RNF185;ATXN3;UGGT1
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),-0.4945309153104772,-0.8020946495131929,0.7313432835820896,1.0,1.0,3/7,14.12%,TGFB2;DHX36;FOXC1
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.40794332199418765,-0.8014092824018371,0.7543859649122807,1.0,1.0,3/21,8.77%,HINT1;RHOQ;ACAT1
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.4572995922780102,-0.8011127094601941,0.7384615384615385,1.0,1.0,1/11,1.46%,TM7SF3
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.4696066039466022,0.8008210482806525,0.6923076923076923,0.9988575963660544,1.0,3/9,10.47%,IRS2;IRS1;PPARA
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.4305849886111002,0.800686642680448,0.6785714285714286,0.9982160222703059,1.0,3/12,15.74%,RAP1A;RAPGEF2;RAPGEF1
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.3991966082990249,-0.8001538433567102,0.6764705882352942,1.0,1.0,5/23,14.26%,PRPF6;SNRNP200;SRSF10;SRPK1;CELF2
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),0.4917450516941374,0.8001145862614476,0.7073170731707317,0.99834694750806,1.0,3/6,35.79%,EIF2S1;HERPUD1;EIF2AK3
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.4231734710145987,0.7991481657021969,0.7906976744186046,0.999175803079612,1.0,3/13,2.23%,NOTCH1;TNFRSF1B;HEY2
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.48008760344454604,0.7985965494629403,0.6486486486486487,0.9993056576501578,1.0,2/9,2.81%,TNFRSF1B;TIMP3
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.44012293954024545,-0.7985956997279919,0.7142857142857143,1.0,1.0,3/16,14.36%,SUPT6H;LARP7;RNF8
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),0.5122507168018283,0.7984358904039212,0.7857142857142857,0.9986840406695708,1.0,1/6,4.41%,AKAP8
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.5038339821104126,-0.798419349141627,0.723404255319149,1.0,1.0,1/5,8.20%,ABCB7
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),-0.4339289442249836,-0.7983281277382938,0.7714285714285715,1.0,1.0,5/20,22.65%,PHLDB2;DHX36;NR2C2;DAG1;CLASP2
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,0.4163835282179863,0.7980142300983426,0.717391304347826,0.9985518450146056,1.0,3/13,8.50%,TNFRSF1B;EPOR;KIF5B
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.4596140079235318,-0.7979973723232504,0.7419354838709677,1.0,1.0,1/7,8.20%,ABCB7
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),-0.4543038659297406,-0.797901502705799,0.6779661016949152,1.0,1.0,5/10,13.23%,TGFB2;SLIT2;NOTCH2;SMAD6;ROBO2
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.4287235221104477,-0.7978930102935055,0.6721311475409836,1.0,1.0,5/14,14.82%,RIPOR2;BOC;MAPK14;SRA1;BTG1
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),-0.3315544924101564,-0.797797730271878,0.7384615384615385,1.0,1.0,11/74,17.07%,AFG3L2;SGK1;ALCAM;GPM6A;NGF;S100A6;EPB41L3;MINK1;DTNBP1;DCDC2;CCK
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),-0.48968761219021234,-0.7973514592302066,0.7755102040816326,1.0,1.0,2/5,19.09%,DTNBP1;PRKN
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),-0.42263447302980667,-0.7971211174922648,0.7213114754098361,1.0,1.0,3/20,10.28%,HSP90AB1;SMG6;MAP3K4
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.48143348736274577,-0.7969779047970329,0.7,1.0,1.0,3/8,23.97%,WNK2;STC1;NEDD4
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),-0.4590602455634111,-0.7968738283379685,0.7407407407407407,1.0,1.0,1/9,0.88%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),-0.49788233633265,-0.7960724224902305,0.7966101694915254,1.0,1.0,4/7,20.66%,GPR137C;LARS1;RRAGB;GPR137B
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),-0.5006667828057563,-0.7958675751642375,0.7333333333333333,1.0,1.0,1/7,6.26%,THBS1
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),-0.3961855213854383,-0.7958578153765543,0.7457627118644068,1.0,1.0,7/34,21.74%,SLC4A4;NUP58;PRKAG2;SEC13;NUP107;RANBP2;PSEN1
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.3878804822138973,-0.7957975691301722,0.8360655737704918,1.0,1.0,8/34,13.52%,MT2A;SLC8B1;STIM2;SLC10A7;SLC24A3;TMCO1;SLC41A1;ATP1B1
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),0.5036757112725949,0.795663818624955,0.7692307692307693,1.0,1.0,1/6,3.10%,DNAJC15
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.4499919406297892,-0.7954533938514343,0.765625,1.0,1.0,2/12,6.06%,VEGFA;CHD6
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.4021152268951949,-0.7953875535783018,0.7272727272727273,1.0,1.0,5/27,17.92%,SUPT6H;SRSF10;SRPK1;LARP7;KHDRBS2
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),-0.5039006454382509,-0.7953350583295001,0.7164179104477612,1.0,1.0,2/7,11.08%,FGF13;NGF
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.26871011185227894,0.7951178406016981,1.0,1.0,1.0,11/115,11.61%,SRSF12;CWC27;TXNL4A;HSPA8;METTL14;WDR33;HNRNPUL1;PCF11;SMU1;HNRNPF;SART3
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.48727060471521755,0.7941170565002518,0.75,1.0,1.0,2/5,36.33%,ROCK1;PPP1R12A
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.38042929234261225,0.7939577747117803,0.7435897435897436,1.0,1.0,6/17,19.79%,ACVR2A;ADGRV1;CEBPB;BMPR1A;ATP2B1;SLC8A1
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.53554627741564,-0.7938516295627589,0.711864406779661,1.0,1.0,1/6,4.01%,SVIP
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.4199689616918423,-0.7936402320804153,0.7796610169491526,1.0,1.0,5/21,19.87%,DTWD2;TARBP1;NSUN2;NSUN6;TRMT44
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.46605048888710443,0.7935848236077803,0.7073170731707317,1.0,1.0,3/7,29.52%,OSBPL10;OSBPL5;OSBPL8
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),-0.4531783571109939,-0.7931882294261445,0.711864406779661,1.0,1.0,3/13,9.08%,MSH6;XPC;RPA1
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.424541079928303,0.7931269090194127,0.7272727272727273,1.0,1.0,2/9,4.96%,ST3GAL2;ABO
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),0.522283346991216,0.7929561389143969,0.782608695652174,1.0,1.0,4/5,33.83%,TAF1B;BDP1;TAF7;GTF2B
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),-0.48782122924033267,-0.792926764854343,0.746031746031746,1.0,1.0,1/5,12.86%,CHRM3
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.46190276753137455,-0.7929194760384702,0.7321428571428571,1.0,1.0,2/11,5.65%,NR4A3;BORCS5
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),-0.3101919611399982,-0.7925081518913863,0.9420289855072463,1.0,1.0,14/150,11.65%,NR4A2;NR4A1;PARP1;SUPT6H;PGR;ELOB;NR4A3;NOTCH2;SNW1;NR2F1;TSC22D1;DDX5;NFX1;THRB
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.44168528426087733,0.7923745896392361,0.7391304347826086,1.0,1.0,3/8,15.16%,BACH1;CDK17;BRD4
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.509709486860852,-0.7922712336293827,0.7454545454545455,1.0,1.0,2/5,14.36%,MSH6;RNF8
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.31769853414846816,0.7921281418930989,0.7931034482758621,1.0,1.0,6/83,7.73%,HSPA1A;PTGES3;TESC;SMAD7;USP7;MARCHF7
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),-0.34318954839468396,-0.791851278392615,0.7777777777777778,1.0,1.0,19/72,21.19%,KCNMB1;GABRB2;GRIA4;AMPH;GRIK1;PRKAR1A;CHRM3;PMP22;MINK1;SLC1A2;SLC1A3;GRIA3;SLC1A1;SLC12A6;PRKACA;PLP1;CALM1;DLG2;GABBR2
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.40280285416062567,-0.7916930536951967,0.7580645161290323,1.0,1.0,7/25,16.91%,NRP1;TGFBR1;CD47;LIMCH1;TPM1;LPAR1;RGCC
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.4758790079067763,0.7916703866244565,0.74,1.0,1.0,1/6,10.03%,PXN
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.31376327874973897,-0.7916254741301579,0.9041095890410958,1.0,1.0,25/159,13.11%,CD55;SLC2A3;PGRMC1;PKM;IQGAP2;FTL;SVIP;PLD1;FTH1;GSN;SRP14;CD47;AP2A2;HSP90AB1;ACTR10;HLA-B;HEXB;LGALS3;ASAH1;PSMC2;PPIA;MAPK14;ANO6;TIMP2;EEF2
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.3928142003659207,0.7911607960371592,0.725,1.0,1.0,6/14,28.65%,CTNNA2;DISC1;GSK3B;CCDC88A;ULK4;FBXO7
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.39129519449267364,0.7905327554095282,0.825,1.0,1.0,6/18,10.09%,NOTCH1;TNFRSF1B;HEY2;ELN;HEYL;SLIT3
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.31959670831190756,-0.7905327128447573,0.8767123287671232,1.0,1.0,15/86,13.46%,ELMO1;PARP1;TNFRSF19;SEPTIN4;NOTCH2;FASTKD2;TCHP;PDCD4;AKAP1;BCL2L14;PPIA;THOC1;DAPK2;PLAGL1;PLSCR1
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.3137287278211087,-0.7899218951619694,0.9041095890410958,1.0,1.0,25/160,13.11%,CD55;SLC2A3;PGRMC1;PKM;IQGAP2;FTL;SVIP;PLD1;FTH1;GSN;SRP14;CD47;AP2A2;HSP90AB1;ACTR10;HLA-B;HEXB;LGALS3;ASAH1;PSMC2;PPIA;MAPK14;ANO6;TIMP2;EEF2
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.4213365385471538,0.7888629081809104,0.7872340425531915,1.0,1.0,1/15,0.21%,CSF1R
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),-0.4604431760736304,-0.7887644347665312,0.7894736842105263,1.0,1.0,3/10,18.24%,LEPR;PRKAG2;MT3
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.2880343596975962,0.7877223011149025,0.9354838709677419,1.0,1.0,10/81,13.28%,CNTN4;CTNND2;MICALL2;VAPA;ADGRV1;CAMSAP1;DNM2;ATXN10;RAPGEF2;CNTNAP2
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.5054620115340167,-0.7877138388844038,0.734375,1.0,1.0,3/6,23.68%,CALM1;PYGB;PGM2L1
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.361918664738284,-0.7875593391062412,0.8,1.0,1.0,6/40,11.79%,ANXA1;N4BP1;CD47;POLA1;HLA-B;MAPK14
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.4027774057303879,0.7873076713348446,0.7692307692307693,1.0,1.0,3/13,20.16%,ATP6V1H;HVCN1;ATP6V1A
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.48524922517198765,-0.7871540169085822,0.8214285714285714,1.0,1.0,5/10,25.25%,TPM2;TPM1;TPM3;VIM;TMOD1
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.48524922517198765,-0.7871540169085822,0.8214285714285714,1.0,1.0,5/10,25.25%,TPM2;TPM1;TPM3;VIM;TMOD1
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),-0.42310517473568776,-0.7869651328600666,0.75,1.0,1.0,3/13,9.02%,SEMA3C;SEMA6D;SEMA3D
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.35373066499665046,0.7869273090085831,0.7777777777777778,1.0,1.0,3/30,4.89%,SORBS3;NCK2;CDC42EP4
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.416645113852949,0.7865971846093975,0.7560975609756098,1.0,1.0,5/12,23.32%,RAB27A;STAM2;VTA1;CHMP4B;TSG101
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.40225217033084604,0.7865415257923277,0.6976744186046512,1.0,1.0,3/11,18.83%,XRN1;DIS3;TENT4B
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.38809371110241747,-0.7862769096396599,0.7777777777777778,1.0,1.0,6/32,19.68%,NT5E;WRN;LSM8;TOPBP1;HNRNPA3;DDX24
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",0.2644518819870653,0.7860801594671265,1.0,1.0,1.0,12/125,11.61%,SRSF12;CWC27;TXNL4A;HSPA8;METTL14;WDR33;TGS1;HNRNPUL1;PCF11;SMU1;HNRNPF;SART3
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.4602633428332961,0.7853442255473887,0.6829268292682927,1.0,1.0,2/5,21.25%,BTRC;THRAP3
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),-0.45530595996686407,-0.7851569181253559,0.7543859649122807,1.0,1.0,2/13,4.65%,LEPR;NR4A3
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.46001817122152666,-0.7843410307652409,0.7547169811320755,1.0,1.0,2/6,20.24%,BTG1;BCL2L11
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.3484641961871102,-0.7838856199758196,0.8656716417910447,1.0,1.0,3/62,1.96%,AFG3L2;SLC25A36;PARP1
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.48351326834871333,0.7838513943275234,0.8,1.0,1.0,2/8,10.25%,RFX3;PDE3A
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.3720301273494026,0.7837282456696774,0.7058823529411765,1.0,1.0,5/19,12.43%,ADCY9;GNAI1;ADCY3;ADCY5;HTR1F
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.5052448366223268,0.7829954127574976,0.7619047619047619,1.0,1.0,1/7,3.02%,CTBP2
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.40097535315250166,0.7828324249837189,0.7209302325581395,1.0,1.0,3/17,15.40%,PHC1;YAF2;APAF1
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.40097535315250166,0.7828324249837189,0.7209302325581395,1.0,1.0,3/17,15.40%,PHC1;YAF2;APAF1
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),-0.4996257475263345,-0.7828081654494256,0.8392857142857143,1.0,1.0,3/7,22.65%,DAG1;GCC2;CLASP2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.4365182071062322,0.7820216794668957,0.7837837837837838,1.0,1.0,3/19,4.65%,BCL2;BCL2L1;UBQLN1
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.46249256218516854,0.7818299340518198,0.7555555555555555,1.0,1.0,2/8,10.47%,ABCA1;PPARA
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.40347967891429054,0.781713057600187,0.7878787878787878,1.0,1.0,5/11,18.90%,CPT1A;RPS6KB1;ACSL3;SLC27A1;ACSL1
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.5187360018988227,-0.7816667570588005,0.7857142857142857,1.0,1.0,4/6,43.66%,PCCA;BTD;MCCC2;MCCC1
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.5060882558169127,-0.7810465201851978,0.6666666666666666,1.0,1.0,3/5,24.61%,APH1B;PSEN1;GALNT11
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),-0.36303773839248066,-0.780511771323725,0.8166666666666667,1.0,1.0,6/40,17.07%,AFG3L2;TBCD;S100A6;MINK1;DCDC2;CCK
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,-0.36338739791263786,-0.780436692274269,0.8059701492537313,1.0,1.0,11/42,15.16%,SPTLC3;CYP3A5;PLD1;FMO2;CACNA1D;SLC22A6;THRB;PLEKHA5;ATP1B1;ATP5MK;NIPSNAP2
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.38428274864082956,-0.7802831186112762,0.8253968253968254,1.0,1.0,3/25,5.79%,NR4A2;SFRP4;PLPP3
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.5228263664618931,0.7802049756235289,0.7954545454545454,1.0,1.0,1/5,12.21%,ARL3
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),-0.453571970823639,-0.780089441217487,0.7818181818181819,1.0,1.0,4/17,16.99%,PIP4P2;MTM1;SYNJ2;INPP5B
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.37555966740989444,-0.7800415826904723,0.8032786885245902,1.0,1.0,13/36,23.98%,PARP1;UBL5;FBXW2;FBXO22;PRKDC;CHRM3;ST3GAL6;GGCX;SERP1;UBA52;MANBA;UBE2L3;STK38
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.4281533382595736,0.7792954720559685,0.7777777777777778,1.0,1.0,2/8,16.57%,SMAD7;PARD3
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.36633470155603787,-0.779286945213867,0.8070175438596491,1.0,1.0,5/33,14.21%,PRKDC;PSMC2;DHX36;FOXC1;PSMD8
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.3557210115427323,-0.7791612968511075,0.8307692307692308,1.0,1.0,13/56,13.54%,CLU;ELOB;RNF19A;RACK1;UCHL5;N4BP1;HSP90AB1;FBXO22;ARIH2;NUB1;FHIT;UFL1;CSNK1D
prerank,MSigDB_Hallmark_2020__Adipogenesis,0.28877694661209585,0.7789697542130812,1.0,1.0,1.0,14/89,12.26%,TOB1;ATL2;DNAJC15;CD151;UBQLN1;LIFR;MTARC2;ABCA1;SDHB;ITGA7;DBT;BCL6;ELOVL6;CAT
prerank,PanglaoDB_Augmented_2021__Thymocytes,0.4626804206649863,0.7783503550281455,0.7441860465116279,1.0,1.0,1/10,1.07%,NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),0.49648574312965527,0.7778725350603802,0.7333333333333333,1.0,1.0,1/6,4.41%,AKAP8
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.3299510114863511,0.7778013146424524,0.7878787878787878,1.0,1.0,7/33,15.80%,APC;RHOA;RHOB;ARL3;CECR2;SPIRE1;SEPTIN9
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.42774761550029405,0.7775841562774263,0.6888888888888889,1.0,1.0,2/10,13.62%,USP7;EP300
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.4349498342435003,0.7775652406934224,0.7083333333333334,1.0,1.0,2/13,10.47%,PDK4;PPARA
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.3797232843767068,-0.7771503726304315,0.8676470588235294,1.0,1.0,10/44,19.06%,CYP3A5;AKR1C1;PER2;GNPAT;DLD;LDHA;NPC1;LPL;PTGR1;PNPLA8
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.4295062008019012,-0.7766685039922883,0.7586206896551724,1.0,1.0,2/12,3.06%,ARHGAP15;EPSTI1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.3735198212870419,-0.7766545794292802,0.8805970149253731,1.0,1.0,3/38,7.43%,CTSL;AP2A2;ACTR10
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.46666492892531003,0.7766348477723769,0.8571428571428571,1.0,1.0,3/7,20.28%,EGFR;ADAM17;CCND3
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),0.4340336028286107,0.7765273288460046,0.65,1.0,1.0,1/10,0.91%,NOX4
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),-0.49585371582770715,-0.7764347032918346,0.8166666666666667,1.0,1.0,4/8,18.67%,EXTL2;CSGALNACT1;GMDS;PARG
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),-0.49135862356947296,-0.7762196949786228,0.8055555555555556,1.0,1.0,2/7,13.52%,KCNMA1;ATP1B1
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.44234667404829164,0.7761544209444265,0.75,1.0,1.0,2/11,10.75%,APC;CAMSAP1
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),-0.46991784291662597,-0.7760503922515392,0.7407407407407407,1.0,1.0,3/8,9.02%,SEMA3C;SEMA6D;SEMA3D
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.4222752154143735,0.7758474679215234,0.7666666666666667,1.0,1.0,4/12,22.47%,PPARA;ELOVL5;SLC27A1;CREB1
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.2845043175540746,0.7756596689099806,0.9565217391304348,0.999601003120746,1.0,17/89,18.88%,HIPK2;CAMK1D;SMG1;MAP2K2;CAB39;RICTOR;RPS6KA5;PAK2;RPS6KB1;CSNK2A1;MAP3K13;GAS6;WNK1;VRK2;PRKX;SRPK2;CSNK1G2
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.40863695375959413,-0.7754611406211235,0.7931034482758621,1.0,1.0,3/15,17.73%,ANXA1;RGCC;EIF4G1
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.40128367906860934,-0.7747384204341211,0.7868852459016393,1.0,1.0,7/26,16.91%,NRP1;TGFBR1;CD47;LIMCH1;TPM1;LPAR1;RGCC
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),0.5104598973992028,0.774141629997628,0.8444444444444444,1.0,1.0,2/5,20.23%,MTERF4;NSUN3
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),0.4575774630303487,0.7732703020790342,0.7631578947368421,1.0,1.0,1/5,25.51%,AGT
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),0.29905348288953665,0.7731580565197963,0.875,1.0,1.0,11/74,14.65%,BCL2;TMEM30A;MICALL2;TCAF1;OAZ2;FBXW7;MAVS;CEP290;SAE1;EFCAB7;GAS6
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.4140200445827423,0.7727229256051813,0.7857142857142857,1.0,1.0,4/15,14.81%,PDGFA;PACSIN2;PARVB;CDC42
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.4979146294279768,0.7726412196190673,0.7441860465116279,0.9998658493118608,1.0,3/5,16.57%,TNFRSF1B;RNF10;PARD3
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.3444715199741797,0.7724531648260501,0.7948717948717948,0.9992948933472655,1.0,7/37,15.29%,ATP2B4;CDKN1A;FBXW7;ANAPC16;UBE2D1;BTRC;ANAPC1
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.43203693023532813,0.7720959601053489,0.7948717948717948,0.9990199737798126,1.0,3/15,9.10%,TNFRSF1B;HEY2;HEYL
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.4071655340105307,-0.771990889794299,0.7377049180327869,1.0,1.0,3/15,7.89%,AFDN;ACTG1;TBCD
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),-0.42106715589759197,-0.7717853455380937,0.7547169811320755,1.0,1.0,4/19,7.07%,ZFPM1;BMP5;SGCD;NOTCH2
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.3521691814264144,0.7716511479951598,0.7894736842105263,0.9987628584317813,1.0,2/22,8.81%,MAP3K7;AZI2
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.3989633814122925,0.771578773878696,0.8723404255319149,0.9979776576881227,1.0,2/15,2.23%,MYH11;HEY2
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.48119785918302865,0.7713644422521119,0.7804878048780488,0.9974794514531298,1.0,1/7,0.72%,HSPB1
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.41635014040506624,-0.7708981070344205,0.84375,1.0,1.0,4/17,20.36%,CEMIP;PRKAG2;EIF4G1;CALM1
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),-0.4260001858655004,-0.7706146924653906,0.8103448275862069,1.0,1.0,3/17,9.34%,PHLDB2;ARHGAP28;TMEFF2
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),0.41696171033921925,0.7706035737680021,0.7297297297297297,0.9978470493463842,1.0,2/7,10.68%,IRS1;SERGEF
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.508900466151429,-0.7705251645488032,0.7538461538461538,1.0,1.0,3/5,23.68%,CALM1;PYGB;PGM2L1
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.508900466151429,-0.7705251645488032,0.7538461538461538,1.0,1.0,3/5,23.68%,CALM1;PYGB;PGM2L1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.3812832548426708,-0.7703862514850589,0.7962962962962963,1.0,1.0,3/19,13.68%,MAP3K4;CCT6A;TNKS2
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,0.5230520111684651,0.7700616047397019,0.7608695652173914,0.9977473390983254,1.0,1/5,17.16%,IRF3
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.32910747288829795,0.7699458499252603,0.7941176470588235,0.9970605983960992,1.0,3/29,11.07%,BCL2;SMG1;MCL1
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.27702695823672496,0.7698815739893815,0.9615384615384616,0.996288723745063,1.0,26/156,17.26%,PML;RNF185;UBQLN1;MAEA;SPOPL;ZSWIM8;AMFR;STT3B;FBXL20;ATXN3;KLHL20;ZNRF1;FBXW7;NEDD4L;ANAPC16;UBE2D1;PLAA;UBE2J1;BTRC;UBE4A;RNF34;ANAPC1;AREL1;UBE4B;KLHL42;RNF121
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.5012535787190157,0.7691599268282006,0.7391304347826086,0.996604363310451,1.0,2/7,10.81%,HEY2;BMPR1A
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.45590053969039424,0.7685887495532542,0.75,0.9959430919678122,1.0,2/7,17.04%,GAS6;GSTP1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),0.45590053969039424,0.7685887495532542,0.75,0.9959430919678122,1.0,2/7,17.04%,GAS6;GSTP1
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),-0.35410215322318744,-0.7684811424961127,0.8153846153846154,1.0,1.0,11/47,10.76%,ST6GALNAC3;SPTLC3;PDXDC1;ENPP2;PLPP3;ALDH3A2;HEXB;NSMAF;GALC;ASAH1;ELOVL2
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),-0.40266712703026664,-0.768403168284792,0.8813559322033898,1.0,1.0,5/15,9.02%,SEMA3C;SEMA6D;THBS1;SLIT2;SEMA3D
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.3579548537100013,-0.7674914286919391,0.7878787878787878,1.0,1.0,7/48,10.83%,COLEC12;IFITM3;OTULIN;TRIM13;AKAP1;NUB1;ALPK1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.33363101739774503,-0.767143022053458,0.7887323943661971,1.0,1.0,10/67,13.12%,CLU;TGFB2;VEGFA;HSP90AB1;STRADB;EPHA4;PRKAG2;MRNIP;CCN1;PDCD10
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),-0.4612674170495312,-0.7670521371319134,0.7887323943661971,1.0,1.0,3/9,17.61%,KCNMA1;ATP1B1;SLC12A6
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.48134017210043656,-0.766943007466126,0.71875,1.0,1.0,3/7,18.21%,ADM;TPM1;EDN3
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),-0.3762241245284782,-0.7668274238858862,0.8032786885245902,1.0,1.0,4/28,7.12%,ANXA1;GPC3;CD47;SGK1
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),0.4258514379419478,0.7668198252691049,0.7333333333333333,0.9981500839947725,1.0,1/8,2.05%,TNFRSF1B
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.4026503450467909,-0.7664554507014537,0.8135593220338984,1.0,1.0,6/19,9.11%,IFITM3;IFIT3;CMKLR1;ZFP36L2;VCAN;FN1
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.37991723483459944,0.7661875315837321,0.7209302325581395,0.9984545346044502,1.0,2/14,8.71%,RNF185;RNF139
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.45133326182480316,0.7657519730979577,0.8181818181818182,0.9982605468227036,1.0,2/10,1.07%,HSPB1;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),-0.33299164099530965,-0.7653978602126106,0.8450704225352113,1.0,1.0,7/77,7.75%,VEGFA;PHLDB2;ENPP2;BMP5;HSP90AB1;RALBP1;DCN
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.3956130425544555,0.7653330430221464,0.8888888888888888,0.9981355043830534,1.0,4/16,7.73%,PML;HIPK2;PSME3IP1;MARCHF7
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),0.40465670866229003,0.7651829887523522,0.775,0.9976249829222804,1.0,2/7,7.48%,CAMKK2;SLC25A4
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),-0.5210052876252665,-0.7650036680721539,0.7543859649122807,1.0,1.0,1/5,11.02%,FGF13
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),-0.4870586751205425,-0.76442390056344,0.796875,1.0,1.0,1/7,5.09%,GLI2
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.37095697394273525,-0.7643421109265914,0.8571428571428571,1.0,1.0,1/19,1.22%,RIMS1
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.46996233852730307,-0.7640220598925923,0.7894736842105263,1.0,1.0,3/7,27.32%,NEDD4;KHDRBS1;TPR
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.48095493721772153,-0.7636495055898839,0.75,1.0,1.0,4/6,26.34%,SQSTM1;ATG14;PRKN;ATG13
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.4458361464730176,0.7630784726352163,0.8,1.0,1.0,3/7,15.74%,RAP1A;RAPGEF2;RAPGEF1
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.4280011438169321,0.7625483944278876,0.75,1.0,1.0,1/9,3.99%,TDG
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.5096408171105467,-0.7624475001625995,0.7627118644067796,1.0,1.0,2/6,17.15%,ENO1;TMSB4X
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),-0.5096408171105467,-0.7624475001625995,0.7627118644067796,1.0,1.0,2/6,17.15%,ENO1;TMSB4X
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.4204932482317193,-0.7621894875380081,0.8135593220338984,1.0,1.0,1/11,8.90%,HPS4
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.3432775896444884,0.762045935658323,0.8095238095238095,0.9998602838410255,1.0,6/27,10.03%,PTPRK;CAMKK2;ERCC6L2;EGFR;RHOB;PXN
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.2723194824220161,0.7618873535935021,0.9705882352941176,0.9992816848139073,1.0,17/104,16.83%,PML;RNF185;MAEA;SPOPL;ZSWIM8;RNF139;ATXN3;KLHL20;ZNRF1;FBXW7;NEDD4L;PLAA;BTRC;RNF34;AREL1;UBE4B;KLHL42
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.3339262820017132,0.7617860515631878,0.8648648648648649,0.9986186871459761,1.0,5/43,14.31%,MFHAS1;HIPK2;EGFR;AIDA;MECOM
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.37425198215815225,-0.7615879958581473,0.9193548387096774,1.0,1.0,3/36,7.43%,CTSL;AP2A2;ACTR10
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.5166973816181522,-0.7615619090448151,0.78,1.0,1.0,1/5,19.10%,XRCC6
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),0.40579261583328563,0.7614749491529289,0.9166666666666666,0.998306447067862,1.0,4/15,29.27%,RNF139;PTPN1;TTC21B;LAMP1
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.3971565367233072,0.7608869808907177,0.7619047619047619,0.99838670382381,1.0,1/13,1.67%,PML
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.359747201028255,-0.760594089380153,0.8656716417910447,1.0,1.0,6/43,11.29%,RACK1;GSN;F3;BEX3;NGF;RPS3
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),-0.49482864534977866,-0.760414704403246,0.7966101694915254,1.0,1.0,3/5,38.50%,PIP4K2B;PIP4K2A;RUBCN
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.486273173894826,0.7601594678559515,0.7857142857142857,0.9986882009108063,1.0,1/7,4.67%,MGRN1
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.463192404025752,-0.7600846338993666,0.7846153846153846,1.0,1.0,4/10,21.30%,ACTR10;MAP1A;DLG2;DYNC1H1
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),-0.4646435418787246,-0.7600080644620978,0.8260869565217391,1.0,1.0,1/7,6.90%,APH1B
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),-0.3432978147462403,-0.7599368236256654,0.8194444444444444,1.0,1.0,3/43,5.55%,NRP1;PLD1;SEPTIN4
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.37536184925823346,-0.7598944600156974,0.7758620689655172,1.0,1.0,3/33,9.11%,NRP1;FBLN2;FN1
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.40281677834046137,0.7598758424117904,0.8043478260869565,0.9982575720866507,1.0,5/14,16.03%,NOTCH1;NOTCH3;HEYL;EP300;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.31603218987311343,-0.7598726584558099,0.9444444444444444,1.0,1.0,10/68,15.46%,NKD1;IGFBP2;DKK3;SFRP4;GLI3;TLE4;PSMC2;APOE;PSMD8;TCF7L2
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),-0.5077911951526793,-0.7595154609771406,0.803921568627451,1.0,1.0,1/5,14.74%,SQSTM1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.4421393310522646,0.7593437642530557,0.7111111111111111,0.9982696684339232,1.0,1/6,9.67%,ARNT
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.40633300334300987,-0.7587851704662452,0.75,1.0,1.0,3/17,9.13%,PHLDB2;THBS1;BCAS3
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.2902628462555902,-0.7587616110014817,0.9534883720930233,1.0,1.0,50/297,15.58%,CLU;VEGFA;IFIT3;RASGRF2;KCNMA1;FHL2;STAT1;ANXA1;VAV3;ANXA5;SFRP4;RACK1;ARHGEF3;SEPTIN4;THBS1;HTT;SLIT2;OLFM1;APH1B;NOTCH2;SGK1;MYO18A;PRMT2;BIRC2;DDX42;NDRG1;SMAD6;PRKDC;BCL2L14;NGF;RPS3;PPIA;CYP1B1;ANO6;ITGB3BP;DAPK2;WRN;PDCD10;ARF4;SRA1;APIP;NAE1;SQSTM1;MTCH2;MGMT;GADD45B;NET1;PTMA;SPTLC1;PHLDA1
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.3664495014535554,-0.7584580083155046,0.84375,1.0,1.0,2/35,5.20%,KLHL13;PIK3R4
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.3681791958166456,-0.7583576527923663,0.7076923076923077,1.0,1.0,13/39,22.83%,RHEB;NPRL3;LARP1;ATP6V1E1;LARS1;SEC13;RRAGB;ATP6V1D;ATP6V0D1;ATP6V0E1;SESN3;ITFG2;SZT2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.4252147071115744,-0.758210238221505,0.7833333333333333,1.0,1.0,2/12,6.06%,VEGFA;CHD6
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),0.389788894799841,0.7580608777059783,0.7959183673469388,0.9994962925725097,1.0,4/14,8.82%,SOX6;SOX5;ZBTB16;CD44
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.414878457624081,-0.7576920208118743,0.8260869565217391,1.0,1.0,3/17,11.79%,AKR1C1;THBS1;MAPK14
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),-0.40094363865905736,-0.7575940253124283,0.765625,1.0,1.0,2/15,7.88%,SULF2;CREB3L2
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),-0.4603404247378655,-0.7573742395746167,0.7719298245614035,1.0,1.0,1/8,8.77%,ACAT1
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.4229620975958377,0.7572815682646861,0.7906976744186046,0.9998977249348735,1.0,4/9,23.29%,GAS6;ZFP36L1;KDR;TSC2
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4310872436875435,-0.7572657714545601,0.8208955223880597,1.0,1.0,1/12,11.29%,RPS3
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),-0.48095611306244235,-0.7572084814647593,0.8135593220338984,1.0,1.0,1/5,1.62%,VEGFA
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.37264970932196895,0.7568458979194966,0.7567567567567568,0.9997388579137726,1.0,3/15,14.60%,MRPS27;ETF1;GFM2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.4048448951597212,-0.756441966921948,0.7068965517241379,1.0,1.0,3/16,17.73%,ANXA1;RGCC;EIF4G1
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),0.4385983742074094,0.7564092257221777,0.813953488372093,0.9997158106118259,1.0,4/8,19.09%,MAVS;DHX9;HLA-E;RIOK3
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),-0.32714094153487583,-0.7563781605385048,0.9594594594594594,1.0,1.0,10/64,12.72%,TGFB2;GLI2;TENM4;BTG2;TBCD;GPM6A;LAMB1;EPHA5;HDGFL3;APOE
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.3438889464978881,-0.7563180717281903,0.8194444444444444,1.0,1.0,8/55,14.26%,CIRBP;SNW1;NCL;DDX5;SRSF10;SRPK1;LARP7;CELF2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3840096287242338,0.7560507018066714,0.7567567567567568,0.9994473010933156,1.0,3/16,10.35%,APC;CDKN1A;RBL1
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.3335063600841055,-0.7554911223488541,0.8831168831168831,1.0,1.0,12/74,14.32%,MT2A;SLC38A1;NOTCH2;UCK2;NCL;MARCKS;CTCF;SRSF10;MAPK14;ORC5;WRN;NASP
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.3015779955568902,0.7546887630152702,0.8888888888888888,1.0,1.0,9/65,13.80%,BACH1;PPP2R1A;CEP70;CDKN1A;CCP110;NDE1;CEP290;DNM2;BTRC
prerank,PanglaoDB_Augmented_2021__Spermatozoa,0.3474165996765478,0.7542894408098769,0.7142857142857143,1.0,1.0,2/39,2.15%,CSF1R;CHL1
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),0.5091922724975668,0.7540093393828373,0.7878787878787878,1.0,1.0,1/5,2.05%,TNFRSF1B
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),-0.4613686941696014,-0.7536040100081438,0.7592592592592593,1.0,1.0,2/7,14.12%,GLI2;FOXC1
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),0.3848841232715743,0.7535402073692437,0.8333333333333334,0.9999808428395709,1.0,2/14,10.54%,PML;PPP1CC
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.3569525204818319,0.7531441938181224,0.8292682926829268,0.9990416600533976,1.0,4/27,12.38%,IPO8;PUM2;AGO2;NUP54
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.3569525204818319,0.7531441938181224,0.8292682926829268,0.9990416600533976,1.0,4/27,12.38%,IPO8;PUM2;AGO2;NUP54
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.3929401024155905,-0.753120831646944,0.864406779661017,1.0,1.0,10/22,21.61%,RPL5;UCHL5;N4BP1;HSP90AB1;FHIT;RPL11;RPS7;CSNK2A2;MAP1A;RPL23
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),0.5069460827411945,0.7524535941799089,0.7857142857142857,0.999322352005326,1.0,2/5,12.80%,PPP2R3C;DOCK11
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.3585473598688181,-0.7520770434447537,0.8082191780821918,1.0,1.0,6/40,9.13%,RIPOR2;NRP1;HTT;RHOQ;GPM6A;BCAS3
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),0.4299988941850058,0.7520525619810048,0.7857142857142857,0.999022268812221,1.0,1/10,3.34%,ACADVL
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,-0.33890510304544386,-0.7519352143302597,0.8307692307692308,1.0,1.0,9/52,14.81%,ALDH1A1;ALDH3A2;GABARAPL1;PTS;ACO2;SUCLG2;DLD;LDHA;HSPH1
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),-0.4369291286863646,-0.7517634218778337,0.7857142857142857,1.0,1.0,1/9,6.53%,HSP90AB1
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),0.3501125446851341,0.7516300865663977,0.8666666666666667,0.9987646914259661,1.0,5/25,13.11%,TNFRSF1B;AXL;RHOA;PLAA;NFKB1
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.41711107176090295,-0.7514369818210339,0.803921568627451,1.0,1.0,1/15,0.56%,CD55
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.3933314969837858,-0.750784327152655,0.8421052631578947,1.0,1.0,4/18,11.81%,AGPAT4;TPK1;AGPAT5;GNPAT
prerank,MSigDB_Hallmark_2020__DNA Repair,-0.339488408046716,-0.7506416474502321,0.8666666666666667,1.0,1.0,4/42,6.38%,NME3;DDB2;XPC;POLA1
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.35672443673803866,0.7504887137902307,0.825,0.9996998705582233,1.0,6/24,15.70%,ST3GAL2;OGA;STT3B;GANAB;PCSK6;LARGE1
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.40997480878433357,-0.7500375816088595,0.8103448275862069,1.0,1.0,3/18,9.34%,PHLDB2;ARHGAP28;TMEFF2
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.4001065371726132,0.7492999466541469,0.8235294117647058,1.0,1.0,4/17,8.82%,SOX6;SOX5;ZBTB16;CD44
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.3581800646284935,-0.7491084009929154,0.8333333333333334,1.0,1.0,3/33,6.26%,VEGFA;ANXA1;THBS1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.4021659329955478,0.7488919193962948,0.803921568627451,1.0,1.0,6/10,22.30%,HACD2;ELOVL6;ELOVL5;ACSL3;ACSL1;TECR
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.35077243930030994,0.7486139608962294,0.6896551724137931,0.9999499085281097,1.0,4/14,20.52%,ACTR2;CDC42;ACTR3;CYFIP1
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.4623640850126972,-0.7479740210286762,0.7857142857142857,1.0,1.0,2/7,6.26%,TWIST1;THBS1
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),-0.431387004949354,-0.7476769308088425,0.7931034482758621,1.0,1.0,1/10,8.90%,HPS4
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.31476713131923895,-0.7474374791749022,0.8823529411764706,1.0,1.0,11/56,25.33%,VAV3;PSMC2;PSMD8;PIK3CB;JUN;PIK3R1;CALM1;LYN;PSMD14;MAPK9;PSMA3
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),-0.45298536683417523,-0.7474047065725106,0.7321428571428571,1.0,1.0,1/9,1.96%,PARP1
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),0.4953845586970552,0.7473052289009672,0.7906976744186046,1.0,1.0,1/5,3.03%,ATP8B1
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),0.38398772390297803,0.7472931309106842,0.8648648648648649,1.0,1.0,9/18,24.78%,HACD2;FADS3;ELOVL6;ELOVL5;SCD5;SCD;TECR;MLYCD;ABHD2
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),-0.44283914863308294,-0.7471618003348669,0.7692307692307693,1.0,1.0,1/6,10.09%,ARIH2
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.38981331373547234,0.7469423665029811,0.7317073170731707,0.9999814772148728,1.0,2/13,10.75%,HSPA8;CAMSAP1
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.42493924094374524,-0.7466582101067072,0.7959183673469388,1.0,1.0,2/13,7.09%,SRP54;PEX1
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),-0.43416396893437803,-0.7462413924773076,0.7884615384615384,1.0,1.0,5/8,35.71%,EIF4G1;GPC6;LRFN5;APP;GPC4
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),-0.43416396893437803,-0.7462413924773076,0.7884615384615384,1.0,1.0,5/8,35.71%,EIF4G1;GPC6;LRFN5;APP;GPC4
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.3587261833009851,0.7460226740030923,0.8260869565217391,1.0,1.0,4/21,10.23%,PDGFA;UBE2N;SMG1;YLPM1
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.44846313560053375,-0.7458315513093006,0.8448275862068966,1.0,1.0,2/8,12.72%,ATG10;APOE
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),-0.4928297297658096,-0.7457660372513027,0.8688524590163934,1.0,1.0,1/5,8.63%,TCHP
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.46830279906221894,-0.7452326230446341,0.7755102040816326,1.0,1.0,2/5,20.48%,NAMPT;SELENOS
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.402593316127951,0.7450434892386479,0.7857142857142857,1.0,1.0,4/12,18.83%,AGO2;PRKRA;PIWIL4;TENT4B
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),-0.438757575604505,-0.7448256972124302,0.8703703703703703,1.0,1.0,1/10,2.04%,PHLDB2
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.4055526353973662,0.7437792860639726,0.7045454545454546,1.0,1.0,3/10,8.39%,SOX6;SOX5;ZBTB16
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),-0.34205449641643687,-0.7435990924141112,0.8656716417910447,1.0,1.0,8/55,13.23%,PLXNC1;EPHA3;SLIT2;PTK7;NGF;APOE;PLXNA2;ROBO2
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.3347254115672172,0.7431673466155475,0.9032258064516129,1.0,1.0,8/40,11.36%,GNB1;ADCY9;PTH1R;MYH9;ADCY3;MAPKBP1;ADCY5;ADAM17
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.48404240117151565,-0.7429451535121341,0.8301886792452831,1.0,1.0,2/6,16.43%,METTL15;DIMT1
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.3525801379890295,0.7428839451101532,0.8235294117647058,1.0,1.0,10/26,27.57%,PPP2R1A;RANGAP1;KPNB1;REEP3;UBXN2A;CHMP4B;SUMO1;AHCTF1;IST1;NSFL1C
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),0.4091054321238442,0.7427423645575154,0.7027027027027027,1.0,1.0,2/8,15.01%,CEBPB;UBASH3B
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.35126244276943963,0.742718876013551,0.7727272727272727,1.0,1.0,7/30,13.62%,NOTCH1;HEY2;NOTCH3;HEYL;ADAM17;SORBS2;EP300
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),-0.30986289121560284,-0.74266497552053,0.8767123287671232,1.0,1.0,4/93,2.18%,KCNMB1;RIMS1;GABRB2;GRIA4
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),0.4398080658191039,0.742617424106984,0.9047619047619048,0.9999403817105548,1.0,2/6,23.12%,PHF8;FLNA
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),-0.38632752011336957,-0.742085134314969,0.84375,1.0,1.0,6/25,17.02%,SLC8B1;LEPR;HECTD4;TCF7L2;CYB5R4;APPL2
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.33011196540617666,0.741409177230483,0.9,1.0,1.0,8/28,23.39%,KIFC2;RHOA;NDE1;KPNB1;CHMP4B;EPS8;FLNA;LSM14A
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.41587346985024964,0.7413653789678762,0.8048780487804879,1.0,1.0,4/11,17.48%,HDAC9;HDAC1;HDAC2;ELK4
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),-0.33643522884508814,-0.7412528453431138,0.9014084507042254,1.0,1.0,7/54,13.01%,PLD1;RIN2;RHEB;RALBP1;G3BP2;MAPK14;KRAS
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.27837610739525026,0.7406203462769325,0.9696969696969697,1.0,1.0,9/78,10.47%,PDK4;HSPA8;ATP6V1H;CLEC16A;ZFYVE1;RNF152;CEBPB;CDKN1A;PPARA
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3258793495168436,0.7405438180059002,0.825,0.9999158935063716,1.0,4/29,12.53%,BCL2;MICALL2;FBXW7;SAE1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.4489498344148961,-0.7404357956401078,0.746031746031746,1.0,1.0,1/12,1.56%,MDFIC
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),-0.47015328979528204,-0.7397182394437896,0.75,1.0,1.0,1/6,1.68%,NRP1
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.43089241728177496,0.7391963171209731,0.813953488372093,1.0,1.0,2/9,11.89%,FMNL3;FHOD1
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),-0.5177496256848568,-0.739033035279517,0.8524590163934426,1.0,1.0,2/5,4.60%,ST6GALNAC3;ST3GAL5
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),0.4893328034010468,0.7388507915558221,0.8,1.0,1.0,1/5,3.45%,EMP2
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.31273323586073376,-0.7387297611137426,0.875,1.0,1.0,11/74,14.21%,SULF2;SFRP4;GPC3;COL1A1;RNF220;PTK7;PSMC2;CSNK1D;WNK2;TNKS2;PSMD8
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.4600412652592757,-0.7382924326523292,0.84,1.0,1.0,3/9,32.77%,TRIM62;EXOC7;HS3ST5
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),-0.4686002773696935,-0.7381753373235918,0.8571428571428571,1.0,1.0,3/7,33.09%,ANXA2;PIP4K2B;SH3GLB1
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.40622617163552216,-0.7378735780970194,0.8,1.0,1.0,1/14,5.20%,PIK3R4
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.40602695510525433,0.7376690586309411,0.8297872340425532,1.0,1.0,1/8,1.86%,BCL2
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),0.38400883842944955,0.7374948471815457,0.8787878787878788,1.0,1.0,2/16,2.81%,SERPINB6;TIMP3
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.4157192555800842,0.7372008310432494,0.8,1.0,1.0,2/9,14.15%,CPT1A;CERT1
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.4462103937324067,-0.7371682716490094,0.8064516129032258,1.0,1.0,5/8,20.48%,THBS1;EIF2B3;TCF7L2;LPL;SELENOS
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.4335538007411872,0.7370861490726159,0.8611111111111112,0.9995417708571014,1.0,5/7,34.26%,DHX9;TRAF3;RNF216;ILRUN;ITCH
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.38792001299040174,-0.7370097202599334,0.8115942028985508,1.0,1.0,7/26,19.09%,UCHL5;HSP90AB1;PSMC2;APOE;UFL1;PRKACA;PRKN
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),0.38603112917015525,0.7368927218948542,0.88,0.9990257642219184,1.0,2/13,10.54%,PML;PPP1CC
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.4703142774478041,0.7367423304671463,0.8333333333333334,0.9984283479297676,1.0,2/7,16.49%,UBN1;HAT1
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.4258464716078219,-0.7365629368253923,0.7884615384615384,1.0,1.0,1/13,2.31%,CTSL
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.38861821636940636,-0.7358419742731459,0.7627118644067796,1.0,1.0,2/17,5.73%,TGFB2;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.4286779335850836,0.7358103866377644,0.8292682926829268,0.9984809873244257,1.0,1/10,0.72%,HSPB1
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),-0.43095150365318413,-0.735229299593891,0.8888888888888888,1.0,1.0,3/10,21.37%,PRDM5;WDR82;SETDB2
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),-0.41204283810341247,-0.734233405358569,0.8103448275862069,1.0,1.0,4/15,13.23%,TWIST1;SLIT2;SMAD6;ROBO2
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),-0.38539342744081617,-0.73351399261785,0.7962962962962963,1.0,1.0,1/19,2.76%,VAMP4
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.4468087587748836,0.7330620981526499,0.7674418604651163,1.0,1.0,1/5,3.45%,EMP2
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),-0.35582446392126266,-0.7328182859799309,0.8115942028985508,1.0,1.0,2/33,2.79%,SLC8B1;LEPR
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.4208877779790769,-0.7326517835163737,0.8064516129032258,1.0,1.0,3/13,27.21%,RNASEH2B;NUDT5;NCBP1
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.3506259320748078,-0.7318476435430679,0.9104477611940298,1.0,1.0,5/37,14.65%,ACTG1;EPHA3;THBS1;LIMCH1;MINK1
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.3308824608899018,-0.7313999534939933,0.9848484848484849,1.0,1.0,3/46,5.79%,NR4A2;SFRP4;PLPP3
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.3592237363434548,-0.7312270848770243,0.8870967741935484,1.0,1.0,3/20,14.21%,AZIN1;PSMC2;PSMD8
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),-0.3785662377666967,-0.7311915448725225,0.8392857142857143,1.0,1.0,3/20,8.49%,ALDH1A1;RHEB;LAMA4
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.3589680556836465,-0.7310231812217424,0.859375,1.0,1.0,2/29,8.89%,TUBGCP5;CEP126
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),0.46281323658507356,0.730877185643115,0.7894736842105263,1.0,1.0,1/5,9.66%,CAB39
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.35893034140121743,0.7307948550016325,0.8,1.0,1.0,3/29,7.36%,ST3GAL2;NUS1;B3GNT2
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.3791318854662611,0.7306637367218236,0.94,1.0,1.0,3/17,9.72%,USP7;USP16;ATXN3
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),-0.38607740090568937,-0.7306516023451827,0.8148148148148148,1.0,1.0,1/15,4.30%,RACK1
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.33488314579867584,0.7302690751266306,0.9024390243902439,1.0,1.0,2/28,5.58%,HSPB1;IRS2
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.42579278591238656,-0.7297093113073807,0.8125,1.0,1.0,7/14,30.04%,PRMT2;PRMT3;NSD3;NSD1;PRMT7;LCMT1;EHMT1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),-0.49424092348855303,-0.7295215885836972,0.8070175438596491,1.0,1.0,1/5,6.26%,THBS1
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.46237824480256207,-0.7289866039922253,0.847457627118644,1.0,1.0,1/6,3.96%,ENPP2
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),-0.4533202332823745,-0.7284753828906472,0.8431372549019608,1.0,1.0,3/5,27.32%,PLSCR1;CSNK2A2;TPR
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),0.41360561726876693,0.7280839741844795,0.717391304347826,1.0,1.0,1/8,8.84%,CACNB2
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.43363122853533476,0.7278646640889631,0.8666666666666667,1.0,1.0,3/9,19.43%,RYR2;ERO1A;RYR3
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),-0.44179902109048913,-0.727291718876023,0.8387096774193549,1.0,1.0,3/11,17.00%,SLCO1A2;SLC22A6;LRRC8B
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.47511270720171184,0.7266742826836116,0.75,1.0,1.0,3/5,27.33%,EIF2AK4;NFKBIA;DNAJC3
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.44669122144259243,0.7255806228646616,0.82,1.0,1.0,2/6,10.22%,ARHGEF7;EML2
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),-0.46110712116113045,-0.7250309688159403,0.8,1.0,1.0,1/5,7.12%,SGK1
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),-0.3652107937606345,-0.7249814651509309,0.8484848484848485,1.0,1.0,2/22,2.98%,NRP1;STAT1
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.3901049304655472,0.7249809749107999,0.86,1.0,1.0,2/11,17.02%,SEC23A;SEC24D
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),-0.43385040722444557,-0.7244244859534155,0.7959183673469388,1.0,1.0,2/8,9.53%,TBCD;JAM3
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.3622062337248585,-0.7243130264294908,0.8611111111111112,1.0,1.0,2/29,3.63%,RIMS1;SLC38A1
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.4092685461203009,-0.723999563465793,0.8135593220338984,1.0,1.0,3/22,8.57%,PARP1;MSH6;NCL
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.3396399375817,0.7234937419644991,0.8235294117647058,1.0,1.0,6/37,18.83%,WDR33;PCF11;GRSF1;CPSF2;PAPOLG;TENT4B
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),-0.35306498906737394,-0.7234397961753936,0.8840579710144928,1.0,1.0,4/39,6.56%,PARP1;PKM;EPRS1;RHOQ
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.45700148937386414,0.723308188004625,0.875,1.0,1.0,4/8,25.26%,RAP1A;RAPGEF2;EZR;MAP4K4
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.45700148937386414,0.723308188004625,0.875,1.0,1.0,4/8,25.26%,RAP1A;RAPGEF2;EZR;MAP4K4
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.3040198559218285,-0.7232347145245179,0.9420289855072463,1.0,1.0,17/67,21.61%,RPL5;RPS20;SGK1;BRCA1;RPA1;RAD17;MAPK14;PRKAG2;WRN;RPL11;RPL37;TOPBP1;RBBP7;MRE11;CSNK2A2;MAPKAP1;RPL23
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.37379191260984157,0.7232105900152316,0.9117647058823529,1.0,1.0,3/14,9.18%,TNFRSF10B;BCL2L1;MADD
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.3192796750203127,-0.7231887394061539,0.9117647058823529,1.0,1.0,14/63,23.00%,RAD51B;PSMC2;CSNK1D;FHL1;PSMD8;NINL;SDCCAG8;PRKACA;FBXL7;DYNC1H1;PSMD14;CKAP5;YWHAE;MECP2
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),-0.4182596038490535,-0.7230978553034614,0.828125,1.0,1.0,3/11,13.04%,BMP5;BRCA1;PRMT3
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.4240511716685607,0.7230088986930764,0.7692307692307693,1.0,1.0,4/7,35.02%,HAT1;KAT6A;TOP1;ABL1
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.4392400903634408,0.7229624971014319,0.7954545454545454,1.0,1.0,1/5,23.55%,TASOR
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.31090637776770824,0.7228829865231242,0.9534883720930233,1.0,1.0,6/35,13.11%,TNFRSF1B;AXL;RHOA;ADAM17;PLAA;NFKB1
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.38663551416757475,-0.7225410419712662,0.8548387096774194,1.0,1.0,11/20,26.97%,UBL5;HPS4;ARIH2;ABLIM3;SREBF2;PRKN;CSNK2A2;LMAN1;UBE2L3;ATG13;NPEPPS
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),-0.4123019681710332,-0.7225266407973208,0.8,1.0,1.0,2/11,10.30%,AMPH;SYNJ2
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),-0.3677063698322567,-0.7218789518681284,0.796875,1.0,1.0,1/16,4.30%,RACK1
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.4451122733879563,-0.7212875355974258,0.8793103448275862,1.0,1.0,4/8,30.48%,DIMT1;WDR43;SHQ1;USP36
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.3535499986019031,-0.7211472600933396,1.0,1.0,1.0,5/31,19.10%,STAT1;PRKDC;DHX36;MRE11;XRCC6
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),0.39556927602384695,0.7209913674115807,0.8055555555555556,1.0,1.0,3/16,8.87%,CACNA1B;GNAI1;IRS1
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),-0.49352713640422397,-0.7207920401855913,0.875,1.0,1.0,2/5,16.33%,LPL;SREBF2
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.4387579653153444,0.7207007501051292,0.7804878048780488,1.0,1.0,1/7,4.70%,TRAK1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),-0.4584860398153696,-0.7206525304436562,0.8913043478260869,1.0,1.0,1/5,11.49%,CCT6A
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.3434926901655968,-0.7205467400357216,0.8947368421052632,1.0,1.0,6/35,19.10%,POLA1;PRKDC;DHX36;UFD1;MRE11;XRCC6
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.41851794291288524,0.7202690570748367,0.8444444444444444,1.0,1.0,3/8,14.65%,AXL;PPP2R3C;GAS6
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),-0.4075498766242257,-0.720218990861757,0.7903225806451613,1.0,1.0,2/12,10.30%,AMPH;SYNJ2
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.36080267387136244,0.7201345421625076,0.8780487804878049,1.0,1.0,3/15,12.34%,TRAK1;KIF5B;NDE1
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.3431584971332279,0.7199106084337175,0.8461538461538461,1.0,1.0,3/24,7.01%,GPRC5B;SNX4;NFKBIZ
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.3890868731321764,-0.7196824791320905,0.8135593220338984,1.0,1.0,4/18,11.58%,HINT1;SNW1;DDX5;FHIT
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,-0.31331241104849206,-0.7196149255036738,0.9295774647887324,1.0,1.0,8/64,10.07%,LAMC1;GLI2;SLIT2;COL12A1;MID1;LAMB1;FN1;SMAD6
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.35162371269891635,-0.7195096302662363,0.9354838709677419,1.0,1.0,3/39,7.43%,CTSL;AP2A2;ACTR10
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.39533044422728325,0.718882725872252,0.9259259259259259,1.0,1.0,3/13,13.11%,ABCA1;PPARA;NFKB1
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.4295971132888982,-0.7188776791453707,0.8064516129032258,1.0,1.0,5/12,29.88%,RGCC;EDN3;PHIP;PDGFRB;LCMT1
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),-0.3286031966106483,-0.7187041176572744,0.864406779661017,1.0,1.0,6/30,14.36%,EYA1;BRCA1;UIMC1;DDX5;RPS3;RNF8
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,0.4200166226919938,0.7183061312963794,0.7954545454545454,1.0,1.0,2/11,3.93%,DNAH9;GFAP
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.36218431926337635,0.7182251929532775,0.9444444444444444,1.0,1.0,2/20,4.89%,NCK2;CDC42EP4
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.38437560688302125,0.7171073429475818,0.8918918918918919,1.0,1.0,2/15,3.83%,BCL2;BCL2L1
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),-0.41301695117022014,-0.716955509152816,0.8307692307692308,1.0,1.0,1/10,2.74%,KCNMA1
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),-0.41537160503694337,-0.7165553436098542,0.84375,1.0,1.0,2/13,10.20%,PRRC1;PRKAR1A
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.424261743956146,-0.7163791717276943,0.8392857142857143,1.0,1.0,1/8,19.09%,PRKN
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.3862841502613844,-0.7157242853255698,0.8548387096774194,1.0,1.0,1/14,5.50%,ARHGAP28
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.4192828113266551,0.7152154466184365,0.8035714285714286,1.0,1.0,2/7,17.23%,BNIP3;CALCOCO2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.4146530916926633,0.7147793797053921,0.82,1.0,1.0,2/6,6.54%,RFX3;VEZF1
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),-0.45366884413803105,-0.7147338980510424,0.8421052631578947,1.0,1.0,3/7,19.44%,SPEF2;BBS4;VPS51
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.2829954663066449,0.7142228914092681,1.0,1.0,1.0,22/118,15.93%,NCK2;APC;RASAL2;CDC42EP4;MYH9;ARHGEF7;ARHGAP10;MYO1E;ABR;KIF5B;KLC1;PXN;RICTOR;BIN1;SORBS2;PPP4R2;PDLIM5;CDC42;PREX1;RANBP9;SEPTIN9;PLEKHG2
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),0.358771699699233,0.7141926065070725,0.8571428571428571,1.0,1.0,5/23,14.81%,ARF1;RALA;HNRNPF;PAK2;CDC42
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.37362342488776495,0.7140544584730195,0.875,1.0,1.0,5/14,20.18%,RHOA;CYTH3;CDC42;PARD3;EZR
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.35246609373910387,0.7136405704150806,0.8974358974358975,1.0,1.0,3/22,8.39%,MFHAS1;HIPK2;ZBTB16
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.3891700148001971,-0.7134368311285739,0.8448275862068966,1.0,1.0,3/14,20.26%,PIK3R4;ATG14;PIK3R1
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),0.2919148673754134,0.7132297615984042,0.925,1.0,1.0,6/55,9.14%,GNB1;GNAO1;MAP3K7;FZD3;AGO2;RHOA
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.2869155778537132,0.7125990381974632,0.9354838709677419,1.0,1.0,8/58,10.28%,ACTR2;ARF1;UBE2N;MAP3K7;RAF1;EGFR;CAB39;CDKN1A
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.45816056388170756,0.7125726177326192,0.8409090909090909,1.0,1.0,3/9,23.05%,SETD7;MECOM;HP1BP3
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),0.3845431770225532,0.7125417462436541,0.8372093023255814,0.9992674121463895,1.0,1/12,1.32%,CNOT7
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.3939945716292553,-0.7123260172650977,0.8985507246376812,1.0,1.0,1/13,0.93%,RIPOR2
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),-0.4794028117667101,-0.7120881668754724,0.8771929824561403,1.0,1.0,1/5,9.05%,PDCD4
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),-0.45133044708618464,-0.711593413260529,0.8363636363636363,1.0,1.0,1/10,1.68%,NRP1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.41191562797263404,-0.7115886828556889,0.896551724137931,1.0,1.0,3/11,7.28%,THBS1;HSP90AB1;SNW1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.41191562797263404,-0.7115886828556889,0.896551724137931,1.0,1.0,3/11,7.28%,THBS1;HSP90AB1;SNW1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.3357132489684217,0.7113987941323818,0.8571428571428571,0.9991449920250206,1.0,8/23,27.17%,PPP2R1A;RANGAP1;KPNB1;REEP3;CHMP4B;SUMO1;AHCTF1;IST1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.3357132489684217,0.7113987941323818,0.8571428571428571,0.9991449920250206,1.0,8/23,27.17%,PPP2R1A;RANGAP1;KPNB1;REEP3;CHMP4B;SUMO1;AHCTF1;IST1
prerank,GO_Biological_Process_2021__axon development (GO:0061564),-0.3374784510516468,-0.711169718198023,0.875,1.0,1.0,1/35,1.03%,AFG3L2
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),-0.3411827133712284,-0.7105429413774969,0.8955223880597015,1.0,1.0,6/42,12.83%,ARHGAP24;TBC1D2B;BCAS3;TBC1D9;TBC1D22A;GARNL3
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.2977797117382324,0.7103678154825227,0.9142857142857143,0.9996577249752444,1.0,8/39,15.27%,UBQLN1;SMAD7;FBXW7;UBE2D1;SAE1;COMMD1;NDFIP2;DCUN1D4
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.325872368313906,-0.7102022140182694,0.9558823529411765,1.0,1.0,12/42,21.74%,NMD3;NGF;DERL1;APOE;PARP9;FOXC1;RPL11;TCF7L2;HES1;PRKN;ZNF618;PSEN1
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.3943310245499345,-0.7100334782037657,0.8823529411764706,1.0,1.0,1/12,0.93%,RIPOR2
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.3955297923270417,-0.709980502557333,0.7796610169491526,1.0,1.0,2/11,16.75%,PIK3R4;ATG14
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.3074298371364077,-0.7092120530170547,0.9354838709677419,1.0,1.0,10/64,14.21%,SFRP4;GPC3;COL1A1;RNF220;PTK7;PSMC2;CSNK1D;WNK2;TNKS2;PSMD8
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.42470717792248863,-0.7083156714310708,0.8245614035087719,1.0,1.0,3/8,27.74%,LYN;STAT6;STAT3
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.4343668854426796,0.708177633921839,0.782608695652174,1.0,1.0,3/6,15.54%,NEDD4L;COMMD1;WNK1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.40088921383489523,0.7077141857738709,0.8536585365853658,1.0,1.0,5/10,22.59%,TIMP3;CAMK2N1;PRNP;DNAJC1;ROCK1
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),-0.3669410669648438,-0.7073482985847817,0.8412698412698413,1.0,1.0,3/18,10.47%,TET1;BRCA1;SAP30BP
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.39226332999048946,0.7065221142196723,0.8666666666666667,1.0,1.0,2/9,14.85%,AGO2;PRKRA
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.30178843351918677,0.7063662136665794,0.9444444444444444,0.9995444888568992,1.0,7/42,13.80%,MAP3K7;RAF1;RPS6KA5;PAK2;NFKB1;EP300;BTRC
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.30178843351918677,0.7063662136665794,0.9444444444444444,0.9995444888568992,1.0,7/42,13.80%,MAP3K7;RAF1;RPS6KA5;PAK2;NFKB1;EP300;BTRC
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.30178843351918677,0.7063662136665794,0.9444444444444444,0.9995444888568992,1.0,7/42,13.80%,MAP3K7;RAF1;RPS6KA5;PAK2;NFKB1;EP300;BTRC
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.43994229026282733,-0.706252246225064,0.75,1.0,1.0,2/6,28.83%,RER1;ANKRD13C
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.3991993742499518,0.7054314789991096,0.8205128205128205,0.9998401425907919,1.0,1/9,9.93%,INPP5A
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),0.44548981772507457,0.7050547862584319,0.7906976744186046,0.9994779326390754,1.0,1/5,3.45%,EMP2
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.33557661629303853,-0.7045634929017864,0.8823529411764706,1.0,1.0,8/34,17.73%,ANXA1;PRMT2;INO80;FHL1;RBL2;RGCC;APPL2;EIF4G1
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),-0.3860125523287006,-0.7045622831300009,0.8225806451612904,1.0,1.0,2/12,16.75%,PIK3R4;ATG14
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.37356751434715785,-0.7045054159938537,0.8923076923076924,1.0,1.0,3/18,11.28%,AKR1C2;PTGFR;LARP1
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),-0.3589740666408978,-0.7038373910941389,0.8363636363636363,1.0,1.0,1/22,4.30%,RACK1
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),-0.45891899241359646,-0.7038076400097479,0.9285714285714286,1.0,1.0,1/8,1.30%,LMF1
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),0.4224163861779576,0.7030700068207502,0.8461538461538461,1.0,1.0,2/7,22.59%,CDKN1A;ROCK1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.41138447155323454,-0.702374528934576,0.864406779661017,1.0,1.0,3/11,20.56%,HSP90AB1;TM9SF4;MAP1A
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.3926012941665882,-0.7022033392738093,0.8181818181818182,1.0,1.0,5/17,12.50%,PER2;RHEB;NOTCH2;FBXO22;BHLHE40
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),0.45944767314206136,0.7021272230843901,0.8333333333333334,1.0,1.0,2/5,35.10%,NEK4;PNPT1
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),-0.43793927711054326,-0.7020754112780779,0.8727272727272727,1.0,1.0,1/10,0.93%,RIPOR2
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.4348296582784867,0.7020594855609992,0.8076923076923077,1.0,1.0,1/5,4.04%,RFX3
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),0.31685950375421257,0.7017019948603334,1.0,0.999992935621043,1.0,4/34,8.37%,SGPL1;PPP2R1A;CPM;MTHFD2L
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.45326144242318045,-0.7014715232445097,0.82,1.0,1.0,2/6,17.37%,SOAT1;NECAB1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.46101086111702577,-0.7013394009907896,0.8955223880597015,1.0,1.0,1/5,13.52%,ATP1B1
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.3463979955540336,-0.7009982468793652,0.9516129032258065,1.0,1.0,3/21,14.21%,AZIN1;PSMC2;PSMD8
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.2773032349588383,0.7008525894986427,0.9629629629629629,1.0,1.0,9/66,13.80%,AKAP8;PPP2R1A;CEP70;CDKN1A;CCP110;NDE1;CEP290;DNM2;BTRC
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.358070199476942,-0.7008244386629809,0.8636363636363636,1.0,1.0,9/23,21.72%,ELOVL2;CYP1B1;AIG1;PLA2G4C;GPX4;PNPLA8;HSD17B4;FADS2;MGLL
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.344080886263297,-0.6999650432373885,0.953125,1.0,1.0,8/35,19.09%,FOXQ1;KDM2B;RETREG1;NGF;APOE;EIF4G1;MT3;PRKN
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.3394919835665666,0.6997899469182477,0.8333333333333334,1.0,1.0,1/14,3.83%,BCL2L1
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.39382160601808897,-0.6996580472878245,0.8461538461538461,1.0,1.0,2/15,4.60%,PIGG;ST3GAL5
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.3672959844974733,-0.6994255649626999,0.8363636363636363,1.0,1.0,6/21,19.87%,CMTR1;TARBP1;DIMT1;NSUN2;NSUN6;TRMT44
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),-0.43015624624204307,-0.6992666123808331,0.8775510204081632,1.0,1.0,3/6,28.09%,DTNBP1;PRKN;KCNB1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.3561799489034317,0.6986188541553986,0.875,1.0,1.0,6/16,25.36%,IRS1;RPS6KB1;KANK1;PTPN1;TSC2;TNS2
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.26190721145280693,0.6980437030375877,1.0,1.0,1.0,19/105,16.01%,RNF185;RC3H2;UBQLN1;RNF14;AMFR;CBL;ATXN3;NEDD4L;ANAPC16;FBXO11;UBE2D1;BTRC;UBE4A;RNF34;NDFIP2;ANAPC1;AREL1;RNF168;UBE4B
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.2930742082581512,-0.6979188793674114,0.9855072463768116,1.0,1.0,15/78,15.94%,AFG3L2;HADHA;ATP5PF;ABCB7;ACAT1;ACO2;NQO2;ATP6V1E1;COX4I1;ATP1B1;DLD;LDHA;NDUFB7;GPX4;HSPA9
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.3548068429733086,-0.6978707256594022,0.8656716417910447,1.0,1.0,2/21,11.29%,TBCD;RPS3
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.28039728320826773,-0.6975800658331475,1.0,1.0,1.0,14/121,14.21%,DDB2;UCHL5;TGFBR1;USP31;OTULIN;BIRC2;BRCA1;UIMC1;INO80;PSMC2;USP40;UFD1;OTUD6B;PSMD8
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.40193090646456575,-0.6973643778784122,0.8412698412698413,1.0,1.0,3/14,14.55%,PRPF6;SRSF10;PRPF8
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.330280229809976,0.697345582967387,0.84375,1.0,1.0,8/24,16.38%,CDH2;GRID2;NRXN1;NLGN4Y;GABRB3;KIRREL3;NLGN2;LRRTM3
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),-0.3504745485791856,-0.6971724793780935,0.8947368421052632,1.0,1.0,3/22,8.49%,ALDH1A1;RHEB;LAMA4
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.35720492649714086,-0.6969179809135847,0.8709677419354839,1.0,1.0,5/25,14.36%,SUPT6H;INO80;CTCF;NASP;RNF8
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.35489983778770684,-0.6966182951235808,0.8823529411764706,1.0,1.0,9/20,24.66%,MSH6;BCAS3;MAPK14;WRN;YWHAB;MT3;PSEN1;SSBP1;MSH3
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),0.46253698916848196,0.6966145512879355,0.82,1.0,1.0,1/6,2.23%,HEY2
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.34179793529018226,-0.6962229950770642,0.8615384615384616,1.0,1.0,12/38,22.83%,RHEB;NPRL3;ATP6V1E1;LARS1;SEC13;RRAGB;ATP6V1D;ATP6V0D1;ATP6V0E1;SESN3;ITFG2;SZT2
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),-0.3101090300646537,-0.6960898609542762,0.9420289855072463,1.0,1.0,7/51,12.16%,ACTG1;VAV3;EPHA3;AP2A2;APH1B;EPHA5;EPHA4
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),-0.450830432013873,-0.6959810381090398,0.8070175438596491,1.0,1.0,2/7,21.00%,FGD6;DNM3
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),-0.3896047487095419,-0.6957913834250219,0.8135593220338984,1.0,1.0,7/14,22.83%,GPR137C;LARS1;RRAGB;GPR137B;SESN3;ITFG2;SZT2
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.2523116167390239,0.6957328004268645,1.0,1.0,1.0,48/180,23.93%,PML;RNF185;RC3H2;UBQLN1;RNF14;MAEA;SPOPL;ZSWIM8;AMFR;CBL;ATXN3;KLHL20;ZNRF1;FBXW7;NEDD4L;ANAPC16;FBXO11;UBE2D1;PLAA;BTRC;UBE4A;RNF34;NDFIP2;ANAPC1;AREL1;RNF168;UBE4B;KLHL42;MVB12B;ARIH1;CNOT4;CUL4A;RNF149;PSMD11;PSMB2;UBXN2A;RBBP6;PSMF1;PPP2R5C;MIB1;USP9X;SIAH1;SMURF1;TSG101;UBE3B;FAF1;PSMA7;COP1
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),-0.36586022590581846,-0.6951782786782418,0.8947368421052632,1.0,1.0,1/16,6.58%,ESCO1
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.43015662563867224,0.6946197564151256,0.7894736842105263,1.0,1.0,1/6,7.99%,RNF152
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.41405575297671154,-0.6943181365140044,0.803921568627451,1.0,1.0,3/9,13.59%,GLRX;ATP1B1;WNK2
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),0.3651048151635349,0.6941480692295459,0.8085106382978723,1.0,1.0,2/11,12.59%,EGFR;DNM2
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.40713725218638996,0.693654835851159,0.8723404255319149,1.0,1.0,2/7,10.78%,MTMR1;MTMR4
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),-0.47322001880420583,-0.693597641920642,0.8484848484848485,1.0,1.0,2/6,14.65%,CNIH3;MINK1
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.35066617478926093,-0.6935013874881681,0.9122807017543859,1.0,1.0,5/25,12.09%,TGFB2;TGFBR1;OLFM1;DDX5;TGFBR3
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.45029980449394263,-0.6934388655611743,0.9047619047619048,1.0,1.0,1/7,3.16%,RPL5
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.4057177650755239,0.6929891939867499,0.8048780487804879,1.0,1.0,1/9,4.70%,TRAK1
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.31178418732857927,-0.6919876732131578,0.9393939393939394,1.0,1.0,12/51,17.15%,ANXA1;ADAMTS12;CD47;OTULIN;BIRC2;PDCD4;IL1R1;APOE;UFL1;IL16;LPL;TMSB4X
prerank,MSigDB_Hallmark_2020__Apical Junction,-0.3118468183745409,-0.6915931268674333,0.9242424242424242,1.0,1.0,19/73,21.21%,LIMA1;ACTG1;ADAM9;SLIT2;VCAN;JAM3;MAPK14;EPB41L2;MYL12B;PIK3CB;ITGA10;BMP1;FBN1;MYH10;NEXN;TSPAN4;EVL;ARPC2;CDH11
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),0.4376265403873815,0.6913311263876112,0.8809523809523809,1.0,1.0,1/7,0.59%,EPN2
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.43295923937999187,0.6913093199362181,0.7555555555555555,1.0,1.0,1/5,4.09%,TCAF1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.34787698367677006,-0.6910701529400349,0.8813559322033898,1.0,1.0,12/32,29.34%,INO80;PLSCR1;SVIL;RGCC;PKN2;EDN3;DYNC1H1;PKP4;PHIP;TPR;CDC14B;PDGFRB
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.4266132643880276,0.6908656424046764,0.8048780487804879,1.0,1.0,1/5,1.78%,CDH2
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.39003136372684066,0.6907353461233695,0.8285714285714286,0.999913518294916,1.0,3/13,10.59%,ADGRA2;ZSWIM8;P2RX4
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.4310496592289314,-0.6906065806082791,0.828125,1.0,1.0,3/7,21.46%,ELOVL2;HSD17B4;FADS2
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.42418211873834516,-0.6905702426093854,0.8,1.0,1.0,1/9,3.18%,IQGAP2
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.3721599749757257,0.6902943320176289,0.9166666666666666,0.9996815371331286,1.0,3/16,10.75%,APC;EML2;CAMSAP1
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),-0.2968992336634947,-0.6899022397519129,0.9863013698630136,1.0,1.0,19/90,19.97%,PRMT9;RSRC1;PRPF6;FASTKD2;FUS;NONO;TSEN2;WBP4;THOC1;SRPK1;CELF2;PRPF8;ADARB1;DHX8;PRKACA;SRSF7;TUT7;DDX17;SRSF5
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.2802658885706083,-0.689764782560198,0.9620253164556962,1.0,1.0,24/140,18.83%,PRMT9;CMTR1;RSRC1;PRPF6;UBL5;SNW1;DDX42;FUS;NONO;DDX5;PPWD1;WBP4;SNRNP200;SRSF10;THOC1;PRPF8;LSM8;EFTUD2;DHX8;GTF2H1;PNN;HNRNPA3;PRKACA;SRSF7
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.43599220823923174,0.6893074161831265,0.7551020408163265,0.9998708450388735,1.0,2/5,20.18%,PRNP;EZR
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.46977229927805225,0.6888259627133987,0.8809523809523809,0.9996158777805946,1.0,1/5,0.50%,ADGRB3
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.3574055063467809,0.6885937532689196,0.8636363636363636,0.9991511418957377,1.0,4/10,22.59%,TJP1;CBFB;NPHP1;ROCK1
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.28854350600375456,0.6884987411478392,0.9777777777777777,0.9985315539172862,1.0,4/35,7.48%,BNIP3L;MAP3K7;BNIP3;SLC25A4
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.4521155918131086,-0.6883658710638243,0.803921568627451,1.0,1.0,1/5,10.14%,LGALS3
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.4521155918131086,-0.6883658710638243,0.803921568627451,1.0,1.0,1/5,10.14%,LGALS3
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.3861440079758912,-0.6882445133003259,0.8431372549019608,1.0,1.0,3/10,13.27%,PRKDC;MRNIP;PARP9
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.3009856388099341,-0.6875521258075331,0.9411764705882353,1.0,1.0,16/48,28.89%,SMG6;NUP58;THOC1;SEC13;SRSF7;NUP107;SRSF5;RANBP2;FYTTD1;U2AF2;NUP133;SMG7;NCBP1;TPR;SRSF11;POLDIP3
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.3009856388099341,-0.6875521258075331,0.9411764705882353,1.0,1.0,16/48,28.89%,SMG6;NUP58;THOC1;SEC13;SRSF7;NUP107;SRSF5;RANBP2;FYTTD1;U2AF2;NUP133;SMG7;NCBP1;TPR;SRSF11;POLDIP3
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.34284984230615556,-0.6873545580158447,0.8620689655172413,1.0,1.0,2/25,4.97%,WASHC3;GSN
prerank,PanglaoDB_Augmented_2021__Reticulocytes,0.30405041107077707,0.6851081488013142,1.0,1.0,1.0,13/44,19.99%,EIF3B;STT3B;GTF3C2;GANAB;DDX21;ABCB10;UGGT1;KPNB1;DHX9;ZDHHC5;CUL4A;POLR2B;IMMT
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),-0.4341343377579051,-0.6847855390384471,0.8936170212765957,1.0,1.0,1/6,11.49%,CCT6A
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),-0.3587410839507654,-0.6840659682314487,0.9384615384615385,1.0,1.0,4/26,11.73%,ALDH3A2;HADHA;ACAT1;AIG1
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.3839293908062668,0.683972901574755,0.8205128205128205,1.0,1.0,2/13,10.75%,APC;CAMSAP1
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.4094981366549252,0.6839171401155106,0.8125,1.0,1.0,1/6,3.29%,RNF185
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.4151687282469554,-0.6827684352210441,0.8305084745762712,1.0,1.0,3/12,15.75%,GSN;ATP1B1;TPM1
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),-0.4341537429332427,-0.6827100674002563,0.8813559322033898,1.0,1.0,1/9,10.22%,ZC3H14
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.35793173185297233,-0.6825893304922463,0.8870967741935484,1.0,1.0,2/23,5.41%,COL6A3;SGCD
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),0.47965964313375314,0.682001677932629,0.8205128205128205,1.0,1.0,1/5,9.19%,HDAC1
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),-0.4227543630437022,-0.6818924533784657,0.9,1.0,1.0,2/5,10.60%,SMAD6;PTCH1
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.3501864223186584,0.6816938546321775,0.8666666666666667,1.0,1.0,2/13,8.87%,IRS2;IRS1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.34316268624323926,0.6811830724105904,0.8378378378378378,1.0,1.0,1/12,3.83%,BCL2L1
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),-0.43547681656843584,-0.6808081146298819,0.8524590163934426,1.0,1.0,3/7,21.72%,PLA2G4C;GPCPD1;MGLL
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),-0.41378368988771186,-0.680466475557842,0.8870967741935484,1.0,1.0,2/8,17.02%,KDM2B;APPL2
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.3394992312393092,-0.6801330772034747,0.8888888888888888,1.0,1.0,5/27,16.91%,HSP90AB1;MAP3K4;CCT6A;TNKS2;RGCC
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),-0.3048631635688289,-0.6801102109832609,0.9384615384615385,1.0,1.0,4/33,14.66%,TNFRSF19;MAPK14;MINK1;MAP3K8
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),0.366470531115682,0.67919934204672,0.8367346938775511,1.0,1.0,1/9,4.91%,UBE2N
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.4194896094959673,0.6788528348617778,0.9148936170212766,1.0,1.0,2/6,11.15%,KDM7A;PHF8
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),-0.41834914375568033,-0.678460346025884,0.8070175438596491,1.0,1.0,2/6,18.61%,PPIA;CD4
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.3567918008503291,0.6784017947298452,0.9069767441860465,1.0,1.0,3/11,18.83%,AGO2;PRKRA;TENT4B
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),0.3740463146384799,0.6783120159186498,0.925,1.0,1.0,3/14,10.28%,DACH1;MSH2;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.3489973492870567,0.6782959955473609,0.8529411764705882,1.0,1.0,1/11,3.83%,BCL2L1
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),0.4361320053952071,0.6774934767783529,0.8974358974358975,0.9995109312433242,1.0,1/6,12.01%,ITPK1
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),0.4361320053952071,0.6774934767783529,0.8974358974358975,0.9995109312433242,1.0,1/6,12.01%,ITPK1
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),-0.4568990989394382,-0.6769777313277525,0.8518518518518519,1.0,1.0,1/5,6.40%,SLIT2
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),-0.35412848145953646,-0.676723813868796,0.9264705882352942,1.0,1.0,3/20,11.32%,AMPH;SYNJ2;SNAP91
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),-0.42603970562444815,-0.6762247847936916,0.875,1.0,1.0,2/8,22.28%,YWHAB;PKD2
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.4381756134488592,0.6760955431059135,0.8837209302325582,1.0,1.0,1/5,6.59%,CPT1A
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),-0.33045989483469657,-0.6760929124564223,0.9310344827586207,1.0,1.0,5/28,14.12%,TGFB2;TGFBR1;DDX5;TGFBR3;FOXC1
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),0.40262079693937536,0.6760919920589851,0.8536585365853658,0.9995770993753932,1.0,2/6,8.76%,MICAL2;DSTN
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.37101827345420274,0.6758186914730131,0.9444444444444444,0.9990952111506288,1.0,1/16,2.23%,HEY2
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.3202438966739706,-0.6757029132790325,0.9375,1.0,1.0,7/32,22.09%,CNIH3;CSNK1D;SEC13;USO1;ANKRD28;MCFD2;LMAN1
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.3202438966739706,-0.6757029132790325,0.9375,1.0,1.0,7/32,22.09%,CNIH3;CSNK1D;SEC13;USO1;ANKRD28;MCFD2;LMAN1
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.3202438966739706,-0.6757029132790325,0.9375,1.0,1.0,7/32,22.09%,CNIH3;CSNK1D;SEC13;USO1;ANKRD28;MCFD2;LMAN1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.31861593128906873,0.6756660355677225,0.9117647058823529,0.9985756422426624,1.0,2/27,6.21%,APC;GNL3L
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),0.41004185442593105,0.6750775230688029,0.8484848484848485,0.9984635477844602,1.0,3/6,19.35%,AP3D1;DNM2;PICALM
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.2908025347720407,-0.6744460773605211,0.9571428571428572,1.0,1.0,17/51,28.89%,SMG6;NUP58;THOC1;SEC13;SRSF7;NUP107;SRSF5;RANBP2;FYTTD1;U2AF2;FMR1;NUP133;SMG7;NCBP1;TPR;SRSF11;POLDIP3
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.32060012732453164,0.6740972436414422,0.918918918918919,0.9986123299033973,1.0,3/27,10.47%,PDK4;OAZ2;PPARA
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.4568346010945474,-0.6740393117282202,0.7962962962962963,1.0,1.0,3/6,18.08%,SFRP4;FOXC1;PRKCH
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.35561809462607885,0.6740373621861838,0.8611111111111112,0.99792570457838,1.0,2/11,13.86%,CTNNA2;PDLIM5
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),-0.36788375736906254,-0.6739599451337505,0.95,1.0,1.0,2/20,6.29%,BORCS5;HTT
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.43200526838194675,0.6738676969633309,0.88,0.9974315112021378,1.0,1/7,1.86%,BCL2
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),-0.4120338555003421,-0.673824680968551,0.864406779661017,1.0,1.0,1/8,11.05%,DHX36
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.2957930746198178,0.6735352428597302,0.9777777777777777,0.9969610021873878,1.0,1/39,1.07%,NOTCH1
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.29323372196543507,-0.6734136445467247,0.9322033898305084,1.0,1.0,5/39,17.15%,STAT1;BIRC2;PSMC2;PSMD8;TMSB4X
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),-0.42255743638290943,-0.6729440652513343,0.847457627118644,1.0,1.0,3/5,28.06%,SLC6A13;MGST1;SLC13A4
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.3466377446072147,0.6725632757217405,0.9111111111111111,0.997156327049201,1.0,2/16,7.35%,PTGES3;HMBOX1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.4036344218595832,0.672553555047631,0.8297872340425532,0.996434609727225,1.0,2/9,10.28%,PRKG1;CDKN1A
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.3699204300591349,-0.6720889970722375,0.8923076923076924,1.0,1.0,5/15,23.97%,CACNA1D;ATP1B1;FHL1;YWHAE;NEDD4
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.3945742801827731,0.6716703920257476,0.8775510204081632,0.9964773554447097,1.0,2/8,9.34%,SMAD7;ABCA1
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),-0.36478661359581743,-0.6716274627690497,0.9090909090909091,1.0,1.0,5/19,19.41%,DTWD2;ADARB1;NSUN2;PUS7L;NSUN6
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.31006310643868906,-0.6715897155229917,0.9107142857142857,1.0,1.0,3/30,14.21%,HLA-B;PSMC2;PSMD8
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),0.3841102606607464,0.6715757187382326,0.8717948717948718,0.9957953461539423,1.0,1/8,3.96%,LEMD3
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.3738847480355967,-0.671556806928895,0.9032258064516129,1.0,1.0,2/15,14.12%,ZFP36L2;FOXC1
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.3350222480930479,0.6712241234023021,1.0,0.9953658922174824,1.0,3/19,12.08%,SORBS3;KATNBL1;SURF4
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.31166733396370233,0.6710719001255656,1.0,0.9947771122740277,1.0,6/29,12.26%,PTPRK;CAMKK2;ERCC6L2;EGFR;PXN;CAT
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.3965676059706611,0.6706909950954,0.8648648648648649,0.9943414291376745,1.0,1/9,8.87%,IRS1
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.32706309614486845,0.6701107660628544,0.9210526315789473,0.9941421695610834,1.0,5/16,19.79%,ACVR2A;ADGRV1;BMPR1A;ATP2B1;SLC8A1
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.3161932374781004,-0.6700006035292148,0.9714285714285714,1.0,1.0,7/50,13.30%,SVIP;TPCN1;HTT;DCN;TRIM13;LARP1;UFL1
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),0.3217994807526026,0.6699758245054013,0.9230769230769231,0.9935099864494222,1.0,5/18,16.43%,SOX13;ZBTB16;CEBPB;WDFY2;ZFP36L1
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.4403879787311099,0.6690477682681142,0.8727272727272727,0.9936078241358346,1.0,2/6,15.35%,GNL3L;CCT3
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.42380130030512636,0.6689885116651283,0.825,0.9929086594931735,1.0,1/6,5.20%,SMARCA4
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.4023561932806583,0.6688268513525575,0.9166666666666666,0.9923925262623055,1.0,2/10,11.15%,SMARCA4;PHF8
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.3206402492149728,0.6685829417095461,1.0,0.9918089478038649,1.0,3/17,13.80%,TNFRSF1B;HDAC2;BTRC
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),-0.4308604787359776,-0.6683749294911169,0.8301886792452831,1.0,1.0,2/6,16.99%,SYNJ2;INPP5B
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.4308604787359776,-0.6683749294911169,0.8301886792452831,1.0,1.0,2/6,16.99%,SYNJ2;INPP5B
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),-0.4308604787359776,-0.6683749294911169,0.8301886792452831,1.0,1.0,2/6,16.99%,SYNJ2;INPP5B
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.31743533266189616,-0.6679042276129269,0.9433962264150944,1.0,1.0,2/33,2.98%,LEPR;STAT1
prerank,MSigDB_Hallmark_2020__Protein Secretion,0.2517041509090973,0.6672489697204663,1.0,0.992271222602275,1.0,6/68,9.50%,ARF1;ATP6V1H;BNIP3;SNAP23;ABCA1;EGFR
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.36598131171677367,-0.6661401092423412,0.8688524590163934,1.0,1.0,3/13,11.05%,TERF2IP;SMG6;DHX36
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.3216379780717765,-0.6658639290721671,0.9705882352941176,1.0,1.0,8/44,22.20%,TMEM87A;SNX2;GOSR1;RHOBTB3;VPS51;DENND2A;LMAN1;GCC2
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.3072896815749635,-0.6653004258640325,0.9692307692307692,1.0,1.0,8/41,22.02%,FBXO38;PSMC2;PSMD8;FBXL18;FBXL4;FBXL13;FBXL7;PSMD14
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.41897552100813584,0.6647499804984501,0.8888888888888888,0.993792187576017,1.0,1/7,5.74%,PACS2
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.40355959407835384,-0.6645177203759621,0.9,1.0,1.0,4/11,19.49%,HTT;SREBF2;PRKN;CSNK2A2
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.3676707798300899,-0.664469940409957,0.9310344827586207,1.0,1.0,6/16,19.49%,UBL5;HPS4;ARIH2;ABLIM3;SREBF2;CSNK2A2
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.39367042024865995,0.6642778788035039,0.9024390243902439,0.9935188821809149,1.0,7/11,29.45%,USP7;USP16;BRCC3;USP22;USP15;ATXN7;USP3
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.39541914451654814,-0.6639734168695588,0.9245283018867925,1.0,1.0,1/15,6.29%,HTT
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.33115316916900706,-0.6639332131136132,0.9565217391304348,1.0,1.0,7/27,24.64%,GCNT2;LARP1;PARP9;ATG14;EIF2A;ZC3H7A;RBM4B
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.4380512145213169,-0.6633840658860325,0.8983050847457628,1.0,1.0,2/6,23.12%,VPS36;TMEM50B
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.4236800503865308,0.6633812594203577,0.8095238095238095,0.9936237685776134,1.0,2/5,17.56%,PPARA;ABHD5
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),0.3263148333576808,0.6623483497937948,0.8913043478260869,0.9938946088981828,1.0,6/19,18.91%,PDGFA;CDKN1A;GAS6;GSTP1;DHX9;SKI
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),-0.371151389752548,-0.662337590695148,0.8666666666666667,1.0,1.0,1/11,7.15%,PDZRN3
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),0.41586665738403894,0.6622827921375959,0.813953488372093,0.9932144072648609,1.0,2/5,11.85%,ARF1;WASHC5
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.4232597881437837,-0.6615834973610791,0.8571428571428571,1.0,1.0,4/7,20.10%,PARP6;PARP9;PARP8;PARP14
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),-0.3513891031300129,-0.661552310394923,0.9076923076923077,1.0,1.0,6/22,19.31%,NGF;FOXC1;SP100;HES1;PRKN;JUN
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),0.38667895530727403,0.6608041209562453,0.8809523809523809,0.993862116616112,1.0,2/10,9.50%,VAPA;EGFR
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.4512485384724147,-0.6607582116438879,0.8979591836734694,1.0,1.0,2/5,7.75%,RACK1;DCN
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),-0.4316418183136277,-0.660199317819279,0.9107142857142857,1.0,1.0,2/6,10.07%,ZFPM1;SMAD6
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.23855441962885715,0.6600650964752254,1.0,0.9937404325782204,1.0,11/155,8.02%,TBC1D4;EIF4ENIF1;ARF1;TRAK1;HERC2;GGA2;AP3D1;IPO8;SNX13;IPO11;RAB31
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.35195082712447534,-0.65994872849238,0.9016393442622951,1.0,1.0,2/15,17.02%,THBS1;APPL2
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),-0.3677582726143533,-0.6597358685010485,0.9180327868852459,1.0,1.0,3/13,8.55%,EPHA3;SNW1;PTK7
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),-0.4013005509930415,-0.6585729187582671,0.8245614035087719,1.0,1.0,3/5,38.95%,WDR1;CRACD;SEMA5A
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.4010372631233722,0.6575231258171333,0.8695652173913043,0.995327856391938,1.0,1/7,3.34%,ACADVL
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),-0.404096548355788,-0.6566851930908463,0.896551724137931,1.0,1.0,1/7,11.05%,DHX36
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.35942791392908846,-0.6563604807844329,0.8823529411764706,1.0,1.0,1/12,5.50%,ARHGAP28
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.40314153104212364,0.6563319187424138,0.875,0.9955137195387785,1.0,1/8,9.19%,HDAC1
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.37561543239053896,-0.6556982000829676,0.8653846153846154,1.0,1.0,1/11,2.78%,FHL2
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.4138876125344574,0.6556600342490293,0.7906976744186046,0.9953159260442412,1.0,3/6,22.44%,NDUFS2;ATP6V1A;ATP6V1G1
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.33356062001819375,-0.6553879490961098,0.9482758620689655,1.0,1.0,3/24,9.64%,PGR;CALCOCO1;DDX5
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),-0.4422591039251976,-0.6551072674562596,0.8301886792452831,1.0,1.0,1/5,6.40%,SLIT2
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),0.36805668572235034,0.65462813672054,0.8666666666666667,0.9954865038812258,1.0,4/9,27.57%,UBXN2A;CHMP4B;TOR1AIP1;NSFL1C
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.339891612011129,-0.654607292539764,0.9322033898305084,1.0,1.0,4/26,18.82%,ASPA;ACAT1;DLD;DDAH1
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.41328453951376243,0.65428984886116,0.8260869565217391,0.9950863430170694,1.0,2/7,9.99%,CNTN4;ARHGAP35
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.36668133040024903,-0.6534548942138046,0.9285714285714286,1.0,1.0,4/13,24.40%,CDC27;PRKN;UBE2L3;UBE2E3
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.32367376564245215,0.6533299280157697,0.95,0.9952418378619914,1.0,3/24,12.67%,HDAC9;HDAC1;HDAC2
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.43291612558009923,-0.6531079967935175,0.896551724137931,1.0,1.0,2/5,22.83%,LMBRD1;SZT2
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.27855873854286234,-0.6525161721534847,0.9661016949152542,1.0,1.0,1/48,0.98%,MT2A
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.28978792994203234,-0.6523950984465595,1.0,1.0,1.0,3/56,6.10%,ZFPM1;RACK1;NMD3
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.45306041041842504,-0.6523620243567023,0.8727272727272727,1.0,1.0,2/5,10.27%,ACO1;ACO2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.4220176238240055,0.6520940418655906,0.9722222222222222,0.9956369655255946,1.0,1/6,13.80%,BTRC
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),-0.36807773036090796,-0.651632501669029,0.9032258064516129,1.0,1.0,3/12,8.55%,EPHA3;SNW1;PTK7
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.356667803097699,-0.6513842937290286,0.9464285714285714,1.0,1.0,2/15,11.41%,HSP90AB1;PPIA
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),-0.4401829334187869,-0.6511687113986698,0.9423076923076923,1.0,1.0,1/5,2.78%,FHL2
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.4401829334187869,-0.6511687113986698,0.9423076923076923,1.0,1.0,1/5,2.78%,FHL2
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.3277275677846117,-0.6510016171142521,0.9230769230769231,1.0,1.0,5/24,15.94%,CD47;PDCD4;PPIA;ANXA2;HSPA9
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.39797115305795605,-0.6505587731027586,0.8867924528301887,1.0,1.0,1/8,6.00%,CD47
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.27052394247885964,0.6494178536476973,1.0,0.9968104952517267,1.0,13/51,19.07%,HSPB1;CAMKK2;CDKN1A;PAK2;RAP1A;RAPGEF2;TTN;GAS6;UBASH3B;CACUL1;GSTP1;PPM1E;CAMK2N1
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.38035747068190673,-0.6493595185100222,0.86,1.0,1.0,2/10,18.35%,CCT6A;EXOSC10
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),-0.42597834876249796,-0.6492972099166388,0.8225806451612904,1.0,1.0,2/5,10.07%,LDLRAD4;SMAD6
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),-0.422863666571173,-0.6491406667258323,0.8214285714285714,1.0,1.0,2/5,29.98%,PTGR1;LTA4H
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.3723483011898378,0.6489619186549284,0.8571428571428571,0.9965228054811287,1.0,4/7,22.59%,RANBP9;PICALM;PRNP;ROCK1
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),-0.38572505272068924,-0.6485962646301443,0.8823529411764706,1.0,1.0,2/11,6.56%,GSN;RHOQ
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.42072662187343035,-0.6483955525075434,0.8888888888888888,1.0,1.0,3/7,33.09%,SLC25A46;TMCC1;SH3GLB1
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.25771203486295474,-0.6478691240841624,1.0,1.0,1.0,13/125,14.21%,DDB2;UCHL5;TGFBR1;USP31;BIRC2;BRCA1;UIMC1;INO80;PSMC2;USP40;UFD1;OTUD6B;PSMD8
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.3582626946965817,-0.6475520442061856,0.9454545454545454,1.0,1.0,1/11,13.55%,VGLL4
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,-0.2986365191072454,-0.6467490588524644,1.0,1.0,1.0,9/40,17.69%,SLC7A14;GRIA4;ASPA;FGF13;HCN1;MCF2L2;SLC1A2;CCK;CA4
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.3350922467552625,0.6465445344995204,0.9318181818181818,0.9975818063885015,1.0,3/18,12.45%,EHD2;OAZ2;CEP290
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),-0.31681132252191513,-0.6461162896215248,0.9436619718309859,1.0,1.0,1/34,0.88%,TGFB2
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.40588178207395814,0.6448270208181672,0.8958333333333334,0.9981833683157627,1.0,1/5,10.47%,PPARA
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.3783930825512594,-0.6447484018966638,0.9523809523809523,1.0,1.0,3/15,9.37%,AKR1C1;SLCO1A2;SLCO1C1
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),-0.32513680462121036,-0.6444567381704961,0.9836065573770492,1.0,1.0,1/21,3.10%,TNFRSF19
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),-0.2744052459975108,-0.6437406865810135,1.0,1.0,1.0,4/65,10.30%,PIGG;PIK3R4;MTM1;SYNJ2
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),0.31886474185379876,0.6436182921114613,0.9318181818181818,0.9982687348722171,1.0,3/16,15.29%,ANAPC16;UBE2D1;ANAPC1
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.36496296754685353,-0.6435708240333942,0.9047619047619048,1.0,1.0,2/9,18.75%,PTGFR;PRKACA
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.28990333780814354,0.6433078668016092,0.9166666666666666,0.9977569300570172,1.0,6/33,15.32%,GGA2;RAB31;EXOC6;ARL3;COMMD1;GGA3
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.40890878555584503,0.643245010050174,0.9047619047619048,0.9970892517283,1.0,2/8,13.11%,FBXW7;NFKB1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),0.3830999352948392,0.6431136473149871,0.8461538461538461,0.9965045119027867,1.0,2/5,25.44%,BIN1;SESTD1
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.3957413653556788,-0.643055164359907,0.8793103448275862,1.0,1.0,4/7,28.28%,DLD;AASS;PHYKPL;ALDH7A1
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.3957413653556788,-0.643055164359907,0.8793103448275862,1.0,1.0,4/7,28.28%,DLD;AASS;PHYKPL;ALDH7A1
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.37146305172292443,-0.6424766376478239,0.9285714285714286,1.0,1.0,1/11,1.36%,ZFPM1
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),-0.26542556765998837,-0.6423645419965984,1.0,1.0,1.0,20/163,13.23%,VEGFA;ARNT2;ADAM22;GSN;DHX30;TGFBR1;ALDH3A2;VCAN;SPOCK1;NOTCH2;GRIK1;GPM6A;MARCKS;FN1;PTS;FGF13;NGF;CHRM3;PMP22;ROBO2
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),0.3789642860907479,0.6423145146104634,0.8648648648648649,0.9963227510548494,1.0,3/6,22.39%,SERGEF;NDFIP2;SNX3
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.29425978729724234,-0.6412443377074092,0.9714285714285714,1.0,1.0,11/43,23.13%,ZFP36L2;PRMT2;PSMC2;FHL1;PSMD8;RBL2;RGCC;FBXL7;PSMD14;PKD2;CDK6
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.43014698349228137,-0.6409422321981588,0.9245283018867925,1.0,1.0,1/5,10.86%,PSMC2
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.2781802136272653,0.6407005602202879,1.0,0.9967886719238159,1.0,1/38,0.72%,HSPB1
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.4052240304929492,0.6403164650580401,0.875,0.9963318267154355,1.0,2/6,8.05%,CLEC16A;SMG1
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),0.3989097665508603,0.6395350303014408,0.8863636363636364,0.9963363547588912,1.0,1/5,12.95%,ACTA2
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.358678535132434,0.6393377447522556,0.8604651162790697,0.995717128309856,1.0,3/8,20.63%,MYOCD;ATP2B1;SETD3
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.39723827874116896,0.6381457479671873,0.9024390243902439,0.9958556554603183,1.0,6/6,60.31%,TP53BP1;RIF1;SHLD2;KMT5B;NECTIN2;PAXIP1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.41889983427137356,-0.6378654789111149,0.9655172413793104,1.0,1.0,2/6,7.75%,ADAMTS12;DCN
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.3171430652074497,0.6377254671264851,0.918918918918919,0.9954971843803447,1.0,3/12,16.20%,PAK2;TJP1;NLGN2
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),0.336823978918529,0.6373523477562735,0.9142857142857143,0.9951021792259057,1.0,2/15,8.82%,NCK2;CD44
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.26609778484931634,-0.6371294384543956,1.0,1.0,1.0,17/67,22.23%,FN1;SPRY3;TGFBR3;CCN1;PEBP1;APIP;MINK1;LPAR1;EPHA7;NBR1;CD4;JCAD;LBH;DAG1;BCAR3;LYN;ROR1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.410739229159752,-0.636626009272228,0.896551724137931,1.0,1.0,2/5,19.57%,DDX5;DDX17
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.31227334551941993,-0.6363138414672372,1.0,1.0,1.0,5/28,18.35%,SMG6;MAP3K4;CCT6A;TNKS2;EXOSC10
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.32978956134723947,-0.6354646441212304,0.9473684210526315,1.0,1.0,1/18,2.98%,STAT1
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.3342112584980974,-0.6353878523926203,0.9523809523809523,1.0,1.0,6/22,19.49%,ENPP2;LPCAT2;PLA2G4C;SLC44A1;PNPLA8;CSNK2A2
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),0.42400399074133527,0.635226276422085,0.8780487804878049,0.9960701301807465,1.0,1/5,5.20%,SMARCA4
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),-0.376544065995308,-0.6352055318506343,0.896551724137931,1.0,1.0,4/8,22.94%,GPC3;HGSNAT;GPC6;SDC2
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.36690935885233944,0.6349885759812789,0.8717948717948718,0.9955568964945845,1.0,5/16,22.44%,ATP6V1H;RAB31;RAB14;ATP6V1A;ATP6V1G1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),0.3719248536489812,0.6349661803602029,0.9111111111111111,0.9948669482035466,1.0,2/11,11.23%,ZNF143;ELL
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),-0.41009741521953164,-0.6347544017780773,0.8676470588235294,1.0,1.0,1/6,5.73%,TGFBR1
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.2608134791587774,0.6342933841157101,1.0,0.9946730101880688,1.0,7/46,14.63%,UBE2N;MAP3K7;PELI2;RPS6KA5;NFKB1;BTRC;EGR1
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.40259891931358904,0.6340177392223002,0.8518518518518519,0.9941249585340579,1.0,1/5,14.74%,CPEB3
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.40042728452443094,-0.6323599375272235,0.9047619047619048,1.0,1.0,4/6,15.48%,ADAM9;APOE;SH3D19;SNX9
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.37563771920259614,-0.6323457043232553,0.9016393442622951,1.0,1.0,2/9,21.05%,SVIL;BASP1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.33345607883350464,-0.6321566060231502,0.92,1.0,1.0,5/17,25.62%,NUBPL;NDUFB7;NDUFB9;COA1;NDUFC1
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.33345607883350464,-0.6321566060231502,0.92,1.0,1.0,5/17,25.62%,NUBPL;NDUFB7;NDUFB9;COA1;NDUFC1
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.31040856079462814,0.6308445817690694,0.95,0.995717271415084,1.0,4/19,21.77%,SMG1;IP6K1;PIK3CD;PIK3C3
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.29714477249192583,0.6299710309472405,0.918918918918919,0.995700084452262,1.0,4/22,16.43%,RC3H2;METTL14;CPEB3;ZFP36L1
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.3574792792999048,0.6294075612522514,0.8541666666666666,0.9954692687744705,1.0,1/9,6.11%,NOL10
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),-0.38085702628945406,-0.6292140256487371,0.9193548387096774,1.0,1.0,1/9,8.69%,BRCA1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.3916198135823824,0.628851365479948,0.825,0.9951872471599986,1.0,2/6,16.20%,SYN3;NLGN2
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),-0.33212057599903344,-0.6288374843208457,0.9333333333333333,1.0,1.0,5/18,20.48%,RHOQ;PRKAG2;APPL2;PIK3R1;SELENOS
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.397957809437018,-0.6276891502243693,0.9333333333333333,1.0,1.0,5/8,21.72%,CYP1B1;PLA2G4C;GPX4;PNPLA8;MGLL
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.30852937693978266,-0.6254032453803527,0.9491525423728814,1.0,1.0,4/26,20.45%,EYA1;NUP58;NUP107;RANBP2
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),0.3855920069727772,0.6248983449718191,0.9333333333333333,0.9972083257186856,1.0,1/5,19.28%,SPIN1
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.2696147087905386,0.6240453620948416,0.9705882352941176,0.9969695781849617,1.0,6/31,16.92%,EIF4ENIF1;IPO8;IPO11;IPO9;KPNB1;TNPO3
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.370310222608793,-0.6235702824224187,0.8888888888888888,1.0,1.0,3/12,14.15%,KCNIP1;CACNA1D;FHL1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),-0.3841941124007517,-0.6233132534192474,0.8461538461538461,1.0,1.0,2/8,22.65%,RGCC;CLASP2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),-0.331314732821236,-0.6223268880875746,0.9152542372881356,1.0,1.0,3/22,7.75%,HTT;RALBP1;DCN
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.3434995635427212,0.6215312142050522,0.9285714285714286,0.997994752094606,1.0,5/13,14.65%,RAB27A;CAMK1D;RAB31;TUB;GAS6
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.4108614700460354,0.6212031929233679,0.9148936170212766,0.9974621375583091,1.0,1/6,6.30%,NUS1
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),-0.4131489279074024,-0.6210370754040286,0.9032258064516129,1.0,1.0,3/5,19.94%,APOE;PRKACA;BMP1
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),-0.4065994190295418,-0.620165874429544,0.9107142857142857,1.0,1.0,4/6,17.47%,ABCB1;SLC1A2;SLC1A3;SLC1A1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.2993396643044976,-0.61964069027695,0.9411764705882353,1.0,1.0,6/21,25.62%,NUBPL;NDUFB7;NDUFB9;COA1;TTC19;NDUFC1
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.3040733387204772,-0.6193805648057457,0.967741935483871,1.0,1.0,4/17,20.40%,COX4I1;NDUFB7;AFG1L;NDUFB9
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.3040733387204772,-0.6193805648057457,0.967741935483871,1.0,1.0,4/17,20.40%,COX4I1;NDUFB7;AFG1L;NDUFB9
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.3999325382937801,-0.6193462716582937,0.8703703703703703,1.0,1.0,2/6,28.73%,LRPAP1;ANKRD13A
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.31311438597121755,0.6191574356405195,1.0,0.998082027831598,1.0,4/23,16.99%,LEMD3;NUP54;BIN1;REEP3
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.3250364459191547,-0.6188645578432687,0.9615384615384616,1.0,1.0,6/29,17.15%,TERF2IP;SASH1;PDCD4;RPS3;UACA;TMSB4X
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),-0.3085112983114277,-0.6186512925568527,0.9193548387096774,1.0,1.0,3/28,14.93%,HTT;G3BP2;BBS4
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),0.275879743246319,0.6185716978654624,1.0,0.9976454069768882,1.0,4/32,12.64%,HIPK2;PPP2CB;AMFR;RAPGEF2
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.36905270118342365,-0.6172503025128125,0.8888888888888888,1.0,1.0,2/10,10.46%,GSN;NCKAP5
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.2596782005220815,-0.6171566788391458,0.972972972972973,1.0,1.0,12/58,19.49%,PIK3R4;ATG10;GABARAPL1;VPS36;PRKAG2;STX17;SQSTM1;ATG14;NBR1;ACBD5;PRKN;CSNK2A2
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),-0.3962748783845762,-0.6169393452902422,0.9245283018867925,1.0,1.0,1/7,9.37%,SLCO1C1
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.3155170763652251,-0.6169081216201134,0.9322033898305084,1.0,1.0,5/26,15.74%,CD47;PDCD4;PLSCR1;IL16;LPL
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),-0.38317586371170403,-0.6165468927816998,0.9259259259259259,1.0,1.0,2/6,30.51%,MT3;SLC30A6
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.39928887640308175,-0.616331766214167,0.9,1.0,1.0,3/8,20.34%,SNAP91;PIK3CB;AAK1
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),-0.36429871026859845,-0.6138868301508841,0.9298245614035088,1.0,1.0,3/9,34.44%,SETDB2;TPR;MPHOSPH8
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.317828141978221,-0.6138413944102038,0.9649122807017544,1.0,1.0,9/24,27.32%,NUP58;PRKAG2;SEC13;NUP107;RANBP2;AK4;NUP133;COX7A2;TPR
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),-0.4112642554356648,-0.6131968126834458,0.9193548387096774,1.0,1.0,2/7,22.09%,SNX2;LMAN1
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),-0.3122746342992877,-0.6124045547988575,0.9672131147540983,1.0,1.0,1/22,3.19%,ANXA1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.38978969336972225,0.6115984066047292,0.9795918367346939,1.0,1.0,5/5,61.05%,RAB3GAP2;RAB3GAP1;ATL3;TMEM33;LNPK
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.32596775250959786,-0.6094276991110346,0.9354838709677419,1.0,1.0,2/19,4.07%,DKK3;SFRP4
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),0.399049291967315,0.6089089813469575,0.9024390243902439,1.0,1.0,3/5,18.90%,SLC25A17;SLC27A1;ACSL1
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),-0.4124015338871834,-0.6087108090853297,0.8846153846153846,1.0,1.0,1/5,8.39%,SASH1
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.2675789207904113,-0.608667755852117,0.9841269841269841,1.0,1.0,16/50,28.89%,SMG6;NUP58;THOC1;SEC13;SRSF7;NUP107;SRSF5;RANBP2;FYTTD1;U2AF2;NUP133;SMG7;NCBP1;TPR;SRSF11;POLDIP3
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),0.3360824467025782,0.6085975284401751,0.9302325581395349,1.0,1.0,3/11,19.63%,NOL10;RIOK3;BMS1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.3037993683746984,0.6085317041708211,0.9210526315789473,1.0,1.0,4/19,24.24%,GRIN1;GRIN2B;MAP3K5;DDX3X
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),-0.3951365775705495,-0.6084515244891492,0.8813559322033898,1.0,1.0,2/5,23.48%,PHF14;ING5
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.3809515672107411,0.6072221622221833,0.8888888888888888,1.0,1.0,2/7,15.54%,SH2B3;WNK1
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.37807738950375397,0.6056966937750257,0.9148936170212766,1.0,1.0,2/9,15.22%,CECR2;KPNB1
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.32879721736345124,0.6042482242765892,0.9230769230769231,1.0,1.0,2/14,10.01%,MTFR1;SDHB
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.40271035619140483,0.603975745165911,0.9272727272727272,1.0,1.0,1/5,11.23%,ELL
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),0.34218150053498214,0.6038552611221985,0.9523809523809523,0.9999278667886544,1.0,1/8,6.02%,SMAD7
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.39984645443363553,0.6038413967563152,0.9069767441860465,0.9992309713861328,1.0,1/5,6.05%,LTBP1
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),-0.4113463078046252,-0.6033225852137396,0.9245283018867925,1.0,1.0,1/5,20.76%,CRY1
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.3160129695608509,0.602502879292211,0.8913043478260869,0.9994079403155941,1.0,2/8,15.90%,NELFA;RNF168
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),-0.3347588945321359,-0.6013272652892903,0.9696969696969697,1.0,1.0,6/17,21.64%,SLIT2;ABI2;PIK3R1;AUTS2;ARPC2;WASF2
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.338402728328663,-0.599974933416587,0.9180327868852459,1.0,1.0,4/11,21.54%,ALDH3A2;EMC3;SERP1;TRAM1
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.33835019194403626,0.5993762476322849,0.9555555555555556,1.0,1.0,3/9,20.29%,SHISA6;SLC4A10;GRIK2
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.3213820331437965,-0.5993163951417444,0.96875,1.0,1.0,4/21,19.41%,DTWD2;TSEN2;NSUN2;NSUN6
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),-0.33137199885033924,-0.5990667045874494,0.92,1.0,1.0,1/10,14.00%,CYP27A1
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.34952393845947394,-0.598882578933694,0.9122807017543859,1.0,1.0,2/10,12.16%,APH1B;EPHA4
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.3993191514757499,-0.5966727965333001,0.9423076923076923,1.0,1.0,1/7,21.35%,STX8
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),0.4058169273315781,0.5961766190361031,0.975609756097561,1.0,1.0,1/5,7.35%,HMBOX1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),-0.3364236755119684,-0.5959896224035105,0.9803921568627451,1.0,1.0,2/13,7.75%,RALBP1;DCN
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),0.3500887302399681,0.5959322228447763,0.9555555555555556,1.0,1.0,1/8,8.52%,AXL
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),-0.3450687957494848,-0.5958394796322635,0.9090909090909091,1.0,1.0,4/10,29.34%,ROBO2;PKD2;LRP1;PDGFRB
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.3405114234136191,0.5950123735438642,0.95,1.0,1.0,2/8,16.15%,CPT1A;SLC27A1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.32585614904093163,-0.5948679945520835,0.8775510204081632,1.0,1.0,2/19,8.77%,HADHA;ACAT1
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),-0.39598340852125735,-0.5939155745467126,0.9672131147540983,1.0,1.0,2/5,14.93%,GNAL;BBS4
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.37572107375767994,-0.5932832940315005,0.975609756097561,1.0,1.0,1/7,11.49%,CCT6A
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.2611060190238973,-0.5913544001852227,1.0,1.0,1.0,9/34,22.30%,POLA1;BRCA1;UIMC1;PRKDC;RNF8;MRE11;XRCC6;PSMD14;BABAM2
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),-0.42167715044523313,-0.5905452079188294,0.9782608695652174,1.0,1.0,2/5,24.83%,MECP2;PRMT7
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.36623762807026333,-0.5893238002050095,0.9230769230769231,1.0,1.0,1/9,9.42%,CACNA1D
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.27533195457965076,-0.5866760627399842,1.0,1.0,1.0,3/32,14.21%,HLA-B;PSMC2;PSMD8
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),0.3999409966833641,0.5864547619019326,0.9649122807017544,1.0,1.0,1/5,14.65%,GAS6
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.3425143154832055,-0.5863292130054208,0.9516129032258065,1.0,1.0,3/13,15.75%,SGCD;ATP1B1;TPM1
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.26693068388273233,0.5858277964358211,1.0,1.0,1.0,4/36,9.50%,PML;UBE2N;USP7;EGFR
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.21592510897602224,0.5857329889184243,1.0,1.0,1.0,19/95,21.37%,PPP2R1A;CEP70;PPP6C;CDKN1A;PHF8;CCP110;NDE1;CEP290;DNM2;BTRC;RPS6KB1;ANAPC1;CACUL1;CUL4A;ACVR1B;EIF4E;CCND3;RB1;CHMP4B
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),-0.34580276706258617,-0.5839237405532268,0.9508196721311475,1.0,1.0,5/11,24.24%,TANC2;APOE;SRGAP2C;PSEN1;FMR1
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.3685978265875727,-0.5838816113642827,0.95,1.0,1.0,2/7,15.40%,LGALS3;S100A11
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.3879468871475855,-0.5835456143197676,0.9454545454545454,1.0,1.0,3/6,21.46%,ELOVL2;PNPLA8;FADS2
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.3710831688124172,-0.5833683016170362,0.9375,1.0,1.0,1/6,19.09%,PRKN
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),-0.39273193451365257,-0.5831732827528185,0.9310344827586207,1.0,1.0,2/5,19.09%,BIRC2;PRKN
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.3551701991008351,0.5829068360337105,0.9230769230769231,1.0,1.0,6/6,64.52%,TP53BP1;RIF1;SHLD2;KMT5B;PAXIP1;TGFB1
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.37960817652308765,-0.5826025456176349,0.9259259259259259,1.0,1.0,1/6,15.90%,WDR82
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.2624945842424738,-0.582055293736625,0.9836065573770492,1.0,1.0,5/40,15.62%,SPRY1;PRKAR1A;SPRY3;APOE;SPRY4
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.3424947573395499,0.5818939392226762,0.9534883720930233,1.0,1.0,1/9,4.11%,EPAS1
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.3707348329970019,0.5815391800336456,0.875,1.0,1.0,2/5,28.30%,SMC5;SMC6
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),-0.33652823934666737,-0.5815054009543367,0.9824561403508771,1.0,1.0,2/9,21.58%,PRKCH;LYN
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.27992275039365755,0.5795583980811265,1.0,1.0,1.0,4/23,13.68%,ZBTB7A;NUP54;EP300;SCARB2
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.2839959045572008,-0.5793876876574222,0.96875,1.0,1.0,3/32,7.64%,ARHGAP28;SLIT2;BAIAP2L2
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),0.28729167366796854,0.5781511347647885,1.0,1.0,1.0,5/18,20.89%,KIF5B;KLC1;GFM2;ATG2B;ULK2
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.36066463857058284,-0.5771648277330098,0.9565217391304348,1.0,1.0,1/6,6.14%,GCNT2
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),-0.3746023976052425,-0.5770197200578174,0.9464285714285714,1.0,1.0,1/7,17.12%,CDC27
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.3746023976052425,-0.5770197200578174,0.9464285714285714,1.0,1.0,1/7,17.12%,CDC27
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.3746023976052425,-0.5770197200578174,0.9464285714285714,1.0,1.0,1/7,17.12%,CDC27
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.3320212355830536,-0.5767156577512434,0.9333333333333333,1.0,1.0,3/13,21.59%,MRPS25;GFM1;MRPL3
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.2967802135516954,-0.5766591868685184,0.9545454545454546,1.0,1.0,6/24,24.30%,ADM;CALCRL;LMBRD1;DNM3;NEDD4;LRP1
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),-0.37656159102379544,-0.5743000212570186,0.8909090909090909,1.0,1.0,2/5,17.73%,ABCB1;EIF4G1
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),-0.3796821855809944,-0.5741589651761515,0.9491525423728814,1.0,1.0,1/5,12.42%,PRKAG2
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.3587441243754436,-0.5734280679952234,0.9666666666666667,1.0,1.0,3/8,22.28%,HSP90AB1;RGCC;PKD2
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.31654948902820607,-0.5721005178100347,0.9672131147540983,1.0,1.0,3/17,13.30%,PRMT2;DDX5;UFL1
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.294350391449412,0.5719239511232227,0.8918918918918919,1.0,1.0,3/11,27.27%,ATG2B;ULK2;WDR45B
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.33552946446488713,-0.5718062493752726,0.9347826086956522,1.0,1.0,3/7,24.27%,LPL;PRKCH;MAPK9
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),0.35511318028576017,0.5703635547058932,0.8604651162790697,1.0,1.0,5/5,64.52%,CSF1;RIPK1;IL34;PRKCA;TGFB1
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),-0.3268720261030545,-0.5692132544613658,0.9361702127659575,1.0,1.0,4/9,26.15%,RHOQ;GTPBP1;AK4;MFN1
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.3268720261030545,-0.5692132544613658,0.9361702127659575,1.0,1.0,4/9,26.15%,RHOQ;GTPBP1;AK4;MFN1
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.27599523356299926,0.5691992202851226,1.0,1.0,1.0,2/21,10.81%,ACVR2A;BMPR1A
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.24984790374015925,-0.5689253285309919,0.9863013698630136,1.0,1.0,24/64,31.94%,RMDN1;CEP126;ITGB3BP;SEC13;SPC25;SMC3;NUP107;EML4;RANBP2;DYNC1H1;CKAP5;CLASP2;MECP2;GOLGA2;NUP133;EFHC1;DYNLL1;NEK9;VCP;CENPC;MAP9;NUP98;NDEL1;GPSM2
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),0.2502745298570857,0.5687958776730653,0.9761904761904762,1.0,1.0,9/25,25.23%,UBE2N;RNF152;RNF168;TRAF3IP2;HECTD1;TRAF3;UBE2E2;TRAF6;RNF115
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),-0.300325979964592,-0.5686529308072524,0.9636363636363636,1.0,1.0,5/22,20.45%,NUP58;PRKAG2;SEC13;NUP107;RANBP2
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.2988842143727829,-0.5679218315614095,0.971830985915493,1.0,1.0,6/19,21.64%,ENPP2;ABI2;PIK3R1;AUTS2;ARPC2;WASF2
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),-0.39571299080764666,-0.5675285792653806,0.9636363636363636,1.0,1.0,1/5,18.90%,ACBD5
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.27449917828070414,-0.5664772102509589,1.0,1.0,1.0,9/48,22.68%,SCLT1;TCTN1;CSNK1D;NINL;SDCCAG8;PRKACA;DYNC1H1;CKAP5;YWHAE
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),-0.29651634945142713,-0.5654697344873287,0.9642857142857143,1.0,1.0,5/23,20.45%,NUP58;PRKAG2;SEC13;NUP107;RANBP2
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),-0.35310787157808216,-0.5643678449701174,0.9444444444444444,1.0,1.0,2/6,23.13%,CD4;CDK6
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),0.2391272447578128,0.5634755122372351,1.0,1.0,1.0,8/37,20.89%,UBQLN1;UBE2N;AMBRA1;WDFY3;CALCOCO2;ATG2B;DYNC1LI1;ULK2
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),-0.23411177708719433,-0.5631475562427755,1.0,1.0,1.0,11/90,19.49%,PARP1;TGFBR1;SGK1;PRKDC;MAPK14;CSNK1D;PKN2;PRKCH;PRKACA;MARK1;CSNK2A2
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.3645640620487521,0.5627477702432261,0.9285714285714286,1.0,1.0,2/7,22.55%,SYT17;SYT1
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.37613692974811985,0.5613876682401001,0.9555555555555556,1.0,1.0,1/5,9.14%,RHOA
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.32365438886360726,-0.561112851157445,0.9230769230769231,1.0,1.0,4/11,29.74%,SUCLG2;ACBD6;SUCLA2;ACACB
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.3277003064957759,-0.5610914415436928,0.9661016949152542,1.0,1.0,1/11,8.69%,BRCA1
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.31048826148612935,-0.5607976777355942,0.9649122807017544,1.0,1.0,1/14,8.61%,BIRC2
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.31048826148612935,-0.5607976777355942,0.9649122807017544,1.0,1.0,1/14,8.61%,BIRC2
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.3479070800597626,0.5603757220323135,0.9574468085106383,1.0,1.0,1/6,8.26%,PHF2
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.3187944578002051,0.5603468426948337,0.9069767441860465,1.0,1.0,2/7,15.90%,NELFA;RNF168
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.3543766241511822,-0.5599561267446047,0.9444444444444444,1.0,1.0,1/10,13.97%,IL16
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.36439706708403785,0.5574209166989224,0.9583333333333334,1.0,1.0,1/7,6.30%,NUS1
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),-0.3174765204106516,-0.557412206558958,0.8928571428571429,1.0,1.0,1/8,6.66%,ZFP36L2
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),-0.275044825104772,-0.5571045391037055,1.0,1.0,1.0,1/24,4.54%,PLCH1
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.2752250044627332,0.5569296292890464,0.9555555555555556,1.0,1.0,5/17,22.44%,ATP6V1H;DNM2;CLTC;ATP6V1A;ATP6V1G1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),-0.30947581393354734,-0.5560499024298878,0.9803921568627451,1.0,1.0,2/11,14.63%,ATG10;NAE1
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.34474169002258953,-0.5556940029541972,0.92,1.0,1.0,2/7,16.33%,LPL;SREBF2
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.3491183534408344,-0.5554472695540584,0.9122807017543859,1.0,1.0,4/8,35.08%,GTF2H1;TAF1;POLR1C;TAF1D
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.3491183534408344,-0.5554472695540584,0.9122807017543859,1.0,1.0,4/8,35.08%,GTF2H1;TAF1;POLR1C;TAF1D
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),-0.3154608167473649,-0.553723016451184,0.9538461538461539,1.0,1.0,3/14,16.52%,ALDH3A2;SVEP1;EMP1
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.3499505381018802,0.5526556323508017,0.9433962264150944,1.0,1.0,2/6,17.23%,CLEC16A;CALCOCO2
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),0.3689062069986116,0.5521261101860444,0.9347826086956522,1.0,1.0,1/5,12.59%,DNM2
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),0.3689062069986116,0.5521261101860444,0.9347826086956522,1.0,1.0,1/5,12.59%,DNM2
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),-0.2780701968622978,-0.5520053969932892,1.0,1.0,1.0,1/23,4.54%,PLCH1
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),-0.33639904743634297,-0.5511044921477543,0.9682539682539683,1.0,1.0,2/11,14.93%,HTT;BBS4
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.32460502799922786,-0.5505690650626668,0.9464285714285714,1.0,1.0,4/9,26.80%,EXOSC10;TUT7;TUT4;SSB
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),-0.2775113707869239,-0.5503754919496685,1.0,1.0,1.0,4/27,20.04%,PER2;PRDM5;MIDEAS;TRERF1
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),-0.31694047438167583,-0.5497097534094478,0.9692307692307692,1.0,1.0,1/16,2.09%,MEGF10
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.3721379182374624,0.5490908464380919,0.9444444444444444,1.0,1.0,2/5,9.30%,CBLB;CBL
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),-0.2924450653163856,-0.5488229291550016,0.9859154929577465,1.0,1.0,4/12,23.97%,ANO6;CHRM3;YWHAE;NEDD4
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),-0.38081866528550534,-0.5481451900278749,0.975609756097561,1.0,1.0,2/5,28.55%,LRP1;MIA3
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.3616988692679493,-0.5469073148862774,0.9387755102040817,1.0,1.0,2/5,21.74%,MAP1A;PSEN1
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.3496771044595682,-0.546489149237645,0.9818181818181818,1.0,1.0,1/7,16.76%,GTF2H1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),-0.30269781711920685,-0.5459998423399025,0.9692307692307692,1.0,1.0,3/14,19.07%,CCDC57;PKN2;HES1
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.2980591769818465,-0.5459603020692475,1.0,1.0,1.0,2/14,19.09%,PDCD4;PRKN
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.36747644446855654,-0.5456858746431822,0.9574468085106383,1.0,1.0,2/5,23.29%,SREBF2;LPCAT3
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),-0.36747644446855654,-0.5456858746431822,0.9574468085106383,1.0,1.0,2/5,23.29%,SREBF2;LPCAT3
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.27386651677154483,-0.5453642599473707,0.9666666666666667,1.0,1.0,2/28,5.61%,ERAP1;CPQ
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),-0.36636154188660175,-0.544748840655414,0.9454545454545454,1.0,1.0,2/5,22.68%,ATP1B1;YWHAE
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),-0.3214028328156072,-0.544673967587062,0.9354838709677419,1.0,1.0,4/9,24.24%,DHX36;APOE;PSEN1;FMR1
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.31932740595698744,0.5441910803100943,0.8888888888888888,1.0,1.0,1/7,14.58%,CCDC3
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),-0.32562605554597646,-0.5422523446140946,0.9642857142857143,1.0,1.0,1/8,10.14%,LGALS3
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.2766122761961253,0.5406088839152846,1.0,1.0,1.0,2/12,13.92%,MAVS;EFCAB7
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.2766122761961253,0.5406088839152846,1.0,1.0,1.0,2/12,13.92%,MAVS;EFCAB7
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.30743415037938515,0.5403218863537923,0.9767441860465116,1.0,1.0,1/10,9.14%,RHOA
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.30743415037938515,0.5403218863537923,0.9767441860465116,1.0,1.0,1/10,9.14%,RHOA
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),-0.3545455736930641,-0.5399684981244461,0.975609756097561,1.0,1.0,3/6,34.87%,LRP1;MIA3;ZDHHC3
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.36515800284302863,0.5353745962932981,0.9245283018867925,1.0,1.0,1/5,11.20%,ARHGEF10L
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.36515800284302863,0.5353745962932981,0.9245283018867925,1.0,1.0,1/5,11.20%,ARHGEF10L
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),-0.2708069362107059,-0.5334593339780468,1.0,1.0,1.0,5/28,14.08%,RHEB;NPRL3;LARS1;SEC13;RRAGB
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.3500541928332345,0.5326549139616628,1.0,1.0,1.0,2/5,11.07%,FBXW7;MCL1
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.34750458618497015,0.5321804111256752,0.9024390243902439,1.0,1.0,3/6,20.07%,CASK;PTPRS;CRK
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),0.3421399851731559,0.5317905648353192,0.9302325581395349,1.0,1.0,1/5,8.00%,FBH1
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),-0.25305357854417876,-0.5316295894497638,1.0,1.0,1.0,4/36,14.36%,FBXO38;PELI1;ARIH2;RNF8
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),-0.33737506515881627,-0.5311389828116904,0.9811320754716981,1.0,1.0,1/6,16.46%,LMCD1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.33737506515881627,-0.5311389828116904,0.9811320754716981,1.0,1.0,1/6,16.46%,LMCD1
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.31945995995701526,0.530042405409358,0.975,1.0,1.0,3/6,24.24%,AGO2;DHX9;DDX3X
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.326725159453388,-0.5294323372285383,1.0,1.0,1.0,1/7,20.36%,CALM1
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),-0.2957442238215991,-0.5284440466064162,0.9333333333333333,1.0,1.0,4/13,21.11%,ATP6V1E1;ATP6V1D;ATP6V0D1;ATP6V0E1
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.36588997812532875,-0.5283888512804333,0.9523809523809523,1.0,1.0,2/5,22.68%,ATP1B1;YWHAE
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),-0.2505370117919218,-0.5283488446763432,1.0,1.0,1.0,3/44,10.89%,ESCO1;EYA1;NUP58
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.31909501435166365,0.5279803443348757,0.896551724137931,1.0,1.0,2/9,13.01%,RYR2;RBPMS2
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.34549723350586287,0.5274283136459667,0.9565217391304348,1.0,1.0,3/5,27.30%,SEC63;CHMP4B;SEC61A1
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.2823609901238785,-0.5272433854379106,1.0,1.0,1.0,4/21,19.09%,GABARAPL1;SQSTM1;ATG14;PRKN
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.31390427418347894,0.5265997268592989,0.9622641509433962,1.0,1.0,2/6,25.79%,DYNC1LI1;DUSP1
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.3647265349779353,0.5261895992278494,0.9565217391304348,1.0,1.0,2/5,34.26%,TNIP1;ITCH
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.3272318561335902,0.5250472841472275,0.9,1.0,1.0,6/6,67.31%,LRSAM1;RAB3GAP2;RAB3GAP1;PIP4K2A;SH3GLB1;PIP4K2B
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.2613869414959069,-0.5249666671422251,1.0,1.0,1.0,6/31,19.06%,PER2;GNPAT;LPL;GPX4;ACBD5;PNPLA8
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),0.3178432741395862,0.5243856272251274,0.9090909090909091,1.0,1.0,2/5,23.28%,UBASH3B;PTPN1
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.2780306933503254,0.524090626696606,0.9772727272727273,1.0,1.0,2/12,16.15%,OSBPL10;SLC27A1
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.286411009750493,0.5236414328827848,0.9318181818181818,1.0,1.0,3/6,32.48%,CBFB;ELF2;RC3H1
prerank,PanglaoDB_Augmented_2021__T Helper Cells,0.3023129358705413,0.5233022237930696,0.9583333333333334,1.0,1.0,2/9,15.94%,NFKB1;CD38
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.2704305122021461,-0.522907379640572,0.9814814814814815,1.0,1.0,2/17,13.12%,BCAS3;PDCD10
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.2955358530661639,-0.5228140039834122,0.9830508474576272,1.0,1.0,1/10,11.28%,LARP1
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),-0.3382271253718807,-0.5205865320233105,0.9444444444444444,1.0,1.0,1/7,15.61%,ANXA2
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.3025248112488204,0.5189888188832731,0.9555555555555556,1.0,1.0,1/8,10.01%,SDHB
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.3396608605054823,-0.5187402933596402,0.9310344827586207,1.0,1.0,2/5,19.20%,APOD;MTR
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),0.27845290928098065,0.5187065165388011,1.0,1.0,1.0,2/12,14.60%,MRPS27;GFM2
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),-0.34525495794388245,-0.5185914312745731,0.9508196721311475,1.0,1.0,2/5,24.57%,PDCD10;ARHGAP21
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.3148782073019263,0.5178585733768044,0.9782608695652174,1.0,1.0,1/6,8.84%,CACNB2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.3324045851259547,-0.5153958842707421,0.9803921568627451,1.0,1.0,1/5,10.70%,ST3GAL4
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),-0.33044315992292866,-0.5149100079650915,0.9622641509433962,1.0,1.0,6/6,67.00%,PPP3CB;NFATC3;NFATC4;PPP3CA;NFAT5;PPP3CC
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),-0.33044315992292866,-0.5149100079650915,0.9622641509433962,1.0,1.0,6/6,67.00%,PPP3CB;NFATC3;NFATC4;PPP3CA;NFAT5;PPP3CC
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),-0.2719437791727358,-0.5145010388664025,0.984375,1.0,1.0,3/16,18.99%,FGF13;MT3;OMG
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.29207061574997695,0.5143784456793727,1.0,1.0,1.0,2/11,14.81%,RHOA;CDC42
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.28772707840501904,0.5135182575990361,1.0,1.0,1.0,1/10,8.52%,AXL
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),-0.31424596964137086,-0.5134040980353104,1.0,1.0,1.0,2/11,15.77%,DPY19L1;DPY19L3
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.23367848622378717,0.511823632503546,1.0,1.0,1.0,3/33,13.33%,WDR33;PCF11;CPSF2
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.34475454071779055,-0.5075040969473589,0.9655172413793104,1.0,1.0,1/5,11.23%,CTCF
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),-0.24447444620472986,-0.5067999626689025,1.0,1.0,1.0,5/34,19.49%,TGFBR1;PRKDC;CDC42BPA;ACVR1;CSNK2A2
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),-0.3579580723127305,-0.5034162308342394,0.9661016949152542,1.0,1.0,2/5,21.58%,EPHA4;LYN
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.32300529780061016,0.4999302962390898,0.9818181818181818,1.0,1.0,5/5,67.73%,PCM1;DOCK7;CEP120;NUMB;HOOK3
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.31802167244909585,0.49731822635417006,0.9772727272727273,1.0,1.0,1/6,9.34%,ABCA1
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),-0.3278112629441169,-0.49642488631400394,0.9655172413793104,1.0,1.0,2/7,34.47%,DLGAP1;APP
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.26072883161597815,0.4953782278564657,1.0,1.0,1.0,4/16,20.18%,AIDA;MECOM;GSTP1;EZR
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),-0.3395536232318088,-0.4952641721338221,1.0,1.0,1.0,2/5,21.00%,SNAP91;DNM3
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.29962489255736624,-0.49490307440792347,0.9411764705882353,1.0,1.0,2/8,20.48%,TMEFF2;SELENOS
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),-0.33344879634487856,-0.49483828255586615,0.9803921568627451,1.0,1.0,1/5,12.72%,APOE
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.31817187216983556,0.49409222942592435,0.9767441860465116,1.0,1.0,2/5,19.79%,ACTA2;SLC8A1
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),0.31817187216983556,0.49409222942592435,0.9767441860465116,1.0,1.0,2/5,19.79%,ACTA2;SLC8A1
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.33797034282065785,0.4914463599706881,1.0,1.0,1.0,4/5,36.14%,SLC22A3;ANTXR1;SLC22A2;ADAM10
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.31780870999544714,-0.4914172979837587,0.9821428571428571,1.0,1.0,3/7,27.32%,TCF7L2;YWHAE;TPR
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.27512809003198846,-0.49004518985052936,1.0,1.0,1.0,4/17,21.11%,ATP6V1E1;ATP6V1D;ATP6V0D1;ATP6V0E1
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.287741074028643,0.48956528461912874,1.0,1.0,1.0,3/9,28.92%,PSMB2;PSMA7;PSMB1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.2935603019110326,0.4891095182803339,1.0,1.0,1.0,7/7,70.68%,NAA11;NAA50;NAA35;METAP1;NAA15;METAP2;NAA16
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),-0.3043866399764369,-0.4888594583547892,1.0,1.0,1.0,1/7,22.18%,LATS2
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.3279952087974438,-0.48775442227751126,0.9661016949152542,1.0,1.0,1/6,10.56%,EPHA5
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.2938866643291349,0.4857560177578745,0.9285714285714286,1.0,1.0,1/6,12.19%,RAP1A
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.30502488360892593,0.4856261363640648,0.9545454545454546,1.0,1.0,5/5,69.52%,SLC39A11;SLC30A5;SLC39A10;SLC30A10;SLC30A6
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),-0.2968276610475176,-0.4837898926510467,1.0,1.0,1.0,1/8,21.37%,SETDB2
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.3133235344186829,-0.48024037993654073,0.9833333333333333,1.0,1.0,2/8,15.00%,HPS4;DTNBP1
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),-0.3040839375641644,-0.4792449651277452,0.9714285714285714,1.0,1.0,1/7,13.52%,ATP1B1
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.2712957446660588,0.4783472214825462,0.975609756097561,1.0,1.0,3/11,18.83%,CPSF2;XRN1;TENT4B
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.2771520243472969,0.47803203540540407,0.975,1.0,1.0,1/5,18.83%,TENT4B
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),-0.31495861088008686,-0.47694474912896195,0.9642857142857143,1.0,1.0,1/5,24.86%,PTPN2
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),-0.3111292071769288,-0.4766254257105284,0.9811320754716981,1.0,1.0,1/5,16.33%,SREBF2
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),-0.2924938861275979,-0.4742997336635255,1.0,1.0,1.0,2/9,21.16%,FAR2;HSD17B4
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.28127801345541903,0.47319344647525174,0.9565217391304348,1.0,1.0,3/6,30.32%,CHMP4B;EPS8;CLASP1
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.21646779927432053,0.47164793993538073,1.0,1.0,1.0,6/23,23.15%,MAVS;EFCAB7;GAS6;DHX9;FLNA;GSK3B
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),-0.31693697215868677,-0.4683814130423888,0.9591836734693877,1.0,1.0,1/5,11.79%,MAPK14
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.23383416023695675,-0.4681649484082157,1.0,1.0,1.0,6/23,23.97%,DTNBP1;PRKN;TF;CA2;STC1;NEDD4
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.31626264247872854,-0.46707565222935715,1.0,1.0,1.0,5/5,68.42%,PTPN2;PRKCA;IL34;RIPK1;CSF1
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.2602002830171553,0.46654679133113003,1.0,1.0,1.0,1/11,10.03%,PXN
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),0.2944292823888262,0.4638244394131774,0.9767441860465116,1.0,1.0,5/5,70.58%,IFNAR1;PNPT1;TRAP1;IDE;VCP
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),-0.2705441211072248,-0.4607956576564917,0.9818181818181818,1.0,1.0,1/11,11.24%,HHAT
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.2612235863921748,-0.46069726752474666,1.0,1.0,1.0,5/12,28.95%,SP100;TCF7L2;YWHAE;TPR;BARD1
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),-0.2973368658912502,-0.4594423287578657,0.9838709677419355,1.0,1.0,1/7,12.72%,APOE
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.24675750894412518,0.4584339613561591,0.9772727272727273,1.0,1.0,5/19,24.09%,ZDHHC6;EP300;ZDHHC5;KAT6A;KAT2B
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),-0.2136069876803244,-0.45766212702486164,1.0,1.0,1.0,5/39,19.49%,TGFBR1;PRKDC;CDC42BPA;ACVR1;CSNK2A2
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.21063415114445566,-0.4574435077021167,1.0,1.0,1.0,3/36,14.21%,AP2A2;PSMC2;PSMD8
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.24832246926049678,-0.45711515740359604,0.9836065573770492,1.0,1.0,3/19,19.09%,GABARAPL1;SQSTM1;PRKN
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.21203122579773337,-0.4554075094369503,1.0,1.0,1.0,3/34,14.21%,AP2A2;PSMC2;PSMD8
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),0.23353616455818693,0.4546038564104483,1.0,1.0,1.0,3/16,19.17%,MAVS;IRF3;PTPRS
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),-0.26389335046578866,-0.45267640651222246,0.9824561403508771,1.0,1.0,8/8,73.66%,CKAP5;RTRAF;HNRNPA2B1;ATXN2;YBX1;SIDT1;SIDT2;RBFOX1
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),-0.28175765713445355,-0.4519871805428729,0.984375,1.0,1.0,3/9,23.85%,MAPK14;EFNB2;NRG1
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.25414763568163673,0.4483691005436734,1.0,1.0,1.0,4/8,24.46%,MTSS1;MAP2K5;KLF2;MEF2C
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.25356546141198577,0.44220511076241437,0.9777777777777777,1.0,1.0,2/6,20.98%,PTPRS;PTPRD
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),-0.30205205659785833,-0.4399396794498081,1.0,1.0,1.0,2/5,20.26%,RBL2;PIK3R1
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.28511799646813296,0.4398922505673704,0.9772727272727273,1.0,1.0,5/5,71.51%,KDM5D;KDM5B;KDM5A;KDM1A;KDM5C
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.21135792981434473,0.43727592422569866,1.0,1.0,1.0,8/24,26.77%,NFKB1;FOXO3;EIF4E;CYFIP1;GRM5;NFKBIA;AGT;MAPKAPK5
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),-0.28427542699793173,-0.43585040394171753,0.9841269841269841,1.0,1.0,2/6,24.75%,RGCC;VIM
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),-0.28427542699793173,-0.43585040394171753,0.9841269841269841,1.0,1.0,2/6,24.75%,RGCC;VIM
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),-0.28427542699793173,-0.43585040394171753,0.9841269841269841,1.0,1.0,2/6,24.75%,RGCC;VIM
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),-0.2594050628356763,-0.4355403885645139,1.0,1.0,1.0,2/10,19.02%,ST8SIA1;MAN2A1
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),0.23121570099492653,0.43484295781978327,1.0,1.0,1.0,5/11,27.17%,STAM2;VTA1;CHMP4B;TSG101;IST1
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),-0.2785225630448533,-0.43384715309274213,0.9811320754716981,1.0,1.0,3/8,31.63%,NUP107;TPR;NUP98
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.244929862187374,0.4334105398270384,1.0,1.0,1.0,3/10,25.49%,NUP54;RTN4;AHCTF1
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),0.29153957296516303,0.4333580366099182,0.9777777777777777,1.0,1.0,5/5,70.87%,LPIN1;PRKCB;PRKCA;AKAP8L;NEK9
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),0.283903283319214,0.43171579289913703,0.9545454545454546,1.0,1.0,2/5,24.29%,MTDH;IL18
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),-0.2828710241505666,-0.43151263454727984,0.9811320754716981,1.0,1.0,2/6,26.05%,NAE1;RBX1
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.25421761928511727,-0.4276151038315155,1.0,1.0,1.0,1/10,15.90%,WDR82
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.27032692573217715,-0.4266749024907779,1.0,1.0,1.0,1/8,14.28%,SVIL
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.24358615344684276,-0.42443423858860757,0.984375,1.0,1.0,4/11,34.47%,PSEN1;LRPAP1;ANKRD13A;APP
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),-0.2551526238979456,-0.42427217519686505,0.9818181818181818,1.0,1.0,3/8,27.14%,PDCD10;ARHGAP21;UVRAG
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.24668438616828464,-0.4240072796807511,0.9803921568627451,0.9998055298848286,1.0,3/11,24.19%,VPS36;NEDD4;VPS37A
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.2358876093033887,-0.4214095182099704,1.0,0.9995999483022818,1.0,7/11,36.33%,NDUFB7;NDUFB9;NDUFC1;NDUFA10;NDUFA5;NDUFV1;NDUFS4
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),-0.2793784425178989,-0.4204692525868771,0.9818181818181818,0.9992049898320403,1.0,1/5,18.61%,CD4
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.2559497202685571,0.4161037956725389,0.9761904761904762,1.0,1.0,2/5,28.94%,GRM5;GRM8
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.24161968931340835,0.41251827108744116,1.0,1.0,1.0,7/10,34.71%,TET2;ASH2L;OGT;KMT2C;KDM6A;TET3;KMT2A
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),0.2728218743301699,0.41054250372745876,1.0,1.0,1.0,2/5,24.29%,PRNP;IL18
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),-0.2587393288040875,-0.4085999802230981,1.0,0.9997720480107385,1.0,2/6,31.39%,CALM1;CAMK2D
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.20886761984668614,-0.4080091690643038,1.0,0.9993395104961399,1.0,7/23,28.86%,EPHA4;RPL23;PSEN1;LRP1;VIM;FYN;GJA1
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.27918816367713906,0.4073745263418616,1.0,1.0,1.0,2/5,21.77%,PIK3CD;PIK3C3
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.2459858702633269,0.4068342678505775,1.0,0.9998007040488578,1.0,6/6,75.43%,GALNT1;GALNT16;EOGT;GALNT2;GALNTL6;GALNT11
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.23078384445485695,0.4029749351948689,1.0,0.9994799995709986,1.0,2/8,24.05%,RPS6KB1;PRKAA2
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.1971468670337889,-0.39981494924911265,1.0,0.9993664466380995,1.0,5/33,22.02%,PSMC2;PSMD8;CDC27;UBA52;PSMD14
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),-0.2630522411501002,-0.3962273597057651,1.0,0.9991237336296055,1.0,2/6,22.65%,DYNC1H1;CLASP2
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),0.21037638172264667,0.3960801564841886,1.0,0.9993037580714544,1.0,5/16,23.21%,GRIN1;PRNP;GRM5;GSK3B;CACNA1A
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.20035347043701807,0.3875402007452667,1.0,0.9991208959404722,1.0,10/10,80.00%,TFPI;ABHD2;GPER1;URI1;NR3C1;ATP1A2;ATP1A1;AKR1C3;UBE2L3;TRERF1
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),-0.2375733853077617,-0.37951330677498807,1.0,0.9994155127554801,1.0,2/7,29.64%,ATP6V0D1;FOXO1
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.22884213907178427,0.3753933144303292,1.0,0.9991026721191323,1.0,7/7,77.14%,MEAF6;EPC1;EP400;TRRAP;MORF4L1;MORF4L2;BRD8
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.22595150152561427,-0.3506173821293044,1.0,0.9997117352122527,1.0,7/7,77.45%,VCL;ZDHHC21;ROCK2;IKBKB;PPP1R12A;TNFRSF1A;ROCK1
